
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-a68b4900.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-0a3f24ce.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            GABAB Receptor: Structure, Biological Functions, and Therapy for Diseases - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="3D96E0BB80955AD300E0BB001A4333F3.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="mcomm">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12000685/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="MedComm">
<meta name="citation_title" content="GABAB Receptor: Structure, Biological Functions, and Therapy for Diseases">
<meta name="citation_author" content="Weijie Xie">
<meta name="citation_author_institution" content="Clinical Research Center for Mental Disorders, Shanghai Pudong New Area Mental Health Center, Tongji University School of Medicine, Shanghai, China">
<meta name="citation_author_institution" content="Shanghai Key Laboratory of Psychotic Disorders, Brain Health Institute, National Center for Mental Disorders, Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai, China">
<meta name="citation_author" content="Yuan Li">
<meta name="citation_author_institution" content="Shanghai Key Laboratory of Psychotic Disorders, Brain Health Institute, National Center for Mental Disorders, Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai, China">
<meta name="citation_author" content="Xinyue Wang">
<meta name="citation_author_institution" content="Shanghai Key Laboratory of Psychotic Disorders, Brain Health Institute, National Center for Mental Disorders, Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai, China">
<meta name="citation_author" content="Elena Blokhina">
<meta name="citation_author_institution" content="Valdman Institute of Pharmacology, Pavlov University, St. Petersburg, Russia">
<meta name="citation_author" content="Evgeny Krupitsky">
<meta name="citation_author_institution" content="Valdman Institute of Pharmacology, Pavlov University, St. Petersburg, Russia">
<meta name="citation_author_institution" content="Bekhterev National Medical Research Center for Psychiatry and Neurology, St. Petersburg, Russia">
<meta name="citation_author" content="Marina Vetrova">
<meta name="citation_author_institution" content="Valdman Institute of Pharmacology, Pavlov University, St. Petersburg, Russia">
<meta name="citation_author" content="Ji Hu">
<meta name="citation_author_institution" content="ShanghaiTech University, Shanghai, China">
<meta name="citation_author" content="Ti‐Fei Yuan">
<meta name="citation_author_institution" content="Shanghai Key Laboratory of Psychotic Disorders, Brain Health Institute, National Center for Mental Disorders, Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai, China">
<meta name="citation_author_institution" content="Co‐innovation Center of Neuroregeneration, Nantong University, Nantong, Jiangsu, China">
<meta name="citation_author" content="Jue Chen">
<meta name="citation_author_institution" content="Shanghai Key Laboratory of Psychotic Disorders, Brain Health Institute, National Center for Mental Disorders, Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai, China">
<meta name="citation_author" content="Hua Wang">
<meta name="citation_author_institution" content="Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, China">
<meta name="citation_author" content="Xiangfang Chen">
<meta name="citation_author_institution" content="Department of Endocrinology, Second Affiliated Hospital of Naval Medical University, Shanghai, China">
<meta name="citation_publication_date" content="2025 Apr 16">
<meta name="citation_volume" content="6">
<meta name="citation_issue" content="5">
<meta name="citation_firstpage" content="e70163">
<meta name="citation_doi" content="10.1002/mco2.70163">
<meta name="citation_pmid" content="40242161">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12000685/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12000685/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12000685/pdf/MCO2-6-e70163.pdf">
<meta name="description" content="Gamma‐aminobutyric acid (GABA) B receptors (GABABRs) that acts slowly and maintains the inhibitory tone are versatile regulators in the complex nervous behaviors and their involvement in various neuropsychiatric disorders, such as anxiety, epilepsy, ...">
<meta name="og:title" content="GABAB Receptor: Structure, Biological Functions, and Therapy for Diseases">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Gamma‐aminobutyric acid (GABA) B receptors (GABABRs) that acts slowly and maintains the inhibitory tone are versatile regulators in the complex nervous behaviors and their involvement in various neuropsychiatric disorders, such as anxiety, epilepsy, ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12000685/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-testid="header" data-header >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            
                <a class="ncbi-header__logo-container" href="https://www.ncbi.nlm.nih.gov/">
                    <img alt="
                                  NCBI home page
                              "
                         class="ncbi-header__logo-image"
                         src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg" />
                </a>
            

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-testid="searchPanel"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      aria-describedby="search-field-desktop-navigation-help-text"
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only"
                           data-testid="label"
                           for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           data-testid="textInput"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    data-testid="button"
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  role="search">
                <label class="usa-sr-only" for="search-field">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="search" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        <a class="usa-link" href="https://www.ncbi.nlm.nih.gov/pmc/advanced/" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12000685">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1002/mco2.70163"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/MCO2-6-e70163.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12000685%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12000685/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12000685/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12000685/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-mcomm.jpg" alt="MedComm logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to MedComm" title="Link to MedComm" shape="default" href="https://onlinelibrary.wiley.com/journal/26882663" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">MedComm (2020)</button></div>. 2025 Apr 16;6(5):e70163. doi: <a href="https://doi.org/10.1002/mco2.70163" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1002/mco2.70163</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22MedComm%20(2020)%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22MedComm%20(2020)%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22MedComm%20(2020)%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22MedComm%20(2020)%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>GABA<sub>B</sub> Receptor: Structure, Biological Functions, and Therapy for Diseases</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xie%20W%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Weijie Xie</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Weijie Xie</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Clinical Research Center for Mental Disorders, Shanghai Pudong New Area Mental Health Center, Tongji University School of Medicine, Shanghai, China</div>
<div class="p">
<sup>
<sup>2</sup>
</sup>Shanghai Key Laboratory of Psychotic Disorders, Brain Health Institute, National Center for Mental Disorders, Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xie%20W%22%5BAuthor%5D" class="usa-link"><span class="name western">Weijie Xie</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Yuan Li</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Yuan Li</span></h3>
<div class="p">
<sup>
<sup>2</sup>
</sup>Shanghai Key Laboratory of Psychotic Disorders, Brain Health Institute, National Center for Mental Disorders, Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yuan Li</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20X%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Xinyue Wang</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Xinyue Wang</span></h3>
<div class="p">
<sup>
<sup>2</sup>
</sup>Shanghai Key Laboratory of Psychotic Disorders, Brain Health Institute, National Center for Mental Disorders, Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20X%22%5BAuthor%5D" class="usa-link"><span class="name western">Xinyue Wang</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Blokhina%20E%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Elena Blokhina</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Elena Blokhina</span></h3>
<div class="p">
<sup>
<sup>3</sup>
</sup>Valdman Institute of Pharmacology, Pavlov University, St. Petersburg, Russia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Blokhina%20E%22%5BAuthor%5D" class="usa-link"><span class="name western">Elena Blokhina</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Krupitsky%20E%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Evgeny Krupitsky</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Evgeny Krupitsky</span></h3>
<div class="p">
<sup>
<sup>3</sup>
</sup>Valdman Institute of Pharmacology, Pavlov University, St. Petersburg, Russia</div>
<div class="p">
<sup>
<sup>4</sup>
</sup>Bekhterev National Medical Research Center for Psychiatry and Neurology, St. Petersburg, Russia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Krupitsky%20E%22%5BAuthor%5D" class="usa-link"><span class="name western">Evgeny Krupitsky</span></a>
</div>
</div>
<sup>3,</sup><sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Vetrova%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Marina Vetrova</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Marina Vetrova</span></h3>
<div class="p">
<sup>
<sup>3</sup>
</sup>Valdman Institute of Pharmacology, Pavlov University, St. Petersburg, Russia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Vetrova%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Marina Vetrova</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hu%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Ji Hu</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Ji Hu</span></h3>
<div class="p">
<sup>
<sup>5</sup>
</sup>ShanghaiTech University, Shanghai, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hu%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Ji Hu</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yuan%20TF%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Ti‐Fei Yuan</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Ti‐Fei Yuan</span></h3>
<div class="p">
<sup>
<sup>2</sup>
</sup>Shanghai Key Laboratory of Psychotic Disorders, Brain Health Institute, National Center for Mental Disorders, Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai, China</div>
<div class="p">
<sup>
<sup>6</sup>
</sup>Co‐innovation Center of Neuroregeneration, Nantong University, Nantong, Jiangsu, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yuan%20TF%22%5BAuthor%5D" class="usa-link"><span class="name western">Ti‐Fei Yuan</span></a>
</div>
</div>
<sup>2,</sup><sup>6,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chen%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Jue Chen</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Jue Chen</span></h3>
<div class="p">
<sup>
<sup>2</sup>
</sup>Shanghai Key Laboratory of Psychotic Disorders, Brain Health Institute, National Center for Mental Disorders, Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chen%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jue Chen</span></a>
</div>
</div>
<sup>2,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Hua Wang</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Hua Wang</span></h3>
<div class="p">
<sup>
<sup>7</sup>
</sup>Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Hua Wang</span></a>
</div>
</div>
<sup>7,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chen%20X%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Xiangfang Chen</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Xiangfang Chen</span></h3>
<div class="p">
<sup>
<sup>8</sup>
</sup>Department of Endocrinology, Second Affiliated Hospital of Naval Medical University, Shanghai, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chen%20X%22%5BAuthor%5D" class="usa-link"><span class="name western">Xiangfang Chen</span></a>
</div>
</div>
<sup>8,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="mco270163-aff-0001">
<sup>
<sup>1</sup>
</sup>Clinical Research Center for Mental Disorders, Shanghai Pudong New Area Mental Health Center, Tongji University School of Medicine, Shanghai, China</div>
<div id="mco270163-aff-0002">
<sup>
<sup>2</sup>
</sup>Shanghai Key Laboratory of Psychotic Disorders, Brain Health Institute, National Center for Mental Disorders, Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai, China</div>
<div id="mco270163-aff-0003">
<sup>
<sup>3</sup>
</sup>Valdman Institute of Pharmacology, Pavlov University, St. Petersburg, Russia</div>
<div id="mco270163-aff-0004">
<sup>
<sup>4</sup>
</sup>Bekhterev National Medical Research Center for Psychiatry and Neurology, St. Petersburg, Russia</div>
<div id="mco270163-aff-0005">
<sup>
<sup>5</sup>
</sup>ShanghaiTech University, Shanghai, China</div>
<div id="mco270163-aff-0006">
<sup>
<sup>6</sup>
</sup>Co‐innovation Center of Neuroregeneration, Nantong University, Nantong, Jiangsu, China</div>
<div id="mco270163-aff-0007">
<sup>
<sup>7</sup>
</sup>Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, China</div>
<div id="mco270163-aff-0008">
<sup>
<sup>8</sup>
</sup>Department of Endocrinology, Second Affiliated Hospital of Naval Medical University, Shanghai, China</div>
<div class="author-notes p"><div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Revised 2024 Dec 29; Received 2024 Jul 9; Accepted 2025 Feb 19; Collection date 2025 May.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2025 The Author(s). <em>MedComm</em> published by Sichuan International Medical Exchange &amp; Promotion Association (SCIMEA) and John Wiley &amp; Sons Australia, Ltd.</div>
<p>This is an open access article under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12000685  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40242161/" class="usa-link">40242161</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>ABSTRACT</h2>
<p>Gamma‐aminobutyric acid (GABA) B receptors (GABA<sub>B</sub>Rs) that acts slowly and maintains the inhibitory tone are versatile regulators in the complex nervous behaviors and their involvement in various neuropsychiatric disorders, such as anxiety, epilepsy, pain, drug addiction, and Alzheimer's disease. Additional study advances have implied the crucial roles of GABA<sub>B</sub>Rs in regulating feeding‐related behaviors, yet their therapeutic potential in addressing the neuropsychiatric disorders, binge eating, and feeding‐related disorders remains underutilized. This general review summarized the physiological structure and functions of GABA<sub>B</sub>R, explored the regulation in various psychiatric disorders, feeding behaviors, binge eating, and metabolism disorders, and fully discussed the potential of targeting GABA<sub>B</sub>Rs and its regulator‐binding sites for the treatment of different psychiatric disorders, binge eating and even obesity. While agonists that directly bind to GABA<sub>B</sub>R1 have some negative side effects, positive allosteric modulators (PAMs) that bind to GABA<sub>B</sub>R2 demonstrate excellent therapeutic efficacy and tolerability and have better safety and therapeutic indexes. Moreover, phosphorylation sites of downstream GABA<sub>B</sub>Rs regulators may be novel therapeutic targets for psychiatric disorders, binge eating, and obesity. Further studies, clinical trials in particular, will be essential for confirming the therapeutic value of PAMs and other agents targeting the GABA<sub>B</sub>R pathways in a clinical setting.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> allosteric modulator, binge eating, GABA<sub>B</sub> receptors, metabolism disorders, molecular signaling, psychiatric disorders</p></section></section><section class="abstract" id="mco270163-abs-0001"><hr class="headless">
<p>Within the GABAergic system, GABA<sub>B</sub>Rs are potential therapeutic targets for dealing multiple metabolic and binge eating disorders and food addiction. Allosteric modulators and small peptides targeting GABA<sub>B</sub>R signaling pathways may be developed as attractive drug candidates that avoid the side effects of agents that directly bind these receptors.
</p>
<section class="bt xbox font-sm" id="boxed-text1"><p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50fe/12000685/1677f8671018/MCO2-6-e70163-g005.jpg" loading="lazy" id="jats-graphic-1" height="107" width="180" alt="graphic file with name MCO2-6-e70163-g005.jpg"></p></section></section><section id="mco270163-sec-0010"><h2 class="pmc_sec_title">1. Introduction</h2>
<p>Obesity is a growing problem worldwide, as over 2.1 billion people were overweight or obese in 2015 [<a href="#mco270163-bib-0001" class="usa-link" aria-describedby="mco270163-bib-0001">1</a>, <a href="#mco270163-bib-0002" class="usa-link" aria-describedby="mco270163-bib-0002">2</a>]. China, in particular, has the highest number of affected individuals worldwide, with about 46% of adults and 15% of children being obese or overweight [<a href="#mco270163-bib-0003" class="usa-link" aria-describedby="mco270163-bib-0003">3</a>, <a href="#mco270163-bib-0004" class="usa-link" aria-describedby="mco270163-bib-0004">4</a>]; the risk of these conditions is emerging as a major public health threat among children and adolescents, leading to considerable morbidity and mortality [<a href="#mco270163-bib-0001" class="usa-link" aria-describedby="mco270163-bib-0001">1</a>, <a href="#mco270163-bib-0005" class="usa-link" aria-describedby="mco270163-bib-0005">5</a>, <a href="#mco270163-bib-0006" class="usa-link" aria-describedby="mco270163-bib-0006">6</a>]. The central mechanism of weight gain or the development of obesity is an energy imbalance caused by complex interactions among an individual's genetic makeup [<a href="#mco270163-bib-0007" class="usa-link" aria-describedby="mco270163-bib-0007">7</a>], pathological stress [<a href="#mco270163-bib-0008" class="usa-link" aria-describedby="mco270163-bib-0008">8</a>, <a href="#mco270163-bib-0009" class="usa-link" aria-describedby="mco270163-bib-0009">9</a>, <a href="#mco270163-bib-0010" class="usa-link" aria-describedby="mco270163-bib-0010">10</a>], and environmental influences [<a href="#mco270163-bib-0006" class="usa-link" aria-describedby="mco270163-bib-0006">6</a>, <a href="#mco270163-bib-0011" class="usa-link" aria-describedby="mco270163-bib-0011">11</a>, <a href="#mco270163-bib-0012" class="usa-link" aria-describedby="mco270163-bib-0012">12</a>] or psychological factors [<a href="#mco270163-bib-0010" class="usa-link" aria-describedby="mco270163-bib-0010">10</a>, <a href="#mco270163-bib-0013" class="usa-link" aria-describedby="mco270163-bib-0013">13</a>, <a href="#mco270163-bib-0014" class="usa-link" aria-describedby="mco270163-bib-0014">14</a>, <a href="#mco270163-bib-0015" class="usa-link" aria-describedby="mco270163-bib-0015">15</a>] in diet behaviors. At present, limited progress in the development of treatments for obesity have been made, and effective and widely accessible treatments for controlling weight gain in obese people need further development [<a href="#mco270163-bib-0006" class="usa-link" aria-describedby="mco270163-bib-0006">6</a>, <a href="#mco270163-bib-0009" class="usa-link" aria-describedby="mco270163-bib-0009">9</a>, <a href="#mco270163-bib-0016" class="usa-link" aria-describedby="mco270163-bib-0016">16</a>]. For instance, receptors of glucagon‐like peptide 1 (GLP‐1) and its agonists show great potential in treating obesity and overweight [<a href="#mco270163-bib-0017" class="usa-link" aria-describedby="mco270163-bib-0017">17</a>, <a href="#mco270163-bib-0018" class="usa-link" aria-describedby="mco270163-bib-0018">18</a>, <a href="#mco270163-bib-0019" class="usa-link" aria-describedby="mco270163-bib-0019">19</a>]. Given that obesity has a complex and multifactorial etiology involving pathological mechanisms and psychopathological mechanisms [<a href="#mco270163-bib-0013" class="usa-link" aria-describedby="mco270163-bib-0013">13</a>, <a href="#mco270163-bib-0014" class="usa-link" aria-describedby="mco270163-bib-0014">14</a>], the existing approaches for sustained weight loss and weight gain prevention are relatively lacking.</p>
<p>Feeding behavioral patterns are primarily influenced by metabolic requirements and hedonic drive, especially when it comes to extremely calorie‐rich, sugary, or fatty foods [<a href="#mco270163-bib-0009" class="usa-link" aria-describedby="mco270163-bib-0009">9</a>, <a href="#mco270163-bib-0020" class="usa-link" aria-describedby="mco270163-bib-0020">20</a>, <a href="#mco270163-bib-0021" class="usa-link" aria-describedby="mco270163-bib-0021">21</a>, <a href="#mco270163-bib-0022" class="usa-link" aria-describedby="mco270163-bib-0022">22</a>]. Overweight is mainly driven by overconsumption, binge eating (BE) of high‐calorie diets, and physical inactivity under various economic conditions [<a href="#mco270163-bib-0002" class="usa-link" aria-describedby="mco270163-bib-0002">2</a>, <a href="#mco270163-bib-0006" class="usa-link" aria-describedby="mco270163-bib-0006">6</a>, <a href="#mco270163-bib-0012" class="usa-link" aria-describedby="mco270163-bib-0012">12</a>, <a href="#mco270163-bib-0016" class="usa-link" aria-describedby="mco270163-bib-0016">16</a>]. BE or overeating behaviors seem to be tightly associated with not only hedonic motivation [<a href="#mco270163-bib-0023" class="usa-link" aria-describedby="mco270163-bib-0023">23</a>, <a href="#mco270163-bib-0024" class="usa-link" aria-describedby="mco270163-bib-0024">24</a>] but also natural addiction or craving for food [<a href="#mco270163-bib-0025" class="usa-link" aria-describedby="mco270163-bib-0025">25</a>, <a href="#mco270163-bib-0026" class="usa-link" aria-describedby="mco270163-bib-0026">26</a>] and decision‐making or top‐down neural control [<a href="#mco270163-bib-0027" class="usa-link" aria-describedby="mco270163-bib-0027">27</a>, <a href="#mco270163-bib-0028" class="usa-link" aria-describedby="mco270163-bib-0028">28</a>, <a href="#mco270163-bib-0029" class="usa-link" aria-describedby="mco270163-bib-0029">29</a>]. Under normal conditions, hedonic or reward‐based eating, which involves food craving, seeking, and consumption, is well balanced and homeostatic [<a href="#mco270163-bib-0020" class="usa-link" aria-describedby="mco270163-bib-0020">20</a>, <a href="#mco270163-bib-0029" class="usa-link" aria-describedby="mco270163-bib-0029">29</a>]. When an individual suffers from heavy social stress and a negative mood [<a href="#mco270163-bib-0009" class="usa-link" aria-describedby="mco270163-bib-0009">9</a>, <a href="#mco270163-bib-0010" class="usa-link" aria-describedby="mco270163-bib-0010">10</a>, <a href="#mco270163-bib-0030" class="usa-link" aria-describedby="mco270163-bib-0030">30</a>], severe pathological changes in the gastrointestinal environment [<a href="#mco270163-bib-0013" class="usa-link" aria-describedby="mco270163-bib-0013">13</a>, <a href="#mco270163-bib-0014" class="usa-link" aria-describedby="mco270163-bib-0014">14</a>], metabolic abnormalities in periapical organs [<a href="#mco270163-bib-0031" class="usa-link" aria-describedby="mco270163-bib-0031">31</a>, <a href="#mco270163-bib-0032" class="usa-link" aria-describedby="mco270163-bib-0032">32</a>, <a href="#mco270163-bib-0033" class="usa-link" aria-describedby="mco270163-bib-0033">33</a>, <a href="#mco270163-bib-0034" class="usa-link" aria-describedby="mco270163-bib-0034">34</a>], neuropathological disorders [<a href="#mco270163-bib-0035" class="usa-link" aria-describedby="mco270163-bib-0035">35</a>, <a href="#mco270163-bib-0036" class="usa-link" aria-describedby="mco270163-bib-0036">36</a>], and dysfunction of brain circuit networks [<a href="#mco270163-bib-0020" class="usa-link" aria-describedby="mco270163-bib-0020">20</a>, <a href="#mco270163-bib-0029" class="usa-link" aria-describedby="mco270163-bib-0029">29</a>, <a href="#mco270163-bib-0037" class="usa-link" aria-describedby="mco270163-bib-0037">37</a>] other than those that regulate hunger and satiety [<a href="#mco270163-bib-0010" class="usa-link" aria-describedby="mco270163-bib-0010">10</a>, <a href="#mco270163-bib-0029" class="usa-link" aria-describedby="mco270163-bib-0029">29</a>] can cause pathological ingestive behaviors [<a href="#mco270163-bib-0036" class="usa-link" aria-describedby="mco270163-bib-0036">36</a>, <a href="#mco270163-bib-0038" class="usa-link" aria-describedby="mco270163-bib-0038">38</a>], BE [<a href="#mco270163-bib-0039" class="usa-link" aria-describedby="mco270163-bib-0039">39</a>, <a href="#mco270163-bib-0040" class="usa-link" aria-describedby="mco270163-bib-0040">40</a>, <a href="#mco270163-bib-0041" class="usa-link" aria-describedby="mco270163-bib-0041">41</a>, <a href="#mco270163-bib-0042" class="usa-link" aria-describedby="mco270163-bib-0042">42</a>], compulsive eating [<a href="#mco270163-bib-0037" class="usa-link" aria-describedby="mco270163-bib-0037">37</a>, <a href="#mco270163-bib-0043" class="usa-link" aria-describedby="mco270163-bib-0043">43</a>], and spontaneous eating [<a href="#mco270163-bib-0014" class="usa-link" aria-describedby="mco270163-bib-0014">14</a>, <a href="#mco270163-bib-0026" class="usa-link" aria-describedby="mco270163-bib-0026">26</a>, <a href="#mco270163-bib-0043" class="usa-link" aria-describedby="mco270163-bib-0043">43</a>], resulting in abnormal overeating or BE behaviors and food addiction. (Food addiction is a relative explanation concept that refers to the intense cravings, loss of control, and excessive consumption often associated with highly palatable foods [<a href="#mco270163-bib-0044" class="usa-link" aria-describedby="mco270163-bib-0044">44</a>].) These behavioral phenotypes notably resemble substance addiction‐like behaviors [<a href="#mco270163-bib-0025" class="usa-link" aria-describedby="mco270163-bib-0025">25</a>, <a href="#mco270163-bib-0026" class="usa-link" aria-describedby="mco270163-bib-0026">26</a>, <a href="#mco270163-bib-0045" class="usa-link" aria-describedby="mco270163-bib-0045">45</a>] and have long‐term negative consequences on physical and mental health [<a href="#mco270163-bib-0013" class="usa-link" aria-describedby="mco270163-bib-0013">13</a>, <a href="#mco270163-bib-0014" class="usa-link" aria-describedby="mco270163-bib-0014">14</a>].</p>
<p>Obesity is partly caused by a food dependency that closely resembles a drug addiction, both in terms of behaviors and the neural processes involved [<a href="#mco270163-bib-0006" class="usa-link" aria-describedby="mco270163-bib-0006">6</a>, <a href="#mco270163-bib-0013" class="usa-link" aria-describedby="mco270163-bib-0013">13</a>, <a href="#mco270163-bib-0014" class="usa-link" aria-describedby="mco270163-bib-0014">14</a>, <a href="#mco270163-bib-0046" class="usa-link" aria-describedby="mco270163-bib-0046">46</a>]. People who are obese may exhibit irregular eating patterns, such as increased indulgence in pleasurable eating, which partially contributes to excessive fat accumulation and a greater body mass [<a href="#mco270163-bib-0036" class="usa-link" aria-describedby="mco270163-bib-0036">36</a>, <a href="#mco270163-bib-0038" class="usa-link" aria-describedby="mco270163-bib-0038">38</a>]. Based on the DSM‐5 criteria [<a href="#mco270163-bib-0047" class="usa-link" aria-describedby="mco270163-bib-0047">47</a>, <a href="#mco270163-bib-0048" class="usa-link" aria-describedby="mco270163-bib-0048">48</a>, <a href="#mco270163-bib-0049" class="usa-link" aria-describedby="mco270163-bib-0049">49</a>], bulimia nervosa (BN) and BE disorder (BED) patients show an amount of eating food without control in a discrete period, but BN is additionally characterized by recurrent inappropriate compensatory behaviors to prevent weight [<a href="#mco270163-bib-0048" class="usa-link" aria-describedby="mco270163-bib-0048">48</a>, <a href="#mco270163-bib-0049" class="usa-link" aria-describedby="mco270163-bib-0049">49</a>]. BN and BED are prevalent mental eating disorders that impact approximately 4–5.8% of adults [<a href="#mco270163-bib-0050" class="usa-link" aria-describedby="mco270163-bib-0050">50</a>, <a href="#mco270163-bib-0051" class="usa-link" aria-describedby="mco270163-bib-0051">51</a>]. These disorders are often accompanied by BE and food addiction behaviors out of control, which can contribute to obesity in 30–45% of individuals [<a href="#mco270163-bib-0013" class="usa-link" aria-describedby="mco270163-bib-0013">13</a>, <a href="#mco270163-bib-0036" class="usa-link" aria-describedby="mco270163-bib-0036">36</a>, <a href="#mco270163-bib-0052" class="usa-link" aria-describedby="mco270163-bib-0052">52</a>] and related metabolic disorders [<a href="#mco270163-bib-0007" class="usa-link" aria-describedby="mco270163-bib-0007">7</a>, <a href="#mco270163-bib-0036" class="usa-link" aria-describedby="mco270163-bib-0036">36</a>, <a href="#mco270163-bib-0038" class="usa-link" aria-describedby="mco270163-bib-0038">38</a>, <a href="#mco270163-bib-0052" class="usa-link" aria-describedby="mco270163-bib-0052">52</a>].</p>
<p>Given the existing fact that the pathological influence and brain network dysfunctions of BE and food addiction‐related eating in the development of obesity, future treatments for overweight and obesity should specifically focus on the key molecules and neural circuits responsible for impulsive or compulsive overeating, and abnormal food craving [<a href="#mco270163-bib-0053" class="usa-link" aria-describedby="mco270163-bib-0053">53</a>], including psychotherapy and psychopharmacological interventions [<a href="#mco270163-bib-0054" class="usa-link" aria-describedby="mco270163-bib-0054">54</a>, <a href="#mco270163-bib-0055" class="usa-link" aria-describedby="mco270163-bib-0055">55</a>, <a href="#mco270163-bib-0056" class="usa-link" aria-describedby="mco270163-bib-0056">56</a>]. In the aspect of psychotherapy, cognitive behavioral therapy has been recommended as the vital treatment of adults with BN and BED, which can significantly improve the pathological features related to BE, also ameliorate the depressive and anxious emotion symptoms and boost their self‐esteem [<a href="#mco270163-bib-0054" class="usa-link" aria-describedby="mco270163-bib-0054">54</a>, <a href="#mco270163-bib-0055" class="usa-link" aria-describedby="mco270163-bib-0055">55</a>, <a href="#mco270163-bib-0057" class="usa-link" aria-describedby="mco270163-bib-0057">57</a>, <a href="#mco270163-bib-0058" class="usa-link" aria-describedby="mco270163-bib-0058">58</a>]. Additionally, family‐based treatments, self‐help interventions, and digital interventions [<a href="#mco270163-bib-0054" class="usa-link" aria-describedby="mco270163-bib-0054">54</a>, <a href="#mco270163-bib-0057" class="usa-link" aria-describedby="mco270163-bib-0057">57</a>] have some evidence of effectiveness and may be proposed to further develop in individuals with BE‐related disorders [<a href="#mco270163-bib-0054" class="usa-link" aria-describedby="mco270163-bib-0054">54</a>, <a href="#mco270163-bib-0056" class="usa-link" aria-describedby="mco270163-bib-0056">56</a>, <a href="#mco270163-bib-0057" class="usa-link" aria-describedby="mco270163-bib-0057">57</a>]. In the future, research on CNS‐targeting treatments should focus on the function of neurocircuits and molecular processes involved in BE and natural addiction to food [<a href="#mco270163-bib-0010" class="usa-link" aria-describedby="mco270163-bib-0010">10</a>, <a href="#mco270163-bib-0014" class="usa-link" aria-describedby="mco270163-bib-0014">14</a>, <a href="#mco270163-bib-0059" class="usa-link" aria-describedby="mco270163-bib-0059">59</a>, <a href="#mco270163-bib-0060" class="usa-link" aria-describedby="mco270163-bib-0060">60</a>], such as reward sensitivity, impaired decision‐making, conditioning, and cognitive control, implying potential novel clues for interventions. Regulation of neurons and receptors involved in the GABAergic and glutamatergic systems could be novel pharmacological strategies for the treatment of food intake disorders [<a href="#mco270163-bib-0010" class="usa-link" aria-describedby="mco270163-bib-0010">10</a>, <a href="#mco270163-bib-0042" class="usa-link" aria-describedby="mco270163-bib-0042">42</a>, <a href="#mco270163-bib-0061" class="usa-link" aria-describedby="mco270163-bib-0061">61</a>], overeating [<a href="#mco270163-bib-0042" class="usa-link" aria-describedby="mco270163-bib-0042">42</a>, <a href="#mco270163-bib-0062" class="usa-link" aria-describedby="mco270163-bib-0062">62</a>, <a href="#mco270163-bib-0063" class="usa-link" aria-describedby="mco270163-bib-0063">63</a>], and obesity [<a href="#mco270163-bib-0064" class="usa-link" aria-describedby="mco270163-bib-0064">64</a>, <a href="#mco270163-bib-0065" class="usa-link" aria-describedby="mco270163-bib-0065">65</a>]. Interestingly, the activation and regulation of GABA<sub>B</sub> receptors (GABA<sub>B</sub>Rs) in both peripheral and central systems [<a href="#mco270163-bib-0064" class="usa-link" aria-describedby="mco270163-bib-0064">64</a>, <a href="#mco270163-bib-0066" class="usa-link" aria-describedby="mco270163-bib-0066">66</a>] significantly contribute to the regulation of feeding behaviors and the development of food addiction (It is craving for palatable diets but could not be directly regarded as a critical definition of substance addiction [<a href="#mco270163-bib-0044" class="usa-link" aria-describedby="mco270163-bib-0044">44</a>].) and BE‐related behaviors [<a href="#mco270163-bib-0066" class="usa-link" aria-describedby="mco270163-bib-0066">66</a>, <a href="#mco270163-bib-0067" class="usa-link" aria-describedby="mco270163-bib-0067">67</a>]. Evidence suggests that GABA<sub>B</sub>R could serve as promising targets for the treatment of BE‐like behaviors and food addiction [<a href="#mco270163-bib-0028" class="usa-link" aria-describedby="mco270163-bib-0028">28</a>, <a href="#mco270163-bib-0064" class="usa-link" aria-describedby="mco270163-bib-0064">64</a>, <a href="#mco270163-bib-0065" class="usa-link" aria-describedby="mco270163-bib-0065">65</a>, <a href="#mco270163-bib-0068" class="usa-link" aria-describedby="mco270163-bib-0068">68</a>], contributing to prevent overweight and obesity.</p>
<p>Nevertheless, the safety and therapeutic efficacy of GABA<sub>B</sub>R‐targeting strategies on these mental disorders and feeding‐related disorders (including food addiction, BE, and obesity) in preclinical and clinical settings remain limited, insufficiently summarized, and only briefly discussed in the literature. Herein, our general review described the basic physiological structural features and functions of GABA<sub>B</sub>R in the CNS (Section <a href="#mco270163-sec-0020" class="usa-link">2</a>); then summarized the different roles of GABA<sub>B</sub>R in the various neuro‐psychiatric disorders, including epilepsy, anxiety and depression, drug addiction, pain‐related disorders, schizophrenia, Alzheimer's disease (AD), and cognitive impairment (Section <a href="#mco270163-sec-0040" class="usa-link">3.1</a>–<a href="#mco270163-sec-0100" class="usa-link">3.7</a>), and further explored the regulation effects of GABA<sub>B</sub>R‐targeting strategies on the feeding behaviors, BE or overeating, food addiction with impulsivity, overeating‐related overweight or obesity (Section <a href="#mco270163-sec-0120" class="usa-link">4.1</a>–<a href="#mco270163-sec-0210" class="usa-link">4.4</a>), and others (Section <a href="#mco270163-sec-0220" class="usa-link">5</a>). At last, this work fully discussed the treatment efficacy and the potential prospects of direct, partial, and negative activation of GABA<sub>B</sub>Rs and several regulatory sites associated with the GABA<sub>B</sub>R pathways (Section <a href="#mco270163-sec-0240" class="usa-link">6.1</a>–<a href="#mco270163-sec-0270" class="usa-link">6.4</a>). In general, our comprehensive work contributes to identifying agents and clinical intervention strategies with good tolerability, great potential, and provide perspectives and insights for preventing and treating various neuro‐psychiatric disorders, food addiction, BE, and BE‐related metabolism disorders.</p></section><section id="mco270163-sec-0020"><h2 class="pmc_sec_title">2. Physiological Structure and Functions</h2>
<p>GABA<sub>B</sub>Rs, which belong to the family of G‐protein‐coupled receptors, are metabotropic receptors that are widely distributed in the brain and body [<a href="#mco270163-bib-0069" class="usa-link" aria-describedby="mco270163-bib-0069">69</a>, <a href="#mco270163-bib-0070" class="usa-link" aria-describedby="mco270163-bib-0070">70</a>]. X‐ray crystallography and single‐particle cryo‐electron microscopy studies [<a href="#mco270163-bib-0071" class="usa-link" aria-describedby="mco270163-bib-0071">71</a>] have proven (Figure <a href="#mco270163-fig-0001" class="usa-link">1A,B</a>) that GABA<sub>B</sub>Rs consist of two subunits, GABA<sub>B</sub>R1 (GB1) and GABA<sub>B</sub>R2 (GB2), and function as obligate heterodimers [<a href="#mco270163-bib-0069" class="usa-link" aria-describedby="mco270163-bib-0069">69</a>, <a href="#mco270163-bib-0071" class="usa-link" aria-describedby="mco270163-bib-0071">71</a>, <a href="#mco270163-bib-0072" class="usa-link" aria-describedby="mco270163-bib-0072">72</a>]. With the development of artificial intelligence, the protein structure of GABA<sub>B</sub>Rs was predicted by Critical Assessment of Protein Structure Prediction and AlphaFold [<a href="#mco270163-bib-0073" class="usa-link" aria-describedby="mco270163-bib-0073">73</a>]. These valuable data offer crucial insights into the identification of biological processes linked to GABA<sub>B</sub>Rs, the structure‐based drug development, the design of interventions, and targeted mutagenesis.</p>
<figure class="fig xbox font-sm" id="mco270163-fig-0001"><h3 class="obj_head">FIGURE 1.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50fe/12000685/90571e95d2f6/MCO2-6-e70163-g006.jpg" loading="lazy" id="jats-graphic-3" height="661" width="560" alt="FIGURE 1"></p>
<div class="p text-right font-secondary"><a href="figure/mco270163-fig-0001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Structure, physiological functions, central distribution, and models of GABA<sub>B</sub>R heterodimers and their potential role in mental disorders. Maps (A) and models (B) of four different conformations of GABA<sub>B</sub>Rs, including active and inactive states and two intermediate conformations. The numbers in parentheses indicate the estimated resolution of the cryo‐EM maps. GB1 and GB2 are blue and yellow, respectively. The agonist (<a href="https://www.ncbi.nlm.nih.gov/protein/SKF97541" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">SKF97541</a>)‐ and PAM (GS39783)‐bound state is the active state. (C) Possible sites of action of presynaptic and postsynaptic GABA<sub>B</sub>Rs. (D) The distribution of GABA<sub>B</sub>Rs in the brain and their underlying mechanism in neuropathologic diseases, including epilepsy, pain regulation, depression, anxiety and drug addiction, revealed by recent studies. (E) It remains unclear whether GABA<sub>B</sub>Rs represent a major pharmacological target for treating BE‐like behaviors, food addiction, and imbalanced diet‐related overweight and obesity.</p></figcaption></figure><p>As illustrated in Figure <a href="#mco270163-fig-0001" class="usa-link">1A,B</a>, each subunit of GABA<sub>B</sub>R consists of seven helices that span the cellular membrane, and it contains an extracellular N‐terminus and an intracellular C‐terminus that are connected by both three extracellular loops and three intracellular loops [<a href="#mco270163-bib-0070" class="usa-link" aria-describedby="mco270163-bib-0070">70</a>, <a href="#mco270163-bib-0072" class="usa-link" aria-describedby="mco270163-bib-0072">72</a>, <a href="#mco270163-bib-0074" class="usa-link" aria-describedby="mco270163-bib-0074">74</a>]. GB1/GB2 is composed of an extracellular Venus flytrap (VFT) domain, a descending peptide linker, a seven‐helix transmembrane domain (TMD) and a cytoplasmic tail [<a href="#mco270163-bib-0069" class="usa-link" aria-describedby="mco270163-bib-0069">69</a>, <a href="#mco270163-bib-0071" class="usa-link" aria-describedby="mco270163-bib-0071">71</a>]. When GABA or GB1 agonists/antagonists (Figure <a href="#mco270163-fig-0002" class="usa-link">2</a>) bind to the VFT domain of GB1 (Figure <a href="#mco270163-fig-0001" class="usa-link">1A,B</a>), a series of conformational alterations are initiated, leading to the transmission of transduction signals to the TMD of GB2, thereby initiating G protein signaling [<a href="#mco270163-bib-0072" class="usa-link" aria-describedby="mco270163-bib-0072">72</a>, <a href="#mco270163-bib-0075" class="usa-link" aria-describedby="mco270163-bib-0075">75</a>]. On the other hand, the GB2 ectodomain does not bind GABA, but interacts with the GB1 ectodomain to increase agonist affinity by stabilizing the agonist‐bound conformation of GB1, and the binding of an agonist to the extracellular VFT of GB1 leads to G protein activation through rearrangement of the intracellular interface of the TMD of GB2 [<a href="#mco270163-bib-0071" class="usa-link" aria-describedby="mco270163-bib-0071">71</a>, <a href="#mco270163-bib-0074" class="usa-link" aria-describedby="mco270163-bib-0074">74</a>, <a href="#mco270163-bib-0075" class="usa-link" aria-describedby="mco270163-bib-0075">75</a>].</p>
<figure class="fig xbox font-sm" id="mco270163-fig-0002"><h3 class="obj_head">FIGURE 2.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50fe/12000685/c6c38acaf7aa/MCO2-6-e70163-g004.jpg" loading="lazy" id="jats-graphic-5" height="1005" width="600" alt="FIGURE 2"></p>
<div class="p text-right font-secondary"><a href="figure/mco270163-fig-0002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Chemical structures of representative full agonists, partial agonists, antagonists, and allosteric modulators of GABA<sub>B</sub>Rs. PAM is a positive allosteric modulator of GABA<sub>B</sub>R. The structures of these GABA<sub>B</sub>R‐targeting chemical compounds were verified by recent reports and study results.</p></figcaption></figure><p>GABA<sub>B</sub>Rs, which are major inhibitory receptors, are present at both presynaptic and postsynaptic sites throughout the mammalian CNS [<a href="#mco270163-bib-0072" class="usa-link" aria-describedby="mco270163-bib-0072">72</a>, <a href="#mco270163-bib-0074" class="usa-link" aria-describedby="mco270163-bib-0074">74</a>]. Presynaptically (Figure <a href="#mco270163-fig-0001" class="usa-link">1C</a>), they inhibit neurotransmitter release by inhibiting Ca<sup>2+</sup> channels; postsynaptically (Figure <a href="#mco270163-fig-0001" class="usa-link">1C</a>), they generate low inhibitory postsynaptic potentials by activating inwardly rectifying GIRK channels [<a href="#mco270163-bib-0070" class="usa-link" aria-describedby="mco270163-bib-0070">70</a>, <a href="#mco270163-bib-0071" class="usa-link" aria-describedby="mco270163-bib-0071">71</a>, <a href="#mco270163-bib-0072" class="usa-link" aria-describedby="mco270163-bib-0072">72</a>]. Thus, GABA<sub>B</sub>Rs mediate slow and prolonged inhibitory neurotransmission and synaptic inhibition via indirect gating of neuronal K<sup>+</sup> and Ca<sup>2+</sup> channels and decreasing the levels of other second messenger targets (cAMPs) [<a href="#mco270163-bib-0070" class="usa-link" aria-describedby="mco270163-bib-0070">70</a>, <a href="#mco270163-bib-0074" class="usa-link" aria-describedby="mco270163-bib-0074">74</a>]. Classical studies (Figure <a href="#mco270163-fig-0001" class="usa-link">1D</a>) mapped the distribution of GABA<sub>B</sub>R binding site regions in the CNS, including the frontal cortex (medial prefrontal cortex, mPFC), the anterior olfactory nucleus [<a href="#mco270163-bib-0027" class="usa-link" aria-describedby="mco270163-bib-0027">27</a>, <a href="#mco270163-bib-0076" class="usa-link" aria-describedby="mco270163-bib-0076">76</a>, <a href="#mco270163-bib-0077" class="usa-link" aria-describedby="mco270163-bib-0077">77</a>, <a href="#mco270163-bib-0078" class="usa-link" aria-describedby="mco270163-bib-0078">78</a>], the nucleus accumbens (NAc), the ventral tegmental area (VTA) [<a href="#mco270163-bib-0079" class="usa-link" aria-describedby="mco270163-bib-0079">79</a>, <a href="#mco270163-bib-0080" class="usa-link" aria-describedby="mco270163-bib-0080">80</a>, <a href="#mco270163-bib-0081" class="usa-link" aria-describedby="mco270163-bib-0081">81</a>], the interpeduncular nucleus, thalamic nuclei, different areas of the hypothalamus (mainly including lateral hypothalamus [LH], dorsomedial hypothalamus [DMH], ventromedial hypothalamus, periventricular nucleus, arcuate nucleus [ARC]) [<a href="#mco270163-bib-0063" class="usa-link" aria-describedby="mco270163-bib-0063">63</a>, <a href="#mco270163-bib-0082" class="usa-link" aria-describedby="mco270163-bib-0082">82</a>, <a href="#mco270163-bib-0083" class="usa-link" aria-describedby="mco270163-bib-0083">83</a>], the molecular layer of the cerebellum [<a href="#mco270163-bib-0076" class="usa-link" aria-describedby="mco270163-bib-0076">76</a>, <a href="#mco270163-bib-0078" class="usa-link" aria-describedby="mco270163-bib-0078">78</a>], and the dorsal horn of the spinal cord [<a href="#mco270163-bib-0084" class="usa-link" aria-describedby="mco270163-bib-0084">84</a>]. Given the central roles of GABA<sub>B</sub>Rs in neurobiology and psychiatric disorders (Figure <a href="#mco270163-fig-0001" class="usa-link">1D</a>) [<a href="#mco270163-bib-0070" class="usa-link" aria-describedby="mco270163-bib-0070">70</a>, <a href="#mco270163-bib-0085" class="usa-link" aria-describedby="mco270163-bib-0085">85</a>, <a href="#mco270163-bib-0086" class="usa-link" aria-describedby="mco270163-bib-0086">86</a>], it highlights the potential of the GABA<sub>B</sub>R system as a target for therapeutic intervention [<a href="#mco270163-bib-0085" class="usa-link" aria-describedby="mco270163-bib-0085">85</a>, <a href="#mco270163-bib-0086" class="usa-link" aria-describedby="mco270163-bib-0086">86</a>, <a href="#mco270163-bib-0087" class="usa-link" aria-describedby="mco270163-bib-0087">87</a>, <a href="#mco270163-bib-0088" class="usa-link" aria-describedby="mco270163-bib-0088">88</a>, <a href="#mco270163-bib-0089" class="usa-link" aria-describedby="mco270163-bib-0089">89</a>]. Therapeutic drugs that target GABA<sub>B</sub>Rs, such as baclofen (Figure <a href="#mco270163-fig-0002" class="usa-link">2</a>), are used to treat various neurological diseases and pathophysiological feeding disorders, including epilepsy [<a href="#mco270163-bib-0075" class="usa-link" aria-describedby="mco270163-bib-0075">75</a>, <a href="#mco270163-bib-0078" class="usa-link" aria-describedby="mco270163-bib-0078">78</a>, <a href="#mco270163-bib-0090" class="usa-link" aria-describedby="mco270163-bib-0090">90</a>], pain [<a href="#mco270163-bib-0085" class="usa-link" aria-describedby="mco270163-bib-0085">85</a>, <a href="#mco270163-bib-0086" class="usa-link" aria-describedby="mco270163-bib-0086">86</a>, <a href="#mco270163-bib-0091" class="usa-link" aria-describedby="mco270163-bib-0091">91</a>, <a href="#mco270163-bib-0092" class="usa-link" aria-describedby="mco270163-bib-0092">92</a>], depression [<a href="#mco270163-bib-0070" class="usa-link" aria-describedby="mco270163-bib-0070">70</a>, <a href="#mco270163-bib-0077" class="usa-link" aria-describedby="mco270163-bib-0077">77</a>, <a href="#mco270163-bib-0085" class="usa-link" aria-describedby="mco270163-bib-0085">85</a>, <a href="#mco270163-bib-0093" class="usa-link" aria-describedby="mco270163-bib-0093">93</a>, <a href="#mco270163-bib-0094" class="usa-link" aria-describedby="mco270163-bib-0094">94</a>], anxiety [<a href="#mco270163-bib-0085" class="usa-link" aria-describedby="mco270163-bib-0085">85</a>, <a href="#mco270163-bib-0086" class="usa-link" aria-describedby="mco270163-bib-0086">86</a>], and drug addiction [<a href="#mco270163-bib-0089" class="usa-link" aria-describedby="mco270163-bib-0089">89</a>, <a href="#mco270163-bib-0095" class="usa-link" aria-describedby="mco270163-bib-0095">95</a>, <a href="#mco270163-bib-0096" class="usa-link" aria-describedby="mco270163-bib-0096">96</a>, <a href="#mco270163-bib-0097" class="usa-link" aria-describedby="mco270163-bib-0097">97</a>]. For instance, baclofen has significant antiepileptogenic effects in spastic diplegia, multiple sclerosis [<a href="#mco270163-bib-0098" class="usa-link" aria-describedby="mco270163-bib-0098">98</a>], amyotrophic lateral sclerosis, and cerebral palsy [<a href="#mco270163-bib-0070" class="usa-link" aria-describedby="mco270163-bib-0070">70</a>, <a href="#mco270163-bib-0072" class="usa-link" aria-describedby="mco270163-bib-0072">72</a>, <a href="#mco270163-bib-0075" class="usa-link" aria-describedby="mco270163-bib-0075">75</a>, <a href="#mco270163-bib-0085" class="usa-link" aria-describedby="mco270163-bib-0085">85</a>, <a href="#mco270163-bib-0086" class="usa-link" aria-describedby="mco270163-bib-0086">86</a>] and exhibits great potential for treating alcohol use disorder (AUD) [<a href="#mco270163-bib-0088" class="usa-link" aria-describedby="mco270163-bib-0088">88</a>, <a href="#mco270163-bib-0095" class="usa-link" aria-describedby="mco270163-bib-0095">95</a>, <a href="#mco270163-bib-0096" class="usa-link" aria-describedby="mco270163-bib-0096">96</a>, <a href="#mco270163-bib-0099" class="usa-link" aria-describedby="mco270163-bib-0099">99</a>], substance abuse (cocaine [<a href="#mco270163-bib-0100" class="usa-link" aria-describedby="mco270163-bib-0100">100</a>, <a href="#mco270163-bib-0101" class="usa-link" aria-describedby="mco270163-bib-0101">101</a>], morphine [<a href="#mco270163-bib-0102" class="usa-link" aria-describedby="mco270163-bib-0102">102</a>, <a href="#mco270163-bib-0103" class="usa-link" aria-describedby="mco270163-bib-0103">103</a>], and heroin [<a href="#mco270163-bib-0104" class="usa-link" aria-describedby="mco270163-bib-0104">104</a>, <a href="#mco270163-bib-0105" class="usa-link" aria-describedby="mco270163-bib-0105">105</a>]), overeating or BE, and natural food addiction [<a href="#mco270163-bib-0066" class="usa-link" aria-describedby="mco270163-bib-0066">66</a>, <a href="#mco270163-bib-0067" class="usa-link" aria-describedby="mco270163-bib-0067">67</a>, <a href="#mco270163-bib-0070" class="usa-link" aria-describedby="mco270163-bib-0070">70</a>, <a href="#mco270163-bib-0085" class="usa-link" aria-describedby="mco270163-bib-0085">85</a>].</p>
<p>Baclofen, as a clinically available representative agonist of GABA<sub>B</sub>Rs [<a href="#mco270163-bib-0089" class="usa-link" aria-describedby="mco270163-bib-0089">89</a>], has been clinically approved for the treatment of symptoms of spasticity, cerebral palsy, and multiple sclerosis [<a href="#mco270163-bib-0070" class="usa-link" aria-describedby="mco270163-bib-0070">70</a>, <a href="#mco270163-bib-0072" class="usa-link" aria-describedby="mco270163-bib-0072">72</a>, <a href="#mco270163-bib-0075" class="usa-link" aria-describedby="mco270163-bib-0075">75</a>]. <a href="https://www.ncbi.nlm.nih.gov/protein/SKF97541" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">SKF97541</a> (<a href="https://www.ncbi.nlm.nih.gov/protein/CGP35024" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">CGP35024</a> in Figures <a href="#mco270163-fig-0001" class="usa-link">1B</a> and <a href="#mco270163-fig-0002" class="usa-link">2</a>), a selective GABA<sub>B</sub>R agonist that was developed as the first analogue of baclofen, binds to the GB1 VFT domain (via orthosteric ligand recognition) but not to the GB2 VFT domain; following binding, agonist‐induced conformational signals in GB1 promote conformational changes in this subunit via its physical interaction with GB2, allowing functional responses by its cognate G protein [<a href="#mco270163-bib-0067" class="usa-link" aria-describedby="mco270163-bib-0067">67</a>, <a href="#mco270163-bib-0071" class="usa-link" aria-describedby="mco270163-bib-0071">71</a>, <a href="#mco270163-bib-0072" class="usa-link" aria-describedby="mco270163-bib-0072">72</a>, <a href="#mco270163-bib-0074" class="usa-link" aria-describedby="mco270163-bib-0074">74</a>].</p>
<p>Furthermore, positive allosteric modulators (PAMs) bind the transmembrane region of the GB2 subunit (via allosteric ligand recognition) and strengthen the effect of agonists [<a href="#mco270163-bib-0059" class="usa-link" aria-describedby="mco270163-bib-0059">59</a>, <a href="#mco270163-bib-0070" class="usa-link" aria-describedby="mco270163-bib-0070">70</a>, <a href="#mco270163-bib-0071" class="usa-link" aria-describedby="mco270163-bib-0071">71</a>]. For instance, CGP7930 and <a href="https://www.ncbi.nlm.nih.gov/protein/ADX71441" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">ADX71441</a> (Figure <a href="#mco270163-fig-0002" class="usa-link">2</a>), as PAMs and partial agonists of GB2, can facilitate agonist response at low concentrations and activate the receptor alone at higher concentrations [<a href="#mco270163-bib-0070" class="usa-link" aria-describedby="mco270163-bib-0070">70</a>, <a href="#mco270163-bib-0072" class="usa-link" aria-describedby="mco270163-bib-0072">72</a>, <a href="#mco270163-bib-0075" class="usa-link" aria-describedby="mco270163-bib-0075">75</a>] and have demonstrated remarkable preclinical effectiveness and tolerability in various models [<a href="#mco270163-bib-0070" class="usa-link" aria-describedby="mco270163-bib-0070">70</a>, <a href="#mco270163-bib-0074" class="usa-link" aria-describedby="mco270163-bib-0074">74</a>, <a href="#mco270163-bib-0085" class="usa-link" aria-describedby="mco270163-bib-0085">85</a>, <a href="#mco270163-bib-0099" class="usa-link" aria-describedby="mco270163-bib-0099">99</a>]; by acting on presynaptic GABA<sub>B</sub>Rs and its GIRK/Kir3 channels, they inhibit cortico‐mesolimbic neurotransmission [<a href="#mco270163-bib-0070" class="usa-link" aria-describedby="mco270163-bib-0070">70</a>, <a href="#mco270163-bib-0071" class="usa-link" aria-describedby="mco270163-bib-0071">71</a>, <a href="#mco270163-bib-0074" class="usa-link" aria-describedby="mco270163-bib-0074">74</a>, <a href="#mco270163-bib-0075" class="usa-link" aria-describedby="mco270163-bib-0075">75</a>, <a href="#mco270163-bib-0085" class="usa-link" aria-describedby="mco270163-bib-0085">85</a>, <a href="#mco270163-bib-0099" class="usa-link" aria-describedby="mco270163-bib-0099">99</a>]. PAMs with different structural folding patterns and increased potency, including GS39783, rac‐BHFF, and BHF177, have been developed [<a href="#mco270163-bib-0067" class="usa-link" aria-describedby="mco270163-bib-0067">67</a>, <a href="#mco270163-bib-0071" class="usa-link" aria-describedby="mco270163-bib-0071">71</a>, <a href="#mco270163-bib-0072" class="usa-link" aria-describedby="mco270163-bib-0072">72</a>, <a href="#mco270163-bib-0074" class="usa-link" aria-describedby="mco270163-bib-0074">74</a>]; these agents exhibit more advantageous pharmacokinetics and efficacy compared with baclofen, including improved bioavailability, brain‐targeting ability, and reduced cytotoxicity.</p>
<p>Overall, the GABA<sub>B</sub> receptor and its physiological roles are extremely complex, consequently, dysregulation of this receptor is involved in a broad range of neuro‐psychiatric disorders and feeding‐related disorders, and even obesity. As such the GABA<sub>B</sub>R are considered a highly attractive therapeutic target. The next work aims to discuss these issues and provide an overall assessment and comparative analysis of the potential of GABA<sub>B</sub>Rs as therapeutic targets in psychiatric disorders, nutrition and metabolism disorders, and feeding‐related disorders.</p></section><section id="mco270163-sec-0030"><h2 class="pmc_sec_title">3. Effects in Neuro‐Psychiatric Disorders</h2>
<section id="mco270163-sec-0040"><h3 class="pmc_sec_title">3.1. Epilepsy</h3>
<p>Epilepsy is the consequence of an imbalance between inhibitory and excitatory mechanisms within the brain. It is involved in alterations of classical neurotransmitters such as gamma‐aminobutyric acid (GABA), glutamate, serotonin, and neuropeptides in the hypothalamus and thalamus [<a href="#mco270163-bib-0106" class="usa-link" aria-describedby="mco270163-bib-0106">106</a>, <a href="#mco270163-bib-0107" class="usa-link" aria-describedby="mco270163-bib-0107">107</a>]. Recent studies have exhibited that GABA<sub>B</sub> receptors play a significant role in seizures in animal models and clinical trials [<a href="#mco270163-bib-0108" class="usa-link" aria-describedby="mco270163-bib-0108">108</a>, <a href="#mco270163-bib-0109" class="usa-link" aria-describedby="mco270163-bib-0109">109</a>, <a href="#mco270163-bib-0110" class="usa-link" aria-describedby="mco270163-bib-0110">110</a>, <a href="#mco270163-bib-0111" class="usa-link" aria-describedby="mco270163-bib-0111">111</a>, <a href="#mco270163-bib-0112" class="usa-link" aria-describedby="mco270163-bib-0112">112</a>, <a href="#mco270163-bib-0113" class="usa-link" aria-describedby="mco270163-bib-0113">113</a>, <a href="#mco270163-bib-0114" class="usa-link" aria-describedby="mco270163-bib-0114">114</a>]. GABAergic neurons pre‐ or postsynaptically inhibit epileptogenic neurons via GABA<sub>B</sub> receptors, generating the low‐threshold calcium spike required to initiate burst firing, leading researchers to hypothesize [<a href="#mco270163-bib-0106" class="usa-link" aria-describedby="mco270163-bib-0106">106</a>, <a href="#mco270163-bib-0107" class="usa-link" aria-describedby="mco270163-bib-0107">107</a>, <a href="#mco270163-bib-0109" class="usa-link" aria-describedby="mco270163-bib-0109">109</a>]. In contrast, postsynaptic GABA<sub>B</sub> receptors result in a more prolonged inhibitory postsynaptic current and are presynaptic, where they inhibit neurotransmitter release at inhibitory and excitatory synapses (Figure <a href="#mco270163-fig-0001" class="usa-link">1C</a> and Table <a href="#mco270163-tbl-0001" class="usa-link">1</a>), thereby improving inhibitory and excitatory imbalances caused by epilepsy. Furthermore, some active compounds that target GABA<sub>B</sub>Rs enhance neural function and inhibit cell damage [<a href="#mco270163-bib-0115" class="usa-link" aria-describedby="mco270163-bib-0115">115</a>, <a href="#mco270163-bib-0116" class="usa-link" aria-describedby="mco270163-bib-0116">116</a>, <a href="#mco270163-bib-0117" class="usa-link" aria-describedby="mco270163-bib-0117">117</a>].</p>
<section class="tw xbox font-sm" id="mco270163-tbl-0001"><h4 class="obj_head">TABLE 1.</h4>
<div class="caption p"><p>Various compounds (agonists, antagonists, and allosteric modulators) targeting GABA<sub>B</sub>Rs and their related modulations in neuro‐psychiatric disorders.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead><tr style="border-bottom:solid 1px #000000">
<th align="left" rowspan="1" colspan="1">Psychiatric disorders</th>
<th align="center" rowspan="1" colspan="1">Compounds</th>
<th align="center" rowspan="1" colspan="1">Effects</th>
<th align="center" rowspan="1" colspan="1">Mechanisms</th>
<th align="center" rowspan="1" colspan="1">References</th>
</tr></thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">Epilepsy</td>
<td align="center" rowspan="1" colspan="1">
<p>Antagonists:</p>
<p><a href="https://www.ncbi.nlm.nih.gov/protein/CGP55845" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">CGP55845</a></p>
<p><a href="https://www.ncbi.nlm.nih.gov/protein/CGP62349" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">CGP62349</a></p>
<p>CGP 35348</p>
<p><a href="https://www.ncbi.nlm.nih.gov/protein/SCH50911" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">SCH50911</a></p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>
<strong>↓</strong> Absence syndromes</p>
<p>
<strong>↑</strong> Learning and memory</p>
<p>
<strong>↓</strong> Hyperpolarization</p>
<p>
<strong>↓</strong> SWD occurrence</p>
<p>
<strong>↓</strong> Paired pulse depression</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>GABA<sub>B</sub>R:</p>
<p>
<strong>↓</strong> Neural hyperexcitability</p>
<p>
<strong>↑</strong> Hippocampal discharges</p>
<p>
<strong>↑</strong> Frequency of EPSCs</p>
<p>
<strong>↑</strong> Cell synaptic responses</p>
</td>
<td align="center" rowspan="1" colspan="1">[<a href="#mco270163-bib-0118" class="usa-link" aria-describedby="mco270163-bib-0118">118</a>, <a href="#mco270163-bib-0119" class="usa-link" aria-describedby="mco270163-bib-0119">119</a>, <a href="#mco270163-bib-0120" class="usa-link" aria-describedby="mco270163-bib-0120">120</a>, <a href="#mco270163-bib-0121" class="usa-link" aria-describedby="mco270163-bib-0121">121</a>]</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Epilepsy</td>
<td align="center" rowspan="1" colspan="1">
<p>Agonists:</p>
<p>Baclofen</p>
<p>GHB</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>
<strong>↑</strong> Memory impairment</p>
<p>
<strong>↓</strong> Locomotor activity</p>
<p>
<strong>↑</strong> Hyperpolarization</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>GABA<sub>B</sub>R:</p>
<p>
<strong>↓</strong> Glutamatergic synapses</p>
<p>
<strong>↑</strong> Inhibition of transmission</p>
</td>
<td align="center" rowspan="1" colspan="1">[<a href="#mco270163-bib-0122" class="usa-link" aria-describedby="mco270163-bib-0122">122</a>, <a href="#mco270163-bib-0123" class="usa-link" aria-describedby="mco270163-bib-0123">123</a>, <a href="#mco270163-bib-0124" class="usa-link" aria-describedby="mco270163-bib-0124">124</a>, <a href="#mco270163-bib-0125" class="usa-link" aria-describedby="mco270163-bib-0125">125</a>, <a href="#mco270163-bib-0126" class="usa-link" aria-describedby="mco270163-bib-0126">126</a>]</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Epilepsy</td>
<td align="center" rowspan="1" colspan="1">
<p>PAM:</p>
<p>CGS 39783</p>
<p>BHF177</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>
<strong>↓</strong> Aberrant hippocampal spikes</p>
<p>
<strong>↓</strong> Hyperexcitability</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>
<strong>↑</strong> Presynaptic Ca<sup>2+</sup> signaling</p>
<p>
<strong>↑</strong> Postsynaptic currents</p>
<p>
<strong>↓</strong> VCAM‐1, ICAM‐1, TNF‐α</p>
</td>
<td align="center" rowspan="1" colspan="1">[<a href="#mco270163-bib-0115" class="usa-link" aria-describedby="mco270163-bib-0115">115</a>, <a href="#mco270163-bib-0116" class="usa-link" aria-describedby="mco270163-bib-0116">116</a>, <a href="#mco270163-bib-0117" class="usa-link" aria-describedby="mco270163-bib-0117">117</a>, <a href="#mco270163-bib-0124" class="usa-link" aria-describedby="mco270163-bib-0124">124</a>, <a href="#mco270163-bib-0125" class="usa-link" aria-describedby="mco270163-bib-0125">125</a>].</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Pain and analgesia</td>
<td align="center" rowspan="1" colspan="1">
<p>Agonists:</p>
<p>Baclofen</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>
<strong>↓</strong> Hyperexcitability</p>
<p>
<strong>↓</strong> Nociceptive responses</p>
<p>
<strong>↑</strong> Pain facilitation</p>
<p>
<strong>↑</strong> Analgesic effect.</p>
<p>
<strong>↓</strong> Membrane excitability</p>
<p>
<strong>↑</strong> Presynaptic inhibition</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>GABA<sub>B</sub>R:</p>
<p>
<strong>↑</strong> Rate‐dependent depression</p>
<p>Spinal inhibition</p>
<p>
<strong>↑</strong> Kir current</p>
<p>
<strong>↓</strong> Cav2.2 channels</p>
<p>
<strong>↑</strong> GINIP, TREK‐2</p>
</td>
<td align="center" rowspan="1" colspan="1">[<a href="#mco270163-bib-0127" class="usa-link" aria-describedby="mco270163-bib-0127">127</a>, <a href="#mco270163-bib-0128" class="usa-link" aria-describedby="mco270163-bib-0128">128</a>, <a href="#mco270163-bib-0129" class="usa-link" aria-describedby="mco270163-bib-0129">129</a>, <a href="#mco270163-bib-0130" class="usa-link" aria-describedby="mco270163-bib-0130">130</a>, <a href="#mco270163-bib-0131" class="usa-link" aria-describedby="mco270163-bib-0131">131</a>]</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Pain and analgesia</td>
<td align="center" rowspan="1" colspan="1">
<p>PAM:</p>
<p>rac‐BHFF BHF177</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>
<strong>↓</strong> Neuropathic pain</p>
<p>
<strong>↑</strong> Antinociceptive effects</p>
<p>
<strong>↓</strong> Trigeminal nociception</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>GABA<sub>B</sub>R:</p>
<p>
<strong>↑</strong> GABA<sub>B</sub>(1a)</p>
<p>
<strong>↑</strong> GABA<sub>B</sub>(2a)</p>
</td>
<td align="center" rowspan="1" colspan="1">[<a href="#mco270163-bib-0132" class="usa-link" aria-describedby="mco270163-bib-0132">132</a>, <a href="#mco270163-bib-0133" class="usa-link" aria-describedby="mco270163-bib-0133">133</a>, <a href="#mco270163-bib-0134" class="usa-link" aria-describedby="mco270163-bib-0134">134</a>, <a href="#mco270163-bib-0135" class="usa-link" aria-describedby="mco270163-bib-0135">135</a>]</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Anxiety and depression</td>
<td align="center" rowspan="1" colspan="1">
<p>Agonists:</p>
<p>Baclofen</p>
<p><a href="https://www.ncbi.nlm.nih.gov/protein/CGP44532" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">CGP44532</a></p>
<p><a href="https://www.ncbi.nlm.nih.gov/protein/SKF97541" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">SKF97541</a></p>
<p>2‐OH‐saclofen</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>
<strong>↑</strong> Anxiogenic‐like effect</p>
<p>
<strong>↑</strong> Antidepressant effects</p>
<p>
<strong>↓</strong> Locomotor behavior</p>
<p>
<strong>↓</strong> Anxiety‐like effect</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>GABA<sub>B</sub>R</p>
<p>
<strong>↓</strong> c‐Fos</p>
<p>
<strong>↑</strong> GABA<sub>B</sub>R2</p>
<p>
<strong>↑</strong> BDNF–TrkB</p>
<p>
<strong>↑</strong> Synaptic transmission</p>
</td>
<td align="center" rowspan="1" colspan="1">[<a href="#mco270163-bib-0136" class="usa-link" aria-describedby="mco270163-bib-0136">136</a>, <a href="#mco270163-bib-0137" class="usa-link" aria-describedby="mco270163-bib-0137">137</a>, <a href="#mco270163-bib-0138" class="usa-link" aria-describedby="mco270163-bib-0138">138</a>, <a href="#mco270163-bib-0139" class="usa-link" aria-describedby="mco270163-bib-0139">139</a>, <a href="#mco270163-bib-0140" class="usa-link" aria-describedby="mco270163-bib-0140">140</a>]</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Anxiety and depression</td>
<td align="center" rowspan="1" colspan="1">
<p>PAM:</p>
<p>CGP 7930</p>
<p>BHF177</p>
<p>GS39783</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>
<strong>↓</strong> Anxiety‐like behaviors</p>
<p>
<strong>↑</strong> Anxiolytic activity</p>
<p>
<strong>↑</strong> Antidepressant activity</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>GABA<sub>B</sub>R</p>
<p>
<strong>↑</strong> GABA<sub>B</sub>R‐Kir channel</p>
<p>
<strong>↑</strong> Synaptic transmission</p>
</td>
<td align="center" rowspan="1" colspan="1">[<a href="#mco270163-bib-0133" class="usa-link" aria-describedby="mco270163-bib-0133">133</a>, <a href="#mco270163-bib-0137" class="usa-link" aria-describedby="mco270163-bib-0137">137</a>, <a href="#mco270163-bib-0141" class="usa-link" aria-describedby="mco270163-bib-0141">141</a>, <a href="#mco270163-bib-0142" class="usa-link" aria-describedby="mco270163-bib-0142">142</a>, <a href="#mco270163-bib-0143" class="usa-link" aria-describedby="mco270163-bib-0143">143</a>, <a href="#mco270163-bib-0144" class="usa-link" aria-describedby="mco270163-bib-0144">144</a>]</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Anxiety and depression</td>
<td align="center" rowspan="1" colspan="1">
<p>Antagonists:</p>
<p>SCH 50911</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>
<strong>↑</strong> Anxiolytic‐like effects</p>
<p>
<strong>↑</strong> Antidepressant activity</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>GABA<sub>B</sub>R:</p>
<p>Cortical inhibition</p>
</td>
<td align="center" rowspan="1" colspan="1">[<a href="#mco270163-bib-0137" class="usa-link" aria-describedby="mco270163-bib-0137">137</a>, <a href="#mco270163-bib-0145" class="usa-link" aria-describedby="mco270163-bib-0145">145</a>, <a href="#mco270163-bib-0146" class="usa-link" aria-describedby="mco270163-bib-0146">146</a>, <a href="#mco270163-bib-0147" class="usa-link" aria-describedby="mco270163-bib-0147">147</a>]</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Drug abuse and addiction</td>
<td align="center" rowspan="1" colspan="1">
<p>Agonists:</p>
<p>Baclofen</p>
<p>SKF 97541</p>
<p>CGP 44532</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>
<strong>↓</strong> Context‐induced reinstatement</p>
<p>
<strong>↓</strong> Self‐administration</p>
<p>
<strong>↓</strong> Cue‐induced reinstatement</p>
<p>
<strong>↓</strong> Active lever presses</p>
<p>
<strong>↓</strong> Morphine sensitization</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>GABA<sub>B</sub>R:</p>
<p>
<strong>↓</strong> DA neurons</p>
<p>
<strong>↓</strong> Dopamine release</p>
<p>
<strong>↓</strong> Reward enhancement</p>
<p>Synaptic plasticity</p>
<p>Neuronal excitability</p>
</td>
<td align="center" rowspan="1" colspan="1">[<a href="#mco270163-bib-0148" class="usa-link" aria-describedby="mco270163-bib-0148">148</a>, <a href="#mco270163-bib-0149" class="usa-link" aria-describedby="mco270163-bib-0149">149</a>, <a href="#mco270163-bib-0150" class="usa-link" aria-describedby="mco270163-bib-0150">150</a>, <a href="#mco270163-bib-0151" class="usa-link" aria-describedby="mco270163-bib-0151">151</a>, <a href="#mco270163-bib-0152" class="usa-link" aria-describedby="mco270163-bib-0152">152</a>, <a href="#mco270163-bib-0153" class="usa-link" aria-describedby="mco270163-bib-0153">153</a>, <a href="#mco270163-bib-0154" class="usa-link" aria-describedby="mco270163-bib-0154">154</a>]</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Drug abuse and addiction</td>
<td align="center" rowspan="1" colspan="1">
<p>PAM:</p>
<p>rac‐BHFF</p>
<p>BHF177</p>
<p><a href="https://www.ncbi.nlm.nih.gov/protein/ADX71441" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">ADX71441</a></p>
<p>GS39873</p>
<p>KK‐92A</p>
<p>NVP998</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>↓ Self‐administration</p>
<p>↓ Ethanol drinking</p>
<p>↓ Reward effects</p>
<p>↓ Threshold lowering effect</p>
<p>↓ Negative aspects</p>
<p>
<strong>↑</strong> Antismoking</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>GABA<sub>B</sub>R:</p>
<p>GABA<sub>B</sub>R1</p>
<p>D1 receptors</p>
<p>Intracellular calcium</p>
<p>Synaptic plasticity</p>
</td>
<td align="center" rowspan="1" colspan="1">[<a href="#mco270163-bib-0148" class="usa-link" aria-describedby="mco270163-bib-0148">148</a>, <a href="#mco270163-bib-0155" class="usa-link" aria-describedby="mco270163-bib-0155">155</a>, <a href="#mco270163-bib-0156" class="usa-link" aria-describedby="mco270163-bib-0156">156</a>, <a href="#mco270163-bib-0157" class="usa-link" aria-describedby="mco270163-bib-0157">157</a>, <a href="#mco270163-bib-0158" class="usa-link" aria-describedby="mco270163-bib-0158">158</a>]</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Schizophrenia</td>
<td align="center" rowspan="1" colspan="1">
<p>Agonists:</p>
<p>baclofen</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>
<strong>↑</strong> Antipsychotic effect</p>
<p>↓ Behavioral hypersensitivity</p>
<p>↓ Cognitive impairment</p>
<p>↓ Negative emotion</p>
<p>
<strong>↑</strong> Prepulse inhibition</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>GABA<sub>B</sub>R:</p>
<p>LICI</p>
<p>DA release</p>
<p>GABA release</p>
</td>
<td align="center" rowspan="1" colspan="1">[<a href="#mco270163-bib-0159" class="usa-link" aria-describedby="mco270163-bib-0159">159</a>, <a href="#mco270163-bib-0160" class="usa-link" aria-describedby="mco270163-bib-0160">160</a>, <a href="#mco270163-bib-0161" class="usa-link" aria-describedby="mco270163-bib-0161">161</a>, <a href="#mco270163-bib-0162" class="usa-link" aria-describedby="mco270163-bib-0162">162</a>, <a href="#mco270163-bib-0163" class="usa-link" aria-describedby="mco270163-bib-0163">163</a>, <a href="#mco270163-bib-0164" class="usa-link" aria-describedby="mco270163-bib-0164">164</a>]</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Schizophrenia</td>
<td align="center" rowspan="1" colspan="1">
<p>PAM:</p>
<p>GS39783</p>
<p>CGP7930</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>
<strong>↑</strong> Antipsychotic effect</p>
<p>
<strong>↑</strong> Social interaction</p>
<p>
<strong>↑</strong> Prepulse inhibition</p>
<p>↓ Cognitive impairment</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>GABA<sub>B</sub>R:</p>
<p>Fos‐positive cells</p>
<p>Neuronal excitability</p>
</td>
<td align="center" rowspan="1" colspan="1">[<a href="#mco270163-bib-0159" class="usa-link" aria-describedby="mco270163-bib-0159">159</a>, <a href="#mco270163-bib-0160" class="usa-link" aria-describedby="mco270163-bib-0160">160</a>, <a href="#mco270163-bib-0165" class="usa-link" aria-describedby="mco270163-bib-0165">165</a>]</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Alzheimer's disease and cognitive impairment</td>
<td align="center" rowspan="1" colspan="1">
<p>Agonists:</p>
<p>baclofen</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>↑ Spatial memory</p>
<p>↑ Learning ability</p>
<p>↓ Oxidative injury</p>
<p>↓ Neuronal apoptosis</p>
<p>↓ p‐Tau and Aβ formation</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>GABA<sub>B</sub>R:</p>
<p>GABA<sub>B</sub>R–GIRK2</p>
<p>PI3K–AkT, MDA, SOD</p>
<p>PKA–AAK1 pathway</p>
<p>p‐Tau and Aβ formation</p>
<p>Excitatory–inhibitory balance</p>
</td>
<td align="center" rowspan="1" colspan="1">[<a href="#mco270163-bib-0166" class="usa-link" aria-describedby="mco270163-bib-0166">166</a>, <a href="#mco270163-bib-0167" class="usa-link" aria-describedby="mco270163-bib-0167">167</a>, <a href="#mco270163-bib-0168" class="usa-link" aria-describedby="mco270163-bib-0168">168</a>, <a href="#mco270163-bib-0169" class="usa-link" aria-describedby="mco270163-bib-0169">169</a>]</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Alzheimer's disease and cognitive impairment</td>
<td align="center" rowspan="1" colspan="1">
<p>Antagonists:</p>
<p>CGP 36742</p>
<p>SGS742</p>
<p><a href="https://www.ncbi.nlm.nih.gov/protein/CGP55845" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">CGP55845</a></p>
<p><a href="https://www.ncbi.nlm.nih.gov/protein/CGP52432" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">CGP52432</a></p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>↓ Learning and memory impairment</p>
<p>
<strong>↑</strong> Memory function</p>
<p>
<strong>↑</strong> Synaptic functions</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>GABA<sub>B</sub>R:</p>
<p>
<strong>↑</strong> GABA<sub>B</sub>R/GIRK2</p>
<p>
<strong>↑</strong> Glu, GABA and GABA<sub>B</sub>R</p>
<p>
<strong>↑</strong> ATF4/CREB2</p>
</td>
<td align="center" rowspan="1" colspan="1">[<a href="#mco270163-bib-0170" class="usa-link" aria-describedby="mco270163-bib-0170">170</a>, <a href="#mco270163-bib-0171" class="usa-link" aria-describedby="mco270163-bib-0171">171</a>, <a href="#mco270163-bib-0172" class="usa-link" aria-describedby="mco270163-bib-0172">172</a>, <a href="#mco270163-bib-0173" class="usa-link" aria-describedby="mco270163-bib-0173">173</a>]</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Autism disorder</td>
<td align="center" rowspan="1" colspan="1">
<p>Agonists:</p>
<p>Baclofen</p>
<p>STX209</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>↓ Autism‑like behaviors</p>
<p>
<strong>↑</strong> Novelty recognition</p>
<p>↓ Repetitive self‐grooming</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>GABA<sub>B</sub>R:</p>
<p>
<strong>↑</strong> GABA<sub>B</sub>R2</p>
<p>
<strong>↑</strong> Spine density</p>
<p>↓ Network excitability</p>
</td>
<td align="center" rowspan="1" colspan="1">[<a href="#mco270163-bib-0174" class="usa-link" aria-describedby="mco270163-bib-0174">174</a>, <a href="#mco270163-bib-0175" class="usa-link" aria-describedby="mco270163-bib-0175">175</a>, <a href="#mco270163-bib-0176" class="usa-link" aria-describedby="mco270163-bib-0176">176</a>, <a href="#mco270163-bib-0177" class="usa-link" aria-describedby="mco270163-bib-0177">177</a>]</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/mco270163-tbl-0001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="mco270163-tbl1-note-0001"><p>Abbreviations: AAK1, adaptor‐associated kinase 1; CREB, CRE‐binding; EPSC, excitatory postsynaptic current; GHB, gamma‐hydroxybutyrate; ICAM‐1, intercellular cell adhesion molecule‐1; LICI, long‐interval intracortical inhibition; PAM, positive allosteric modulator; PKA, protein kinase A; SWDs, spike‐and‐wave discharges; TNF, tumor necrosis factor‐α; TREK‐2, two‐pore domain potassium channel; VCAM‐1, vascular cell adhesion molecule.</p></div></div></section><p>Previous evidence indicates that GABA<sub>B</sub>R activity can generate the low threshold calcium spike and initiate abnormal burst firings and spontaneous spike‐and‐wave discharges (SWDs), leading to these seizure‐related clinical symptoms [<a href="#mco270163-bib-0109" class="usa-link" aria-describedby="mco270163-bib-0109">109</a>, <a href="#mco270163-bib-0122" class="usa-link" aria-describedby="mco270163-bib-0122">122</a>, <a href="#mco270163-bib-0178" class="usa-link" aria-describedby="mco270163-bib-0178">178</a>]. In contrast, GABA<sub>B</sub>R antagonists suppress absence behaviors. For instance, GABA<sub>B</sub>R antagonists CGP55845A and <a href="https://www.ncbi.nlm.nih.gov/protein/CGP62349" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">CGP62349</a> markedly suppressed the development of absence syndromes to a greater degree, improved learning and memory retention and retrieval [<a href="#mco270163-bib-0118" class="usa-link" aria-describedby="mco270163-bib-0118">118</a>], and infusion of baclofen into the cerebrospinal fluid improved three distinct varieties of memory impairment [<a href="#mco270163-bib-0123" class="usa-link" aria-describedby="mco270163-bib-0123">123</a>]. The endogenous ligand gamma‐hydroxybutyrate (GHB) was reported to elicit a dose‐dependent reduction in locomotor activity [<a href="#mco270163-bib-0122" class="usa-link" aria-describedby="mco270163-bib-0122">122</a>]. However, CGP 35348 (GABA<sub>B</sub>R antagonist) reversibly antagonized GHB‐elicited hyperpolarization [<a href="#mco270163-bib-0119" class="usa-link" aria-describedby="mco270163-bib-0119">119</a>], and <a href="https://www.ncbi.nlm.nih.gov/protein/SCH50911" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">SCH50911</a> significantly reversed the changes in SWDs occurrence and locomotion induced by baclofen and GHB [<a href="#mco270163-bib-0122" class="usa-link" aria-describedby="mco270163-bib-0122">122</a>]. Moreover, CGP 62349 completely prevented hypothermia and the absence of seizures in both chemical models [<a href="#mco270163-bib-0120" class="usa-link" aria-describedby="mco270163-bib-0120">120</a>]. Further studies indicate that GABA<sub>B</sub>Rs regulate hippocampal neural hyperexcitability by inhibiting glutamatergic synapses [<a href="#mco270163-bib-0124" class="usa-link" aria-describedby="mco270163-bib-0124">124</a>, <a href="#mco270163-bib-0125" class="usa-link" aria-describedby="mco270163-bib-0125">125</a>] and significantly reversing seizures and cognitive impairment.</p>
<p>GABA<sub>B</sub>R contributes to cortical and subcortical hyperexcitability and augments presynaptic calcium (Ca<sup>2+</sup>) signaling and postsynaptic currents in in vivo animal and in vitro cells or brain slices. First, CGS 39783 (a PAM of GABA<sub>B</sub>R) reduced aberrant hippocampal spikes in a mouse hippocampal kindling model [<a href="#mco270163-bib-0125" class="usa-link" aria-describedby="mco270163-bib-0125">125</a>]. The GABA<sub>B</sub>R antagonist CGP 55845 prolonged hippocampal discharges and increased spike incidences [<a href="#mco270163-bib-0125" class="usa-link" aria-describedby="mco270163-bib-0125">125</a>], attenuated the paired‐pulse depression of CA3 population spikes, and increased EPSC frequency in individual CA3 pyramidal neurons [<a href="#mco270163-bib-0124" class="usa-link" aria-describedby="mco270163-bib-0124">124</a>, <a href="#mco270163-bib-0125" class="usa-link" aria-describedby="mco270163-bib-0125">125</a>]. Second, the presynaptic and postsynaptic functions of GABA<sub>B</sub>R were disrupted in hippocampal area CA1 in a chronic model of temporal lobe epilepsy [<a href="#mco270163-bib-0121" class="usa-link" aria-describedby="mco270163-bib-0121">121</a>]. In contrast, antagonists of GABA<sub>B</sub>Rs eliminated IPSPs and enhanced cell synaptic responses [<a href="#mco270163-bib-0121" class="usa-link" aria-describedby="mco270163-bib-0121">121</a>]. Third, GABA<sub>B</sub>R‐mediated cortical inhibition contributes to long‐interval intracortical inhibition [<a href="#mco270163-bib-0126" class="usa-link" aria-describedby="mco270163-bib-0126">126</a>]. GABA<sub>B</sub>Rs can potently inhibit transmission in tottering and reduce Purkinje cell output from the cerebellum of the Ca<sup>2+</sup> channel‐mutant mouse [<a href="#mco270163-bib-0179" class="usa-link" aria-describedby="mco270163-bib-0179">179</a>]. In contrast, the abnormal alterations of GABA<sub>B</sub>R decreased paired‐pulse depression, caused neocortical hyperexcitability in epileptic WAG/Rij rat neocortex [<a href="#mco270163-bib-0178" class="usa-link" aria-describedby="mco270163-bib-0178">178</a>], and some variants impaired cell functions of GABA<sub>B</sub>R, perturbed neurotransmission by elevating presynaptic Ca<sup>2+</sup> signaling [<a href="#mco270163-bib-0180" class="usa-link" aria-describedby="mco270163-bib-0180">180</a>]. Furthermore, glucose metabolism and AMP‐activated protein kinase can augment postsynaptic currents in thalamocortical neurons, regulate thalamocortical circuit excitability, and increase spike‐wave seizures, which are dependent on GABA<sub>B</sub>R cooperativity [<a href="#mco270163-bib-0181" class="usa-link" aria-describedby="mco270163-bib-0181">181</a>]. The positive modulation compounds of targeting GABA<sub>B</sub>R may reduce seizure‐related hyperexcitability.</p>
<p>Furthermore, some clinical and basic reports exhibit that GABA<sub>B</sub>R antibody‐related encephalitis may induce neuroimmune reactions and are accompanied by a stereotyped feature with epilepsy [<a href="#mco270163-bib-0112" class="usa-link" aria-describedby="mco270163-bib-0112">112</a>, <a href="#mco270163-bib-0116" class="usa-link" aria-describedby="mco270163-bib-0116">116</a>, <a href="#mco270163-bib-0117" class="usa-link" aria-describedby="mco270163-bib-0117">117</a>, <a href="#mco270163-bib-0182" class="usa-link" aria-describedby="mco270163-bib-0182">182</a>]. A retrospective clinical study of GABA<sub>B</sub>R antibodies exhibited that the most frequent first symptom was recurrent seizures, amounting to 77% [<a href="#mco270163-bib-0111" class="usa-link" aria-describedby="mco270163-bib-0111">111</a>, <a href="#mco270163-bib-0183" class="usa-link" aria-describedby="mco270163-bib-0183">183</a>]. In several antibody‐mediated encephalitis disorders, the epilepsy and cognitive decline risk is markedly high for disorders [<a href="#mco270163-bib-0111" class="usa-link" aria-describedby="mco270163-bib-0111">111</a>, <a href="#mco270163-bib-0112" class="usa-link" aria-describedby="mco270163-bib-0112">112</a>, <a href="#mco270163-bib-0116" class="usa-link" aria-describedby="mco270163-bib-0116">116</a>], including antibodies against NMDA, AMPA, and GABA<sub>B</sub> receptors. Additionally, GABA<sub>B</sub> receptor activation by BHF177 decreases VCAM‐1, ICAM‐1, and tumor necrosis factor‐α (TNF‐α) levels and relieves the inflammatory response in the hippocampal tissues of RE rats [<a href="#mco270163-bib-0115" class="usa-link" aria-describedby="mco270163-bib-0115">115</a>]. The underlying mechanisms are antibodies against neuronal surface antigens. The robust effects of antibody–antigen binding are involved in the inflammation‐related transcriptional and nontranscriptional pathways, resulting in hyperexcitability and contributing to synaptic function impairments [<a href="#mco270163-bib-0116" class="usa-link" aria-describedby="mco270163-bib-0116">116</a>, <a href="#mco270163-bib-0117" class="usa-link" aria-describedby="mco270163-bib-0117">117</a>].</p>
<p>Epilepsy is a common neurological disorder characterized by recurrent convulsions and transient changes in consciousness. Targeting GABA<sub>B</sub>Rs is effective in treating partial‐onset and generalized seizures, can alleviate seizure‐related hyperactivity and hyperexcitability, and improves the deregulation of burst firing and neurotransmission (Table <a href="#mco270163-tbl-0001" class="usa-link">1</a>). Furthermore, potential antagonists or agents of GABA<sub>B</sub>Rs ameliorate synaptic dysfunction and inflammation, inhibit neuronal apoptosis, and protect against refractory epilepsy through the IRS‐1/PI3K/AKT axis [<a href="#mco270163-bib-0115" class="usa-link" aria-describedby="mco270163-bib-0115">115</a>].</p></section><section id="mco270163-sec-0050"><h3 class="pmc_sec_title">3.2. Pain and Analgesia</h3>
<p>GABA<sub>B</sub>Rs are vital for pain modulation and exhibit antinociceptive properties [<a href="#mco270163-bib-0113" class="usa-link" aria-describedby="mco270163-bib-0113">113</a>]. Regulating GABA<sub>B</sub>Rs affects intracellular signaling pathways through activation, thereby regulating neuronal excitability and inhibition [<a href="#mco270163-bib-0184" class="usa-link" aria-describedby="mco270163-bib-0184">184</a>]. Downregulating GABA<sub>B</sub> receptors may contribute to the diminished inhibitory control of neurons in neuropathic pain models in rats and mice [<a href="#mco270163-bib-0113" class="usa-link" aria-describedby="mco270163-bib-0113">113</a>, <a href="#mco270163-bib-0184" class="usa-link" aria-describedby="mco270163-bib-0184">184</a>, <a href="#mco270163-bib-0185" class="usa-link" aria-describedby="mco270163-bib-0185">185</a>], diabetic neuropathy models, and acute inflammatory pain models [<a href="#mco270163-bib-0127" class="usa-link" aria-describedby="mco270163-bib-0127">127</a>, <a href="#mco270163-bib-0132" class="usa-link" aria-describedby="mco270163-bib-0132">132</a>, <a href="#mco270163-bib-0186" class="usa-link" aria-describedby="mco270163-bib-0186">186</a>, <a href="#mco270163-bib-0187" class="usa-link" aria-describedby="mco270163-bib-0187">187</a>]. Current evidence (Table <a href="#mco270163-tbl-0001" class="usa-link">1</a>) has exhibited that GABA<sub>B</sub>R activation is involved in processing pain signals and analgesia induction in chronic pain conditions [<a href="#mco270163-bib-0185" class="usa-link" aria-describedby="mco270163-bib-0185">185</a>, <a href="#mco270163-bib-0188" class="usa-link" aria-describedby="mco270163-bib-0188">188</a>, <a href="#mco270163-bib-0189" class="usa-link" aria-describedby="mco270163-bib-0189">189</a>]. Specifically, the injection of GABA or GABA<sub>B</sub>R agonist through the brain ventricles can suppress neuropathic pain, demonstrating a dose‐dependent analgesic effect. This suggests that GABA<sub>B</sub>R activation can effectively reduce pain [<a href="#mco270163-bib-0113" class="usa-link" aria-describedby="mco270163-bib-0113">113</a>, <a href="#mco270163-bib-0185" class="usa-link" aria-describedby="mco270163-bib-0185">185</a>].</p>
<p>Both activation of GABA<sub>B</sub> receptor and baclofen produce inhibitory effects on hyperexcitability in response to natural stimuli [<a href="#mco270163-bib-0128" class="usa-link" aria-describedby="mco270163-bib-0128">128</a>, <a href="#mco270163-bib-0129" class="usa-link" aria-describedby="mco270163-bib-0129">129</a>], reduce the mechanical allodynia in the neuropathic pain after spinal cord injury [<a href="#mco270163-bib-0129" class="usa-link" aria-describedby="mco270163-bib-0129">129</a>, <a href="#mco270163-bib-0130" class="usa-link" aria-describedby="mco270163-bib-0130">130</a>, <a href="#mco270163-bib-0131" class="usa-link" aria-describedby="mco270163-bib-0131">131</a>], and exert antinociceptive effects of subtherapeutic Pn3a in a model of acute postsurgical pain [<a href="#mco270163-bib-0131" class="usa-link" aria-describedby="mco270163-bib-0131">131</a>, <a href="#mco270163-bib-0190" class="usa-link" aria-describedby="mco270163-bib-0190">190</a>]. Contrarily, PAMs of the GABA<sub>B</sub> receptor can relieve neuropathic pain induced by chronic pain models with coapplication, including rac‐BHFF and BHF177 [<a href="#mco270163-bib-0133" class="usa-link" aria-describedby="mco270163-bib-0133">133</a>, <a href="#mco270163-bib-0134" class="usa-link" aria-describedby="mco270163-bib-0134">134</a>]. Some compounds that regulate GABA<sub>B</sub>Rs also have antinociceptive activity in formalin and hot plate tests [<a href="#mco270163-bib-0132" class="usa-link" aria-describedby="mco270163-bib-0132">132</a>, <a href="#mco270163-bib-0191" class="usa-link" aria-describedby="mco270163-bib-0191">191</a>], increase mRNA expression of GABA<sub>B</sub>(1a) and GABA<sub>B</sub>(2a) [<a href="#mco270163-bib-0188" class="usa-link" aria-describedby="mco270163-bib-0188">188</a>], enhance central descending inhibitory pain pathways, and suppress trigeminal nociception [<a href="#mco270163-bib-0135" class="usa-link" aria-describedby="mco270163-bib-0135">135</a>]. Moreover, GABA acting on GABA<sub>B</sub>Rs may decrease nociceptive responses [<a href="#mco270163-bib-0132" class="usa-link" aria-describedby="mco270163-bib-0132">132</a>], regulate somatosensory transduction [<a href="#mco270163-bib-0192" class="usa-link" aria-describedby="mco270163-bib-0192">192</a>], and enhance pain facilitation [<a href="#mco270163-bib-0127" class="usa-link" aria-describedby="mco270163-bib-0127">127</a>] during inflammatory sensitization and pain.</p>
<p>Further studies demonstrate that activation of GABA<sub>B</sub>Rs also regulates peripheral neuropathic pain, particularly in diabetic neuropathic pain. Painful diabetic peripheral neuropathy always involves damage to small neural fibers [<a href="#mco270163-bib-0187" class="usa-link" aria-describedby="mco270163-bib-0187">187</a>, <a href="#mco270163-bib-0193" class="usa-link" aria-describedby="mco270163-bib-0193">193</a>], resulting in nociceptor hyperexcitability and dysregulation of synthesis and ionic channels [<a href="#mco270163-bib-0128" class="usa-link" aria-describedby="mco270163-bib-0128">128</a>, <a href="#mco270163-bib-0187" class="usa-link" aria-describedby="mco270163-bib-0187">187</a>]. In contrast, the GABA<sub>B</sub>R agonist baclofen can mediate spinal inhibition, restore impaired rate‐dependent depression, and alleviate neuropathic pain in diabetic rats [<a href="#mco270163-bib-0194" class="usa-link" aria-describedby="mco270163-bib-0194">194</a>]. Intrathecal injection of baclofen significantly increased the paw withdrawal threshold in streptozotocin‐induced diabetic neuropathy rats [<a href="#mco270163-bib-0186" class="usa-link" aria-describedby="mco270163-bib-0186">186</a>]. It induced a significant reduction in spinal NR2B protein and mRNA levels (an NMDA receptor subunit) and downregulated the phosphorylated cAMP response element‐binding (CREB) protein levels [<a href="#mco270163-bib-0186" class="usa-link" aria-describedby="mco270163-bib-0186">186</a>, <a href="#mco270163-bib-0195" class="usa-link" aria-describedby="mco270163-bib-0195">195</a>]. Additionally, GABA<sub>B</sub>R modulates the K<sup>+</sup> (Kir) current in the trigeminal ganglia and increases the mean peak amplitude of Kir currents, suppressing trigeminal pain [<a href="#mco270163-bib-0128" class="usa-link" aria-describedby="mco270163-bib-0128">128</a>]. Baclofen can mediate gastric hypersensitivity and attenuate pain‐associated responses in a validated rat model of functional dyspepsia.</p>
<p>As for mechanisms, interactions of GABA<sub>B</sub>Rs with coupled Kir channels and some calcium channel proteins play vital roles in regulating neuronal excitability and neurotransmitter release. The activation of GABA<sub>B</sub>Rs can lead to the activation of G proteins, which in turn affect the opening of K<sup>+</sup> channels (GIRK), thereby regulating the membrane potential and excitability of neurons (Figure <a href="#mco270163-fig-0001" class="usa-link">1C</a>). For instance, the GABA<sub>B</sub>R agonist baclofen induces Kir currents [<a href="#mco270163-bib-0128" class="usa-link" aria-describedby="mco270163-bib-0128">128</a>, <a href="#mco270163-bib-0196" class="usa-link" aria-describedby="mco270163-bib-0196">196</a>], GeXIVA (a 28 amino acid peptide) inhibits high‐voltage activated (HVA) N‐type calcium (Cav2.2) channels [<a href="#mco270163-bib-0197" class="usa-link" aria-describedby="mco270163-bib-0197">197</a>], reducing membrane excitability in mouse dorsal root ganglion (DRG) neurons, and reversibly potentiates inwardly rectifying Kir currents mediated by GIRK1/2 channels coexpressed with GABA<sub>B</sub>Rs in vitro [<a href="#mco270163-bib-0197" class="usa-link" aria-describedby="mco270163-bib-0197">197</a>]. On the one hand, baclofen significantly inhibits low‐voltage‐activated HVA Ca<sup>2+</sup> channels and their currents in DRG neurons [<a href="#mco270163-bib-0198" class="usa-link" aria-describedby="mco270163-bib-0198">198</a>]. Contrarily, some peptides potently inhibit the Cav2.2 channels by activating pertussis toxin‐sensitive G<sub>i/o</sub> proteins via the GABA<sub>B</sub>Rs [<a href="#mco270163-bib-0197" class="usa-link" aria-describedby="mco270163-bib-0197">197</a>, <a href="#mco270163-bib-0199" class="usa-link" aria-describedby="mco270163-bib-0199">199</a>], such as analgesic α‐conotoxin Vc1.1 and GeXIVA, contributing to relieving peripheral pain. Moreover, GINIP, a G<sub>ai</sub>‐interacting protein, is involved in the mechanical hypersensitivity in the peripheral neuropathic pain [<a href="#mco270163-bib-0200" class="usa-link" aria-describedby="mco270163-bib-0200">200</a>, <a href="#mco270163-bib-0201" class="usa-link" aria-describedby="mco270163-bib-0201">201</a>, <a href="#mco270163-bib-0202" class="usa-link" aria-describedby="mco270163-bib-0202">202</a>]. GINIP deficiency can decrease baclofen‐evoked inhibition of HVA Ca<sup>2+</sup> channels and impair presynaptic inhibition, thus blocking downstream signaling triggered by activation of G<sub>ai</sub> proteins [<a href="#mco270163-bib-0203" class="usa-link" aria-describedby="mco270163-bib-0203">203</a>].</p>
<p>Furthermore, TREK‐2, a two‐pore‐domain potassium channel, can mediate leak Kir currents [<a href="#mco270163-bib-0204" class="usa-link" aria-describedby="mco270163-bib-0204">204</a>], and TREK‐2 can be enhanced following GABA<sub>B</sub>R activation, reducing neuron excitability in the trigeminal ganglion [<a href="#mco270163-bib-0205" class="usa-link" aria-describedby="mco270163-bib-0205">205</a>]. GABA<sub>B</sub>Rs inhibit the excitability of spinal dorsal horn neurons by regulating NMDAR, affecting synaptic input and function levels in diabetic neuropathic pain [<a href="#mco270163-bib-0186" class="usa-link" aria-describedby="mco270163-bib-0186">186</a>, <a href="#mco270163-bib-0195" class="usa-link" aria-describedby="mco270163-bib-0195">195</a>]. Fibulin‐2 (extracellular matrix protein) also interacts with presynaptic GABA<sub>B</sub>Rs, regulates the presynaptic inhibition of neurotransmitter release, and weakens the GABA<sub>B</sub>‐mediated inhibitory effects [<a href="#mco270163-bib-0206" class="usa-link" aria-describedby="mco270163-bib-0206">206</a>]. An additional study has found that 14‐3‐3£ (a GABA<sub>B</sub>R1‐binding protein) interacts with GABA<sub>B</sub>R1 and impairs the downregulation of GABA<sub>B</sub> signaling in the dorsal horn [<a href="#mco270163-bib-0207" class="usa-link" aria-describedby="mco270163-bib-0207">207</a>], and negatively modulate GABA<sub>B</sub>R signaling pathways by using related peptide inhibitors of Gαo<sub>1</sub> and Gαi<sub>1–3</sub> in Het mice [<a href="#mco270163-bib-0196" class="usa-link" aria-describedby="mco270163-bib-0196">196</a>].</p>
<p>These studies indicate that GABA<sub>B</sub>Rs can relieve or alleviate neuropathic pain via their mediated slow inhibitory neurotransmission and cross‐talk regulatory interactions with important GPCR channels or receptors, such as GIRK, NMDAR, Ca<sup>2+</sup> channels, and TREK‐2 (Table <a href="#mco270163-tbl-0001" class="usa-link">1</a>). However, further research is needed on the mechanism of action and optimization of treatment regimens to reduce side effects [<a href="#mco270163-bib-0208" class="usa-link" aria-describedby="mco270163-bib-0208">208</a>, <a href="#mco270163-bib-0209" class="usa-link" aria-describedby="mco270163-bib-0209">209</a>], such as motor function impairments.</p></section><section id="mco270163-sec-0060"><h3 class="pmc_sec_title">3.3. Anxiety and Depression</h3>
<p>Anxiety disorder is a common mental disorder characterized by excessive, persistent anxiety and worry that is difficult to control and significantly impacts an individual's daily life, work, and social interactions. Preclinical and clinical studies have demonstrated that alterations in GABA<sub>B</sub>Rs are involved in anxiety‐related disorders [<a href="#mco270163-bib-0210" class="usa-link" aria-describedby="mco270163-bib-0210">210</a>, <a href="#mco270163-bib-0211" class="usa-link" aria-describedby="mco270163-bib-0211">211</a>, <a href="#mco270163-bib-0212" class="usa-link" aria-describedby="mco270163-bib-0212">212</a>]. In animal anxiety models, the use of GABABR agents or agonists can significantly reduce anxiety‐like behaviors. Clinical studies have also explored the application of drugs related to the GABA<sub>B</sub> receptor in the treatment of anxiety disorders and have already exhibited certain antianxiety effects via regulating the central GABAergic system, thereby reversing anxiety symptoms [<a href="#mco270163-bib-0113" class="usa-link" aria-describedby="mco270163-bib-0113">113</a>, <a href="#mco270163-bib-0212" class="usa-link" aria-describedby="mco270163-bib-0212">212</a>, <a href="#mco270163-bib-0213" class="usa-link" aria-describedby="mco270163-bib-0213">213</a>, <a href="#mco270163-bib-0214" class="usa-link" aria-describedby="mco270163-bib-0214">214</a>]. Additional mechanisms are associated with presynaptic and postsynaptic inhibition regulation, excitatory transmission, neuroplasticity (Figure <a href="#mco270163-fig-0001" class="usa-link">1C</a> and Table <a href="#mco270163-tbl-0001" class="usa-link">1</a>), and complex interactions with other neurotransmitter systems (such as 5‐HT) [<a href="#mco270163-bib-0215" class="usa-link" aria-describedby="mco270163-bib-0215">215</a>, <a href="#mco270163-bib-0216" class="usa-link" aria-describedby="mco270163-bib-0216">216</a>, <a href="#mco270163-bib-0217" class="usa-link" aria-describedby="mco270163-bib-0217">217</a>].</p>
<p>It is reported that <a href="https://www.ncbi.nlm.nih.gov/protein/CGP44532" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">CGP44532</a> (a GABA<sub>B</sub>R agonist) exhibits an anxiogenic‐like effect in several animal tests of anxiolytic activity [<a href="#mco270163-bib-0136" class="usa-link" aria-describedby="mco270163-bib-0136">136</a>]. The PAMs of GABA<sub>B</sub>R, including BHF177 [<a href="#mco270163-bib-0133" class="usa-link" aria-describedby="mco270163-bib-0133">133</a>, <a href="#mco270163-bib-0141" class="usa-link" aria-describedby="mco270163-bib-0141">141</a>], CGP 7930 [<a href="#mco270163-bib-0137" class="usa-link" aria-describedby="mco270163-bib-0137">137</a>], and GS39783 [<a href="#mco270163-bib-0142" class="usa-link" aria-describedby="mco270163-bib-0142">142</a>], significantly increase time spent in the open areas and attenuate anxiety‐like behaviors [<a href="#mco270163-bib-0137" class="usa-link" aria-describedby="mco270163-bib-0137">137</a>, <a href="#mco270163-bib-0143" class="usa-link" aria-describedby="mco270163-bib-0143">143</a>], displaying anxiolytic activity in behavioral experiments. Moreover, the differential modulation of targeting GABA<sub>B</sub>Rs may enhance the modulation of synaptic inhibition without significant effects on synaptic excitation and demonstrate a greatly reduced side effect [<a href="#mco270163-bib-0137" class="usa-link" aria-describedby="mco270163-bib-0137">137</a>, <a href="#mco270163-bib-0143" class="usa-link" aria-describedby="mco270163-bib-0143">143</a>, <a href="#mco270163-bib-0144" class="usa-link" aria-describedby="mco270163-bib-0144">144</a>]. Furthermore, SCH 50911 (a GABA<sub>B</sub>R antagonist) significantly produces anxiolytic‐like effects, while GABA<sub>B</sub>R agonists (baclofen and <a href="https://www.ncbi.nlm.nih.gov/protein/SKF97541" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">SKF97541</a>) produce antidepressant and anxiogenic‐like effects [<a href="#mco270163-bib-0137" class="usa-link" aria-describedby="mco270163-bib-0137">137</a>].</p>
<p>Further studies suggest that GABA<sub>B</sub>Rs are also vital for modulating the anxiety‐related symptoms induced by ethanol and nicotine exposure or other mental disorders [<a href="#mco270163-bib-0138" class="usa-link" aria-describedby="mco270163-bib-0138">138</a>, <a href="#mco270163-bib-0139" class="usa-link" aria-describedby="mco270163-bib-0139">139</a>, <a href="#mco270163-bib-0140" class="usa-link" aria-describedby="mco270163-bib-0140">140</a>, <a href="#mco270163-bib-0217" class="usa-link" aria-describedby="mco270163-bib-0217">217</a>, <a href="#mco270163-bib-0218" class="usa-link" aria-describedby="mco270163-bib-0218">218</a>]. Baclofen (GABA<sub>B</sub>R agonists) markedly inhibited locomotor behavior in high‐anxiety rats that were exposed to single‐trial nicotine‐conditioned place preference [<a href="#mco270163-bib-0138" class="usa-link" aria-describedby="mco270163-bib-0138">138</a>] and abolished the rewarding properties induced by repeated nicotine administration [<a href="#mco270163-bib-0139" class="usa-link" aria-describedby="mco270163-bib-0139">139</a>]. Interestingly, the knockout of GABA<sub>B</sub>R1 subunit can block a global withdrawal score and an anxiety‐like behaviors caused by NIC withdrawal [<a href="#mco270163-bib-0140" class="usa-link" aria-describedby="mco270163-bib-0140">140</a>]. Besides, baclofen treatment alleviates the motor deficits and the elevated anxiety symptoms in BTBR mice [<a href="#mco270163-bib-0219" class="usa-link" aria-describedby="mco270163-bib-0219">219</a>] and rats with chronic cerebral hypoperfusion [<a href="#mco270163-bib-0220" class="usa-link" aria-describedby="mco270163-bib-0220">220</a>].</p>
<p>Regarding molecular mechanisms, it was found that the 2‐OH‐saclofen administration produced similar inhibition regulations of anxiety‐like effects and somatic manifestations and prevented the c‐Fos alterations induced by NIC [<a href="#mco270163-bib-0140" class="usa-link" aria-describedby="mco270163-bib-0140">140</a>, <a href="#mco270163-bib-0217" class="usa-link" aria-describedby="mco270163-bib-0217">217</a>]. The activation of GABA<sub>B</sub>R2 could enhance the BDNF–TrkB signaling [<a href="#mco270163-bib-0220" class="usa-link" aria-describedby="mco270163-bib-0220">220</a>]. In GABAergic regulation, GABA neurons also depend on the modulation of synaptic transmission via the GABA<sub>B</sub>R‐Kir channel activation [<a href="#mco270163-bib-0144" class="usa-link" aria-describedby="mco270163-bib-0144">144</a>, <a href="#mco270163-bib-0214" class="usa-link" aria-describedby="mco270163-bib-0214">214</a>, <a href="#mco270163-bib-0221" class="usa-link" aria-describedby="mco270163-bib-0221">221</a>]. These studies demonstrate that GABA<sub>B</sub>Rs exert crucial roles in regulating anxiety disorders and may be developed as an important target for antianxiety treatment [<a href="#mco270163-bib-0211" class="usa-link" aria-describedby="mco270163-bib-0211">211</a>, <a href="#mco270163-bib-0212" class="usa-link" aria-describedby="mco270163-bib-0212">212</a>].</p>
<p>In addition, some evidence indicates that the modulation of GABA<sub>B</sub>R is involved in the pathophysiology of depressive disorders. For instance, CGP 7930 and SCH 50911 exhibited antidepressant‐like activity in the forced swimming test [<a href="#mco270163-bib-0137" class="usa-link" aria-describedby="mco270163-bib-0137">137</a>], and baclofen can block the antidepressant‐like effect of ascorbic acid and ketamine [<a href="#mco270163-bib-0222" class="usa-link" aria-describedby="mco270163-bib-0222">222</a>]. Moreover, cortical excitability and inhibition functions were assessed through the established paradigms of paired‐pulse transcranial magnetic stimulation in patients with MDD [<a href="#mco270163-bib-0145" class="usa-link" aria-describedby="mco270163-bib-0145">145</a>, <a href="#mco270163-bib-0223" class="usa-link" aria-describedby="mco270163-bib-0223">223</a>, <a href="#mco270163-bib-0224" class="usa-link" aria-describedby="mco270163-bib-0224">224</a>, <a href="#mco270163-bib-0225" class="usa-link" aria-describedby="mco270163-bib-0225">225</a>, <a href="#mco270163-bib-0226" class="usa-link" aria-describedby="mco270163-bib-0226">226</a>]. The results demonstrated that different MDD subtypes may demonstrate different functions of deficient cortical excitability and inhibition related to GABA<sub>A</sub>Rs [<a href="#mco270163-bib-0224" class="usa-link" aria-describedby="mco270163-bib-0224">224</a>, <a href="#mco270163-bib-0225" class="usa-link" aria-describedby="mco270163-bib-0225">225</a>], GABA<sub>B</sub>Rs [<a href="#mco270163-bib-0145" class="usa-link" aria-describedby="mco270163-bib-0145">145</a>, <a href="#mco270163-bib-0146" class="usa-link" aria-describedby="mco270163-bib-0146">146</a>, <a href="#mco270163-bib-0147" class="usa-link" aria-describedby="mco270163-bib-0147">147</a>], glutamatergic activity [<a href="#mco270163-bib-0147" class="usa-link" aria-describedby="mco270163-bib-0147">147</a>, <a href="#mco270163-bib-0224" class="usa-link" aria-describedby="mco270163-bib-0224">224</a>], lower short‐interval cortical inhibition, lower cortical silent period, and higher intracortical facilitation [<a href="#mco270163-bib-0147" class="usa-link" aria-describedby="mco270163-bib-0147">147</a>, <a href="#mco270163-bib-0226" class="usa-link" aria-describedby="mco270163-bib-0226">226</a>]. However, these existing reports are relatively limited, and further preclinical and clinical studies are needed to prove GABA<sub>B</sub>R modulation in MDD.</p></section><section id="mco270163-sec-0070"><h3 class="pmc_sec_title">3.4. Drug Abuse and Addiction</h3>
<p>Drug addiction is a chronic and relapsing brain disorder with significant social and health implications [<a href="#mco270163-bib-0227" class="usa-link" aria-describedby="mco270163-bib-0227">227</a>, <a href="#mco270163-bib-0228" class="usa-link" aria-describedby="mco270163-bib-0228">228</a>]. The GABA<sub>B</sub> receptor system has emerged as a crucial player in regulating drug addiction. GABA<sub>B</sub>Rs are widely distributed in the central nervous system and are involved in modulating neuronal excitability and neurotransmitter release [<a href="#mco270163-bib-0212" class="usa-link" aria-describedby="mco270163-bib-0212">212</a>, <a href="#mco270163-bib-0229" class="usa-link" aria-describedby="mco270163-bib-0229">229</a>, <a href="#mco270163-bib-0230" class="usa-link" aria-describedby="mco270163-bib-0230">230</a>]. In the context of drug addiction, drug abuse markedly disrupts the normal functions of the GABAergic system, leading to an imbalance between excitatory and inhibitory neurotransmission. Activation of GABA<sub>B</sub>Rs has been demonstrated to counteract some of the effects of drug addiction by reducing the reinforcing properties of drugs, attenuating drug‐seeking behavior, and modulating the neuroadaptations that occur in the brain following chronic drug exposure, ranging from alcohol [<a href="#mco270163-bib-0148" class="usa-link" aria-describedby="mco270163-bib-0148">148</a>, <a href="#mco270163-bib-0149" class="usa-link" aria-describedby="mco270163-bib-0149">149</a>, <a href="#mco270163-bib-0231" class="usa-link" aria-describedby="mco270163-bib-0231">231</a>, <a href="#mco270163-bib-0232" class="usa-link" aria-describedby="mco270163-bib-0232">232</a>], cocaine [<a href="#mco270163-bib-0150" class="usa-link" aria-describedby="mco270163-bib-0150">150</a>, <a href="#mco270163-bib-0233" class="usa-link" aria-describedby="mco270163-bib-0233">233</a>, <a href="#mco270163-bib-0234" class="usa-link" aria-describedby="mco270163-bib-0234">234</a>], heroin [<a href="#mco270163-bib-0235" class="usa-link" aria-describedby="mco270163-bib-0235">235</a>, <a href="#mco270163-bib-0236" class="usa-link" aria-describedby="mco270163-bib-0236">236</a>, <a href="#mco270163-bib-0237" class="usa-link" aria-describedby="mco270163-bib-0237">237</a>] to nicotine [<a href="#mco270163-bib-0139" class="usa-link" aria-describedby="mco270163-bib-0139">139</a>, <a href="#mco270163-bib-0155" class="usa-link" aria-describedby="mco270163-bib-0155">155</a>, <a href="#mco270163-bib-0236" class="usa-link" aria-describedby="mco270163-bib-0236">236</a>]. The underlying mechanisms involve the regulation of various intracellular signaling pathways [<a href="#mco270163-bib-0228" class="usa-link" aria-describedby="mco270163-bib-0228">228</a>, <a href="#mco270163-bib-0230" class="usa-link" aria-describedby="mco270163-bib-0230">230</a>, <a href="#mco270163-bib-0238" class="usa-link" aria-describedby="mco270163-bib-0238">238</a>], modulation of synaptic plasticity, and interaction with other neurotransmitter systems such as the dopaminergic and glutamatergic systems [<a href="#mco270163-bib-0239" class="usa-link" aria-describedby="mco270163-bib-0239">239</a>, <a href="#mco270163-bib-0240" class="usa-link" aria-describedby="mco270163-bib-0240">240</a>], ultimately influencing the neural circuits implicated in reward, motivation, and learning and memory processes that are dysregulated in drug addiction [<a href="#mco270163-bib-0229" class="usa-link" aria-describedby="mco270163-bib-0229">229</a>].</p>
<p>In the self‐administration patterns of alcohol drinking (AUD), re‐exposure to alcohol further induced the renewal of alcohol‐seeking behaviors in rats, increased the expression of Fos in the orbitofrontal cortex [<a href="#mco270163-bib-0151" class="usa-link" aria-describedby="mco270163-bib-0151">151</a>], the refusion of baclofen into the orbital frontal cortex (OFC) attenuated context‐induced reinstatement [<a href="#mco270163-bib-0151" class="usa-link" aria-describedby="mco270163-bib-0151">151</a>], and reduced alcohol self‐administration under the fixed ratio schedule of reinforcement [<a href="#mco270163-bib-0148" class="usa-link" aria-describedby="mco270163-bib-0148">148</a>]. Additional studies indicated that KK‐92A, rac‐BHFF, and <a href="https://www.ncbi.nlm.nih.gov/protein/ADX71441" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">ADX71441</a> are novel PAMs of GABA<sub>B</sub>Rs [<a href="#mco270163-bib-0156" class="usa-link" aria-describedby="mco270163-bib-0156">156</a>]; those treatments effectively reversed self‐administration [<a href="#mco270163-bib-0148" class="usa-link" aria-describedby="mco270163-bib-0148">148</a>, <a href="#mco270163-bib-0155" class="usa-link" aria-describedby="mco270163-bib-0155">155</a>], attenuated ethanol drinking attenuated, and improved ethanol‐induced plasticity [<a href="#mco270163-bib-0155" class="usa-link" aria-describedby="mco270163-bib-0155">155</a>], which depicts nonsedative effects. Besides, SKF 97541 (a GABA<sub>B</sub>R agonist) dose‐dependently increased and decreased sensitivity to ethanol [<a href="#mco270163-bib-0149" class="usa-link" aria-describedby="mco270163-bib-0149">149</a>] in a Drosophila model exposed to alcohol, demonstrating that GABA<sub>B</sub>Rs also play a role in alcohol sensitivity and tolerance. Moreover, the gene promoter methylation of GABA<sub>B</sub>R1 demonstrated significant tissue‐independent changes with sex‐dependent differences in AUD. These studies indicate that GABA<sub>B</sub>R PAMs and agonists have high translational potential for treating patients with severe AUD.</p>
<p>In cocaine self‐administration and cue‐induced reinstatement, baclofen‐activating GABA<sub>B</sub>Rs dose‐dependently reduced the number of active lever presses in rats [<a href="#mco270163-bib-0150" class="usa-link" aria-describedby="mco270163-bib-0150">150</a>], weakened cue‐induced reinstatement [<a href="#mco270163-bib-0150" class="usa-link" aria-describedby="mco270163-bib-0150">150</a>, <a href="#mco270163-bib-0152" class="usa-link" aria-describedby="mco270163-bib-0152">152</a>], and CGP 44532 (an agonist) significantly decreased cocaine‐induced reward enhancement in the brain stimulation reward paradigm, and inhibited the hedonic effects of cocaine [<a href="#mco270163-bib-0233" class="usa-link" aria-describedby="mco270163-bib-0233">233</a>]. Similarly, the novel GABA<sub>B</sub>‐positive modulator GS39873 and rac‐BHFF could modulate the behavioral effects of cocaine, attenuate the threshold‐lowering effect of cocaine administration, and thus suppress the rewarding effects of acute cocaine [<a href="#mco270163-bib-0157" class="usa-link" aria-describedby="mco270163-bib-0157">157</a>, <a href="#mco270163-bib-0158" class="usa-link" aria-describedby="mco270163-bib-0158">158</a>]. Further clinical trials exhibit that baclofen may inhibit the earliest drug cue‐induced motivational processing [<a href="#mco270163-bib-0241" class="usa-link" aria-describedby="mco270163-bib-0241">241</a>]. Additionally, these mechanisms are engaged in inhibitory G‐protein‐dependent feedback pathways in the VTA DA neurons [<a href="#mco270163-bib-0242" class="usa-link" aria-describedby="mco270163-bib-0242">242</a>].</p>
<p>Besides, the baclofen administration significantly decreased the number of active lever‐pressing morphine self‐administrations, reduced morphine maintenance responses [<a href="#mco270163-bib-0153" class="usa-link" aria-describedby="mco270163-bib-0153">153</a>], and inhibited the development of morphine sensitization [<a href="#mco270163-bib-0154" class="usa-link" aria-describedby="mco270163-bib-0154">154</a>]. Moreover, treatment with baclofen decreased dopamine release in the NAc [<a href="#mco270163-bib-0154" class="usa-link" aria-describedby="mco270163-bib-0154">154</a>], altered nicotine‐rewarding properties in the conditioned place preference test [<a href="#mco270163-bib-0139" class="usa-link" aria-describedby="mco270163-bib-0139">139</a>], and reversed the negative aspects of nicotine withdrawal [<a href="#mco270163-bib-0217" class="usa-link" aria-describedby="mco270163-bib-0217">217</a>]. GS39783, BHF177, and NVP998 (allosteric modulators) also display the antismoking therapy nicotine self‐administration procedure and mediate GABA<sub>B</sub>R‐regulated signaling (intracellular calcium and ERK) [<a href="#mco270163-bib-0157" class="usa-link" aria-describedby="mco270163-bib-0157">157</a>]. Baclofen reduced heroin‐seeking behavior at doses [<a href="#mco270163-bib-0235" class="usa-link" aria-describedby="mco270163-bib-0235">235</a>] and ameliorated methamphetamine‐induced prepulse inhibition (PPI) deficits and object recognition memory impairment [<a href="#mco270163-bib-0243" class="usa-link" aria-describedby="mco270163-bib-0243">243</a>].</p>
<p>Overall (Table <a href="#mco270163-tbl-0001" class="usa-link">1</a>), agonists and allosteric modulators targeting GABA<sub>B</sub>Rs are vital for modulating drug addiction. By interacting with GABA<sub>B</sub>R, D1 receptors, and their related signaling in the central nervous system, they can influence neuronal excitability and neurotransmitter release. Specifically, GABA<sub>B</sub>R activation can reduce the reinforcing effects of addictive drugs by decreasing the release of dopamine in the reward pathways of the brain. This leads to diminished craving for the drug and the suppression of drug‐seeking behaviors. Additionally, they may modulate synaptic plasticity and correct neuroadaptations that occur with chronic drug exposure, potentially aiding in the prevention of relapse and offering a promising approach to treating drug addiction. PAMs seem to have a better pharmacological therapeutic index than GABA<sub>B</sub>R agonists; therefore, further exploration of the characterized, rewarding, and aversive stimulus effects of PAM application is required.</p></section><section id="mco270163-sec-0080"><h3 class="pmc_sec_title">3.5. Schizophrenia</h3>
<p>Schizophrenia is regarded as a severe mental illness characterized by cognitive impairment and olfactory dysfunction [<a href="#mco270163-bib-0244" class="usa-link" aria-describedby="mco270163-bib-0244">244</a>, <a href="#mco270163-bib-0245" class="usa-link" aria-describedby="mco270163-bib-0245">245</a>]. The dysfunction of the GABA system has been linked to schizophrenia. Targeting GABA receptors, such as GABA<sub>A</sub> and GABA<sub>B</sub>Rs, to enhance inhibitory neurotransmission is a potential approach [<a href="#mco270163-bib-0246" class="usa-link" aria-describedby="mco270163-bib-0246">246</a>]. Targeting GABA<sub>B</sub>Rs may help in reducing hyperactivity and improving symptoms related to abnormal neuronal excitability in preventing and treating schizophrenia (Table <a href="#mco270163-tbl-0001" class="usa-link">1</a>).</p>
<p>In MK‐801‐induced animal models, it could induce behavioral deficits in the positive, negative, and cognitive symptoms of schizophrenia; baclofen and GS39783 exerted a clear antipsychotic‐like effect on the behavioral deficits [<a href="#mco270163-bib-0159" class="usa-link" aria-describedby="mco270163-bib-0159">159</a>, <a href="#mco270163-bib-0160" class="usa-link" aria-describedby="mco270163-bib-0160">160</a>], and <a href="https://www.ncbi.nlm.nih.gov/protein/SKF97541" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">SKF97541</a> (GABA<sub>B</sub>R antagonist) inhibited cAMP formation. Similarly, GS39783 (a PAM) effectively reversed MK‐801‐induced deficits in social interaction, forced swimming, and head twitch tests [<a href="#mco270163-bib-0247" class="usa-link" aria-describedby="mco270163-bib-0247">247</a>]. In prenatal PCP treatment‐induced adult mice, baclofen pretreatment significantly ameliorated behavioral hypersensitivity and PPI deficits [<a href="#mco270163-bib-0160" class="usa-link" aria-describedby="mco270163-bib-0160">160</a>, <a href="#mco270163-bib-0165" class="usa-link" aria-describedby="mco270163-bib-0165">165</a>] and decreased the c‐Fos‐positive cells in the prefrontal cortex (PFC) [<a href="#mco270163-bib-0165" class="usa-link" aria-describedby="mco270163-bib-0165">165</a>] and PnC [<a href="#mco270163-bib-0160" class="usa-link" aria-describedby="mco270163-bib-0160">160</a>]. Moreover, baclofen dose‐dependently inhibited methamphetamine‐induced cognitive impairment [<a href="#mco270163-bib-0160" class="usa-link" aria-describedby="mco270163-bib-0160">160</a>, <a href="#mco270163-bib-0161" class="usa-link" aria-describedby="mco270163-bib-0161">161</a>] and PPI impairment [<a href="#mco270163-bib-0160" class="usa-link" aria-describedby="mco270163-bib-0160">160</a>], and CGP7930 (a PAM) at doses that prevented ketamine‐induced deficits in PPI and decreased the potential in the hippocampus [<a href="#mco270163-bib-0248" class="usa-link" aria-describedby="mco270163-bib-0248">248</a>].</p>
<p>Clinical evidence demonstrates that GABA<sub>B</sub>Rs are involved in schizophrenia pathophysiology. GABA<sub>B</sub>R expression is reduced in pyramidal cells in Layer V in the entorhinal cortex and the inferior temporal cortex obtained from five patients with schizophrenia, as revealed by immunohistochemical assays [<a href="#mco270163-bib-0249" class="usa-link" aria-describedby="mco270163-bib-0249">249</a>]. In comparisons among 357 patients with treatment‐resistant schizophrenia and HC, the genetic variant analysis exhibited statistical differences for rs3749034 on GAD1 and rs10985765/rs3750344 on GABA<sub>B</sub>R2 [<a href="#mco270163-bib-0250" class="usa-link" aria-describedby="mco270163-bib-0250">250</a>]. The paired‐pulse TMS–EEG helps find that baclofen can induce a trend towards the enhancement of long‐interval intracortical inhibition, and GABA<sub>B</sub>R‐mediated cortical network abnormalities contribute to schizophrenia pathophysiology in patients [<a href="#mco270163-bib-0126" class="usa-link" aria-describedby="mco270163-bib-0126">126</a>, <a href="#mco270163-bib-0162" class="usa-link" aria-describedby="mco270163-bib-0162">162</a>].</p>
<p>Moreover, GABA<sub>B</sub>R agonists can reduce this excitability via GABAergic inhibitory mechanisms, thereby improving gamma‐band responses [<a href="#mco270163-bib-0162" class="usa-link" aria-describedby="mco270163-bib-0162">162</a>]. Contrarily, NMDA‐stimulated GABA release and GABA<sub>B</sub>R activation modulate DA release in the brain by producing feedback regulation of dopamine transporter function via the related neural projections, such as the PFC‐NAc/VTA [<a href="#mco270163-bib-0164" class="usa-link" aria-describedby="mco270163-bib-0164">164</a>, <a href="#mco270163-bib-0165" class="usa-link" aria-describedby="mco270163-bib-0165">165</a>]. Overall, GABA<sub>B</sub>Rs are part of the inhibitory neurotransmitter system and play a crucial role in schizophrenia prevention and treatment. Activation of GABA<sub>B</sub> receptors can modulate neuronal excitability in key brain regions involved in schizophrenia pathophysiology, such as the PFC and the hippocampus. Enhancing inhibitory signals may help counteract the excessive excitatory activity often observed in this disorder.</p>
<p>Hence, GABA<sub>B</sub>R agonists could potentially improve the cognitive deficits associated with schizophrenia by regulating synaptic plasticity and neurotransmitter release. They might also impact reducing positive symptoms, perhaps by modulating the activity of neural circuits related to perception and thought processes. However, further research is needed to fully understand these mechanisms and develop more effective therapeutic strategies based on GABA<sub>B</sub>R modulation in schizophrenia.</p></section><section id="mco270163-sec-0090"><h3 class="pmc_sec_title">3.6. Alzheimer's Disease and Cognitive Impairment</h3>
<p>Alzheimer's disease is a progressive neurodegenerative disorder that primarily affects the brain and is characterized by a gradual decline in learning, memory, and cognitive functions [<a href="#mco270163-bib-0251" class="usa-link" aria-describedby="mco270163-bib-0251">251</a>, <a href="#mco270163-bib-0252" class="usa-link" aria-describedby="mco270163-bib-0252">252</a>]. These cognitive impairments are accompanied by behavioral and psychological symptoms. Previous studies have specifically examined the role of GABA<sub>B</sub>Rs in cognition, learning, and memory processes under these conditions (Table <a href="#mco270163-tbl-0001" class="usa-link">1</a>). GABA<sub>B</sub>Rs are vital for synaptic plasticity, regulate neuronal excitability, and interact with other neurotransmitter systems to influence cognitive functions, hence being involved in the pathophysiological processes of Alzheimer's disease [<a href="#mco270163-bib-0113" class="usa-link" aria-describedby="mco270163-bib-0113">113</a>, <a href="#mco270163-bib-0212" class="usa-link" aria-describedby="mco270163-bib-0212">212</a>].</p>
<p>In animal models, colchicine induction significantly impaired learning and memory ability in mice, whereas treatment with CGP 36742 (an antagonist) significantly inhibited learning and memory impairment [<a href="#mco270163-bib-0170" class="usa-link" aria-describedby="mco270163-bib-0170">170</a>, <a href="#mco270163-bib-0171" class="usa-link" aria-describedby="mco270163-bib-0171">171</a>] and improved the levels of Glu, GABA, and GABA<sub>B</sub>R in the cortex and hippocampus [<a href="#mco270163-bib-0170" class="usa-link" aria-describedby="mco270163-bib-0170">170</a>]. Administration of SGS742 inhibits hippocampal CREB activity in rats by regulating the expression of transcription factors such as ATF4/CREB2 [<a href="#mco270163-bib-0171" class="usa-link" aria-describedby="mco270163-bib-0171">171</a>]. <a href="https://www.ncbi.nlm.nih.gov/protein/CGP55845" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">CGP55845</a> or <a href="https://www.ncbi.nlm.nih.gov/protein/CGP52432" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">CGP52432</a> (an antagonist) enhanced long‐term potentiation (LTP) in the Ts65Dn DG, improving synaptic plasticity [<a href="#mco270163-bib-0172" class="usa-link" aria-describedby="mco270163-bib-0172">172</a>].</p>
<p>In animal models of AD, baclofen can improve the spatial memory and learning ability of AD rats [<a href="#mco270163-bib-0166" class="usa-link" aria-describedby="mco270163-bib-0166">166</a>], activation of GABA<sub>B</sub>R reduces the oxidative stress injury (MDA, SOD, and GSH‐Px) [<a href="#mco270163-bib-0167" class="usa-link" aria-describedby="mco270163-bib-0167">167</a>], and suppresses the neuronal apoptosis, inhibiting p‐tau and Aβ formation by the PI3K/AKT signaling pathway [<a href="#mco270163-bib-0166" class="usa-link" aria-describedby="mco270163-bib-0166">166</a>]. Excessive Aβ induces the functional impairment of pyramidal neurons and their synaptic activation in hippocampus CA3, including the imbalanced excitatory potential and the decreased inhibitory potentials (IPSP). Concurrently, pharmacological modulation of the GABA<sub>B</sub>Rs can reverse the effects caused by Aβ [<a href="#mco270163-bib-0168" class="usa-link" aria-describedby="mco270163-bib-0168">168</a>], causing excitatory–inhibitory imbalance and neuronal death [<a href="#mco270163-bib-0166" class="usa-link" aria-describedby="mco270163-bib-0166">166</a>, <a href="#mco270163-bib-0168" class="usa-link" aria-describedby="mco270163-bib-0168">168</a>, <a href="#mco270163-bib-0253" class="usa-link" aria-describedby="mco270163-bib-0253">253</a>]. Moreover, partial modulation of GIRK2 channels can restore synaptic plasticity and improve impaired cognitive functions [<a href="#mco270163-bib-0168" class="usa-link" aria-describedby="mco270163-bib-0168">168</a>, <a href="#mco270163-bib-0253" class="usa-link" aria-describedby="mco270163-bib-0253">253</a>]. Consequently, targeting GABA<sub>B</sub>R/GIRK2 signaling exerts a neuroprotective effect in AD models.</p>
<p>In other brain disorders accompanied by cognitive impairment, GABA<sub>B</sub>R function is altered. Under chronic cerebral hypoperfusion, baclofen markedly reversed the downregulation of GABA<sub>B</sub>R1, GABA<sub>B</sub>R2, and protein kinase A (PKA)–AAK1 pathways [<a href="#mco270163-bib-0169" class="usa-link" aria-describedby="mco270163-bib-0169">169</a>] and restored the balance of HCN1/HCN2 surface expression in rat hippocampal CA1, alleviating memory impairment and neuronal damage. In Down syndrome (DS), the functional parameters of GABAergic synapses are markedly disrupted, including the presynaptic release of GABA, IPSC, and postsynaptic GABAB/Kir3.2 signaling [<a href="#mco270163-bib-0173" class="usa-link" aria-describedby="mco270163-bib-0173">173</a>]. However, <a href="https://www.ncbi.nlm.nih.gov/protein/CGP55845" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">CGP55845</a> (GABA<sub>B</sub>R antagonist) ameliorates the deficient synaptic plasticity and learning. In epilepsy‐related cognitive impairment, GABA<sub>B</sub>R activation can reduce seizure‐induced cognitive damage, suppress excessive neuronal activity, and protect synaptic plasticity. For instance, <a href="https://www.ncbi.nlm.nih.gov/protein/CGP35348" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">CGP35348</a> (antagonist) improved the working memory and altered LTP.</p>
<p>The above evidence supports that GABA<sub>B</sub>Rs have great potential for treating cognitive impairment and Alzheimer's disease. GABA<sub>B</sub>R‐targeted drugs or modulators may be involved in modulating synaptic plasticity via the PI3K/AKT and CREB2 pathways, regulating neuronal excitability through G‐protein‐coupled signaling pathways (GIRK2, PKA, and CREB2), and exhibiting neuroprotective and anti‐inflammatory and antioxidant properties, promoting neuronal survival. These effects may slow the progression of cognitive impairment and AD by interacting with Aβ‐related processes. However, some reports are controversial in that either activation or inhibition of GABA<sub>B</sub>Rs improves cognitive function and prevents AD in various experimental models. The complexity is associated with both GABA<sub>B</sub>R and cognitive decline, implying that further detailed investigation is needed to confirm the precise roles of GABA<sub>B</sub>R in special AD and cognitive impairment models.</p></section><section id="mco270163-sec-0100"><h3 class="pmc_sec_title">3.7. Other Mental Disorders</h3>
<p>Besides the above summary, several reports exhibit that GABA<sub>B</sub>R plays an important therapeutic modulatory role in autism disorders. In the valproic acid‐induced autism model, treatment of STX209 (a GABA<sub>B</sub>R2 agonist) ameliorated autism‑like behaviors in the locomotion activity, sociability and preference, novelty recognition and marble‑burying via improving the spine density and GABA<sub>B</sub>R2 expression in the hippocampal DG /CA1 [<a href="#mco270163-bib-0174" class="usa-link" aria-describedby="mco270163-bib-0174">174</a>] and offspring of mice, prenatal baclofen administration significantly increased density of dendritic spines in the hippocampus and medial PFC, correcting the core autism‐like behaviors in F2 mice [<a href="#mco270163-bib-0175" class="usa-link" aria-describedby="mco270163-bib-0175">175</a>]. In BTBR and Fmr1‐KO mice models, R‐baclofen treatment can improve social scores [<a href="#mco270163-bib-0176" class="usa-link" aria-describedby="mco270163-bib-0176">176</a>] and reduce repetitive self‐grooming behaviors [<a href="#mco270163-bib-0176" class="usa-link" aria-describedby="mco270163-bib-0176">176</a>, <a href="#mco270163-bib-0219" class="usa-link" aria-describedby="mco270163-bib-0219">219</a>]. Contrarily, baclofen illustrates no improvement effects on clinical autistic‐like features in patients with GABA<sub>B</sub>R1 and GABA<sub>B</sub>R2 gene variants [<a href="#mco270163-bib-0177" class="usa-link" aria-describedby="mco270163-bib-0177">177</a>]. Additionally, baclofen can restore GABA<sub>B</sub>R‐mediated inhibition and reduce network excitability in Tsc2<sup>+/−</sup> mice [<a href="#mco270163-bib-0254" class="usa-link" aria-describedby="mco270163-bib-0254">254</a>]. It is found that neurexophilin‐1 can stabilize presynaptic GABA<sub>B</sub>Rs and postsynaptic GABA<sub>A</sub>R and improve synaptic short‐term plasticity, balancing transmission at excitatory and inhibitory synapses [<a href="#mco270163-bib-0177" class="usa-link" aria-describedby="mco270163-bib-0177">177</a>].</p>
<p>Some studies also have revealed significant pathological alterations in GABA<sub>B</sub>Rs and their mediated signaling pathways in Parkinson's disease [<a href="#mco270163-bib-0212" class="usa-link" aria-describedby="mco270163-bib-0212">212</a>, <a href="#mco270163-bib-0255" class="usa-link" aria-describedby="mco270163-bib-0255">255</a>, <a href="#mco270163-bib-0256" class="usa-link" aria-describedby="mco270163-bib-0256">256</a>], insomnia [<a href="#mco270163-bib-0256" class="usa-link" aria-describedby="mco270163-bib-0256">256</a>, <a href="#mco270163-bib-0257" class="usa-link" aria-describedby="mco270163-bib-0257">257</a>], bipolar disorder [<a href="#mco270163-bib-0258" class="usa-link" aria-describedby="mco270163-bib-0258">258</a>, <a href="#mco270163-bib-0259" class="usa-link" aria-describedby="mco270163-bib-0259">259</a>], and DS [<a href="#mco270163-bib-0172" class="usa-link" aria-describedby="mco270163-bib-0172">172</a>, <a href="#mco270163-bib-0253" class="usa-link" aria-describedby="mco270163-bib-0253">253</a>]. Although dysfunction of GABA<sub>B</sub>R‐mediated inhibition may be involved in the development of these behavioral phenotypes, various strategies for targeting GABA<sub>B</sub>Rs, such as agonism, antagonism, and PAM, should be further investigated to confirm their therapeutic values and thus be developed as precise treatments for each neuropsychiatric and neurodegenerative disorder.</p>
<p>In general, GABA<sub>B</sub>Rs demonstrate excellent therapeutic promises in preventing and treating various mental disorders, mainly including epilepsy, anxiety and depression, drug addiction, pain‐related disorders, schizophrenia, Alzheimer's disease, and cognitive impairment (Table <a href="#mco270163-tbl-0001" class="usa-link">1</a>). On one hand, GABA<sub>B</sub>Rs can reduce the release of excitatory neurotransmitters through presynaptic inhibition, and regulate the hyperpolarization of the postsynaptic membrane via the GABA<sub>B</sub>R–GIRK channel currents, and thus contribute to maintaining the balance between excitation and inhibition. On the other hand, the special agonists and PAMs of GABA<sub>B</sub>R can interfere with the reward system by modulating the release of dopamine, influence the salience of stimuli and the formation of memories associated with rewarding or aversive experiences, and be involved in the psychiatric reward‐related learning, motivation, and cognitive processes in mental disorders, such as drug addiction. Additionally, the GABA<sub>B</sub>R‐triggered cAMP‐dependent signaling cascades are also involved in the regulation of the excitatory–inhibitory balance and synaptic plasticity, such as PI3K/AKT and its downstream signals (CREB2) in the PFC and other areas. More interestingly, these studies also reveal the special pathophysiological alternations of GABA<sub>B</sub>Rs and vital signaling pathways in different brain areas, and may exert different effects in each neuropsychiatric disorder.</p>
<p>There is another question that has been reported some unwanted side effects are produced by agonist or antagonists of directly targeting GABA<sub>B</sub>Rs, including tolerance, sedation, and motor impairment at higher doses. Hence, to avoid these undesirable effects, a unique class of neuroactivity agents should be developed to direct at special physiologic and pathologic processes involving GABA<sub>B</sub>Rs in the different neuropsychiatric disorders. Currently, allosteric modulators might represent a novel approach to have great potentials with fewer side effects. In the further, small allosteric modulators of targeting GABA<sub>B</sub>Rs will be further explored to highlight the therapeutic values in the treatment of mental disorders. In addition to the above‐mentioned brain psychiatric disorders, GABA<sub>B</sub>R‐associated small molecules also play a crucial role in regulating the pathological alternations and behavioral phenotypes involving both central and peripheral processes, such as abnormal eating and metabolism. In the next section, we will provide further detailed summary and discussions on uncovered roles of different GABA<sub>B</sub>R‐targeting strategies in nutrition and metabolism disorders.</p></section></section><section id="mco270163-sec-0110"><h2 class="pmc_sec_title">4. Effects in Nutrition and Metabolism Disorders</h2>
<p>Preclinical and clinical studies have indicated that the binding of agonists or antagonists to GB1/2‐regulating sites in GABA promotes or suppresses food intake or disordered eating [<a href="#mco270163-bib-0064" class="usa-link" aria-describedby="mco270163-bib-0064">64</a>, <a href="#mco270163-bib-0066" class="usa-link" aria-describedby="mco270163-bib-0066">66</a>, <a href="#mco270163-bib-0086" class="usa-link" aria-describedby="mco270163-bib-0086">86</a>] in the nutrition and metabolism disorders. However, the pharmacodynamics of GABA<sub>B</sub>R‐targeted agents in the treatment of BE‐related behaviors or disorders and obesity remain relatively lacking (Figure <a href="#mco270163-fig-0001" class="usa-link">1E</a>), the treatment effects and therapeutic safety need to be further assessed and verified. It is imperative to further evaluate the regulatory effects of GABA<sub>B</sub>R‐targeting agents, including antagonists, agonists, and especially PAMs (Figure <a href="#mco270163-fig-0002" class="usa-link">2</a>), on feeding, BE, food addiction, and obesity; analyze their effectiveness, safety, and therapeutic indices; and explore their mechanism, application prospects, and effects on signaling pathways downstream of GABA<sub>B</sub>Rs. Next, we mainly discussed the physiological regulations and pathological roles in the feeding and metabolism disorders.</p>
<section id="mco270163-sec-0120"><h3 class="pmc_sec_title">4.1. Feeding Behaviors</h3>
<p>The interplay of various brain networks is involved in homeostatic mechanisms versus nonhomeostatic in the ingestive behavior [<a href="#mco270163-bib-0013" class="usa-link" aria-describedby="mco270163-bib-0013">13</a>, <a href="#mco270163-bib-0260" class="usa-link" aria-describedby="mco270163-bib-0260">260</a>]. The hypothalamus is as the primary brain satiety area within the homeostatic system that regulates food ingestion and energy balance [<a href="#mco270163-bib-0261" class="usa-link" aria-describedby="mco270163-bib-0261">261</a>, <a href="#mco270163-bib-0262" class="usa-link" aria-describedby="mco270163-bib-0262">262</a>]; normal ingestive behavior is under the control of the extended reward network that mainly includes the NAc, VTA, and the substantia nigra, and is regulated by cognitive network regions, including the PFC [<a href="#mco270163-bib-0013" class="usa-link" aria-describedby="mco270163-bib-0013">13</a>]. Interestingly, GABA<sub>B</sub>Rs play a key role in feeding behaviors [<a href="#mco270163-bib-0067" class="usa-link" aria-describedby="mco270163-bib-0067">67</a>, <a href="#mco270163-bib-0263" class="usa-link" aria-describedby="mco270163-bib-0263">263</a>, <a href="#mco270163-bib-0264" class="usa-link" aria-describedby="mco270163-bib-0264">264</a>, <a href="#mco270163-bib-0265" class="usa-link" aria-describedby="mco270163-bib-0265">265</a>], which also involves feeding neurocircuits and the different functional CNS regions that are mentioned above, mainly including the metabolic homeostasis‐related hypothalamic ARC, DMH and LH [<a href="#mco270163-bib-0061" class="usa-link" aria-describedby="mco270163-bib-0061">61</a>, <a href="#mco270163-bib-0063" class="usa-link" aria-describedby="mco270163-bib-0063">63</a>], the reward‐related NAc and VTA [<a href="#mco270163-bib-0023" class="usa-link" aria-describedby="mco270163-bib-0023">23</a>, <a href="#mco270163-bib-0029" class="usa-link" aria-describedby="mco270163-bib-0029">29</a>, <a href="#mco270163-bib-0060" class="usa-link" aria-describedby="mco270163-bib-0060">60</a>, <a href="#mco270163-bib-0086" class="usa-link" aria-describedby="mco270163-bib-0086">86</a>], and the PFC involved in decision‐making and executive control [<a href="#mco270163-bib-0023" class="usa-link" aria-describedby="mco270163-bib-0023">23</a>, <a href="#mco270163-bib-0024" class="usa-link" aria-describedby="mco270163-bib-0024">24</a>, <a href="#mco270163-bib-0029" class="usa-link" aria-describedby="mco270163-bib-0029">29</a>]. Based on the distribution of GABA<sub>B</sub>Rs in the different brain regions, we provided a comprehensive overview of the related neuromodulations and circuit pathways involving GABA<sub>B</sub>Rs in various brain regions and their impact on feeding behaviors; further discussed the specific effects and differences of GABA<sub>B</sub>R‐targeted agents on feeding and the underlying mechanisms (Figure <a href="#mco270163-fig-0003" class="usa-link">3</a> and Table <a href="#mco270163-tbl-0002" class="usa-link">2</a>).</p>
<figure class="fig xbox font-sm" id="mco270163-fig-0003"><h4 class="obj_head">FIGURE 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50fe/12000685/230b1b913baa/MCO2-6-e70163-g003.jpg" loading="lazy" id="jats-graphic-7" height="471" width="600" alt="FIGURE 3"></p>
<div class="p text-right font-secondary"><a href="figure/mco270163-fig-0003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Neuromodulatory effects of GABA<sub>B</sub>Rs on normal feeding behaviors and related neural circuits in the brain different regions of CNS. Evidence has shown that activation of GABA<sub>B</sub>Rs in different regions of the CNS significantly regulates feeding behaviors under normal conditions.</p></figcaption></figure><section class="tw xbox font-sm" id="mco270163-tbl-0002"><h4 class="obj_head">TABLE 2.</h4>
<div class="caption p"><p>Summarized effects of targeted GABA<sub>B</sub>R or administration of baclofen on feeding behaviors.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead><tr style="border-bottom:solid 1px #000000">
<th align="left" rowspan="1" colspan="1">Model</th>
<th align="center" rowspan="1" colspan="1">Compounds</th>
<th align="center" rowspan="1" colspan="1">Administration</th>
<th align="center" rowspan="1" colspan="1">Effects</th>
<th align="center" rowspan="1" colspan="1">Targeting</th>
<th align="center" rowspan="1" colspan="1">References</th>
</tr></thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">Male rats: normal diet</td>
<td align="center" rowspan="1" colspan="1">Baclofen</td>
<td align="center" rowspan="1" colspan="1">I.P.: 1, 4 mg/kg</td>
<td align="center" rowspan="1" colspan="1">
<p>↑ Food intake</p>
<p>‐ Normal diet</p>
</td>
<td align="center" rowspan="1" colspan="1">GABA<sub>B</sub>R</td>
<td align="center" rowspan="1" colspan="1">[<a href="#mco270163-bib-0266" class="usa-link" aria-describedby="mco270163-bib-0266">266</a>]</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Rat: satiated normal diet</td>
<td align="center" rowspan="1" colspan="1">Baclofen</td>
<td align="center" rowspan="1" colspan="1">S.C.: 1–4 mg/kg</td>
<td align="center" rowspan="1" colspan="1">↑ Food intake</td>
<td align="center" rowspan="1" colspan="1">GABA<sub>B</sub>R</td>
<td align="center" rowspan="1" colspan="1">[<a href="#mco270163-bib-0267" class="usa-link" aria-describedby="mco270163-bib-0267">267</a>]</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Pigs: normal diet</td>
<td align="center" rowspan="1" colspan="1">
<p>GABA</p>
<p>Muscimol</p>
</td>
<td align="center" rowspan="1" colspan="1">ICV: 25–200 nmol</td>
<td align="center" rowspan="1" colspan="1">↑ Food intake</td>
<td align="center" rowspan="1" colspan="1">GABA<sub>B</sub>R</td>
<td align="center" rowspan="1" colspan="1">[<a href="#mco270163-bib-0268" class="usa-link" aria-describedby="mco270163-bib-0268">268</a>]</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Male Wister rats: non‐deprived deprived‐food</td>
<td align="center" rowspan="1" colspan="1">Baclofen</td>
<td align="center" rowspan="1" colspan="1">I.P.: 1–4 mg/kg</td>
<td align="center" rowspan="1" colspan="1">
<p>↑ Nondeprived</p>
<p>‐ Deprived</p>
</td>
<td align="center" rowspan="1" colspan="1">GABA<sub>B</sub>R</td>
<td align="center" rowspan="1" colspan="1">[<a href="#mco270163-bib-0269" class="usa-link" aria-describedby="mco270163-bib-0269">269</a>]</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Male SD rats: normal diet</td>
<td align="center" rowspan="1" colspan="1">
<p>Baclofen</p>
<p>Muscimol</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>AcbSh:</p>
<p>0–876 pmol</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>↑ Feeding</p>
<p>↓ Food intake</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>GABA<sub>B</sub>R</p>
<p>GABA<sub>A</sub>R</p>
</td>
<td align="center" rowspan="1" colspan="1">[<a href="#mco270163-bib-0270" class="usa-link" aria-describedby="mco270163-bib-0270">270</a>]</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Male SD rats: imbalanced diet</td>
<td align="center" rowspan="1" colspan="1">
<p>NYP</p>
<p>Muscimol</p>
<p>Phaclofen</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>AIC:</p>
<p>2 nmol</p>
<p>79 pmol</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>↓ Thr‐basal diet</p>
<p>↓ Basal diet</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>Peptides</p>
<p>GABA receptors</p>
<p>↓ Pyramidal cells</p>
</td>
<td align="center" rowspan="1" colspan="1">[<a href="#mco270163-bib-0271" class="usa-link" aria-describedby="mco270163-bib-0271">271</a>]</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Lister rats: runway states normal diet</td>
<td align="center" rowspan="1" colspan="1">Baclofen</td>
<td align="center" rowspan="1" colspan="1">
<p>I.P.:</p>
<p>1–4 mg/kg</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>↑ Food intake:1 mg/kg</p>
<p>↑ Running speed</p>
<p>‐ Food intake: 2 /4mg/kg</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>Targeted GABA<sub>B</sub>R</p>
<p>Complex appetites</p>
</td>
<td align="center" rowspan="1" colspan="1">[<a href="#mco270163-bib-0272" class="usa-link" aria-describedby="mco270163-bib-0272">272</a>]</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Female rats: fasted, satiated</td>
<td align="center" rowspan="1" colspan="1">
<p>Muscimol</p>
<p>Baclofen</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>Amygdala: CNA</p>
<p>0.05–1 nmol</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>↓ Palatable food</p>
<p>↓ Deprived of food</p>
</td>
<td align="center" rowspan="1" colspan="1">Activated GABA<sub>A</sub>R</td>
<td align="center" rowspan="1" colspan="1">[<a href="#mco270163-bib-0273" class="usa-link" aria-describedby="mco270163-bib-0273">273</a>]</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Female mice: ovariectomized or normal diet</td>
<td align="center" rowspan="1" colspan="1">
<p>E2</p>
<p>DOI</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>ICV:</p>
<p>20 µM</p>
<p>50 nM</p>
</td>
<td align="center" rowspan="1" colspan="1">↓ Feeding</td>
<td align="center" rowspan="1" colspan="1">
<p>Desensitize</p>
<p>↓ GABA<sub>B</sub>R</p>
<p>↓ 5‐HT<sub>1A</sub>R</p>
</td>
<td align="center" rowspan="1" colspan="1">[<a href="#mco270163-bib-0274" class="usa-link" aria-describedby="mco270163-bib-0274">274</a>]</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Male Wistar rats: nondeprived states peripherally</td>
<td align="center" rowspan="1" colspan="1">
<p>CCK</p>
<p>Baclofen</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>IP: 5 pg/kg</p>
<p>SC: 2 mg/kg</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>‐ Food intake</p>
<p>↓ Food intake</p>
<p>↓ Effects of CCK</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>↓ Release of CCK</p>
<p>CCK: ↓ food intake</p>
</td>
<td align="center" rowspan="1" colspan="1">[<a href="#mco270163-bib-0275" class="usa-link" aria-describedby="mco270163-bib-0275">275</a>]</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Male SD rats: satiated states normal diet</td>
<td align="center" rowspan="1" colspan="1">
<p>Muscimol</p>
<p>Bicuculline</p>
<p>LH: AP‐5</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>LH: 500 ng</p>
<p>AcbSh:100 ng</p>
<p>10–200 ng</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>↑ Food intake</p>
<p>‐ Food intake</p>
<p>↓ AcbSh‐mediated feeding</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>NMDA</p>
<p>Activated GABA<sub>A</sub>R</p>
<p>Targeted GABA<sub>B</sub>R</p>
<p>AcbSh–VPm–LH</p>
</td>
<td align="center" rowspan="1" colspan="1">[<a href="#mco270163-bib-0083" class="usa-link" aria-describedby="mco270163-bib-0083">83</a>]</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<p>Adult male</p>
<p>Albino SD rats</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>Baclofen</p>
<p>Saclofen</p>
<p>Bicuculline</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>NAc shell/VTA:</p>
<p>200 ng, 1.5–5 µg</p>
<p>150 ng</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>↑ Feeding in VTA, NAc</p>
<p>↓ Baclofen‐elicited</p>
<p>feeding</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>GABA<sub>A</sub>R, GABA<sub>B</sub>R</p>
<p>With opioid receptors</p>
</td>
<td align="center" rowspan="1" colspan="1">[<a href="#mco270163-bib-0080" class="usa-link" aria-describedby="mco270163-bib-0080">80</a>, <a href="#mco270163-bib-0276" class="usa-link" aria-describedby="mco270163-bib-0276">276</a>]</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Male SD rats: normal diet</td>
<td align="center" rowspan="1" colspan="1">
<p>CGP‐35348</p>
<p>R‐baclofen</p>
<p>CGP‐35348</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>LH:100–400 pmol</p>
<p>4.4–17.6 nmol</p>
<p>34–936 pmol</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>↑ Food intake</p>
<p>‐ Food intake</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>GABA<sub>A</sub>R</p>
<p>Not GABA<sub>B</sub>R</p>
</td>
<td align="center" rowspan="1" colspan="1">[<a href="#mco270163-bib-0277" class="usa-link" aria-describedby="mco270163-bib-0277">277</a>]</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Male SD rats: SA</td>
<td align="center" rowspan="1" colspan="1">Baclofen</td>
<td align="center" rowspan="1" colspan="1">LS: 1.7 nmol</td>
<td align="center" rowspan="1" colspan="1">↓ Anorectic effects</td>
<td align="center" rowspan="1" colspan="1">GABA<sub>B</sub>R</td>
<td align="center" rowspan="1" colspan="1">[<a href="#mco270163-bib-0278" class="usa-link" aria-describedby="mco270163-bib-0278">278</a>]</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Male SD rats: normal diet</td>
<td align="center" rowspan="1" colspan="1">
<p>Bicuculline</p>
<p>Muscimol</p>
<p>Baclofen</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>VTA: 7.5–75 ng</p>
<p>200–500 ng</p>
<p>200 ng</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>Opioid: ↑ feeding in VTA</p>
<p>Naltrexone: ↓ baclofen‐</p>
<p>induced intake</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>GABA<sub>B</sub>R</p>
<p>Opioid receptors</p>
<p>Coregulation in VTA</p>
</td>
<td align="center" rowspan="1" colspan="1">[<a href="#mco270163-bib-0279" class="usa-link" aria-describedby="mco270163-bib-0279">279</a>]</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Male Wistar rats: vagally stimulate</td>
<td align="center" rowspan="1" colspan="1">Baclofen</td>
<td align="center" rowspan="1" colspan="1">I.P.: 2 mg/kg/day</td>
<td align="center" rowspan="1" colspan="1">
<p>‐ Food intake</p>
<p>↓ Effect of MC</p>
<p>↑ Gastric motility</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>GABA<sub>B</sub>R</p>
<p>Vagal nerve stimulation</p>
</td>
<td align="center" rowspan="1" colspan="1">[<a href="#mco270163-bib-0280" class="usa-link" aria-describedby="mco270163-bib-0280">280</a>]</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Male SD rats: nonfasted states</td>
<td align="center" rowspan="1" colspan="1">Baclofen</td>
<td align="center" rowspan="1" colspan="1">S.C: 1.0–4.0 mg/kg</td>
<td align="center" rowspan="1" colspan="1">↑ Food intake in free a paradigm for 90 min</td>
<td align="center" rowspan="1" colspan="1">GABA<sub>B</sub>R</td>
<td align="center" rowspan="1" colspan="1">[<a href="#mco270163-bib-0281" class="usa-link" aria-describedby="mco270163-bib-0281">281</a>]</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/mco270163-tbl-0002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="mco270163-tbl2-note-0001"><p>Abbreviations: ↑, enhance or improve with significant differences; ↓, downregulate or inhibit with significant differences; ‐, no significant effects; AcbSh, NAc shell; AIC, anterior piriform cortex; CAN, central nucleus of the amygdala; CCK, cholecystokinin; ICV, intracerebroventricular; I.P., intraperitoneal; LS, lateral septum; MC, microchip stimulator; S.C., subcutaneous; SD, Sprague–Dawley.</p></div></div></section><section id="mco270163-sec-0130"><h4 class="pmc_sec_title">4.1.1. Metabolic Homeostasis: The Hypothalamus</h4>
<p>The hypothalamus acts as a hub that integrates information from the CNS and peripheral signals with the external environment [<a href="#mco270163-bib-0013" class="usa-link" aria-describedby="mco270163-bib-0013">13</a>, <a href="#mco270163-bib-0022" class="usa-link" aria-describedby="mco270163-bib-0022">22</a>, <a href="#mco270163-bib-0060" class="usa-link" aria-describedby="mco270163-bib-0060">60</a>, <a href="#mco270163-bib-0282" class="usa-link" aria-describedby="mco270163-bib-0282">282</a>], such as food availability and stress [<a href="#mco270163-bib-0010" class="usa-link" aria-describedby="mco270163-bib-0010">10</a>]. There is no doubt that GABA and GABAergic neurons in the hypothalamic feeding center play a role in promoting or regulating food intake [<a href="#mco270163-bib-0042" class="usa-link" aria-describedby="mco270163-bib-0042">42</a>, <a href="#mco270163-bib-0061" class="usa-link" aria-describedby="mco270163-bib-0061">61</a>, <a href="#mco270163-bib-0062" class="usa-link" aria-describedby="mco270163-bib-0062">62</a>, <a href="#mco270163-bib-0063" class="usa-link" aria-describedby="mco270163-bib-0063">63</a>].</p>
<p>The existing evidence suggests that GABA<sub>B</sub>R neuromodulation in the LH improves feeding behaviors [<a href="#mco270163-bib-0010" class="usa-link" aria-describedby="mco270163-bib-0010">10</a>, <a href="#mco270163-bib-0083" class="usa-link" aria-describedby="mco270163-bib-0083">83</a>, <a href="#mco270163-bib-0277" class="usa-link" aria-describedby="mco270163-bib-0277">277</a>]. Microinjection of picrotoxin into the tuberal‐LH increased food intake, whereas microinjection of this drug into the anterior or posterior LH had no effect [<a href="#mco270163-bib-0277" class="usa-link" aria-describedby="mco270163-bib-0277">277</a>]. While neither blockade nor activation of GABA<sub>B</sub>Rs affected feeding behaviors in satiated rats, partial antagonism of GABA<sub>A</sub>Rs in the LH regulated feeding behavior [<a href="#mco270163-bib-0277" class="usa-link" aria-describedby="mco270163-bib-0277">277</a>]. Furthermore, injections of AP‐5 (an NMDA blocker) into the LH blocked the activation of LH neurons and suppressed NAc shell (AcbSh)‐mediated feeding [<a href="#mco270163-bib-0083" class="usa-link" aria-describedby="mco270163-bib-0083">83</a>]. In contrast, injections of bicuculline (a GABA<sub>A</sub>R blocker) or baclofen did not significantly affect food intake [<a href="#mco270163-bib-0083" class="usa-link" aria-describedby="mco270163-bib-0083">83</a>]. Injection of orexin A into the rostral LH induced feeding via GABAergic transmission, muscimol (a GABA<sub>A</sub>R agonist) significantly inhibited an increase in food intake, but baclofen showed no effects; in additions, in vivo GABA release within the rostral LH significantly coincided with orexin A‐induced feeding [<a href="#mco270163-bib-0283" class="usa-link" aria-describedby="mco270163-bib-0283">283</a>], indicating that projections from the LH to the NAc and GABAergic transmission may mediate feeding behaviors involving NMDA and GABA<sub>A</sub>R.</p>
<p>In addition, baclofen (a GABA<sub>B</sub>R agonist) significantly decreased NYP expression levels and significantly increased proopiomelanocortin (POMC) mRNA levels in the ARC in diabetic and diet‐induced obese mice [<a href="#mco270163-bib-0284" class="usa-link" aria-describedby="mco270163-bib-0284">284</a>]. Blood glucose and HbA1c levels decreased significantly and plasma leptin levels increased significantly increased in the baclofen groups, and the weight of epididymal WAT decreased significantly [<a href="#mco270163-bib-0284" class="usa-link" aria-describedby="mco270163-bib-0284">284</a>], indicating that GABA<sub>B</sub>R agonists decreased excessive adipose stores in obese subjects at least partially via the ARC. Direct injection of baclofen into the LH reduced the anorectic effects of stress and increased the consumption of sucrose [<a href="#mco270163-bib-0278" class="usa-link" aria-describedby="mco270163-bib-0278">278</a>, <a href="#mco270163-bib-0285" class="usa-link" aria-describedby="mco270163-bib-0285">285</a>].</p>
<p>The LH and ARC are vital regions for integration of feeding information and have extensive connections with other hypothalamic and multiple extrahypothalamic brain regions [<a href="#mco270163-bib-0029" class="usa-link" aria-describedby="mco270163-bib-0029">29</a>, <a href="#mco270163-bib-0065" class="usa-link" aria-describedby="mco270163-bib-0065">65</a>]. The current data indicate that orexin and GABAergic signaling within the LH and ARC is important for the regulation of appetite and feeding [<a href="#mco270163-bib-0286" class="usa-link" aria-describedby="mco270163-bib-0286">286</a>, <a href="#mco270163-bib-0287" class="usa-link" aria-describedby="mco270163-bib-0287">287</a>]. It seems that orexin, GABA<sub>A</sub>Rs, and NMDA receptors but not GABA<sub>B</sub>Rs in the LH have a vital role in feeding regulation, but regulation of GABA<sub>B</sub>Rs in the ARC but not the LH is associated with overeating and the decreased anorectic effects induced by neuropathological states [<a href="#mco270163-bib-0285" class="usa-link" aria-describedby="mco270163-bib-0285">285</a>], demonstrating different effects in a brain‐subregion dependence manner. As GABAergic neurons in the LH coexpress GAD67, leptin receptor and melanin‐concentrating hormone [<a href="#mco270163-bib-0042" class="usa-link" aria-describedby="mco270163-bib-0042">42</a>, <a href="#mco270163-bib-0061" class="usa-link" aria-describedby="mco270163-bib-0061">61</a>, <a href="#mco270163-bib-0062" class="usa-link" aria-describedby="mco270163-bib-0062">62</a>, <a href="#mco270163-bib-0063" class="usa-link" aria-describedby="mco270163-bib-0063">63</a>], GABA<sub>B</sub>Rs may interact with them, be mediated by projections to the LH [<a href="#mco270163-bib-0079" class="usa-link" aria-describedby="mco270163-bib-0079">79</a>, <a href="#mco270163-bib-0288" class="usa-link" aria-describedby="mco270163-bib-0288">288</a>, <a href="#mco270163-bib-0289" class="usa-link" aria-describedby="mco270163-bib-0289">289</a>, <a href="#mco270163-bib-0290" class="usa-link" aria-describedby="mco270163-bib-0290">290</a>], and thus be compensated by these neuroprojections.</p></section><section id="mco270163-sec-0140"><h4 class="pmc_sec_title">4.1.2. Rewards Encoding: the NAc and VTA</h4>
<p>The NAc and VTA, serving as major hubs of the brain reward circuitry, play crucial roles in the motivational and rewarding aspects of food seeking [<a href="#mco270163-bib-0291" class="usa-link" aria-describedby="mco270163-bib-0291">291</a>]; dysfunction of these reward processes may contribute to the pathogenesis of abnormal feeding and obesity [<a href="#mco270163-bib-0010" class="usa-link" aria-describedby="mco270163-bib-0010">10</a>, <a href="#mco270163-bib-0292" class="usa-link" aria-describedby="mco270163-bib-0292">292</a>]. The GABAergic system and GABA<sub>B</sub>Rs may be involved in mediating feeding behaviors via a widely distributed reward network within the NAc and VTA [<a href="#mco270163-bib-0079" class="usa-link" aria-describedby="mco270163-bib-0079">79</a>, <a href="#mco270163-bib-0292" class="usa-link" aria-describedby="mco270163-bib-0292">292</a>, <a href="#mco270163-bib-0293" class="usa-link" aria-describedby="mco270163-bib-0293">293</a>, <a href="#mco270163-bib-0294" class="usa-link" aria-describedby="mco270163-bib-0294">294</a>].</p>
<p>Microinjection of baclofen into the NAc shell or VTA significantly resulted in a substantial rise in food consumption above baseline levels [<a href="#mco270163-bib-0080" class="usa-link" aria-describedby="mco270163-bib-0080">80</a>]. In the NAc shell, GABA agonists decreased the firing rate of a population of local neurons and inhibited their neuronal activity [<a href="#mco270163-bib-0270" class="usa-link" aria-describedby="mco270163-bib-0270">270</a>]. Baclofen and muscimol (administration into the NAc shell, 0–876 pmol) significantly increased food intake and feeding at all doses [<a href="#mco270163-bib-0270" class="usa-link" aria-describedby="mco270163-bib-0270">270</a>]. In additions, an increase in local GABA levels elicited robust feeding in satiated rats [<a href="#mco270163-bib-0270" class="usa-link" aria-describedby="mco270163-bib-0270">270</a>]. These results demonstrate that activation of either GABA<sub>A</sub>Rs or GABA<sub>B</sub>Rs near the NAc shell and VTA is sufficient to increase food intake and that administration of endogenous GABA or baclofen into the NAc shell has a pronounced but specific effect on feeding behavior.</p>
<p>The interactions between GABA<sub>B</sub>Rs and GABA<sub>A</sub>Rs or opioid receptors occur within neural circuits between the NAc and VTA [<a href="#mco270163-bib-0080" class="usa-link" aria-describedby="mco270163-bib-0080">80</a>, <a href="#mco270163-bib-0295" class="usa-link" aria-describedby="mco270163-bib-0295">295</a>, <a href="#mco270163-bib-0296" class="usa-link" aria-describedby="mco270163-bib-0296">296</a>, <a href="#mco270163-bib-0297" class="usa-link" aria-describedby="mco270163-bib-0297">297</a>, <a href="#mco270163-bib-0298" class="usa-link" aria-describedby="mco270163-bib-0298">298</a>]. Pretreatment of saclofen (a antagonists, microinjection into the VTA) significantly decreased baclofen (microinjection into the NAc)‐induced food intake enhancement; following injection of saclofen into the VTA, injection of baclofen into the NAc did not significantly increase food intake, whereas following administration of saclofen into the NAc shell, injection of baclofen into the VTA affected food intake; moreover, preinjection of bicuculline into the VTA significantly decreased feeding induced by administration of baclofen into the NAc, whereas administration of baclofen into the VTA after preinjection of bicuculline into the VTA had no effects. Thus, although not to the same extent, induction of feeding by microinjection of baclofen into the VTA depended on the activity of GABA<sub>B</sub>Rs in the NAc shell [<a href="#mco270163-bib-0080" class="usa-link" aria-describedby="mco270163-bib-0080">80</a>], and induction of feeding by microinjection of baclofen into the NAc shell partially depended on the activity of GABA<sub>B</sub>Rs and GABA<sub>A</sub>Rs in the VTA [<a href="#mco270163-bib-0080" class="usa-link" aria-describedby="mco270163-bib-0080">80</a>].</p>
<p>In addition to GABA receptors, multiple selective opioid receptors in the VTA can significantly enhance feeding behaviors [<a href="#mco270163-bib-0276" class="usa-link" aria-describedby="mco270163-bib-0276">276</a>, <a href="#mco270163-bib-0279" class="usa-link" aria-describedby="mco270163-bib-0279">279</a>]. DAMGO (an μ‐opioid agonist, microinjection into the VTA) increased food intake after 2 and 4 h, but this effect was altered by preinjection of an equimolar dose of bicuculline or saclofen into the same site in the VTA [<a href="#mco270163-bib-0279" class="usa-link" aria-describedby="mco270163-bib-0279">279</a>]. Injection of bicuculline alone into the VTA did not alter baseline food intake, whereas injection of muscimol alone into the VTA significantly increased food intake [<a href="#mco270163-bib-0279" class="usa-link" aria-describedby="mco270163-bib-0279">279</a>]. Furthermore, feeding induced by baclofen administration was significantly inhibited by preinjection of naltrexone into the VTA [<a href="#mco270163-bib-0279" class="usa-link" aria-describedby="mco270163-bib-0279">279</a>]; preinjection of a kappa opioid antagonist into the VTA significantly reduced the increase in food consumption elicited by injection of baclofen into the NAc shell [<a href="#mco270163-bib-0276" class="usa-link" aria-describedby="mco270163-bib-0276">276</a>]. Thus, GABA<sub>B</sub> and μ‐opioid receptors in the VTA and NAc coregulate feeding [<a href="#mco270163-bib-0279" class="usa-link" aria-describedby="mco270163-bib-0279">279</a>], indicating the presence and coregulation of GABAergic and enkephalinergic neurons in both regions.</p>
<p>The existing results above imply that GABA<sub>B</sub>Rs and GABA<sub>A</sub>Rs are involved in the regulations of feeding behaviors, and obviously interactions with intact opioid receptors, mainly mu and delta opioid receptors [<a href="#mco270163-bib-0276" class="usa-link" aria-describedby="mco270163-bib-0276">276</a>]. Activated opioid receptors inhibit local GABAergic interneurons in the VTA and NAc, and opioids act through mu and kappa opioid receptors in the VTA. GABA<sub>B</sub>R and opioid receptor signaling in the VTA and NAc can synergize and engage in crosstalk to mediate feeding behaviors (Figure <a href="#mco270163-fig-0003" class="usa-link">3</a> and Table <a href="#mco270163-tbl-0002" class="usa-link">2</a>).</p></section><section id="mco270163-sec-0150"><h4 class="pmc_sec_title">4.1.3. Control and Decision: the Cortex</h4>
<p>Motivating factors, emotional cues, and certain cognitive functions can play important roles in overeating or BE, food addiction, and obesity, which are related to the functions of the ventral striatum, PFC, and OFC [<a href="#mco270163-bib-0064" class="usa-link" aria-describedby="mco270163-bib-0064">64</a>, <a href="#mco270163-bib-0077" class="usa-link" aria-describedby="mco270163-bib-0077">77</a>]. Control and decision‐making‐abilities related to the urge to eat desirable food vary among individuals and might be one of the factors that contribute to vulnerability to overeating, food addiction, and obesity. Currently, there is limited evidence for whether GABAergic neurons and GABA receptors in the cortex play crucial roles in feeding behaviors [<a href="#mco270163-bib-0027" class="usa-link" aria-describedby="mco270163-bib-0027">27</a>, <a href="#mco270163-bib-0077" class="usa-link" aria-describedby="mco270163-bib-0077">77</a>, <a href="#mco270163-bib-0078" class="usa-link" aria-describedby="mco270163-bib-0078">78</a>]. Herein, we further discussed the regulation of targeting GABA<sub>B</sub>R in cortex on food consumption.</p>
<p>Under food‐restriction conditions, neural processing and neuromodulation in the anterior piriform cortex (AIC) and ventromedial PFC (vmPFC) regulated palatability‐driven feeding, motivation, and the duration of individual feeding bouts [<a href="#mco270163-bib-0027" class="usa-link" aria-describedby="mco270163-bib-0027">27</a>]. Injecting muscimol into the AIC significantly reduced the consumption of food, the overall duration of feeding, and the average duration of feeding on palatable food. In contrast, injection of muscimol into the vmPFC markedly increased the feeding bout duration, did not impact the total consumption of food (either chow or a chocolate shake), and significantly reduced food exploration‐like behavior [<a href="#mco270163-bib-0027" class="usa-link" aria-describedby="mco270163-bib-0027">27</a>]. Microinjection of bicuculline into AIC elicited the intake of an amino acid‐imbalanced diet, and administration of phaclofen into the AIC decreased the intake of basal diets but did not affect the consumption of an imbalanced diet, implying that GABAergic receptors in the mPFC and AIC in the cortex may mediate abnormal intake of an imbalanced diet [<a href="#mco270163-bib-0271" class="usa-link" aria-describedby="mco270163-bib-0271">271</a>] and HFD [<a href="#mco270163-bib-0064" class="usa-link" aria-describedby="mco270163-bib-0064">64</a>], at least in part. Furthermore, GABA<sub>A</sub>Rs and possibly GABA<sub>B</sub>Rs affected the intake of an amino acid‐imbalanced diet [<a href="#mco270163-bib-0273" class="usa-link" aria-describedby="mco270163-bib-0273">273</a>]. Direct injection of baclofen into the lateral septum (LS) decreased the anorectic effects of stress and increased sucrose intake [<a href="#mco270163-bib-0278" class="usa-link" aria-describedby="mco270163-bib-0278">278</a>].</p>
<p>GABA<sub>B</sub>Rs in the AIC and mPFC of the cortex have a crucial role in the selection of food and intake of an amino acid imbalanced diets or HFD [<a href="#mco270163-bib-0064" class="usa-link" aria-describedby="mco270163-bib-0064">64</a>, <a href="#mco270163-bib-0271" class="usa-link" aria-describedby="mco270163-bib-0271">271</a>]. mPFC and OFC neurons are involved in decision‐making and behavior driven by reward and motivations [<a href="#mco270163-bib-0013" class="usa-link" aria-describedby="mco270163-bib-0013">13</a>, <a href="#mco270163-bib-0299" class="usa-link" aria-describedby="mco270163-bib-0299">299</a>, <a href="#mco270163-bib-0300" class="usa-link" aria-describedby="mco270163-bib-0300">300</a>]. If the cortex is affected by an imbalance between encoding reward value and control‐making decisions, “top‐down” (cortical) regulator functions become imbalanced, similar to substance use disorders (SUDs) [<a href="#mco270163-bib-0301" class="usa-link" aria-describedby="mco270163-bib-0301">301</a>]. Therefore, GABA<sub>B</sub>Rs in the cortex may have a significant role in the treatment of abnormal feeding, BE, and food addiction via blockade of “top‐down” inhibition, which need to be fully explored (Figure <a href="#mco270163-fig-0003" class="usa-link">3</a>).</p>
<p>In general, administration of a GABA<sub>B</sub>R agonist or activation of GABA<sub>B</sub>Rs can induce feeding of a normal diet in a normal state (Figure <a href="#mco270163-fig-0003" class="usa-link">3</a> and Table <a href="#mco270163-tbl-0002" class="usa-link">2</a>), but it has also shown that GABA<sub>B</sub>Rs have complex effects on feeding behaviors through different motivational mechanisms, under different environmental conditions, and via reactions of different intensities (Figure <a href="#mco270163-fig-0003" class="usa-link">3</a>). In additions, GABA<sub>B</sub>Rs may interact with other neuropeptides (CCK), neurotransmitters (DA) or other related receptors to regulate food intake through different mechanisms as shown in Table <a href="#mco270163-tbl-0002" class="usa-link">2</a> and Figure <a href="#mco270163-fig-0003" class="usa-link">3</a>. These roles of GABA<sub>B</sub>Rs demonstrate some differential dependence on its expression in different brain regions, including the metabolic homeostasis‐related hypothalamus, the reward‐related NAc and VTA, and the decision‐making‐related cortex, and its involvement in the different pathological conditions and interactions with other signals, which would be further discussed in the following sections.</p></section></section><section id="mco270163-sec-0160"><h3 class="pmc_sec_title">4.2. Binge Eating</h3>
<p>These results above suggest that GABA<sub>B</sub>R activation can increase intake of a normal diet in a normal state (Figure <a href="#mco270163-fig-0003" class="usa-link">3</a> and Table <a href="#mco270163-tbl-0002" class="usa-link">2</a>) but have also shown that GABA<sub>B</sub>Rs have complex effects on appetitive behaviors that may interfere with its effects on feeding behaviors, as shown in Table <a href="#mco270163-tbl-0003" class="usa-link">3</a> and Figure <a href="#mco270163-fig-0004" class="usa-link">4</a>. Strategies targeting GABA<sub>B</sub>Rs may regulate overeating/BE feeding behaviors and eating‐related disorders [<a href="#mco270163-bib-0066" class="usa-link" aria-describedby="mco270163-bib-0066">66</a>, <a href="#mco270163-bib-0067" class="usa-link" aria-describedby="mco270163-bib-0067">67</a>], but this effect strongly depends on the pathological alternations and models and remains to be verified. Here, our next step mainly discussed the effects of GABA<sub>B</sub>Rs for overeating and BE.</p>
<section class="tw xbox font-sm" id="mco270163-tbl-0003"><h4 class="obj_head">TABLE 3.</h4>
<div class="caption p"><p>Summarized effects of GABA<sub>B</sub>Rs on binge eating behaviors, food addiction for palatable food, and its related obesity through central nervous and peripheral regulation.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead><tr style="border-bottom:solid 1px #000000">
<th align="left" rowspan="1" colspan="1">Model</th>
<th align="center" rowspan="1" colspan="1">Compound</th>
<th align="center" rowspan="1" colspan="1">Administration</th>
<th align="center" rowspan="1" colspan="1">Effects</th>
<th align="center" rowspan="1" colspan="1">Targeting</th>
<th align="center" rowspan="1" colspan="1">References</th>
</tr></thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">
<p>Male SD rats:</p>
<p>Fat emulsion</p>
<p>Palatable diet</p>
<p>Sugar–fat emulsion</p>
</td>
<td align="center" rowspan="1" colspan="1">Baclofen Naltrexone</td>
<td align="center" rowspan="1" colspan="1">
<p>I.P.:</p>
<p>1, 1.8 mg/kg</p>
<p>0.1, 1.0 mg/kg</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>↓ Palatable food intake</p>
<p>‐ Palatable food or chow</p>
<p>Combination: ↓ Palatable diet</p>
</td>
<td align="center" rowspan="1" colspan="1">GABA<sub>B</sub>R</td>
<td align="center" rowspan="1" colspan="1">[<a href="#mco270163-bib-0026" class="usa-link" aria-describedby="mco270163-bib-0026">26</a>, <a href="#mco270163-bib-0302" class="usa-link" aria-describedby="mco270163-bib-0302">302</a>]</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<p>Male SD rats:</p>
<p>Non‐food‐deprived</p>
<p>Limited access</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>Baclofen</p>
<p>SCH 23390</p>
<p>Raclopride</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>I.P.: 0.6–1.8 mg/kg</p>
<p>0.03–0.3 mg/kg</p>
<p>0.03–0.3 mg/kg</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>↓ Intake of shortening of</p>
<p>binge fat or sucrose</p>
<p>‐ Sucrose, chow intake</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>GABA<sub>B</sub>R</p>
<p>opioid receptors</p>
<p>D1, D2 receptors</p>
</td>
<td align="center" rowspan="1" colspan="1">[<a href="#mco270163-bib-0303" class="usa-link" aria-describedby="mco270163-bib-0303">303</a>, <a href="#mco270163-bib-0304" class="usa-link" aria-describedby="mco270163-bib-0304">304</a>]</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<p>Female Wistar rats:</p>
<p>Intermittent access</p>
<p>Chocolate food</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>LDX</p>
<p>SB‐334867</p>
<p>R‐baclofen</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>PO: 0.1–1.5 mg/kg</p>
<p>I.P.: 3–30 mg/kg</p>
<p>I.P.: 1–10 mg/kg</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>↓ Chocolate intake</p>
<p>↓ Chocolate intake</p>
<p>‐ Chow, water intake</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>Orexin‐1</p>
<p>GABA<sub>B</sub>R</p>
<p>D1 receptor</p>
<p>α1‐adrenergic</p>
</td>
<td align="center" rowspan="1" colspan="1">[<a href="#mco270163-bib-0305" class="usa-link" aria-describedby="mco270163-bib-0305">305</a>]</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<p>Male SD rats:</p>
<p>Fat/sucrose mixtures</p>
<p>Limited access</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>Baclofen;</p>
<p>Naltrexone</p>
<p>Raclopride</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>I.P.: 0.6–1.8 mg/kg</p>
<p>0.03–0.3 mg/kg</p>
<p>0.03–0.3 mg/kg</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>↓ FSM intake</p>
<p>‐ 32% FSM</p>
<p>Sucrose concentration</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>GABA<sub>B</sub>R</p>
<p>D2 receptor</p>
<p>mu‐receptor</p>
</td>
<td align="center" rowspan="1" colspan="1">[<a href="#mco270163-bib-0304" class="usa-link" aria-describedby="mco270163-bib-0304">304</a>]</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<p>Male SD rats:</p>
<p>Limited access</p>
<p>Solid fat emulsion</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>Baclofen</p>
<p>Raclopride</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>I.P.:</p>
<p>0.6–1.8 mg/kg</p>
<p>0.03–0.3 mg/kg</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>↓ Emulsion intake</p>
<p>↓ 32%, 56%‐fat emulsion</p>
<p>↓ 18%‐fat emulsion;</p>
<p>↓ Fat emulsion in daily</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>GABA<sub>B</sub>R</p>
<p>D2 receptor</p>
<p>Fat concentration</p>
<p>mu‐opioid receptor</p>
</td>
<td align="center" rowspan="1" colspan="1">[<a href="#mco270163-bib-0263" class="usa-link" aria-describedby="mco270163-bib-0263">263</a>]</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<p>Male db/db mice:</p>
<p>High fat diet‐HFD</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>Baclofen</p>
<p>SKF 97541</p>
<p>3‐APPA</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>OA:</p>
<p>4, 100 × 10<sup>−6</sup> M</p>
<p>10 × 10<sup>−6</sup> M</p>
<p>10 × 10<sup>−6</sup> M</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>↓ Food intake</p>
<p>↑ Plasma leptin</p>
<p>↓ Epididymal WAT</p>
<p>↓ Blood glucose, HbA1c</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>NPY</p>
<p>GABA<sub>B</sub>R</p>
<p>Energy balance</p>
<p>Adipose stores</p>
</td>
<td align="center" rowspan="1" colspan="1">[<a href="#mco270163-bib-0306" class="usa-link" aria-describedby="mco270163-bib-0306">306</a>]</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<p>Male SD rats:</p>
<p>Fat chow</p>
<p>Sweet–fat chow</p>
</td>
<td align="center" rowspan="1" colspan="1">Baclofen</td>
<td align="center" rowspan="1" colspan="1">
<p>I.P.:</p>
<p>0.6–1.8 mg/kg</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>↓ Vegetable‐fat binge</p>
<p>↑ Sweet–fat binge</p>
<p>‐ Sucrose, standard chow</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>GABA<sub>B</sub>R</p>
<p>Galanin</p>
<p>Pure fat intake</p>
</td>
<td align="center" rowspan="1" colspan="1">[<a href="#mco270163-bib-0307" class="usa-link" aria-describedby="mco270163-bib-0307">307</a>]</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<p>Male SD rats:</p>
<p>SA, solid‐fat</p>
<p>Non‐food deprived</p>
</td>
<td align="center" rowspan="1" colspan="1">(R)‐baclofen</td>
<td align="center" rowspan="1" colspan="1">
<p>I.P.:</p>
<p>0.3–1.8 mg/kg</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>↓ Pellet in SA</p>
<p>↓ Shortening responding</p>
</td>
<td align="center" rowspan="1" colspan="1">GABA<sub>B</sub>R</td>
<td align="center" rowspan="1" colspan="1">[<a href="#mco270163-bib-0308" class="usa-link" aria-describedby="mco270163-bib-0308">308</a>]</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<p>Male SD rats:</p>
<p>Limited access</p>
<p>Lard intake,</p>
<p>binge‐type</p>
</td>
<td align="center" rowspan="1" colspan="1">(R‐S)‐baclofen</td>
<td align="center" rowspan="1" colspan="1">
<p>I.P.:</p>
<p>0.0–1.8–3.2 mg/kg</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>↓ Lard intake</p>
<p>‐ Chow intake</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>GABA<sub>B</sub>R</p>
<p>Food type</p>
<p>conditions</p>
</td>
<td align="center" rowspan="1" colspan="1">[<a href="#mco270163-bib-0068" class="usa-link" aria-describedby="mco270163-bib-0068">68</a>]</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<p>Male SD rats:</p>
<p>Under binge‐type</p>
</td>
<td align="center" rowspan="1" colspan="1">(R)‐baclofen</td>
<td align="center" rowspan="1" colspan="1">
<p>I.P.:</p>
<p>0.3–1.8 mg/kg</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>↓ 2‐h shortening intake</p>
<p>no effect</p>
</td>
<td align="center" rowspan="1" colspan="1">GABA<sub>B</sub>R activation</td>
<td align="center" rowspan="1" colspan="1">[<a href="#mco270163-bib-0309" class="usa-link" aria-describedby="mco270163-bib-0309">309</a>]</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<p>Obesity people:</p>
<p>Women, men</p>
</td>
<td align="center" rowspan="1" colspan="1">(R)‐baclofen</td>
<td align="center" rowspan="1" colspan="1">
<p>OA:</p>
<p>25 mg on day 7</p>
<p>30 mg on day 10</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>↓ Body weight, waist</p>
<p>↓ Serum leptin</p>
<p>↓ Appetite and desire for sweets</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>Activation of GABA<sub>B</sub>R</p>
<p>Adipose Regulation</p>
</td>
<td align="center" rowspan="1" colspan="1">[<a href="#mco270163-bib-0310" class="usa-link" aria-describedby="mco270163-bib-0310">310</a>]</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<p>Binge eating:</p>
<p>Women</p>
</td>
<td align="center" rowspan="1" colspan="1">Baclofen</td>
<td align="center" rowspan="1" colspan="1">
<p>OA:</p>
<p>60 mg/day for 10 weeks</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>↓ Binge frequency</p>
<p>↓ Cores of the Food Craving Inventory‐II</p>
</td>
<td align="center" rowspan="1" colspan="1">Targeting GABA<sub>B</sub>R</td>
<td align="center" rowspan="1" colspan="1">[<a href="#mco270163-bib-0311" class="usa-link" aria-describedby="mco270163-bib-0311">311</a>, <a href="#mco270163-bib-0312" class="usa-link" aria-describedby="mco270163-bib-0312">312</a>]</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<p>Male SD rats:</p>
<p>Restricted feeding</p>
<p>Palatable WD diet</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>Muscimol:</p>
<p>VMN‐106.8 ng</p>
<p>NAc‐5.7 ng</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>Baclofen:</p>
<p>VMN‐0.25 µL/side</p>
<p>NAc‐0.5 µL/side</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>↓ WD intake during the</p>
<p>subsequent 15 min M2</p>
</td>
<td align="center" rowspan="1" colspan="1">
<p>Targeting GABA<sub>B</sub>R</p>
<p>Targeting GABA<sub>A</sub>R</p>
</td>
<td align="center" rowspan="1" colspan="1">[<a href="#mco270163-bib-0313" class="usa-link" aria-describedby="mco270163-bib-0313">313</a>]</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/mco270163-tbl-0003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="mco270163-tbl3-note-0001"><p>Abbreviations: ↑ enhance or improve with significant differences; ↓ downregulate or inhibit with significant differences; ‐, no significant effects; FSM, Fat/sucrose mixtures; I.P, intraperitoneal; LDX, lisdexamfetaminedimesylate; OA, orally administered; M2, meal 2 for palatable food consumption; SA, self‐administration; S.C, subcutaneous; SD, Sprague–Dawley; WAT, white adipose tissue; WD, palatable western diet.</p></div></div></section><figure class="fig xbox font-sm" id="mco270163-fig-0004"><h4 class="obj_head">FIGURE 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50fe/12000685/87f41d0a070a/MCO2-6-e70163-g002.jpg" loading="lazy" id="jats-graphic-9" height="662" width="600" alt="FIGURE 4"></p>
<div class="p text-right font-secondary"><a href="figure/mco270163-fig-0004/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Effects of GABA<sub>B</sub>Rs on binge eating, food addiction, and obesity through central and peripheral regulation. On one hand, GABAergic neurons and GABA<sub>B</sub>R may play a vital role in the regulation of energy homeostasis and feeding via the central hypothalamic (leptin, MCH, and CCK) and reward systems (NAc and VTA) and inhibition of food craving, reward abnormalities, and control‐decision imbalance in feeding behaviors (mPFC/OFC); on the other hand, regulation of GABA<sub>B</sub>Rs may be associated with peripheral vagal neuromodulation and regulation, which needs to further explore. These findings imply the potential of GABA<sub>B</sub>R‐targeting strategies in the treatment of BE, food addiction, and obesity.</p></figcaption></figure><section id="mco270163-sec-0170"><h4 class="pmc_sec_title">4.2.1. Effects of GABA<sub>B</sub>Rs Alone on BE</h4>
<p>Overeating or BE, an abnormal increase in feeding behavior that is driven by powerful feeding motivations, food craving, or hedonic seeking and exacerbated by negative emotion or excessive stress [<a href="#mco270163-bib-0013" class="usa-link" aria-describedby="mco270163-bib-0013">13</a>, <a href="#mco270163-bib-0036" class="usa-link" aria-describedby="mco270163-bib-0036">36</a>, <a href="#mco270163-bib-0052" class="usa-link" aria-describedby="mco270163-bib-0052">52</a>, <a href="#mco270163-bib-0064" class="usa-link" aria-describedby="mco270163-bib-0064">64</a>]. BE of sugar, fat, and palatable diets has behavioral and neurochemical similarities to SUDs and may be considered natural addiction or food addiction [<a href="#mco270163-bib-0013" class="usa-link" aria-describedby="mco270163-bib-0013">13</a>, <a href="#mco270163-bib-0026" class="usa-link" aria-describedby="mco270163-bib-0026">26</a>, <a href="#mco270163-bib-0314" class="usa-link" aria-describedby="mco270163-bib-0314">314</a>, <a href="#mco270163-bib-0315" class="usa-link" aria-describedby="mco270163-bib-0315">315</a>, <a href="#mco270163-bib-0316" class="usa-link" aria-describedby="mco270163-bib-0316">316</a>]. In a preclinical setting, activation of GABA<sub>B</sub>Rs reduced drug addiction‐like responses in animal models and showed great promise for the treatment of SUDs in the clinic [<a href="#mco270163-bib-0100" class="usa-link" aria-describedby="mco270163-bib-0100">100</a>, <a href="#mco270163-bib-0317" class="usa-link" aria-describedby="mco270163-bib-0317">317</a>]. Furthermore, activation of GABA<sub>B</sub>Rs generally reduced binge frequency and binge size in animals and humans, decreased fat intake in BE models and inhibited the binge feeding of fat or a palatable diet under non‐food‐deprived and other conditions [<a href="#mco270163-bib-0308" class="usa-link" aria-describedby="mco270163-bib-0308">308</a>, <a href="#mco270163-bib-0309" class="usa-link" aria-describedby="mco270163-bib-0309">309</a>], which was similar to the effects of baclofen on drug SA and SUDs reported by others [<a href="#mco270163-bib-0045" class="usa-link" aria-describedby="mco270163-bib-0045">45</a>, <a href="#mco270163-bib-0318" class="usa-link" aria-describedby="mco270163-bib-0318">318</a>]. Thus, GABA<sub>B</sub>Rs may be important therapeutic targets for BE and food addiction.</p>
<p>When animals were exposed to 12‐h daily access to different chows (sucrose, fat, vegetable–fat, or sweet–fat mixtures) for animal, baclofen (I.P.) suppressed the BE of pure fat during 2 h of access, but increased sweet–fat chow intake and had no effect on sucrose intake [<a href="#mco270163-bib-0307" class="usa-link" aria-describedby="mco270163-bib-0307">307</a>]. Under binge‐type conditions, the fat‐matched group was provided with chow mixed with fat in the appropriate ratio, and it was found that baclofen (1.0 and 1.8 mg/kg) notably decreased the shortening intake within a 2‐h period; conversely, baclofen significantly increased the chow intake for 2 h [<a href="#mco270163-bib-0309" class="usa-link" aria-describedby="mco270163-bib-0309">309</a>]. During access to food pellets or vegetable shortening via SA, administration of baclofen (1.0 mg/kg, I.P.) significantly reduced shortening intake relative to saline intake but had no significant effect on pellet intake, and a dosage of 1.8 mg/kg baclofen significantly decreased both pellet and shortening intake for all schedules [<a href="#mco270163-bib-0308" class="usa-link" aria-describedby="mco270163-bib-0308">308</a>]. Notably, a lower dosage of baclofen was sufficient to significantly reduce shortening intake compared with the dosage needed to reduce food pellet intake.</p>
<p>In a study on binge‐eating like models, baclofen demonstrated a notable reduction in the consumption of semisolid shortening emulsions, but had no effect on the consumption of normal chow [<a href="#mco270163-bib-0068" class="usa-link" aria-describedby="mco270163-bib-0068">68</a>, <a href="#mco270163-bib-0305" class="usa-link" aria-describedby="mco270163-bib-0305">305</a>]. When rats had brief limited access to fat and continuous access to chow, administration of baclofen inhibited the consumption of semisolid vegetable fat (shortening) [<a href="#mco270163-bib-0303" class="usa-link" aria-describedby="mco270163-bib-0303">303</a>, <a href="#mco270163-bib-0304" class="usa-link" aria-describedby="mco270163-bib-0304">304</a>, <a href="#mco270163-bib-0307" class="usa-link" aria-describedby="mco270163-bib-0307">307</a>]; in a study in which daily or intermittent access to fat or sucrose mixtures containing 3.2% (L), 10% (M), or 32% (H) powdered sugar in 100% vegetable shortening, administration of baclofen decreased the consumption of the L and M mixtures by male SD rats [<a href="#mco270163-bib-0304" class="usa-link" aria-describedby="mco270163-bib-0304">304</a>]. In addition, administration of baclofen reduced lard intake under binge‐type and nonbinge‐type conditions when lard was presented alone; decreased shortening intake only under nonbinge‐type conditions and lard intake only under binge‐type conditions [<a href="#mco270163-bib-0033" class="usa-link" aria-describedby="mco270163-bib-0033">33</a>]. Therefore, the ability of baclofen to reduce fat intake appears to be heavily influenced by the type of food consumed (fat), the presentation mode (one fat alone or two fats simultaneously), and the duration between baclofen administration and consumption.</p>
<p>These results indicate (Figure <a href="#mco270163-fig-0004" class="usa-link">4</a> and Table <a href="#mco270163-tbl-0003" class="usa-link">3</a>) that pharmacological interventions modulating GABA<sub>B</sub>Rs can reduce some special conditions of BE, such as binge frequency, binge size, and shortening intake under binge‐condition establishments, but show no effects on normal intake (chow). The inhibitory effects of baclofen on food intake appear to be specific to fat, as baclofen has no effect on sucrose intake and the sucrose concentration affects the inhibitory effects of baclofen. And there are also some differences among underlying intervention effects of GABA<sub>B</sub>Rs; feeding bouts of fatty and sugar‐rich foods may prove to be particularly regulated via crosstalk interactions of modulating GABA<sub>B</sub>Rs, opioids and dopamine.</p></section><section id="mco270163-sec-0180"><h4 class="pmc_sec_title">4.2.2. Effects of GABA<sub>B</sub>Rs and Opioid Receptors</h4>
<p>As shown in Figure <a href="#mco270163-fig-0004" class="usa-link">4</a> and Table <a href="#mco270163-tbl-0003" class="usa-link">3</a>, feeding regulation is related to the central reward system, GABAergic neurons, and related receptors, and excess consumption of palatable food significantly affects synaptic functions, plasticity and receptor molecules in reward‐related regions; all of these effects resemble SUD in terms of abnormal seeking‐substance behaviors and neuropathology. Thus, pharmaceutical interventions for SUD might also prove efficacious in addressing overeating, BE and food addiction. It has also been confirmed that baclofen and naltrexone, an opioid antagonist, can treat addiction and suppress the intake of certain foods [<a href="#mco270163-bib-0026" class="usa-link" aria-describedby="mco270163-bib-0026">26</a>, <a href="#mco270163-bib-0302" class="usa-link" aria-describedby="mco270163-bib-0302">302</a>]. When used to selectively target GABA<sub>B</sub>Rs and opioid receptors, these medications have demonstrated greater efficacy in reducing abnormal substance‐seeking behaviors compared with using each medication individually [<a href="#mco270163-bib-0026" class="usa-link" aria-describedby="mco270163-bib-0026">26</a>, <a href="#mco270163-bib-0302" class="usa-link" aria-describedby="mco270163-bib-0302">302</a>].</p>
<p>An overeating/BE‐like behavior model was induced in male SD rats via 12‐h binge access to standard chow, sugar solution, and fat emulsion or sugar–fat mix emulsion for 21 days [<a href="#mco270163-bib-0026" class="usa-link" aria-describedby="mco270163-bib-0026">26</a>, <a href="#mco270163-bib-0302" class="usa-link" aria-describedby="mco270163-bib-0302">302</a>]; administration of both baclofen and naltrexone (I.P.) deceased the intake of palatable food in both the fat and sugar–fat groups, while having no impact on the consumption of normal chow. Furthermore, administration of baclofen alone significantly reduced the consumption of palatable food in the fat and fat–sugar groups, but naltrexone whereas naltrexone had minimal impact on the intake of either palatable food or chow in these groups [<a href="#mco270163-bib-0026" class="usa-link" aria-describedby="mco270163-bib-0026">26</a>, <a href="#mco270163-bib-0302" class="usa-link" aria-describedby="mco270163-bib-0302">302</a>]. In addition, naltrexone decreased the consumption of sugar at higher amounts compared with the amount needed to decrease the consumption of fat, but it did not have a notable impact on the intake of simultaneously available chow [<a href="#mco270163-bib-0303" class="usa-link" aria-describedby="mco270163-bib-0303">303</a>, <a href="#mco270163-bib-0304" class="usa-link" aria-describedby="mco270163-bib-0304">304</a>]. Conversely, naltrexone significantly reduced the intake of 32% and 56% fat emulsions intake on the intermittent schedule but it did not affect the intake of chow [<a href="#mco270163-bib-0304" class="usa-link" aria-describedby="mco270163-bib-0304">304</a>]; blocking opioid reduced intake of shortening and did not decrease sucrose intake in two of the daily access groups [<a href="#mco270163-bib-0303" class="usa-link" aria-describedby="mco270163-bib-0303">303</a>, <a href="#mco270163-bib-0304" class="usa-link" aria-describedby="mco270163-bib-0304">304</a>]. Consequently, Interventions of targeting GABA<sub>B</sub>R exert vital roles in the regulation of the fat and sugar–fat‐related food intake, irrespective of the access schedule; but it shows little impact on sucrose intake, which is different from the effects of naltrexone in the reducing sucrose intake.</p>
<p>In a BE model, administration of nalmefene exhibited a dose‐dependent reduction in chocolate intake, while it had no effect on 2‐h intake of chow [<a href="#mco270163-bib-0305" class="usa-link" aria-describedby="mco270163-bib-0305">305</a>]. Similarly, baclofen significantly decreased the chocolate intake with a dose‐dependent manner, but did not affect chow intake [<a href="#mco270163-bib-0305" class="usa-link" aria-describedby="mco270163-bib-0305">305</a>]. The additional findings indicate that the fat intake‐reducing effects of GABA<sub>B</sub>R‐targeting agents depend on the fat concentration and access schedule to fat [<a href="#mco270163-bib-0263" class="usa-link" aria-describedby="mco270163-bib-0263">263</a>]. Moreover, SB‐334867 (an orexin‐1 [OX1] receptor antagonist) significantly reduced chocolate intake without significant effects on standard chow intake [<a href="#mco270163-bib-0305" class="usa-link" aria-describedby="mco270163-bib-0305">305</a>].</p>
<p>Thus, OX1, baclofen and nalmefene have similar effects in inhibiting chocolate intake but not standard chow intake. First, administration of baclofen (GABA<sub>B</sub>R agonist) reduces the intake of fat‐enriched palatable dietary, and naltrexone (opioid antagonist) suppressed the intake of some food. Then, a combination of baclofen and naltrexone is a vital pharmacological strategy for BE and food addiction, as both of these medications are used for alcohol dependence [<a href="#mco270163-bib-0319" class="usa-link" aria-describedby="mco270163-bib-0319">319</a>] and other addictions [<a href="#mco270163-bib-0026" class="usa-link" aria-describedby="mco270163-bib-0026">26</a>]. Selectively targeting GABA<sub>B</sub> and opioid receptors has significant effects in suppressing overeating of palatable foods, high‐fat diets and food craving [<a href="#mco270163-bib-0064" class="usa-link" aria-describedby="mco270163-bib-0064">64</a>, <a href="#mco270163-bib-0320" class="usa-link" aria-describedby="mco270163-bib-0320">320</a>]. From a neurobiological perspective, activation of GABA<sub>B</sub>Rs seems to regulate only high‐fat diet or high‐calorie intake, and the underlying mechanisms are still unclear (Figure <a href="#mco270163-fig-0004" class="usa-link">4</a> and Table <a href="#mco270163-tbl-0003" class="usa-link">3</a>).</p></section><section id="mco270163-sec-0190"><h4 class="pmc_sec_title">4.2.3. Effects of GABA<sub>B</sub>Rs and D1/2 Receptors</h4>
<p>In addition to GABA, opioids and their receptors are implicated in food addiction and BE, and sucrose may alter the effects of dopamine and dopamine receptors (D1R and D2R) on the consumption of fatty food [<a href="#mco270163-bib-0303" class="usa-link" aria-describedby="mco270163-bib-0303">303</a>, <a href="#mco270163-bib-0304" class="usa-link" aria-describedby="mco270163-bib-0304">304</a>], indicating that GABA<sub>B</sub>Rs and D1/2 receptors may be involved in the regulation of BE and food addiction.</p>
<p>In a study, rats were given solid fat emulsion at different concentrations (18, 32, and 56%) either every day or intermittently [<a href="#mco270163-bib-0304" class="usa-link" aria-describedby="mco270163-bib-0304">304</a>]. The intake of emulsion was significantly decreased by both baclofen and raclopride (a D2 antagonist) in all daily access groups, as well as in the intermittent access group for the 56% fat emulsion. And administration raclopride reduced the intake of the group with daily access to the L mixture, while increasing the intake of the group with intermittent access to the L mixture; it also reduced the intake of both groups given the M mixture, but had no effect on either group given the H mixture. Under limited‐access conditions, raclopride stimulated fat intake in rats in the intermittent access group but had no effect on rats in the daily access group. Nevertheless, raclopride reduced sucrose intake in all groups and had no effect on or partly reduced chow intake [<a href="#mco270163-bib-0303" class="usa-link" aria-describedby="mco270163-bib-0303">303</a>, <a href="#mco270163-bib-0304" class="usa-link" aria-describedby="mco270163-bib-0304">304</a>].</p>
<p>Additionally, GABA<sub>B</sub>Rs [<a href="#mco270163-bib-0064" class="usa-link" aria-describedby="mco270163-bib-0064">64</a>, <a href="#mco270163-bib-0320" class="usa-link" aria-describedby="mco270163-bib-0320">320</a>] and D2Rs [<a href="#mco270163-bib-0303" class="usa-link" aria-describedby="mco270163-bib-0303">303</a>, <a href="#mco270163-bib-0304" class="usa-link" aria-describedby="mco270163-bib-0304">304</a>] are dysfunctional in animals with a history of BE fat and sucrose. Activation of GABA<sub>B</sub>Rs reduced fat intake, had no effect on sucrose intake, and either stimulated or had no significant effect on chow intake, and these effects were further verified in a GABA<sub>B</sub>R knockout animal model [<a href="#mco270163-bib-0064" class="usa-link" aria-describedby="mco270163-bib-0064">64</a>]. In contrast, DA receptor (both D1R and D2R) blockade consistently decreased consumption of sucrose, while the impact on fat intake varied based on the particular subtypes of receptors being blocked and the access schedule [<a href="#mco270163-bib-0303" class="usa-link" aria-describedby="mco270163-bib-0303">303</a>, <a href="#mco270163-bib-0304" class="usa-link" aria-describedby="mco270163-bib-0304">304</a>].</p>
<p>The above findings validate that a potential therapeutic approach for disorders related to BE and food addiction, could involve targeting GABA<sub>B</sub>Rs, D1R, and D2R simultaneously (Figure <a href="#mco270163-fig-0004" class="usa-link">4</a> and Table <a href="#mco270163-tbl-0003" class="usa-link">3</a>). In addition, these treatments for hedonic overeating not only provides powerful evidence for patients with BE and food addiction but also implies a shared mechanism that underlies addictive behaviors, a topic that has been extensively debated and acknowledge. Thus, BE affects reward‐related molecular targets, and pharmaceutical treatments for SUDs can also be effective in treating food addiction or overeating‐related disorders.</p>
<p>Overall, targeting GABA<sub>B</sub>R can inhibit the binge feeding of fat or a palatable diet under non‐food‐deprived and other conditions, and attenuate this effect of natural reinforcers or craving for food [<a href="#mco270163-bib-0307" class="usa-link" aria-describedby="mco270163-bib-0307">307</a>, <a href="#mco270163-bib-0308" class="usa-link" aria-describedby="mco270163-bib-0308">308</a>, <a href="#mco270163-bib-0309" class="usa-link" aria-describedby="mco270163-bib-0309">309</a>]. Obviously, GABA<sub>B</sub>Rs play a vital role in the regulation of both normal feeding and overeating or BE‐like behaviors. On one hand, the complex effects of GABA<sub>B</sub>R are associated with its multiple interaction with other neuropeptides, neurotransmitters, or related receptors through different mechanisms; on the other hand, the underlying mechanisms are involved in the pathological conditions through different motivational mechanisms, different brain subregional networks, and reactions of different intensities, which needs further in‐depth exploration.</p>
<p>Furthermore, recent studies have shown that leptin increases energy expenditure, and regulates body weight, and its receptors interacts with GABAergic neurons and GABA<sub>B</sub>Rs, alleviating hyperglycemia and regulate energy imbalance [<a href="#mco270163-bib-0321" class="usa-link" aria-describedby="mco270163-bib-0321">321</a>]. GABAergic neurons and GABA<sub>B</sub>Rs are crucial in the regulation of hypothalamic hormones and receptors (such as leptin and CCK) to achieve energy homeostasis, which is likely to account for the effect of GABA<sub>B</sub>R activation in reducing BE of fat. Hence, GABA<sub>B</sub>Rs may be one of the best underlying therapeutic targets for BE and food addictions (Figure <a href="#mco270163-fig-0004" class="usa-link">4</a>). Next, we further discussed the and treatment of targeting GABA<sub>B</sub>R on obesity.</p></section></section><section id="mco270163-sec-0200"><h3 class="pmc_sec_title">4.3. Food Addiction and Obesity</h3>
<p>Promising outcomes have been obtained from clinical studies involving baclofen for the treatment of alcohol [<a href="#mco270163-bib-0322" class="usa-link" aria-describedby="mco270163-bib-0322">322</a>], cocaine [<a href="#mco270163-bib-0323" class="usa-link" aria-describedby="mco270163-bib-0323">323</a>], and opiate use disorders [<a href="#mco270163-bib-0102" class="usa-link" aria-describedby="mco270163-bib-0102">102</a>, <a href="#mco270163-bib-0103" class="usa-link" aria-describedby="mco270163-bib-0103">103</a>, <a href="#mco270163-bib-0105" class="usa-link" aria-describedby="mco270163-bib-0105">105</a>]. For instance, an open‐label study was with an increased dose of 30 mg/day for the remaining 27 days of treatment, and it showed that baclofen reduced alcohol craving and alcohol drinking [<a href="#mco270163-bib-0324" class="usa-link" aria-describedby="mco270163-bib-0324">324</a>, <a href="#mco270163-bib-0325" class="usa-link" aria-describedby="mco270163-bib-0325">325</a>]; a randomized controlled trial investigation found that baclofen reduced alcohol intake and craving in the alcohol‐dependent subjects [<a href="#mco270163-bib-0326" class="usa-link" aria-describedby="mco270163-bib-0326">326</a>]. Targeting GABA<sub>B</sub>Rs has also been employed for BE behaviors [<a href="#mco270163-bib-0041" class="usa-link" aria-describedby="mco270163-bib-0041">41</a>, <a href="#mco270163-bib-0311" class="usa-link" aria-describedby="mco270163-bib-0311">311</a>]. In addition to being a therapeutic target for SUDs, GABA<sub>B</sub>R may be a promising target for treating food addiction and related syndromes, such as BE and obesity.</p>
<p>In both diabetic and diet‐induced obese mice, the peripheral administration of baclofen produced a significant decrease in food intake and body weight; however, it did not have any notable impact on energy balance in lean control mice [<a href="#mco270163-bib-0284" class="usa-link" aria-describedby="mco270163-bib-0284">284</a>]. Baclofen treatment significantly decreased NYP expression in the ARC but significantly increased POMC mRNA levels; furthermore, baclofen significantly decreased blood glucose and HbA1c levels, significantly increased plasma leptin levels, and significantly decreased the weight of epididymal WAT [<a href="#mco270163-bib-0284" class="usa-link" aria-describedby="mco270163-bib-0284">284</a>]. These data imply that GABA<sub>B</sub>R‐targeted regulation may decreases excessive adipose stores via the ARC in only obese subjects when used as a strategy for the treatment of obesity.</p>
<p>In a pilot study of obese patients (seven women and three men, BMI between 31.3 and 41.0 kg/m), baclofen (15 mg/day to 30 mg/day, administered for 12 weeks) exhibited a noteworthy reduction in body weight and serum leptin levels, and suppressed appetite and the desire for sweets, contributing to improvement in hypertension, diabetes, and dyslipidemia, and it did significantly alter the levels of adiponectin, FBS, HbA1c, or serum insulin, HOMA‐IR, serum lipid levels or blood pressure of the patients [<a href="#mco270163-bib-0310" class="usa-link" aria-describedby="mco270163-bib-0310">310</a>]. Furthermore, in an open‐label trial, women with BED and BN took baclofen (60 mg/day) for 10 weeks, and baclofen notably decreased their BE frequency and was well tolerated; four of the five patients exhibited a great reduction in BE scores on the Food Craving Inventory‐II; compared with placebo, baclofen significantly reduced the binge frequency in BE patients [<a href="#mco270163-bib-0311" class="usa-link" aria-describedby="mco270163-bib-0311">311</a>, <a href="#mco270163-bib-0312" class="usa-link" aria-describedby="mco270163-bib-0312">312</a>].</p>
<p>Given that baclofen reduced appetite and leptin levels, its effects on obesity and food addiction might also be enhanced by diet therapy and treatments that decrease adipose stores [<a href="#mco270163-bib-0284" class="usa-link" aria-describedby="mco270163-bib-0284">284</a>, <a href="#mco270163-bib-0310" class="usa-link" aria-describedby="mco270163-bib-0310">310</a>, <a href="#mco270163-bib-0311" class="usa-link" aria-describedby="mco270163-bib-0311">311</a>]. In addition, baclofen may be shown to be more effective in reducing body weight in obese humans or in animal [<a href="#mco270163-bib-0310" class="usa-link" aria-describedby="mco270163-bib-0310">310</a>], as its related side effects of sedation that impact energy expenditure and partly veils the regulator inhibition for food appetite and weight. Hence, the further detailed assessments are needed via an approach of specially targeting‐GABA<sub>B</sub>R measure.</p>
<p>Preclinical and clinical related studies have indicated that the activity of GABA<sub>B</sub>Rs in the CNS plays a role in the regulation of food intake, rewards, and related peripheral activities, at least partially. Targeting GABA<sub>B</sub>Rs can be developed as a novel therapeutic approach for food addiction and obesity, and the underlying mechanisms of regulation of GABA<sub>B</sub>Rs appears to be associated with inhibition of food craving, reward abnormalities and control‐decision imbalance in feeding behaviors (Figure <a href="#mco270163-fig-0004" class="usa-link">4</a>).</p></section><section id="mco270163-sec-0210"><h3 class="pmc_sec_title">4.4. Peripheral Regulatory Effects</h3>
<p>Additionally, GABAergic system is also present in peripheral tissues [<a href="#mco270163-bib-0327" class="usa-link" aria-describedby="mco270163-bib-0327">327</a>, <a href="#mco270163-bib-0328" class="usa-link" aria-describedby="mco270163-bib-0328">328</a>, <a href="#mco270163-bib-0329" class="usa-link" aria-describedby="mco270163-bib-0329">329</a>, <a href="#mco270163-bib-0330" class="usa-link" aria-describedby="mco270163-bib-0330">330</a>]. As shown in Figures <a href="#mco270163-fig-0001" class="usa-link">1</a> and <a href="#mco270163-fig-0004" class="usa-link">4</a>, GABA<sub>B</sub>Rs are widely distributed along central vagal pathways in the nucleus tractus solitarius (NTS) and dorsal vagal nucleus [<a href="#mco270163-bib-0280" class="usa-link" aria-describedby="mco270163-bib-0280">280</a>, <a href="#mco270163-bib-0328" class="usa-link" aria-describedby="mco270163-bib-0328">328</a>]. Studies have shown that baclofen has effects on physiological vagal inputs to the NTS from other viscera and on electrically stimulated inputs by abdominal vagal afferents [<a href="#mco270163-bib-0328" class="usa-link" aria-describedby="mco270163-bib-0328">328</a>, <a href="#mco270163-bib-0331" class="usa-link" aria-describedby="mco270163-bib-0331">331</a>]. GABA<sub>B</sub>Rs markedly inhibit vagal afferent pathways centrally and peripherally; GABA modulates gastric acid secretion [<a href="#mco270163-bib-0328" class="usa-link" aria-describedby="mco270163-bib-0328">328</a>, <a href="#mco270163-bib-0329" class="usa-link" aria-describedby="mco270163-bib-0329">329</a>, <a href="#mco270163-bib-0330" class="usa-link" aria-describedby="mco270163-bib-0330">330</a>] and exerts inhibitory and stimulatory effects on GABAergic system activity in the gastric system in rodents [<a href="#mco270163-bib-0082" class="usa-link" aria-describedby="mco270163-bib-0082">82</a>, <a href="#mco270163-bib-0327" class="usa-link" aria-describedby="mco270163-bib-0327">327</a>, <a href="#mco270163-bib-0328" class="usa-link" aria-describedby="mco270163-bib-0328">328</a>] and humans [<a href="#mco270163-bib-0327" class="usa-link" aria-describedby="mco270163-bib-0327">327</a>, <a href="#mco270163-bib-0332" class="usa-link" aria-describedby="mco270163-bib-0332">332</a>, <a href="#mco270163-bib-0333" class="usa-link" aria-describedby="mco270163-bib-0333">333</a>].</p>
<p>Administration of baclofen (intravenous, 7–14 mmol/kg) reduced decreased the reactions of gastric tension and NTS neuron responses to gastric distension, but did not affect the responses of gastroduodenal mucosal receptors to CCK; these responses were reversed by the antagonist CGP‐35348, suggesting that the GABA<sub>B</sub>Rs might inhibit the mechanosensitivity, but not chemosensitivity, of peripheral vagal afferents [<a href="#mco270163-bib-0327" class="usa-link" aria-describedby="mco270163-bib-0327">327</a>, <a href="#mco270163-bib-0328" class="usa-link" aria-describedby="mco270163-bib-0328">328</a>].</p>
<p>GABA<sub>B</sub>Rs reduced the central mechanosensory inputs to brain stem neurons while having no impact on the transmission of excitatory chemosensory signals. And they decreased the inhibitory mechanosensory and chemosensory inputs to brain stem neurons originating from inhibitory interneurons, but the pathway of chemosensory inputs involved GABA<sub>B</sub>Rs [<a href="#mco270163-bib-0327" class="usa-link" aria-describedby="mco270163-bib-0327">327</a>, <a href="#mco270163-bib-0328" class="usa-link" aria-describedby="mco270163-bib-0328">328</a>]. Peripheral vagal nerve stimulation via microchip implantation increased vagal afferent activity and thus induced alterations in feeding behaviors, resulting in to a decrease of nocturnal food intake and body weight [<a href="#mco270163-bib-0280" class="usa-link" aria-describedby="mco270163-bib-0280">280</a>]. However, these effects were partially attenuated by baclofen; baclofen significantly stimulated gastric motility and elicited the formation of an irregular motor migration complex [<a href="#mco270163-bib-0280" class="usa-link" aria-describedby="mco270163-bib-0280">280</a>], indicating that GABA<sub>B</sub>Rs depend on permanent vagal nerve stimulation. These results suggest that GABA<sub>B</sub>Rs regulate gastric‐related motility and the release and expression of feeding‐related hormones through permanent vagal nerve stimulation (Figure <a href="#mco270163-fig-0004" class="usa-link">4</a>).</p>
<p>In addition, baclofen notably affected and regulated feeding behavior and weight [<a href="#mco270163-bib-0280" class="usa-link" aria-describedby="mco270163-bib-0280">280</a>, <a href="#mco270163-bib-0328" class="usa-link" aria-describedby="mco270163-bib-0328">328</a>] via peripheral regulation of GABA<sub>B</sub>Rs and vagal neuromodulation, small intestinal transit suppression, increased gastric acid and gastrin secretion through vagal‐dependent manners and suppressed food intake and small intestinal transit via u‐opioid receptors coupled to the 5‐HT<sub>1A</sub>, D2, and GABA<sub>B</sub> systems [<a href="#mco270163-bib-0280" class="usa-link" aria-describedby="mco270163-bib-0280">280</a>, <a href="#mco270163-bib-0327" class="usa-link" aria-describedby="mco270163-bib-0327">327</a>, <a href="#mco270163-bib-0328" class="usa-link" aria-describedby="mco270163-bib-0328">328</a>].</p>
<p>The peripheral regulation of GABA<sub>B</sub>Rs may affect not only the gastric secretion of CCK, GLP‐1, and ghrelin, but also gastric‐related motility and activity via vagal nerve stimulation, which may result in further interactions with central nervous circuits and networks associated with feeding or eating disorders (Figure <a href="#mco270163-fig-0004" class="usa-link">4</a>). As the existence of the brain–gut axis and has been confirmed to have play vital roles in feeding or eating disorders, it is essential to further explore the detailed mechanisms of GABA<sub>B</sub>Rs involved in the processes of brain to peripheral organs. For instance, GABA receptors can control intestinal fat absorption via suppression of the midbrain–vagus–jejunum axis [<a href="#mco270163-bib-0334" class="usa-link" aria-describedby="mco270163-bib-0334">334</a>].</p></section></section><section id="mco270163-sec-0220"><h2 class="pmc_sec_title">5. Effects in Oncology</h2>
<p>In addition to the roles in the various neuropsychiatric disorders, BE, and feeding‐related disorders, GABA<sub>B</sub>Rs are involved in the modulations of the tumour biochemical and pathological processes [<a href="#mco270163-bib-0335" class="usa-link" aria-describedby="mco270163-bib-0335">335</a>, <a href="#mco270163-bib-0336" class="usa-link" aria-describedby="mco270163-bib-0336">336</a>, <a href="#mco270163-bib-0337" class="usa-link" aria-describedby="mco270163-bib-0337">337</a>, <a href="#mco270163-bib-0338" class="usa-link" aria-describedby="mco270163-bib-0338">338</a>, <a href="#mco270163-bib-0339" class="usa-link" aria-describedby="mco270163-bib-0339">339</a>, <a href="#mco270163-bib-0340" class="usa-link" aria-describedby="mco270163-bib-0340">340</a>], such as prostate cancer [<a href="#mco270163-bib-0336" class="usa-link" aria-describedby="mco270163-bib-0336">336</a>], breast cancer [<a href="#mco270163-bib-0338" class="usa-link" aria-describedby="mco270163-bib-0338">338</a>], and pancreatic cancer [<a href="#mco270163-bib-0340" class="usa-link" aria-describedby="mco270163-bib-0340">340</a>]. The GABA<sub>B</sub>Rs and GABAergic signaling pathways can inhibit cell proliferation [<a href="#mco270163-bib-0341" class="usa-link" aria-describedby="mco270163-bib-0341">341</a>, <a href="#mco270163-bib-0342" class="usa-link" aria-describedby="mco270163-bib-0342">342</a>, <a href="#mco270163-bib-0343" class="usa-link" aria-describedby="mco270163-bib-0343">343</a>], regulate tumor microenvironment [<a href="#mco270163-bib-0337" class="usa-link" aria-describedby="mco270163-bib-0337">337</a>], and exert vital roles in the tumor metastasis and progression [<a href="#mco270163-bib-0338" class="usa-link" aria-describedby="mco270163-bib-0338">338</a>, <a href="#mco270163-bib-0341" class="usa-link" aria-describedby="mco270163-bib-0341">341</a>, <a href="#mco270163-bib-0344" class="usa-link" aria-describedby="mco270163-bib-0344">344</a>]. For instance, baclofen significantly increases cell invasion and migration and mediates breast cancer metastasis via ERK1/2 pathway [<a href="#mco270163-bib-0338" class="usa-link" aria-describedby="mco270163-bib-0338">338</a>]. In contrast, GABA<sub>B</sub>R antagonists (<a href="https://www.ncbi.nlm.nih.gov/protein/CGP55845" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">CGP55845</a> and <a href="https://www.ncbi.nlm.nih.gov/protein/CGP35348" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">CGP35348</a>) decrease tumor cell growth, invasion, and migration, induce cancer cells apoptosis [<a href="#mco270163-bib-0342" class="usa-link" aria-describedby="mco270163-bib-0342">342</a>, <a href="#mco270163-bib-0343" class="usa-link" aria-describedby="mco270163-bib-0343">343</a>, <a href="#mco270163-bib-0344" class="usa-link" aria-describedby="mco270163-bib-0344">344</a>, <a href="#mco270163-bib-0345" class="usa-link" aria-describedby="mco270163-bib-0345">345</a>], and show antitumor effects via caspase 3/9 apoptotic pathways and PI3/Akt/MAPK pathways [<a href="#mco270163-bib-0341" class="usa-link" aria-describedby="mco270163-bib-0341">341</a>, <a href="#mco270163-bib-0345" class="usa-link" aria-describedby="mco270163-bib-0345">345</a>]. In summary, GABA<sub>B</sub>Rs and their crosstalk with the related signaling pathways play a complex but crucial regulatory role in tumors. However, current neuro‐oncology research focuses on multipathway crosstalk, including tumor‐immune‐metabolic interplay, epigenetic‐genetic synergy, and multimodal therapeutic integration, addressing glioblastoma heterogeneity and resistance mechanisms; those other involvement in complex interplay of neurometabolic and immunity can also affect tumour cell proliferation, apoptosis, angiogenesis, and metastasis, has significant implications for cancer biology, but the literature on these aspects of GABA<sub>B</sub>Rs is relatively limited and is thus not further explored in this review.</p></section><section id="mco270163-sec-0230"><h2 class="pmc_sec_title">6. Therapeutical Prospects of Specially Targeting Sites</h2>
<section id="mco270163-sec-0240"><h3 class="pmc_sec_title">6.1. Overall Therapeutic Effects</h3>
<p>This review provides an overview of the preclinical and clinical research on the effects of GABA<sub>B</sub>Rs and analogues on measures of various mental disorders (Table <a href="#mco270163-tbl-0001" class="usa-link">1</a>) and feeding‐related disorders (including food addiction, BE, and obesity), as well as the potential mechanisms by which GABA<sub>B</sub>R may be involved in brain sub‐regions involved in the complex crosstalk among reward, feeding, motivation, and stress. However, most of this research has focused on common mental disorders and normal feeding behaviors under a normal diet or conditions, and few studies reported are related to special psychiatric disorders, BE, food addiction, and BE‐related obesity. More studies, specifically longitudinal studies involving various stress‐inducing tasks and specific eating‐ and mood‐related questionnaires, are needed to fully assess the therapeutic potential of GABA<sub>B</sub>Rs in stress‐induced neuropsychiatric symptoms, abnormal feeding eating behaviors, and other complicated disorders in humans, and even potentially drug addiction (Figures <a href="#mco270163-fig-0003" class="usa-link">3</a> and <a href="#mco270163-fig-0004" class="usa-link">4</a>).</p>
<p>Recent studies provide powerful support for GABA<sub>B</sub>Rs as therapeutic targets for neuropsychiatric disorders, BE, food addiction, and obesity, which may involve abnormalities in reward‐related neural circuitry, energy encoding, and reward‐driven decision‐making. However, the side effects of strategies directly targeting GB1 cannot be ignored, as systemically administered baclofen and analogue agonists/compounds can drastically activate GABA<sub>B</sub>Rs and have the same adverse effects as other treatments [<a href="#mco270163-bib-0086" class="usa-link" aria-describedby="mco270163-bib-0086">86</a>, <a href="#mco270163-bib-0305" class="usa-link" aria-describedby="mco270163-bib-0305">305</a>]. Thus, candidate ligands or agents should specifically target GB1 or GB2 or target signaling pathways downstream of GB1/2 and slightly activate them, and be well tolerated (Figure <a href="#mco270163-fig-0005" class="usa-link">5A,B</a>).</p>
<figure class="fig xbox font-sm" id="mco270163-fig-0005"><h4 class="obj_head">FIGURE 5.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50fe/12000685/6bb3a9c1c017/MCO2-6-e70163-g001.jpg" loading="lazy" id="jats-graphic-11" height="693" width="700" alt="FIGURE 5"></p>
<div class="p text-right font-secondary"><a href="figure/mco270163-fig-0005/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Regulated sites and signaling pathways and therapeutic prospects of strategies targeting GABA<sub>B</sub>Rs for the treatment of binge eating, food addiction and obesity. (A) The orthosteric ligand recognition site of GB1 binds to its ligands such as GABA and baclofen. (B) The allosteric ligand recognition site of GB2 binds to its allosteric modulators, such as GS39783. (C) Potential phosphorylation sites of the downstream GABA<sub>B</sub>Rs, including Ser867 of GB1, which is phosphorylated by CAMKII and Ser783 of GB2, which is phosphorylated by AMPK, and sites in other regulatory 14‐3‐3‐ζ proteins. (D) PP2A regulates downstream GABA<sub>B</sub>Rs via dephosphorylation. Small peptides and compounds exert marked regulatory effects.</p></figcaption></figure></section><section id="mco270163-sec-0250"><h3 class="pmc_sec_title">6.2. Orthosteric Ligand Recognition by GB1</h3>
<p>The clinical results demonstrate that baclofen has therapeutic promising for SUDs, especially in patients with severe AUD [<a href="#mco270163-bib-0088" class="usa-link" aria-describedby="mco270163-bib-0088">88</a>, <a href="#mco270163-bib-0317" class="usa-link" aria-describedby="mco270163-bib-0317">317</a>]. Despite clinical and preclinical studies have shown positive outcomes for addiction or carving‐like behaviors, the utilization of baclofen is still a subject of controversy and is restricted due to its inadequate clinical safety and adverse effects; baclofen and analogous agents are still not approved by the FDA or EMA for AUD, possibly due to the potential side effects of the compounds.</p>
<p>Baclofen is primarily used as a muscle relaxant in the clinic at a usual dose range of 20–80 mg/day, with few significant side effects [<a href="#mco270163-bib-0309" class="usa-link" aria-describedby="mco270163-bib-0309">309</a>]. In open human trials, baclofen is well tolerated [<a href="#mco270163-bib-0310" class="usa-link" aria-describedby="mco270163-bib-0310">310</a>, <a href="#mco270163-bib-0346" class="usa-link" aria-describedby="mco270163-bib-0346">346</a>, <a href="#mco270163-bib-0347" class="usa-link" aria-describedby="mco270163-bib-0347">347</a>, <a href="#mco270163-bib-0348" class="usa-link" aria-describedby="mco270163-bib-0348">348</a>]. Sedation was the commonly reported adverse reaction to baclofen. In the clinic, two patients experienced minor adverse events during a trial; a single individual encountered slight swelling in her lower limbs, likely associated with earlier sunburn [<a href="#mco270163-bib-0311" class="usa-link" aria-describedby="mco270163-bib-0311">311</a>]. Furthermore, in clinical trials on the use of cocaine and baclofen for treating alcohol‐abusing patients [<a href="#mco270163-bib-0089" class="usa-link" aria-describedby="mco270163-bib-0089">89</a>, <a href="#mco270163-bib-0349" class="usa-link" aria-describedby="mco270163-bib-0349">349</a>], administration of baclofen resulted in the occurrence of symptoms such as headache, nausea, sedation, and dizziness [<a href="#mco270163-bib-0310" class="usa-link" aria-describedby="mco270163-bib-0310">310</a>, <a href="#mco270163-bib-0347" class="usa-link" aria-describedby="mco270163-bib-0347">347</a>, <a href="#mco270163-bib-0348" class="usa-link" aria-describedby="mco270163-bib-0348">348</a>, <a href="#mco270163-bib-0350" class="usa-link" aria-describedby="mco270163-bib-0350">350</a>, <a href="#mco270163-bib-0351" class="usa-link" aria-describedby="mco270163-bib-0351">351</a>, <a href="#mco270163-bib-0352" class="usa-link" aria-describedby="mco270163-bib-0352">352</a>, <a href="#mco270163-bib-0353" class="usa-link" aria-describedby="mco270163-bib-0353">353</a>].</p>
<p>In addition, baclofen has been reported to cause sedation, muscle relaxation, ataxia in rats, mice, and pigs, and nausea in monkeys [<a href="#mco270163-bib-0095" class="usa-link" aria-describedby="mco270163-bib-0095">95</a>, <a href="#mco270163-bib-0352" class="usa-link" aria-describedby="mco270163-bib-0352">352</a>, <a href="#mco270163-bib-0354" class="usa-link" aria-describedby="mco270163-bib-0354">354</a>, <a href="#mco270163-bib-0355" class="usa-link" aria-describedby="mco270163-bib-0355">355</a>, <a href="#mco270163-bib-0356" class="usa-link" aria-describedby="mco270163-bib-0356">356</a>]. These potential side effects could potentially interfere with the drug's impact on food intake [<a href="#mco270163-bib-0087" class="usa-link" aria-describedby="mco270163-bib-0087">87</a>]. Baclofen successfully reduced alcohol consumption in mice at a dose that suppressed the reinforcing effects of SA but also suppressed locomotion [<a href="#mco270163-bib-0089" class="usa-link" aria-describedby="mco270163-bib-0089">89</a>, <a href="#mco270163-bib-0349" class="usa-link" aria-describedby="mco270163-bib-0349">349</a>]. Some of the rats presented signs of ataxia approximately 10–30 min after injection (4 mg/kg baclofen) on the first day [<a href="#mco270163-bib-0279" class="usa-link" aria-describedby="mco270163-bib-0279">279</a>], and it was thought that the ataxia observed in some of the animals might have been interfered with their feeding ability. Furthermore, some sedation was observed in the rats, and these side effects were mild in severity, except at the highest dose tested (10 mg/kg) [<a href="#mco270163-bib-0305" class="usa-link" aria-describedby="mco270163-bib-0305">305</a>]. Recent studies in animals showed that the 0–4 mg/kg dose of baclofen was safe and well tolerated [<a href="#mco270163-bib-0063" class="usa-link" aria-describedby="mco270163-bib-0063">63</a>, <a href="#mco270163-bib-0064" class="usa-link" aria-describedby="mco270163-bib-0064">64</a>, <a href="#mco270163-bib-0085" class="usa-link" aria-describedby="mco270163-bib-0085">85</a>]. The overall discussions and results imply that negative side effects are likely to be cause by a high dose of baclofen, different agonists, or overactivation of GABA<sub>B</sub>Rs.</p>
<p>As GABA<sub>B</sub>Rs are most densely expressed in the cerebral cortex, thalamic nuclei, midbrain, hypothalamus, and cerebellum (Figure <a href="#mco270163-fig-0001" class="usa-link">1</a>), but also highly expressed in several other limbic structures, in the spinal cord [<a href="#mco270163-bib-0089" class="usa-link" aria-describedby="mco270163-bib-0089">89</a>] and even in the gastrointestinal tract. Orthosteric ligands modulate the activity of abundant receptors involved in a variety of brain functions. When the extracellular domain and orthosteric ligand recognition sites of GB1 are directly bound by specific agents or ligands, an active and closed conformation is stabilized by an agonist bound to the VFT domain (Figures <a href="#mco270163-fig-0005" class="usa-link">5A</a> and <a href="#mco270163-fig-0001" class="usa-link">1</a>), resulting in significant and widespread physiological and pathological regulatory effects through a G‐protein coupling mechanism and signal transduction pathways involving downstream effectors, which is the basis of the negative side effects of GABA and baclofen [<a href="#mco270163-bib-0074" class="usa-link" aria-describedby="mco270163-bib-0074">74</a>, <a href="#mco270163-bib-0075" class="usa-link" aria-describedby="mco270163-bib-0075">75</a>]. It is therefore rather unlikely that the unwanted effects of systemically administered drugs that bind to orthosteric or allosteric binding sites can be avoided.</p>
<p>The selective and potent agonist of the GABA<sub>B</sub>Rs include <a href="https://www.ncbi.nlm.nih.gov/protein/CGP44532" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">CGP44532</a>, <a href="https://www.ncbi.nlm.nih.gov/protein/CGP35024" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">CGP35024</a>, and baclofen [<a href="#mco270163-bib-0070" class="usa-link" aria-describedby="mco270163-bib-0070">70</a>, <a href="#mco270163-bib-0089" class="usa-link" aria-describedby="mco270163-bib-0089">89</a>]. Baclofen, as a representative ligand that reacts with the key structural domain of GB1 (Figure <a href="#mco270163-fig-0005" class="usa-link">5A</a>), has stronger binding affinity, thus excessively blocking neurotransmitter release and inhibiting neuroexcitability [<a href="#mco270163-bib-0072" class="usa-link" aria-describedby="mco270163-bib-0072">72</a>, <a href="#mco270163-bib-0075" class="usa-link" aria-describedby="mco270163-bib-0075">75</a>] in both presynapses and postsynapses through G protein coupling voltage‐gated Ca<sup>2+</sup> channels, or inducing the hyperpolarization of neurons by opening GIRK channels [<a href="#mco270163-bib-0071" class="usa-link" aria-describedby="mco270163-bib-0071">71</a>, <a href="#mco270163-bib-0074" class="usa-link" aria-describedby="mco270163-bib-0074">74</a>], which may be involved in its underlying side effects, at least partly.</p>
<p>In general, the potential negative side effects may mainly stem from the wide distribution and vital regulatory effects or overactivation of GABA<sub>B</sub>Rs. To avoid these side effects, promising ligands or agents that selectively bind the GABA<sub>B</sub>R subunit involved in a given pathology, do not affect receptors in healthy neurons, slightly activate GABA<sub>B</sub>Rs, and are well tolerated by patients are needed. In the next sections, we mainly discuss the therapeutic effects and the potential side effects that may be induced by the activations of different‐targets or sites.</p></section><section id="mco270163-sec-0260"><h3 class="pmc_sec_title">6.3. Allosteric Ligand Recognition by GB2</h3>
<p>GABA<sub>B</sub>R activation is proposed to involve a unique allosteric mechanism (Figures <a href="#mco270163-fig-0001" class="usa-link">1</a>, <a href="#mco270163-fig-0002" class="usa-link">2</a>, and <a href="#mco270163-fig-0005" class="usa-link">5B</a>), where binding of an agonist to the VFT domain of GB1 results in a series of conformational rearrangements, which are transmitted to the TMD of GB2 to trigger G protein signaling [<a href="#mco270163-bib-0071" class="usa-link" aria-describedby="mco270163-bib-0071">71</a>, <a href="#mco270163-bib-0075" class="usa-link" aria-describedby="mco270163-bib-0075">75</a>]. In addition to the binding of ligands to GB1, the activity of GABA<sub>B</sub>Rs can be regulated by allosteric modifiers called PAMs, which have analogous efficacy to orthosteric ligands, or negative allosteric modulators (NAMs) [<a href="#mco270163-bib-0072" class="usa-link" aria-describedby="mco270163-bib-0072">72</a>, <a href="#mco270163-bib-0074" class="usa-link" aria-describedby="mco270163-bib-0074">74</a>] via allosteric ligand recognition [<a href="#mco270163-bib-0070" class="usa-link" aria-describedby="mco270163-bib-0070">70</a>, <a href="#mco270163-bib-0074" class="usa-link" aria-describedby="mco270163-bib-0074">74</a>]. Some comparative preclinical studies have demonstrated that NAMs targeting allosteric ligand recognition produce fewer side effects, are better tolerated and are more effective than expected among baclofen and other drugs [<a href="#mco270163-bib-0070" class="usa-link" aria-describedby="mco270163-bib-0070">70</a>, <a href="#mco270163-bib-0085" class="usa-link" aria-describedby="mco270163-bib-0085">85</a>, <a href="#mco270163-bib-0088" class="usa-link" aria-describedby="mco270163-bib-0088">88</a>, <a href="#mco270163-bib-0099" class="usa-link" aria-describedby="mco270163-bib-0099">99</a>].</p>
<p>For instance, Infusion of the <a href="https://www.ncbi.nlm.nih.gov/protein/SKF97541" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">SKF97541</a> (GABA<sub>B</sub>R agonists) into the PFC and STR significantly reduced basal DA levels, and this effect was reversed by the antagonist <a href="https://www.ncbi.nlm.nih.gov/protein/CGP52432" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">CGP52432</a>. Similar to agonists [<a href="#mco270163-bib-0357" class="usa-link" aria-describedby="mco270163-bib-0357">357</a>], PAMs targeting GABA<sub>B</sub>Rs, such as GS39783 [<a href="#mco270163-bib-0088" class="usa-link" aria-describedby="mco270163-bib-0088">88</a>, <a href="#mco270163-bib-0358" class="usa-link" aria-describedby="mco270163-bib-0358">358</a>], CGP7930 [<a href="#mco270163-bib-0358" class="usa-link" aria-describedby="mco270163-bib-0358">358</a>], and BHF177 [<a href="#mco270163-bib-0070" class="usa-link" aria-describedby="mco270163-bib-0070">70</a>, <a href="#mco270163-bib-0359" class="usa-link" aria-describedby="mco270163-bib-0359">359</a>], have been repeatedly reported to suppress multiple substance addiction‐related behaviors in tests involving an oral SA apparatus and preference tests [<a href="#mco270163-bib-0089" class="usa-link" aria-describedby="mco270163-bib-0089">89</a>, <a href="#mco270163-bib-0100" class="usa-link" aria-describedby="mco270163-bib-0100">100</a>, <a href="#mco270163-bib-0359" class="usa-link" aria-describedby="mco270163-bib-0359">359</a>, <a href="#mco270163-bib-0360" class="usa-link" aria-describedby="mco270163-bib-0360">360</a>], including AUD [<a href="#mco270163-bib-0088" class="usa-link" aria-describedby="mco270163-bib-0088">88</a>, <a href="#mco270163-bib-0318" class="usa-link" aria-describedby="mco270163-bib-0318">318</a>, <a href="#mco270163-bib-0361" class="usa-link" aria-describedby="mco270163-bib-0361">361</a>], sucrose‐induced food addiction [<a href="#mco270163-bib-0045" class="usa-link" aria-describedby="mco270163-bib-0045">45</a>, <a href="#mco270163-bib-0089" class="usa-link" aria-describedby="mco270163-bib-0089">89</a>], and cocaine seeking [<a href="#mco270163-bib-0089" class="usa-link" aria-describedby="mco270163-bib-0089">89</a>, <a href="#mco270163-bib-0100" class="usa-link" aria-describedby="mco270163-bib-0100">100</a>]. Furthermore, <a href="https://www.ncbi.nlm.nih.gov/protein/ADX71441" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">ADX71441</a> dose‐dependently decreased alcohol SA without causing sedation and prevented reinstatement of seeking and relapse‐like behavior according to mapping of neuronal activation [<a href="#mco270163-bib-0099" class="usa-link" aria-describedby="mco270163-bib-0099">99</a>]. In addition, it was demonstrated to excellent preclinical efficacy and tolerability in several rodent models [<a href="#mco270163-bib-0059" class="usa-link" aria-describedby="mco270163-bib-0059">59</a>, <a href="#mco270163-bib-0070" class="usa-link" aria-describedby="mco270163-bib-0070">70</a>].</p>
<p>PAMs of GABA<sub>B</sub>R (Figures <a href="#mco270163-fig-0002" class="usa-link">2</a>, <a href="#mco270163-fig-0003" class="usa-link">3</a>, and <a href="#mco270163-fig-0005" class="usa-link">5B</a>), which act by potentiating the signaling resulting from binding to allosteric sites of GB2 rather than binding to intrinsic sites of GB1, offer several advantages over orthosteric ligands, including fewer adverse effects, good tolerance, and better therapeutic efficiency [<a href="#mco270163-bib-0075" class="usa-link" aria-describedby="mco270163-bib-0075">75</a>, <a href="#mco270163-bib-0086" class="usa-link" aria-describedby="mco270163-bib-0086">86</a>, <a href="#mco270163-bib-0088" class="usa-link" aria-describedby="mco270163-bib-0088">88</a>, <a href="#mco270163-bib-0099" class="usa-link" aria-describedby="mco270163-bib-0099">99</a>]. This suggests that the efficacy of GABA<sub>B</sub>‐targeting PAMs have better therapeutic efficacy for addiction, and own high translational potential in humans and merit clinical testing, particularly in patients. Thus, PAMs may have therapeutic benefit for preventing and treating various psychiatric disorders, food addiction, BE, and feeding‐related metabolism disorders (obesity). However, there are relatively few research results of clinical studies targeting the GB2 of GABA<sub>B</sub>Rs. More basic and clinical studies of are needed in the future to further evaluate and investigate the efficacy and safety of PAMs in the treating assessment (Table <a href="#mco270163-tbl-0001" class="usa-link">1</a> and Figure <a href="#mco270163-fig-0005" class="usa-link">5</a>).</p></section><section id="mco270163-sec-0270"><h3 class="pmc_sec_title">6.4. Downstream Phosphorylation Signaling</h3>
<p>In the signaling pathways of GPCRs, phosphorylated regulation are vital functional processes. GABA<sub>B</sub>Rs are phosphorylated by PKA, adenosine 5′‐monophosphate‐activated protein kinase (AMPK), and Ca<sup>2+</sup>‐dependent protein kinase II (CaMKII); the former two stabilize the receptor on the cell surface and the latter promotes receptor endocytosis and degradation. AMPK‐induced phosphorylation facilitates the recycling process, while protein phosphatase 2A (PP2A) triggers dephosphorylation, resulting in lysosomal degradation [<a href="#mco270163-bib-0074" class="usa-link" aria-describedby="mco270163-bib-0074">74</a>, <a href="#mco270163-bib-0362" class="usa-link" aria-describedby="mco270163-bib-0362">362</a>]. Importantly, AMPK and PP2A activity is ideally balanced under basal conditions [<a href="#mco270163-bib-0085" class="usa-link" aria-describedby="mco270163-bib-0085">85</a>, <a href="#mco270163-bib-0094" class="usa-link" aria-describedby="mco270163-bib-0094">94</a>]. Phosphorylation of GB2 at Ser783 can be increased by AMPK and determines receptor fate during postendocytic sorting. Additionally, PP2A‐mediated regulation of GABA<sub>B</sub>R–GIRK signaling has thus far been observed in multiple brain regions in response to various stimuli [<a href="#mco270163-bib-0085" class="usa-link" aria-describedby="mco270163-bib-0085">85</a>, <a href="#mco270163-bib-0094" class="usa-link" aria-describedby="mco270163-bib-0094">94</a>, <a href="#mco270163-bib-0363" class="usa-link" aria-describedby="mco270163-bib-0363">363</a>].</p>
<p>Pharmacological inhibition of PP2A ameliorates depression‐like symptoms by improving GABA<sub>B</sub>R–GIRK function and neuronal excitability in a depression model [<a href="#mco270163-bib-0094" class="usa-link" aria-describedby="mco270163-bib-0094">94</a>]. In layer 5/6 pyramidal neurons of the prelimbic cortex, PP2A‐dependent suppression of GABA<sub>B</sub>R–GIRK, which enhanced cocaine‐induced locomotor activity and inhibited behavioral sensitization and represents an early adaptation that is critical for promoting addiction‐related behaviors, was observed [<a href="#mco270163-bib-0363" class="usa-link" aria-describedby="mco270163-bib-0363">363</a>]. These results demonstrate that the regulatory effects of PP2A by phosphorylating Ser783 of GB2 may be a potential target for regulating aberrant GABA<sub>B</sub>R signaling through GIRK channels and intracellular constitutive endocytosis of GABA<sub>B</sub>Rs (Figure <a href="#mco270163-fig-0005" class="usa-link">5C,D</a>).</p>
<p>Furthermore, CaMKII causes crosstalk between GABA<sub>B</sub>R signaling and glutamate signaling, interacts with NMDA receptors and regulates NMDA‐mediated plasticity [<a href="#mco270163-bib-0172" class="usa-link" aria-describedby="mco270163-bib-0172">172</a>, <a href="#mco270163-bib-0364" class="usa-link" aria-describedby="mco270163-bib-0364">364</a>]. Prevention of the dephosphorylation of GB2 at Ser783 has an added benefit [<a href="#mco270163-bib-0072" class="usa-link" aria-describedby="mco270163-bib-0072">72</a>, <a href="#mco270163-bib-0365" class="usa-link" aria-describedby="mco270163-bib-0365">365</a>]; it supports the phosphorylation of this residue by AMPK under ischemic conditions, and it exerts neuroprotection by stabilizing GABA<sub>B</sub>R functions [<a href="#mco270163-bib-0365" class="usa-link" aria-describedby="mco270163-bib-0365">365</a>]. It is known that that activity of CaMKII and AMPK is mediated by a rise in intracellular Ca<sup>2+</sup> levels and a decrease in the ATP/AMP ratio, and CaMKII binds to GABA<sub>B</sub>Rs and phosphorylates GB1 at Ser867 [<a href="#mco270163-bib-0366" class="usa-link" aria-describedby="mco270163-bib-0366">366</a>], indicating that these effects or inactive regulation maintain glutamatergic excitability stability. Mutational inhibition of Ser867 phosphorylation by CaMKII abolishes the downregulation of GABA<sub>B</sub>R expression. Thus, the interaction of CaMKII and PP2A with GABA<sub>B</sub>Rs maintains normal CNS excitability and inhibitory levels by counteracting overexcitation and excitotoxicity under abnormal conditions or stress [<a href="#mco270163-bib-0094" class="usa-link" aria-describedby="mco270163-bib-0094">94</a>, <a href="#mco270163-bib-0362" class="usa-link" aria-describedby="mco270163-bib-0362">362</a>, <a href="#mco270163-bib-0363" class="usa-link" aria-describedby="mco270163-bib-0363">363</a>, <a href="#mco270163-bib-0365" class="usa-link" aria-describedby="mco270163-bib-0365">365</a>], as shown in Figure <a href="#mco270163-fig-0005" class="usa-link">5C,D</a>.</p>
<p>Identification of the sites at which CaMKII and PP2A interact with GABA<sub>B</sub>Rs would permit the development of synthetic small interfering peptides or agents to disrupt these interactions and prevent phosphorylation of GB1 at Ser867 [<a href="#mco270163-bib-0085" class="usa-link" aria-describedby="mco270163-bib-0085">85</a>, <a href="#mco270163-bib-0094" class="usa-link" aria-describedby="mco270163-bib-0094">94</a>, <a href="#mco270163-bib-0363" class="usa-link" aria-describedby="mco270163-bib-0363">363</a>, <a href="#mco270163-bib-0366" class="usa-link" aria-describedby="mco270163-bib-0366">366</a>] or dephosphorylation of GB2 at Ser783 [<a href="#mco270163-bib-0085" class="usa-link" aria-describedby="mco270163-bib-0085">85</a>, <a href="#mco270163-bib-0094" class="usa-link" aria-describedby="mco270163-bib-0094">94</a>, <a href="#mco270163-bib-0362" class="usa-link" aria-describedby="mco270163-bib-0362">362</a>, <a href="#mco270163-bib-0363" class="usa-link" aria-describedby="mco270163-bib-0363">363</a>, <a href="#mco270163-bib-0365" class="usa-link" aria-describedby="mco270163-bib-0365">365</a>]. Recent findings indicate that a brief peptide corresponding to the PP2A interaction region site on GB1 competes for PP2A binding, enhances phosphorylation of GB2 (Ser783), and impacts signaling through GIRK channels [<a href="#mco270163-bib-0362" class="usa-link" aria-describedby="mco270163-bib-0362">362</a>]. Certain brain peptides, like MIF‐1 (Pro–Leu–Gly–NH2) and Tyr–MIF‐1 (Tyr–Pro–Leu–Gly–NH2), amplify GABA‐stimulated benzodiazepine binding on the membrane in the mouse cortex [<a href="#mco270163-bib-0367" class="usa-link" aria-describedby="mco270163-bib-0367">367</a>]. α‐Conotoxins, a subset of compounds composed of 11–20 amino acid residues, inhibit the GABA<sub>B</sub>R‐coupled N‐type calcium (Cav2.2) channels [<a href="#mco270163-bib-0368" class="usa-link" aria-describedby="mco270163-bib-0368">368</a>], produces both acute and long lasting analgesia [<a href="#mco270163-bib-0091" class="usa-link" aria-describedby="mco270163-bib-0091">91</a>], accelerates the recovery of function after nerve injury, and alleviates neuropathic pain; alpha9–alpha10 antagonists are also potent GABA<sub>B</sub>R agonists [<a href="#mco270163-bib-0091" class="usa-link" aria-describedby="mco270163-bib-0091">91</a>, <a href="#mco270163-bib-0368" class="usa-link" aria-describedby="mco270163-bib-0368">368</a>], and phosphorylation of downstream mitogen‐activated protein kinase/extracellular signal‐regulated kinase (ERK)1/2 is regulated by these GABA<sub>B</sub>R agonists [<a href="#mco270163-bib-0085" class="usa-link" aria-describedby="mco270163-bib-0085">85</a>, <a href="#mco270163-bib-0369" class="usa-link" aria-describedby="mco270163-bib-0369">369</a>]. Moreover, GABA<sub>B</sub>Rs may regulate numerous cellular processes by interacting with 14‐3‐3 proteins (phosphoserine/phosphothreonine‐recognition proteins; Figure <a href="#mco270163-fig-0005" class="usa-link">5B</a>) [<a href="#mco270163-bib-0370" class="usa-link" aria-describedby="mco270163-bib-0370">370</a>], which are regarded as key agents for the treatment of numerous neurological diseases involved 14‐3‐3 dysfunction [<a href="#mco270163-bib-0072" class="usa-link" aria-describedby="mco270163-bib-0072">72</a>, <a href="#mco270163-bib-0085" class="usa-link" aria-describedby="mco270163-bib-0085">85</a>, <a href="#mco270163-bib-0370" class="usa-link" aria-describedby="mco270163-bib-0370">370</a>]. However, there are few direct science date and tests that demonstrate regular effects of the downstream GABA<sub>B</sub>R signaling pathway and its phosphorylation sites on special psychiatric disorders, BE, and feeding‐related obesity.</p>
<p>Based on the above mechanisms, small interfering peptides can optimize the protein–protein interactions between GABA<sub>B</sub>Rs and G protein‐coupled receptors, including the GABA<sub>B</sub>R–GIRK interaction, the NMDA receptor/GABA<sub>B</sub>R–mGluR1 interaction, and the calcium channel pathway, which may allow these peptides to restore normal receptor function selectively at the site of dysfunction under pathological conditions. On the one hand, restoring functional GABA<sub>B</sub>Rs may serve as a new clinical intervention strategy for CNS diseases involving GABA<sub>B</sub>R dysfunction. On the other hand, these phosphorylation sites (CaMKII and PP2A) and the allosteric modulation of GABA<sub>B</sub>R pathways act as promising targets and have been proposed as targets for the development of lead compounds for CNS disorders, such as SUDs [<a href="#mco270163-bib-0045" class="usa-link" aria-describedby="mco270163-bib-0045">45</a>, <a href="#mco270163-bib-0089" class="usa-link" aria-describedby="mco270163-bib-0089">89</a>, <a href="#mco270163-bib-0317" class="usa-link" aria-describedby="mco270163-bib-0317">317</a>, <a href="#mco270163-bib-0318" class="usa-link" aria-describedby="mco270163-bib-0318">318</a>]. These small interfering synthetic peptides (Figure <a href="#mco270163-fig-0005" class="usa-link">5C,D</a>) or agents specifically targeting these potential sites may provide effective therapies that avoid the possible adverse effects of GABA<sub>B</sub>R agonists. Despite, the implications of phosphorylation sites (CaMKII and PP2A) and the allosteric modulations for neuropsychiatric disorders, BE, and feeding‐related metabolism disorders are needed to be explored and confirmed via preclinical and clinical testing.</p></section></section><section id="mco270163-sec-0280"><h2 class="pmc_sec_title">7. Conclusion</h2>
<p>In summary, this work demonstrates that GABA<sub>B</sub>Rs are associated with various physiological processes, neurological and psychiatric disorders, feeding behaviors, BE‐related metabolism disorders, and even oncology. Understanding the role of GABA<sub>B</sub>R provides valuable insights into normal brain function and potential therapeutic targets for different psychiatric disorders, BE, and BE‐related metabolism disorders.</p>
<p>The further discussions imply that novel strategies of specifically targeting GB1 or GB2 or downstream signaling pathways of GABA<sub>B</sub>Rs may be effective in treating psychiatric disorders and equally efficacious in attenuating BE and BE‐related metabolism disorders. Within the GABAergic system, GABA<sub>B</sub>Rs are potential therapeutic targets for dealing psychiatric disorders, multiple metabolic, and behavioral disorders. Allosteric modulators and small peptides targeting GABA<sub>B</sub>R signaling pathways, including protein phosphatase 2A (Ser783), CaMKII (Ser867), and 14‐3‐3 proteins, which were shown to have therapeutic effects in preclinical studies, may be developed as attractive drug candidates that avoid the side effects of agents that directly bind these receptors.</p>
<p>However, there is limited preclinical and clinical evidence directly verifying that strategies targeting phosphorylation sites and the allosteric modulation of GABA<sub>B</sub>R pathways (Figure <a href="#mco270163-fig-0005" class="usa-link">5C,D</a>) are safe and effective potential methods for treating various psychiatric disorders, BE and obesity (Figures <a href="#mco270163-fig-0001" class="usa-link">1</a>, <a href="#mco270163-fig-0003" class="usa-link">3</a>, and <a href="#mco270163-fig-0004" class="usa-link">4</a>). It remains unclear whether the central and peripheric effects and mechanisms of strategies targeting GABA<sub>B</sub>R pathways are confounded by BE, environmental stress, and abnormal diet‐induced obesity.</p>
<p>Overall, future studies should focus on exploring and confirming the clinical efficacy and safety of PAMs and small interfering peptides used in the treatment of different psychiatric disorders, BE, and BE‐related metabolism disorders. It is necessary and vital to further explore the underlying mechanisms of strategies targeting GABA<sub>B</sub>Rs in reducing BE of palatable diet, which will provide some clues to the therapeutic potential of these strategies for special psychiatric disorders, such as BE, addiction, and BE‐related obesity.</p></section><section id="mco270163-sec-0290"><h2 class="pmc_sec_title">Author Contributions</h2>
<p>W. X. designed the review. W. X. and Y. L. wrote the manuscript. X. W., E. B., E. K., and M. V. helped create the figures and discussed and revised the manuscript. J. H., T. Y., J. C., H. W., and X. C. were mainly responsible for the supervision of the work and the management of related projects. All authors discussed, edited, and approved the final version.</p></section><section id="mco270163-sec-0310"><h2 class="pmc_sec_title">Ethics Statement</h2>
<p>The authors have nothing to report.</p></section><section id="mco270163-sec-0320"><h2 class="pmc_sec_title">Conflicts of Interest</h2>
<p>The authors declare no conflicts of interest.</p></section><section id="mco270163-sec-0300" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>We express our sincere gratitude to these foundations, as well as the laboratory team member.</p></section><section id="notes1"><section id="fn-group1" class="fn-group"><div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="mco270163-note-0001"><p>
<strong>Funding</strong>: This work was funded by the National Natural Science Foundation of China (82101622, W. X.), the General Program of Shanghai Municipal Health Commission (202140092, J. C.), the National Natural Science Foundation of China (82071545, J. C.), and the Healthcare Talents Youth Program of Shanghai Pudong New Area (2025PDWSYCQN‐09, W. X.).</p></div></div></section></section><section id="_ci93_" lang="en" class="contrib-info"><h2 class="pmc_sec_title">Contributor Information</h2>
<p>Ti‐Fei Yuan, Email: ytf0707@126.com.</p>
<p>Jue Chen, Email: chenjue2088@163.com.</p>
<p>Hua Wang, Email: wanghua@ahmu.edu.cn.</p>
<p>Xiangfang Chen, Email: Chenxiangfang@smmu.edu.cn.</p></section><section id="mco270163-sec-0340"><h2 class="pmc_sec_title">Data Availability Statement</h2>
<p>The authors have nothing to report.</p></section><section id="mco270163-bibl-0001" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="mco270163-bibl-0001_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="mco270163-bib-0001">
<span class="label">1.</span><cite>
Flegal K. M., “BMI and Obesity Trends in Chinese National Survey Data,” Lancet
398, no. 10294 (2021): 5–7.
</cite> [<a href="https://doi.org/10.1016/S0140-6736(21)00892-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34217400/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=BMI%20and%20Obesity%20Trends%20in%20Chinese%20National%20Survey%20Data&amp;author=K.%20M.%20Flegal&amp;volume=398&amp;issue=10294&amp;publication_year=2021&amp;pages=5-7&amp;pmid=34217400&amp;doi=10.1016/S0140-6736(21)00892-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0002">
<span class="label">2.</span><cite>
Swinburn B. A., Kraak V. I., Allender S., et al., “The Global Syndemic of Obesity, Undernutrition, and Climate Change: The Lancet Commission Report,” Lancet
393, no. 10173 (2019): 791–846.
</cite> [<a href="https://doi.org/10.1016/S0140-6736(18)32822-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30700377/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=The%20Global%20Syndemic%20of%20Obesity,%20Undernutrition,%20and%20Climate%20Change:%20The%20Lancet%20Commission%20Report&amp;author=B.%20A.%20Swinburn&amp;author=V.%20I.%20Kraak&amp;author=S.%20Allender&amp;volume=393&amp;issue=10173&amp;publication_year=2019&amp;pages=791-846&amp;pmid=30700377&amp;doi=10.1016/S0140-6736(18)32822-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0003">
<span class="label">3.</span><cite>
Wang Y., Xue H., Sun M., Zhu X., Zhao L., and Yang Y., “Prevention and Control of Obesity in China,” The Lancet Global Health
7, no. 9 (2019): e1166–e1167.
</cite> [<a href="https://doi.org/10.1016/S2214-109X(19)30276-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31401995/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=The%20Lancet%20Global%20Health&amp;title=Prevention%20and%20Control%20of%20Obesity%20in%20China&amp;author=Y.%20Wang&amp;author=H.%20Xue&amp;author=M.%20Sun&amp;author=X.%20Zhu&amp;author=L.%20Zhao&amp;volume=7&amp;issue=9&amp;publication_year=2019&amp;pages=e1166-e1167&amp;pmid=31401995&amp;doi=10.1016/S2214-109X(19)30276-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0004">
<span class="label">4.</span><cite>
Wang Y., Zhao L., Gao L., Pan A., and Xue H., “Health Policy and Public Health Implications of Obesity in China,” The Lancet Diabetes &amp; Endocrinology
9, no. 7 (2021): 446–461.
</cite> [<a href="https://doi.org/10.1016/S2213-8587(21)00118-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34097869/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=The%20Lancet%20Diabetes%20&amp;%20Endocrinology&amp;title=Health%20Policy%20and%20Public%20Health%20Implications%20of%20Obesity%20in%20China&amp;author=Y.%20Wang&amp;author=L.%20Zhao&amp;author=L.%20Gao&amp;author=A.%20Pan&amp;author=H.%20Xue&amp;volume=9&amp;issue=7&amp;publication_year=2021&amp;pages=446-461&amp;pmid=34097869&amp;doi=10.1016/S2213-8587(21)00118-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0005">
<span class="label">5.</span><cite>
Ng M., Fleming T., Robinson M., et al., “Global, Regional, and National Prevalence of Overweight and Obesity in Children and Adults During 1980–2013: A Systematic Analysis for the Global Burden of Disease Study 2013,” The Lancet
384, no. 9945 (2014): 766–781.</cite> [<a href="https://doi.org/10.1016/S0140-6736(14)60460-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4624264/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24880830/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=The%20Lancet&amp;title=Global,%20Regional,%20and%20National%20Prevalence%20of%20Overweight%20and%20Obesity%20in%20Children%20and%20Adults%20During%201980%E2%80%932013:%20A%20Systematic%20Analysis%20for%20the%20Global%20Burden%20of%20Disease%20Study%202013&amp;author=M.%20Ng&amp;author=T.%20Fleming&amp;author=M.%20Robinson&amp;volume=384&amp;issue=9945&amp;publication_year=2014&amp;pages=766-781&amp;pmid=24880830&amp;doi=10.1016/S0140-6736(14)60460-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0006">
<span class="label">6.</span><cite>
The Prevalence and Correlates of Binge Eating Disorder in the World Health Organization World Mental Health Surveys. Biological Psychiatry
2013;73(9):904–914.
</cite> [<a href="https://doi.org/10.1016/j.biopsych.2012.11.020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3628997/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23290497/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biological%20Psychiatry&amp;title=The%20Prevalence%20and%20Correlates%20of%20Binge%20Eating%20Disorder%20in%20the%20World%20Health%20Organization%20World%20Mental%20Health%20Surveys&amp;volume=73&amp;issue=9&amp;publication_year=2013&amp;pages=904-914&amp;pmid=23290497&amp;doi=10.1016/j.biopsych.2012.11.020&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0007">
<span class="label">7.</span><cite>
Schvey N. A., Pearlman A. T., Klein D. A., Murphy M. A., and Gray J. C., “Obesity and Eating Disorder Disparities among Sexual and Gender Minority Youth,” JAMA Pediatrics
175, no. 4 (2021): 412–415.
</cite> [<a href="https://doi.org/10.1001/jamapediatrics.2020.5152" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7770614/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33369616/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA%20Pediatrics&amp;title=Obesity%20and%20Eating%20Disorder%20Disparities%20among%20Sexual%20and%20Gender%20Minority%20Youth&amp;author=N.%20A.%20Schvey&amp;author=A.%20T.%20Pearlman&amp;author=D.%20A.%20Klein&amp;author=M.%20A.%20Murphy&amp;author=J.%20C.%20Gray&amp;volume=175&amp;issue=4&amp;publication_year=2021&amp;pages=412-415&amp;pmid=33369616&amp;doi=10.1001/jamapediatrics.2020.5152&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0008">
<span class="label">8.</span><cite>
Wang Q., Kong Y., Lin S., et al., “The ATP Level in the mPFC Mediates the Antidepressant Effect of Calorie Restriction,” Neuroscience Bulletin
37, no. 9 (2021): 1303–1313.
</cite> [<a href="https://doi.org/10.1007/s12264-021-00726-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8423953/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34089507/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuroscience%20Bulletin&amp;title=The%20ATP%20Level%20in%20the%20mPFC%20Mediates%20the%20Antidepressant%20Effect%20of%20Calorie%20Restriction&amp;author=Q.%20Wang&amp;author=Y.%20Kong&amp;author=S.%20Lin&amp;volume=37&amp;issue=9&amp;publication_year=2021&amp;pages=1303-1313&amp;pmid=34089507&amp;doi=10.1007/s12264-021-00726-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0009">
<span class="label">9.</span><cite>
Hreins E. G., Goldstone A. P., Brown R. M., and Sumithran P., “The Therapeutic Potential of GLP‐1 Analogues for Stress‐related Eating and Role of GLP‐1 in Stress, Emotion and Mood: A Review,” Progress in Neuro‐Psychopharmacology and Biological Psychiatry
110, no. 3 (2021): 110303.
</cite> [<a href="https://doi.org/10.1016/j.pnpbp.2021.110303" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33741445/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Progress%20in%20Neuro%E2%80%90Psychopharmacology%20and%20Biological%20Psychiatry&amp;title=The%20Therapeutic%20Potential%20of%20GLP%E2%80%901%20Analogues%20for%20Stress%E2%80%90related%20Eating%20and%20Role%20of%20GLP%E2%80%901%20in%20Stress,%20Emotion%20and%20Mood:%20A%20Review&amp;author=E.%20G.%20Hreins&amp;author=A.%20P.%20Goldstone&amp;author=R.%20M.%20Brown&amp;author=P.%20Sumithran&amp;volume=110&amp;issue=3&amp;publication_year=2021&amp;pages=110303&amp;pmid=33741445&amp;doi=10.1016/j.pnpbp.2021.110303&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0010">
<span class="label">10.</span><cite>
Sweeney P. and Yang Y., “Neural Circuit Mechanisms Underlying Emotional Regulation of Homeostatic Feeding,” Trends in Endocrinology &amp; Metabolism (2017): S1043276017300231.</cite> [<a href="https://doi.org/10.1016/j.tem.2017.02.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5438765/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28279562/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Trends%20in%20Endocrinology%20&amp;%20Metabolism&amp;title=Neural%20Circuit%20Mechanisms%20Underlying%20Emotional%20Regulation%20of%20Homeostatic%20Feeding&amp;author=P.%20Sweeney&amp;author=Y.%20Yang&amp;publication_year=2017&amp;pages=S1043276017300231&amp;pmid=28279562&amp;doi=10.1016/j.tem.2017.02.006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0011">
<span class="label">11.</span><cite>
Fellmeth G., Rose‐Clarke K., Zhao C., et al., “Health Impacts of Parental Migration on Left‐Behind Children and Adolescents: A Systematic Review and Meta‐analysis,” Lancet
392, no. 10164 (2018): 2567–2582.
</cite> [<a href="https://doi.org/10.1016/S0140-6736(18)32558-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6294734/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30528471/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Health%20Impacts%20of%20Parental%20Migration%20on%20Left%E2%80%90Behind%20Children%20and%20Adolescents:%20A%20Systematic%20Review%20and%20Meta%E2%80%90analysis&amp;author=G.%20Fellmeth&amp;author=K.%20Rose%E2%80%90Clarke&amp;author=C.%20Zhao&amp;volume=392&amp;issue=10164&amp;publication_year=2018&amp;pages=2567-2582&amp;pmid=30528471&amp;doi=10.1016/S0140-6736(18)32558-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0012">
<span class="label">12.</span><cite>
Teufel F., Seiglie J. A., Geldsetzer P., et al., “Body‐mass Index and Diabetes Risk in 57 Low‐income and Middle‐income Countries: A Cross‐sectional Study of Nationally Representative, Individual‐level Data in 685 616 Adults,” Lancet
398, no. 10296 (2021): 238–248.
</cite> [<a href="https://doi.org/10.1016/S0140-6736(21)00844-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8336025/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34274065/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Body%E2%80%90mass%20Index%20and%20Diabetes%20Risk%20in%2057%20Low%E2%80%90income%20and%20Middle%E2%80%90income%20Countries:%20A%20Cross%E2%80%90sectional%20Study%20of%20Nationally%20Representative,%20Individual%E2%80%90level%20Data%20in%20685%E2%80%88616%20Adults&amp;author=F.%20Teufel&amp;author=J.%20A.%20Seiglie&amp;author=P.%20Geldsetzer&amp;volume=398&amp;issue=10296&amp;publication_year=2021&amp;pages=238-248&amp;pmid=34274065&amp;doi=10.1016/S0140-6736(21)00844-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0013">
<span class="label">13.</span><cite>
Gupta A., Osadchiy V., and Mayer E. A., “Brain–gut–microbiome Interactions in Obesity and Food Addiction,” Nature Reviews Gastroenterology &amp; Hepatology
17, no. 11 (2020): 655–672.
</cite> [<a href="https://doi.org/10.1038/s41575-020-0341-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7841622/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32855515/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Reviews%20Gastroenterology%20&amp;%20Hepatology&amp;title=Brain%E2%80%93gut%E2%80%93microbiome%20Interactions%20in%20Obesity%20and%20Food%20Addiction&amp;author=A.%20Gupta&amp;author=V.%20Osadchiy&amp;author=E.%20A.%20Mayer&amp;volume=17&amp;issue=11&amp;publication_year=2020&amp;pages=655-672&amp;pmid=32855515&amp;doi=10.1038/s41575-020-0341-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0014">
<span class="label">14.</span><cite>
Hisham Z., Sadaf F., and Paul F., “Obesity and the Brain: How Convincing Is the Addiction Model?,” Nature Reviews Neuroscience
13, no. 4 (2012): 279–286.
</cite> [<a href="https://doi.org/10.1038/nrn3212" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22414944/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Reviews%20Neuroscience&amp;title=Obesity%20and%20the%20Brain:%20How%20Convincing%20Is%20the%20Addiction%20Model?&amp;author=Z.%20Hisham&amp;author=F.%20Sadaf&amp;author=F.%20Paul&amp;volume=13&amp;issue=4&amp;publication_year=2012&amp;pages=279-286&amp;pmid=22414944&amp;doi=10.1038/nrn3212&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0015">
<span class="label">15.</span><cite>
Volkow N. D. and Wise R. A., “How Can Drug Addiction Help Us Understand Obesity?,” Nature Neuroscience
8, no. 5 (2005): 555–560.
</cite> [<a href="https://doi.org/10.1038/nn1452" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15856062/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Neuroscience&amp;title=How%20Can%20Drug%20Addiction%20Help%20Us%20Understand%20Obesity?&amp;author=N.%20D.%20Volkow&amp;author=R.%20A.%20Wise&amp;volume=8&amp;issue=5&amp;publication_year=2005&amp;pages=555-560&amp;pmid=15856062&amp;doi=10.1038/nn1452&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0016">
<span class="label">16.</span><cite>
Mendenhall E. and Singer M., “The Global Syndemic of Obesity, Undernutrition, and Climate Change,” Lancet
393, no. 10173 (2019): 741.</cite> [<a href="https://doi.org/10.1016/S0140-6736(19)30310-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30765124/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=The%20Global%20Syndemic%20of%20Obesity,%20Undernutrition,%20and%20Climate%20Change&amp;author=E.%20Mendenhall&amp;author=M.%20Singer&amp;volume=393&amp;issue=10173&amp;publication_year=2019&amp;pages=741&amp;pmid=30765124&amp;doi=10.1016/S0140-6736(19)30310-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0017">
<span class="label">17.</span><cite>
Boer G. A., Hay D. L., and Tups A., “Obesity Pharmacotherapy: Incretin Action in the central Nervous System,” Trends in Pharmacological Sciences
44, no. 1 (2023): 50–63.
</cite> [<a href="https://doi.org/10.1016/j.tips.2022.11.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36462999/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Trends%20in%20Pharmacological%20Sciences&amp;title=Obesity%20Pharmacotherapy:%20Incretin%20Action%20in%20the%20central%20Nervous%20System&amp;author=G.%20A.%20Boer&amp;author=D.%20L.%20Hay&amp;author=A.%20Tups&amp;volume=44&amp;issue=1&amp;publication_year=2023&amp;pages=50-63&amp;pmid=36462999&amp;doi=10.1016/j.tips.2022.11.001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0018">
<span class="label">18.</span><cite>
Hammoud R. and Drucker D. J., “Beyond the Pancreas: Contrasting Cardiometabolic Actions of GIP and GLP1,” Nature Reviews Endocrinology
19, no. 4 (2023): 201–216.</cite> [<a href="https://doi.org/10.1038/s41574-022-00783-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36509857/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Reviews%20Endocrinology&amp;title=Beyond%20the%20Pancreas:%20Contrasting%20Cardiometabolic%20Actions%20of%20GIP%20and%20GLP1&amp;author=R.%20Hammoud&amp;author=D.%20J.%20Drucker&amp;volume=19&amp;issue=4&amp;publication_year=2023&amp;pages=201-216&amp;pmid=36509857&amp;doi=10.1038/s41574-022-00783-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0019">
<span class="label">19.</span><cite>
Zhang Y., Zhao X., Dong X., et al., “Activity‐balanced GLP‐1/GDF15 Dual Agonist Reduces Body Weight and Metabolic Disorder in Mice and Non‐human Primates,” Cell Metabolism
35, no. 2 (2023): 287–298, e4.
</cite> [<a href="https://doi.org/10.1016/j.cmet.2023.01.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36706758/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Metabolism&amp;title=Activity%E2%80%90balanced%20GLP%E2%80%901/GDF15%20Dual%20Agonist%20Reduces%20Body%20Weight%20and%20Metabolic%20Disorder%20in%20Mice%20and%20Non%E2%80%90human%20Primates&amp;author=Y.%20Zhang&amp;author=X.%20Zhao&amp;author=X.%20Dong&amp;volume=35&amp;issue=2&amp;publication_year=2023&amp;pages=287-298&amp;pmid=36706758&amp;doi=10.1016/j.cmet.2023.01.001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0020">
<span class="label">20.</span><cite>
Lee Y. H., Kim M., Lee M., et al., “Food Craving, Seeking, and Consumption Behaviors: Conceptual Phases and Assessment Methods Used in Animal and Human Studies,” Journal of Obesity Metabolic Syndrome
28, no. 3 (2019).</cite> [<a href="https://doi.org/10.7570/jomes.2019.28.3.148" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6774451/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31583379/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Obesity%20Metabolic%20Syndrome&amp;title=Food%20Craving,%20Seeking,%20and%20Consumption%20Behaviors:%20Conceptual%20Phases%20and%20Assessment%20Methods%20Used%20in%20Animal%20and%20Human%20Studies&amp;author=Y.%20H.%20Lee&amp;author=M.%20Kim&amp;author=M.%20Lee&amp;volume=28&amp;issue=3&amp;publication_year=2019&amp;pmid=31583379&amp;doi=10.7570/jomes.2019.28.3.148&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0021">
<span class="label">21.</span><cite>
Jiang X. and Pan Y., “Neural Control of Action Selection among Innate Behaviors,” Neuroscience Bulletin
38, no. 12 (2022): 1541–1558.
</cite> [<a href="https://doi.org/10.1007/s12264-022-00886-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9723052/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35633465/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuroscience%20Bulletin&amp;title=Neural%20Control%20of%20Action%20Selection%20among%20Innate%20Behaviors&amp;author=X.%20Jiang&amp;author=Y.%20Pan&amp;volume=38&amp;issue=12&amp;publication_year=2022&amp;pages=1541-1558&amp;pmid=35633465&amp;doi=10.1007/s12264-022-00886-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0022">
<span class="label">22.</span><cite>
Wu H., Yan X., Tang D., et al., “Internal States Influence the Representation and Modulation of Food Intake by Subthalamic Neurons,” Neuroscience Bulletin
36, no. 11 (2020): 1355–1368.
</cite> [<a href="https://doi.org/10.1007/s12264-020-00533-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7674539/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32567027/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuroscience%20Bulletin&amp;title=Internal%20States%20Influence%20the%20Representation%20and%20Modulation%20of%20Food%20Intake%20by%20Subthalamic%20Neurons&amp;author=H.%20Wu&amp;author=X.%20Yan&amp;author=D.%20Tang&amp;volume=36&amp;issue=11&amp;publication_year=2020&amp;pages=1355-1368&amp;pmid=32567027&amp;doi=10.1007/s12264-020-00533-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0023">
<span class="label">23.</span><cite>
Miguel A. A., Woods S. C., Marcia P., et al., “Food Reward System: Current Perspectives and Future Research Needs,” Nutrition Reviews no. 5 (2015): 296–307.
</cite> [<a href="https://doi.org/10.1093/nutrit/nuv002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4477694/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26011903/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nutrition%20Reviews&amp;title=Food%20Reward%20System:%20Current%20Perspectives%20and%20Future%20Research%20Needs&amp;author=A.%20A.%20Miguel&amp;author=S.%20C.%20Woods&amp;author=P.%20Marcia&amp;issue=5&amp;publication_year=2015&amp;pages=296-307&amp;pmid=26011903&amp;doi=10.1093/nutrit/nuv002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0024">
<span class="label">24.</span><cite>
Gutierrez R., Fonseca E., and Simon S. A., “The Neuroscience of Sugars in Taste, Gut‐reward, Feeding Circuits, and Obesity,” Cellular and Molecular Life Sciences
77, no. 2 (2020).</cite> [<a href="https://doi.org/10.1007/s00018-020-03458-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11105013/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32006052/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cellular%20and%20Molecular%20Life%20Sciences&amp;title=The%20Neuroscience%20of%20Sugars%20in%20Taste,%20Gut%E2%80%90reward,%20Feeding%20Circuits,%20and%20Obesity&amp;author=R.%20Gutierrez&amp;author=E.%20Fonseca&amp;author=S.%20A.%20Simon&amp;volume=77&amp;issue=2&amp;publication_year=2020&amp;pmid=32006052&amp;doi=10.1007/s00018-020-03458-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0025">
<span class="label">25.</span><cite>
Ahmed S. H., Guillem K., and Vandaele Y., “Sugar Addiction: Pushing the Drug‐sugar Analogy to the Limit,” Current Opinion in Clinical Nutrition &amp; Metabolic Care
16 (2013): 434–439.
</cite> [<a href="https://doi.org/10.1097/MCO.0b013e328361c8b8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23719144/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Current%20Opinion%20in%20Clinical%20Nutrition%20&amp;%20Metabolic%20Care&amp;title=Sugar%20Addiction:%20Pushing%20the%20Drug%E2%80%90sugar%20Analogy%20to%20the%20Limit&amp;author=S.%20H.%20Ahmed&amp;author=K.%20Guillem&amp;author=Y.%20Vandaele&amp;volume=16&amp;publication_year=2013&amp;pages=434-439&amp;pmid=23719144&amp;doi=10.1097/MCO.0b013e328361c8b8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0026">
<span class="label">26.</span><cite>
Gold M. S. and Avena N. M., “Animal Models Lead the Way to Further Understanding Food Addiction as Well as Providing Evidence That Drugs Used Successfully in Addictions Can be Successful in Treating Overeating,” Biological Psychiatry
74, no. 7 (2013): E11–E11.
</cite> [<a href="https://doi.org/10.1016/j.biopsych.2013.04.022" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4038094/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23726509/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biological%20Psychiatry&amp;title=Animal%20Models%20Lead%20the%20Way%20to%20Further%20Understanding%20Food%20Addiction%20as%20Well%20as%20Providing%20Evidence%20That%20Drugs%20Used%20Successfully%20in%20Addictions%20Can%20be%20Successful%20in%20Treating%20Overeating&amp;author=M.%20S.%20Gold&amp;author=N.%20M.%20Avena&amp;volume=74&amp;issue=7&amp;publication_year=2013&amp;pages=E11-E11&amp;pmid=23726509&amp;doi=10.1016/j.biopsych.2013.04.022&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0027">
<span class="label">27.</span><cite>
Baldo B. A., Spencer R. C., Sadeghian K., and Mena J. D., “GABA‐Mediated Inactivation of Medial Prefrontal and Agranular Insular Cortex in the Rat: Contrasting Effects on Hunger‐ and Palatability‐Driven Feeding,” Neuropsychopharmacology
41, no. 4 (2016): 960–970.
</cite> [<a href="https://doi.org/10.1038/npp.2015.222" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4748421/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26202102/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuropsychopharmacology&amp;title=GABA%E2%80%90Mediated%20Inactivation%20of%20Medial%20Prefrontal%20and%20Agranular%20Insular%20Cortex%20in%20the%20Rat:%20Contrasting%20Effects%20on%20Hunger%E2%80%90%20and%20Palatability%E2%80%90Driven%20Feeding&amp;author=B.%20A.%20Baldo&amp;author=R.%20C.%20Spencer&amp;author=K.%20Sadeghian&amp;author=J.%20D.%20Mena&amp;volume=41&amp;issue=4&amp;publication_year=2016&amp;pages=960-970&amp;pmid=26202102&amp;doi=10.1038/npp.2015.222&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0028">
<span class="label">28.</span><cite>
Trask S., Shipman M. L., Green J. T., and Bouton M. E., “Inactivation of the Prelimbic Cortex Attenuates Context‐Dependent Operant Responding,” Journal of Neuroscience
37, no. 9 (2017): 2317–2324.
</cite> [<a href="https://doi.org/10.1523/JNEUROSCI.3361-16.2017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5354345/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28137970/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Neuroscience&amp;title=Inactivation%20of%20the%20Prelimbic%20Cortex%20Attenuates%20Context%E2%80%90Dependent%20Operant%20Responding&amp;author=S.%20Trask&amp;author=M.%20L.%20Shipman&amp;author=J.%20T.%20Green&amp;author=M.%20E.%20Bouton&amp;volume=37&amp;issue=9&amp;publication_year=2017&amp;pages=2317-2324&amp;pmid=28137970&amp;doi=10.1523/JNEUROSCI.3361-16.2017&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0029">
<span class="label">29.</span><cite>
Volkow N. D., Wang G. J., and Baler R. D., “Reward, Dopamine and the Control of Food Intake: Implications for Obesity,” Trends in Cognitive Sciences
15, no. 1 (2011): 37–46.
</cite> [<a href="https://doi.org/10.1016/j.tics.2010.11.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3124340/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21109477/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Trends%20in%20Cognitive%20Sciences&amp;title=Reward,%20Dopamine%20and%20the%20Control%20of%20Food%20Intake:%20Implications%20for%20Obesity&amp;author=N.%20D.%20Volkow&amp;author=G.%20J.%20Wang&amp;author=R.%20D.%20Baler&amp;volume=15&amp;issue=1&amp;publication_year=2011&amp;pages=37-46&amp;pmid=21109477&amp;doi=10.1016/j.tics.2010.11.001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0030">
<span class="label">30.</span><cite>
Brahma M. K., Gilglioni E. H., Zhou L., Trépo E., Chen P., and Gurzov E. N., “Oxidative Stress in Obesity‐associated Hepatocellular Carcinoma: Sources, Signaling and Therapeutic Challenges,” Oncogene
40, no. 33 (2021): 5155–5167.
</cite> [<a href="https://doi.org/10.1038/s41388-021-01950-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9277657/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34290399/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=Oxidative%20Stress%20in%20Obesity%E2%80%90associated%20Hepatocellular%20Carcinoma:%20Sources,%20Signaling%20and%20Therapeutic%20Challenges&amp;author=M.%20K.%20Brahma&amp;author=E.%20H.%20Gilglioni&amp;author=L.%20Zhou&amp;author=E.%20Tr%C3%A9po&amp;author=P.%20Chen&amp;volume=40&amp;issue=33&amp;publication_year=2021&amp;pages=5155-5167&amp;pmid=34290399&amp;doi=10.1038/s41388-021-01950-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0031">
<span class="label">31.</span><cite>
James D. E., Stöckli J., and Birnbaum M. J., “The Aetiology and Molecular Landscape of Insulin Resistance,” Nature Reviews Molecular Cell Biology (2021).</cite> [<a href="https://doi.org/10.1038/s41580-021-00390-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34285405/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Reviews%20Molecular%20Cell%20Biology&amp;title=The%20Aetiology%20and%20Molecular%20Landscape%20of%20Insulin%20Resistance&amp;author=D.%20E.%20James&amp;author=J.%20St%C3%B6ckli&amp;author=M.%20J.%20Birnbaum&amp;publication_year=2021&amp;pmid=34285405&amp;doi=10.1038/s41580-021-00390-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0032">
<span class="label">32.</span><cite>
Jia D., Zhang J., Liu X., et al., “Insulin Resistance in Skeletal Muscle Selectively Protects the Heart in Response to Metabolic Stress,” Diabetes (2021).</cite> [<a href="https://doi.org/10.2337/db20-1212" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8576508/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34244238/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes&amp;title=Insulin%20Resistance%20in%20Skeletal%20Muscle%20Selectively%20Protects%20the%20Heart%20in%20Response%20to%20Metabolic%20Stress&amp;author=D.%20Jia&amp;author=J.%20Zhang&amp;author=X.%20Liu&amp;publication_year=2021&amp;pmid=34244238&amp;doi=10.2337/db20-1212&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0033">
<span class="label">33.</span><cite>
Pini M., Czibik G., Sawaki D., et al., “Adipose Tissue Senescence Is Mediated by Increased ATP Content After a Short‐term High‐fat Diet Exposure,” Aging Cell (2021): e13421.
</cite> [<a href="https://doi.org/10.1111/acel.13421" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8373332/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34278707/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Aging%20Cell&amp;title=Adipose%20Tissue%20Senescence%20Is%20Mediated%20by%20Increased%20ATP%20Content%20After%20a%20Short%E2%80%90term%20High%E2%80%90fat%20Diet%20Exposure&amp;author=M.%20Pini&amp;author=G.%20Czibik&amp;author=D.%20Sawaki&amp;publication_year=2021&amp;pages=e13421&amp;pmid=34278707&amp;doi=10.1111/acel.13421&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0034">
<span class="label">34.</span><cite>
Hu Y., He J., Zheng P., et al., “Prebiotic Inulin as a Treatment of Obesity Related Nonalcoholic Fatty Liver Disease Through Gut Microbiota: A Critical Review,” Critical Reviews in Food Science and Nutrition (2021): 1–11.</cite> [<a href="https://doi.org/10.1080/10408398.2021.1955654" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34292103/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Critical%20Reviews%20in%20Food%20Science%20and%20Nutrition&amp;title=Prebiotic%20Inulin%20as%20a%20Treatment%20of%20Obesity%20Related%20Nonalcoholic%20Fatty%20Liver%20Disease%20Through%20Gut%20Microbiota:%20A%20Critical%20Review&amp;author=Y.%20Hu&amp;author=J.%20He&amp;author=P.%20Zheng&amp;publication_year=2021&amp;pages=1-11&amp;pmid=34292103&amp;doi=10.1080/10408398.2021.1955654&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0035">
<span class="label">35.</span><cite>
Aigner M., Treasure J., Kaye W., and Kasper S., “World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Eating Disorders,” The World Journal of Biological Psychiatry: The Official Journal of the World Federation of Societies of Biological Psychiatry
12, no. 6 (2011): 400–443.
</cite> [<a href="https://doi.org/10.3109/15622975.2011.602720" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21961502/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=The%20World%20Journal%20of%20Biological%20Psychiatry:%20The%20Official%20Journal%20of%20the%20World%20Federation%20of%20Societies%20of%20Biological%20Psychiatry&amp;title=World%20Federation%20of%20Societies%20of%20Biological%20Psychiatry%20(WFSBP)%20Guidelines%20for%20the%20Pharmacological%20Treatment%20of%20Eating%20Disorders&amp;author=M.%20Aigner&amp;author=J.%20Treasure&amp;author=W.%20Kaye&amp;author=S.%20Kasper&amp;volume=12&amp;issue=6&amp;publication_year=2011&amp;pages=400-443&amp;pmid=21961502&amp;doi=10.3109/15622975.2011.602720&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0036">
<span class="label">36.</span><cite>
Treasure J., Duarte T. A., and Schmidt U., “Eating Disorders,” Lancet
395, no. 10227 (2020): 899–911.
</cite> [<a href="https://doi.org/10.1016/S0140-6736(20)30059-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32171414/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Eating%20Disorders&amp;author=J.%20Treasure&amp;author=T.%20A.%20Duarte&amp;author=U.%20Schmidt&amp;volume=395&amp;issue=10227&amp;publication_year=2020&amp;pages=899-911&amp;pmid=32171414&amp;doi=10.1016/S0140-6736(20)30059-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0037">
<span class="label">37.</span><cite>
Moore C. F., Leonard M. Z., Micovic N. M., Miczek K. A., Sabino V., and Cottone P., “Reward Sensitivity Deficits in a Rat Model of Compulsive Eating Behavior,” Neuropsychopharmacology
45, no. 4 (2020): 589–596.
</cite> [<a href="https://doi.org/10.1038/s41386-019-0550-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7021808/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31622973/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuropsychopharmacology&amp;title=Reward%20Sensitivity%20Deficits%20in%20a%20Rat%20Model%20of%20Compulsive%20Eating%20Behavior&amp;author=C.%20F.%20Moore&amp;author=M.%20Z.%20Leonard&amp;author=N.%20M.%20Micovic&amp;author=K.%20A.%20Miczek&amp;author=V.%20Sabino&amp;volume=45&amp;issue=4&amp;publication_year=2020&amp;pages=589-596&amp;pmid=31622973&amp;doi=10.1038/s41386-019-0550-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0038">
<span class="label">38.</span><cite>
Treasure J., Claudino A. M., and Zucker N., “Eating Disorders,” Lancet
375, no. 9714 (2010): 583–593.
</cite> [<a href="https://doi.org/10.1016/S0140-6736(09)61748-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19931176/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Eating%20Disorders&amp;author=J.%20Treasure&amp;author=A.%20M.%20Claudino&amp;author=N.%20Zucker&amp;volume=375&amp;issue=9714&amp;publication_year=2010&amp;pages=583-593&amp;pmid=19931176&amp;doi=10.1016/S0140-6736(09)61748-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0039">
<span class="label">39.</span><cite>
Goracci A., Volo S. D., Casamassima F., Bolognesi S., and Fagiolini A., “Pharmacotherapy of Binge‐Eating Disorder: A Review,” Journal of Addiction Medicine
9, no. 1 (2015): 1–19.
</cite> [<a href="https://doi.org/10.1097/ADM.0000000000000089" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25629881/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Addiction%20Medicine&amp;title=Pharmacotherapy%20of%20Binge%E2%80%90Eating%20Disorder:%20A%20Review&amp;author=A.%20Goracci&amp;author=S.%20D.%20Volo&amp;author=F.%20Casamassima&amp;author=S.%20Bolognesi&amp;author=A.%20Fagiolini&amp;volume=9&amp;issue=1&amp;publication_year=2015&amp;pages=1-19&amp;pmid=25629881&amp;doi=10.1097/ADM.0000000000000089&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0040">
<span class="label">40.</span><cite>
Berner L. A., Bocarsly M. E., Hoebel B. G., and Avena N. M., “Pharmacological Interventions for Binge Eating: Lessons From Animal Models, Current Treatments, and Future Directions,” Current Pharmaceutical Design
17, no. 12 (2011): 1180–1187.
</cite> [<a href="https://doi.org/10.2174/138161211795656774" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21492094/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Current%20Pharmaceutical%20Design&amp;title=Pharmacological%20Interventions%20for%20Binge%20Eating:%20Lessons%20From%20Animal%20Models,%20Current%20Treatments,%20and%20Future%20Directions&amp;author=L.%20A.%20Berner&amp;author=M.%20E.%20Bocarsly&amp;author=B.%20G.%20Hoebel&amp;author=N.%20M.%20Avena&amp;volume=17&amp;issue=12&amp;publication_year=2011&amp;pages=1180-1187&amp;pmid=21492094&amp;doi=10.2174/138161211795656774&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0041">
<span class="label">41.</span><cite>
Goracci A., di Volo S., Casamassima F., Bolognesi S., Benbow J., and Fagiolini A., “Pharmacotherapy of Binge‐eating Disorder: A Review,” Journal of Addiction Medicine
9, no. 1 (2015): 1–19.
</cite> [<a href="https://doi.org/10.1097/ADM.0000000000000089" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25629881/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Addiction%20Medicine&amp;title=Pharmacotherapy%20of%20Binge%E2%80%90eating%20Disorder:%20A%20Review&amp;author=A.%20Goracci&amp;author=S.%20di%20Volo&amp;author=F.%20Casamassima&amp;author=S.%20Bolognesi&amp;author=J.%20Benbow&amp;volume=9&amp;issue=1&amp;publication_year=2015&amp;pages=1-19&amp;pmid=25629881&amp;doi=10.1097/ADM.0000000000000089&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0042">
<span class="label">42.</span><cite>
Guardia D., Rolland B., Karila L., and Cottencin O., “GABAergic and Glutamatergic Modulation in Binge Eating: Therapeutic Approach,” Current Pharmaceutical Design
17, no. 14 (2011): 1396–1409.
</cite> [<a href="https://doi.org/10.2174/138161211796150828" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21524265/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Current%20Pharmaceutical%20Design&amp;title=GABAergic%20and%20Glutamatergic%20Modulation%20in%20Binge%20Eating:%20Therapeutic%20Approach&amp;author=D.%20Guardia&amp;author=B.%20Rolland&amp;author=L.%20Karila&amp;author=O.%20Cottencin&amp;volume=17&amp;issue=14&amp;publication_year=2011&amp;pages=1396-1409&amp;pmid=21524265&amp;doi=10.2174/138161211796150828&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0043">
<span class="label">43.</span><cite>
Fontenelle L. F., Oostermeijer S., Harrison B. J., Pantelis C., and Yücel M., “Obsessive‐compulsive Disorder, Impulse Control Disorders and Drug Addiction: Common Features and Potential Treatments,” Drugs
71, no. 7 (2011): 827–840.
</cite> [<a href="https://doi.org/10.2165/11591790-000000000-00000" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21568361/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drugs&amp;title=Obsessive%E2%80%90compulsive%20Disorder,%20Impulse%20Control%20Disorders%20and%20Drug%20Addiction:%20Common%20Features%20and%20Potential%20Treatments&amp;author=L.%20F.%20Fontenelle&amp;author=S.%20Oostermeijer&amp;author=B.%20J.%20Harrison&amp;author=C.%20Pantelis&amp;author=M.%20Y%C3%BCcel&amp;volume=71&amp;issue=7&amp;publication_year=2011&amp;pages=827-840&amp;pmid=21568361&amp;doi=10.2165/11591790-000000000-00000&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0044">
<span class="label">44.</span><cite>
Fletcher P. C. and Kenny P. J., “Food Addiction: A Valid Concept?,” Neuropsychopharmacology
43, no. 13 (2018): 2506–2513.
</cite> [<a href="https://doi.org/10.1038/s41386-018-0203-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6224546/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30188514/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuropsychopharmacology&amp;title=Food%20Addiction:%20A%20Valid%20Concept?&amp;author=P.%20C.%20Fletcher&amp;author=P.%20J.%20Kenny&amp;volume=43&amp;issue=13&amp;publication_year=2018&amp;pages=2506-2513&amp;pmid=30188514&amp;doi=10.1038/s41386-018-0203-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0045">
<span class="label">45.</span><cite>
Moussawi K., Ortiz M. M., Gantz S. C., et al., “Fentanyl Vapor Self‐administration Model in Mice to Study Opioid Addiction,” Science Advances
6, no. 32 (2020): eabc0413.
</cite> [<a href="https://doi.org/10.1126/sciadv.abc0413" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7406365/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32821843/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Science%20Advances&amp;title=Fentanyl%20Vapor%20Self%E2%80%90administration%20Model%20in%20Mice%20to%20Study%20Opioid%20Addiction&amp;author=K.%20Moussawi&amp;author=M.%20M.%20Ortiz&amp;author=S.%20C.%20Gantz&amp;volume=6&amp;issue=32&amp;publication_year=2020&amp;pages=eabc0413&amp;pmid=32821843&amp;doi=10.1126/sciadv.abc0413&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0046">
<span class="label">46.</span><cite>
Kleinert S. and Horton R., “Obesity Needs to be Put Into a Much Wider Context,” Lancet
393, no. 10173 (2019): 724–726.
</cite> [<a href="https://doi.org/10.1016/S0140-6736(18)33192-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30700379/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Obesity%20Needs%20to%20be%20Put%20Into%20a%20Much%20Wider%20Context&amp;author=S.%20Kleinert&amp;author=R.%20Horton&amp;volume=393&amp;issue=10173&amp;publication_year=2019&amp;pages=724-726&amp;pmid=30700379&amp;doi=10.1016/S0140-6736(18)33192-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0047">
<span class="label">47.</span><cite>
Clark L., Boileau I., and Zack M., “Neuroimaging of Reward Mechanisms in Gambling Disorder: An Integrative Review,” Molecular Psychiatry
24, no. 5 (2019): 674–693.
</cite> [<a href="https://doi.org/10.1038/s41380-018-0230-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30214041/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20Psychiatry&amp;title=Neuroimaging%20of%20Reward%20Mechanisms%20in%20Gambling%20Disorder:%20An%20Integrative%20Review&amp;author=L.%20Clark&amp;author=I.%20Boileau&amp;author=M.%20Zack&amp;volume=24&amp;issue=5&amp;publication_year=2019&amp;pages=674-693&amp;pmid=30214041&amp;doi=10.1038/s41380-018-0230-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0048">
<span class="label">48.</span><cite>
Nakai Y., Fukushima M., Taniguchi A., Nin K., and Teramukai S., “Comparison of DSM‐IV versus Proposed DSM‐5 Diagnostic Criteria for Eating Disorders in a Japanese Sample,” European Eating Disorders Review
21, no. 1 (2013): 8–14.
</cite> [<a href="https://doi.org/10.1002/erv.2203" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23059695/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Eating%20Disorders%20Review&amp;title=Comparison%20of%20DSM%E2%80%90IV%20versus%20Proposed%20DSM%E2%80%905%20Diagnostic%20Criteria%20for%20Eating%20Disorders%20in%20a%20Japanese%20Sample&amp;author=Y.%20Nakai&amp;author=M.%20Fukushima&amp;author=A.%20Taniguchi&amp;author=K.%20Nin&amp;author=S.%20Teramukai&amp;volume=21&amp;issue=1&amp;publication_year=2013&amp;pages=8-14&amp;pmid=23059695&amp;doi=10.1002/erv.2203&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0049">
<span class="label">49.</span><cite>
Keel P. K., Brown T. A., Holm‐Denoma J., and Bodell L. P., “Comparison of DSM‐IV versus Proposed DSM‐5 Diagnostic Criteria for Eating Disorders: Reduction of Eating Disorder Not Otherwise Specified and Validity,” International Journal of Eating Disorders
44, no. 6 (2011): 553–560.
</cite> [<a href="https://doi.org/10.1002/eat.20892" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21321984/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Journal%20of%20Eating%20Disorders&amp;title=Comparison%20of%20DSM%E2%80%90IV%20versus%20Proposed%20DSM%E2%80%905%20Diagnostic%20Criteria%20for%20Eating%20Disorders:%20Reduction%20of%20Eating%20Disorder%20Not%20Otherwise%20Specified%20and%20Validity&amp;author=P.%20K.%20Keel&amp;author=T.%20A.%20Brown&amp;author=J.%20Holm%E2%80%90Denoma&amp;author=L.%20P.%20Bodell&amp;volume=44&amp;issue=6&amp;publication_year=2011&amp;pages=553-560&amp;pmid=21321984&amp;doi=10.1002/eat.20892&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0050">
<span class="label">50.</span><cite>
Sonne H., Kildegaard H., Strandberg‐Larsen K., Rasmussen L., Wesselhoeft R., and Bliddal M., “Eating Disorders in Children, Adolescents, and Young Adults during and after the COVID‐19 Pandemic: A Danish Nationwide Register‐Based Study,” International Journal of Eating Disorders (2024).</cite> [<a href="https://doi.org/10.1002/eat.24295" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11629055/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39319539/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Journal%20of%20Eating%20Disorders&amp;title=Eating%20Disorders%20in%20Children,%20Adolescents,%20and%20Young%20Adults%20during%20and%20after%20the%20COVID%E2%80%9019%20Pandemic:%20A%20Danish%20Nationwide%20Register%E2%80%90Based%20Study&amp;author=H.%20Sonne&amp;author=H.%20Kildegaard&amp;author=K.%20Strandberg%E2%80%90Larsen&amp;author=L.%20Rasmussen&amp;author=R.%20Wesselhoeft&amp;publication_year=2024&amp;pmid=39319539&amp;doi=10.1002/eat.24295&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0051">
<span class="label">51.</span><cite>
Solmi M., Radua J., Olivola M., et al., “Age at Onset of Mental Disorders Worldwide: Large‐scale Meta‐analysis of 192 Epidemiological Studies,” Molecular Psychiatry
27, no. 1 (2022): 281–295.
</cite> [<a href="https://doi.org/10.1038/s41380-021-01161-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8960395/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34079068/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20Psychiatry&amp;title=Age%20at%20Onset%20of%20Mental%20Disorders%20Worldwide:%20Large%E2%80%90scale%20Meta%E2%80%90analysis%20of%20192%20Epidemiological%20Studies&amp;author=M.%20Solmi&amp;author=J.%20Radua&amp;author=M.%20Olivola&amp;volume=27&amp;issue=1&amp;publication_year=2022&amp;pages=281-295&amp;pmid=34079068&amp;doi=10.1038/s41380-021-01161-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0052">
<span class="label">52.</span><cite>
Watts G., “Janet Treasure: Advancing a Broad Perspective on Eating Disorders,” Lancet
398, no. 10294 (2021): 17.
</cite> [<a href="https://doi.org/10.1016/S0140-6736(21)01438-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34217386/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Janet%20Treasure:%20Advancing%20a%20Broad%20Perspective%20on%20Eating%20Disorders&amp;author=G.%20Watts&amp;volume=398&amp;issue=10294&amp;publication_year=2021&amp;pages=17&amp;pmid=34217386&amp;doi=10.1016/S0140-6736(21)01438-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0053">
<span class="label">53.</span><cite>
Janet T. A., “Stress and Obesity,” Annual Review of Psychology
70, no. 1 (2018). annurev‐psych‐010418‐102936‐.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Annual%20Review%20of%20Psychology&amp;title=Stress%20and%20Obesity&amp;author=T.%20A.%20Janet&amp;volume=70&amp;issue=1&amp;publication_year=2018&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0054">
<span class="label">54.</span><cite>
Thomas P. C., Curtis K., Potts H. W. W., et al., “Behavior Change Techniques within Digital Interventions for the Treatment of Eating Disorders: Systematic Review and Meta‐Analysis,” JMIR Mental Health
11 (2024): e57577.
</cite> [<a href="https://doi.org/10.2196/57577" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11327638/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39088817/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JMIR%20Mental%20Health&amp;title=Behavior%20Change%20Techniques%20within%20Digital%20Interventions%20for%20the%20Treatment%20of%20Eating%20Disorders:%20Systematic%20Review%20and%20Meta%E2%80%90Analysis&amp;author=P.%20C.%20Thomas&amp;author=K.%20Curtis&amp;author=H.%20W.%20W.%20Potts&amp;volume=11&amp;publication_year=2024&amp;pages=e57577&amp;pmid=39088817&amp;doi=10.2196/57577&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0055">
<span class="label">55.</span><cite>
Zhong J., Zhang Y., Sun Y., Wang Q., Dong G., and Li X., “The Efficacy of Internet‐based Cognitive Behavioral Therapy for Adult Binge Spectrum Eating Disorders: A Meta‐analysis,” Journal of Affective Disorders
361 (2024): 684–692.
</cite> [<a href="https://doi.org/10.1016/j.jad.2024.06.084" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38936703/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Affective%20Disorders&amp;title=The%20Efficacy%20of%20Internet%E2%80%90based%20Cognitive%20Behavioral%20Therapy%20for%20Adult%20Binge%20Spectrum%20Eating%20Disorders:%20A%20Meta%E2%80%90analysis&amp;author=J.%20Zhong&amp;author=Y.%20Zhang&amp;author=Y.%20Sun&amp;author=Q.%20Wang&amp;author=G.%20Dong&amp;volume=361&amp;publication_year=2024&amp;pages=684-692&amp;pmid=38936703&amp;doi=10.1016/j.jad.2024.06.084&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0056">
<span class="label">56.</span><cite>
Matheson B. E., “Bulimia Nervosa and Binge‐Eating Disorder across the Lifespan,” Focus (American Psychiatric Publishing)
22, no. 3 (2024): 278–287.
</cite> [<a href="https://doi.org/10.1176/appi.focus.20240001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11231461/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38988471/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Focus%20(American%20Psychiatric%20Publishing)&amp;title=Bulimia%20Nervosa%20and%20Binge%E2%80%90Eating%20Disorder%20across%20the%20Lifespan&amp;author=B.%20E.%20Matheson&amp;volume=22&amp;issue=3&amp;publication_year=2024&amp;pages=278-287&amp;pmid=38988471&amp;doi=10.1176/appi.focus.20240001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0057">
<span class="label">57.</span><cite>
Monteleone A. M. and Abbate‐Daga G., “Effectiveness and Predictors of Psychotherapy in Eating Disorders: State‐of‐the‐art and Future Directions,” Current Opinion in Psychiatry
37, no. 6 (2024): 417–423.
</cite> [<a href="https://doi.org/10.1097/YCO.0000000000000961" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39146554/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Current%20Opinion%20in%20Psychiatry&amp;title=Effectiveness%20and%20Predictors%20of%20Psychotherapy%20in%20Eating%20Disorders:%20State%E2%80%90of%E2%80%90the%E2%80%90art%20and%20Future%20Directions&amp;author=A.%20M.%20Monteleone&amp;author=G.%20Abbate%E2%80%90Daga&amp;volume=37&amp;issue=6&amp;publication_year=2024&amp;pages=417-423&amp;pmid=39146554&amp;doi=10.1097/YCO.0000000000000961&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0058">
<span class="label">58.</span><cite>
Zaiser C., Laskowski N. M., Müller R., et al., “The Relationship Between Anabolic Androgenic Steroid Use and Body Image, Eating Behavior, and Physical Activity by Gender: A Systematic Review,” Neuroscience and Biobehavioral Reviews
163 (2024): 105772.
</cite> [<a href="https://doi.org/10.1016/j.neubiorev.2024.105772" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38879097/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuroscience%20and%20Biobehavioral%20Reviews&amp;title=The%20Relationship%20Between%20Anabolic%20Androgenic%20Steroid%20Use%20and%20Body%20Image,%20Eating%20Behavior,%20and%20Physical%20Activity%20by%20Gender:%20A%20Systematic%20Review&amp;author=C.%20Zaiser&amp;author=N.%20M.%20Laskowski&amp;author=R.%20M%C3%BCller&amp;volume=163&amp;publication_year=2024&amp;pages=105772&amp;pmid=38879097&amp;doi=10.1016/j.neubiorev.2024.105772&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0059">
<span class="label">59.</span><cite>
Liu J. and Lin L., “Small Molecules for Fat Combustion: Targeting Thermosensory and Satiety Signals in the central Nervous System,” Drug Discovery Today
24 (2018).</cite> [<a href="https://doi.org/10.1016/j.drudis.2018.09.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30248402/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drug%20Discovery%20Today&amp;title=Small%20Molecules%20for%20Fat%20Combustion:%20Targeting%20Thermosensory%20and%20Satiety%20Signals%20in%20the%20central%20Nervous%20System&amp;author=J.%20Liu&amp;author=L.%20Lin&amp;volume=24&amp;publication_year=2018&amp;pmid=30248402&amp;doi=10.1016/j.drudis.2018.09.013&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0060">
<span class="label">60.</span><cite>
Steinbusch L., Labouèbe G. L., and Thorens B., “Brain Glucose Sensing in Homeostatic and Hedonic Regulation,” Trends in Endocrinology &amp; Metabolism Tem (2015): 455–466.
</cite> [<a href="https://doi.org/10.1016/j.tem.2015.06.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26163755/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Trends%20in%20Endocrinology%20&amp;%20Metabolism%20Tem&amp;title=Brain%20Glucose%20Sensing%20in%20Homeostatic%20and%20Hedonic%20Regulation&amp;author=L.%20Steinbusch&amp;author=G.%20L.%20Labou%C3%A8be&amp;author=B.%20Thorens&amp;publication_year=2015&amp;pages=455-466&amp;pmid=26163755&amp;doi=10.1016/j.tem.2015.06.005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0061">
<span class="label">61.</span><cite>
Shigetomo S. and Toshihiko Y., “New Insight Into GABAergic Neurons in the Hypothalamic Feeding Regulation,” Journal of Physiological Sciences (2018): 1–6.</cite> [<a href="https://doi.org/10.1007/s12576-018-0622-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10717766/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30003408/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Physiological%20Sciences&amp;title=New%20Insight%20Into%20GABAergic%20Neurons%20in%20the%20Hypothalamic%20Feeding%20Regulation&amp;author=S.%20Shigetomo&amp;author=Y.%20Toshihiko&amp;publication_year=2018&amp;pages=1-6&amp;pmid=30003408&amp;doi=10.1007/s12576-018-0622-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0062">
<span class="label">62.</span><cite>
Garcia A., Coss A., Luis‐Islas J., Puron‐Sierra L., and Gutierrez R., “Lateral Hypothalamic GABAergic Neurons Encode and Potentiate Sucrose's Palatability,” Frontiers in Neuroscience
14 (2021): 608047.
</cite> [<a href="https://doi.org/10.3389/fnins.2020.608047" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7859279/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33551725/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Neuroscience&amp;title=Lateral%20Hypothalamic%20GABAergic%20Neurons%20Encode%20and%20Potentiate%20Sucrose's%20Palatability&amp;author=A.%20Garcia&amp;author=A.%20Coss&amp;author=J.%20Luis%E2%80%90Islas&amp;author=L.%20Puron%E2%80%90Sierra&amp;author=R.%20Gutierrez&amp;volume=14&amp;publication_year=2021&amp;pages=608047&amp;pmid=33551725&amp;doi=10.3389/fnins.2020.608047&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0063">
<span class="label">63.</span><cite>
Marino R., Mcdevitt R. A., Gantz S. C., Shen H., and Bonci A., “Control of Food Approach and Eating by a GABAergic Projection From Lateral Hypothalamus to Dorsal Pons,” Proceedings of the National Academy of Sciences
117, no. 15 (2020): 201909340.</cite> [<a href="https://doi.org/10.1073/pnas.1909340117" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7165479/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32229573/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proceedings%20of%20the%20National%20Academy%20of%20Sciences&amp;title=Control%20of%20Food%20Approach%20and%20Eating%20by%20a%20GABAergic%20Projection%20From%20Lateral%20Hypothalamus%20to%20Dorsal%20Pons&amp;author=R.%20Marino&amp;author=R.%20A.%20Mcdevitt&amp;author=S.%20C.%20Gantz&amp;author=H.%20Shen&amp;author=A.%20Bonci&amp;volume=117&amp;issue=15&amp;publication_year=2020&amp;pages=201909340&amp;pmid=32229573&amp;doi=10.1073/pnas.1909340117&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0064">
<span class="label">64.</span><cite>
Tsunekawa T., Banno R., Yaginuma H., et al., “GABAB Receptor Signaling in the Mesolimbic System Suppresses Binge‐Like Consumption of a High‐Fat Diet—ScienceDirect,” Iscience
20 (2019): 337–347.
</cite> [<a href="https://doi.org/10.1016/j.isci.2019.09.032" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6817655/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31610370/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Iscience&amp;title=GABAB%20Receptor%20Signaling%20in%20the%20Mesolimbic%20System%20Suppresses%20Binge%E2%80%90Like%20Consumption%20of%20a%20High%E2%80%90Fat%20Diet%E2%80%94ScienceDirect&amp;author=T.%20Tsunekawa&amp;author=R.%20Banno&amp;author=H.%20Yaginuma&amp;volume=20&amp;publication_year=2019&amp;pages=337-347&amp;pmid=31610370&amp;doi=10.1016/j.isci.2019.09.032&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0065">
<span class="label">65.</span><cite>
Rossi M. A., Basiri M. L., McHenry J. A., et al., “Obesity Remodels Activity and Transcriptional state of a Lateral Hypothalamic Brake on Feeding,” Science
364, no. 6447 (2019): 1271–1274.
</cite> [<a href="https://doi.org/10.1126/science.aax1184" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7318865/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31249056/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Obesity%20Remodels%20Activity%20and%20Transcriptional%20state%20of%20a%20Lateral%20Hypothalamic%20Brake%20on%20Feeding&amp;author=M.%20A.%20Rossi&amp;author=M.%20L.%20Basiri&amp;author=J.%20A.%20McHenry&amp;volume=364&amp;issue=6447&amp;publication_year=2019&amp;pages=1271-1274&amp;pmid=31249056&amp;doi=10.1126/science.aax1184&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0066">
<span class="label">66.</span><cite>
Guardia D., Rolland B., Karila L., and Cottencin O., “GABAergic and Glutamatergic Modulation in Binge Eating: Therapeutic Approach,” Current Pharmaceutical Design
17, no. 14 (2011).</cite> [<a href="https://doi.org/10.2174/138161211796150828" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21524265/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Current%20Pharmaceutical%20Design&amp;title=GABAergic%20and%20Glutamatergic%20Modulation%20in%20Binge%20Eating:%20Therapeutic%20Approach&amp;author=D.%20Guardia&amp;author=B.%20Rolland&amp;author=L.%20Karila&amp;author=O.%20Cottencin&amp;volume=17&amp;issue=14&amp;publication_year=2011&amp;pmid=21524265&amp;doi=10.2174/138161211796150828&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0067">
<span class="label">67.</span><cite>
Berner L. A., Bocarsly M. E., Hoebel B. G., and Avena N. M., “Pharmacological Interventions for Binge Eating: Lessons From Animal Models, Current Treatments, and Future Directions,” Current Pharmaceutical Design
17, no. 12 (2011).</cite> [<a href="https://doi.org/10.2174/138161211795656774" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21492094/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Current%20Pharmaceutical%20Design&amp;title=Pharmacological%20Interventions%20for%20Binge%20Eating:%20Lessons%20From%20Animal%20Models,%20Current%20Treatments,%20and%20Future%20Directions&amp;author=L.%20A.%20Berner&amp;author=M.%20E.%20Bocarsly&amp;author=B.%20G.%20Hoebel&amp;author=N.%20M.%20Avena&amp;volume=17&amp;issue=12&amp;publication_year=2011&amp;pmid=21492094&amp;doi=10.2174/138161211795656774&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0068">
<span class="label">68.</span><cite>
Wojnicki F. H. E., Brown S. D., and Corwin R. L. W., “Factors Affecting the Ability of baclofen to Reduce Fat Intake in Rats,” Behavioural Pharmacology
25, no. 2 (2014): 166–172.
</cite> [<a href="https://doi.org/10.1097/FBP.0000000000000031" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24569221/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Behavioural%20Pharmacology&amp;title=Factors%20Affecting%20the%20Ability%20of%20baclofen%20to%20Reduce%20Fat%20Intake%20in%20Rats&amp;author=F.%20H.%20E.%20Wojnicki&amp;author=S.%20D.%20Brown&amp;author=R.%20L.%20W.%20Corwin&amp;volume=25&amp;issue=2&amp;publication_year=2014&amp;pages=166-172&amp;pmid=24569221&amp;doi=10.1097/FBP.0000000000000031&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0069">
<span class="label">69.</span><cite>
Park J., Fu Z., Frangaj A., et al., “Structure of human GABA(B) Receptor in an Inactive state,” Nature
584, no. 7820 (2020): 304–309.
</cite> [<a href="https://doi.org/10.1038/s41586-020-2452-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7725281/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32581365/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Structure%20of%20human%20GABA(B)%20Receptor%20in%20an%20Inactive%20state&amp;author=J.%20Park&amp;author=Z.%20Fu&amp;author=A.%20Frangaj&amp;volume=584&amp;issue=7820&amp;publication_year=2020&amp;pages=304-309&amp;pmid=32581365&amp;doi=10.1038/s41586-020-2452-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0070">
<span class="label">70.</span><cite>
Nieto A., Bailey T., Kaczanowska K., and Mcdonald P., “GABAB Receptor Chemistry and Pharmacology: Agonists, Antagonists, and Allosteric Modulators,” Current Topics in Behavioral Neurosciences (2021).</cite> [<a href="https://doi.org/10.1007/7854_2021_232" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34036555/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Current%20Topics%20in%20Behavioral%20Neurosciences&amp;title=GABAB%20Receptor%20Chemistry%20and%20Pharmacology:%20Agonists,%20Antagonists,%20and%20Allosteric%20Modulators&amp;author=A.%20Nieto&amp;author=T.%20Bailey&amp;author=K.%20Kaczanowska&amp;author=P.%20Mcdonald&amp;publication_year=2021&amp;pmid=34036555&amp;doi=10.1007/7854_2021_232&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0071">
<span class="label">71.</span><cite>
Shaye H., Ishchenko A., Lam J. H., et al., “Structural Basis of the Activation of a Metabotropic GABA Receptor,” Nature
584, no. 7820 (2020): 298–303.
</cite> [<a href="https://doi.org/10.1038/s41586-020-2408-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8020835/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32555460/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Structural%20Basis%20of%20the%20Activation%20of%20a%20Metabotropic%20GABA%20Receptor&amp;author=H.%20Shaye&amp;author=A.%20Ishchenko&amp;author=J.%20H.%20Lam&amp;volume=584&amp;issue=7820&amp;publication_year=2020&amp;pages=298-303&amp;pmid=32555460&amp;doi=10.1038/s41586-020-2408-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0072">
<span class="label">72.</span><cite>
XU C., Zhang W., Rondard P., Pin J.‐p, and Liu J., “Complex GABAB Receptor Complexes: How to Generate Multiple Functionally Distinct Units From a Single Receptor. Review,” Frontiers in Pharmacology
5, no. 12 (2014).</cite> [<a href="https://doi.org/10.3389/fphar.2014.00012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3920572/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24575041/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Pharmacology&amp;title=Complex%20GABAB%20Receptor%20Complexes:%20How%20to%20Generate%20Multiple%20Functionally%20Distinct%20Units%20From%20a%20Single%20Receptor.%20Review&amp;author=C.%20XU&amp;author=W.%20Zhang&amp;author=P.%20Rondard&amp;author=J.%E2%80%90p%20Pin&amp;author=J.%20Liu&amp;volume=5&amp;issue=12&amp;publication_year=2014&amp;pmid=24575041&amp;doi=10.3389/fphar.2014.00012&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0073">
<span class="label">73.</span><cite>
Tunyasuvunakool K., Adler J., Wu Z., et al., “Highly Accurate Protein Structure Prediction for the human Proteome,” Nature (2021).</cite> [<a href="https://doi.org/10.1038/s41586-021-03828-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8387240/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34293799/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Highly%20Accurate%20Protein%20Structure%20Prediction%20for%20the%20human%20Proteome&amp;author=K.%20Tunyasuvunakool&amp;author=J.%20Adler&amp;author=Z.%20Wu&amp;publication_year=2021&amp;pmid=34293799&amp;doi=10.1038/s41586-021-03828-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0074">
<span class="label">74.</span><cite>
Frangaj A. and Fan Q. R., “Structural Biology of GABA(B) Receptor,” Neuropharmacology
136, no. Pt A (2018): 68–79.
</cite> [<a href="https://doi.org/10.1016/j.neuropharm.2017.10.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5897222/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29031577/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuropharmacology&amp;title=Structural%20Biology%20of%20GABA(B)%20Receptor&amp;author=A.%20Frangaj&amp;author=Q.%20R.%20Fan&amp;volume=136&amp;issue=Pt%20A&amp;publication_year=2018&amp;pages=68-79&amp;pmid=29031577&amp;doi=10.1016/j.neuropharm.2017.10.011&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0075">
<span class="label">75.</span><cite>
Shaye H., Stauch B., Gati C., and Cherezov V., “Molecular Mechanisms of Metabotropic GABA(B) Receptor Function,” Science Advances
7, no. 22 (2021).</cite> [<a href="https://doi.org/10.1126/sciadv.abg3362" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8163086/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34049877/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Science%20Advances&amp;title=Molecular%20Mechanisms%20of%20Metabotropic%20GABA(B)%20Receptor%20Function&amp;author=H.%20Shaye&amp;author=B.%20Stauch&amp;author=C.%20Gati&amp;author=V.%20Cherezov&amp;volume=7&amp;issue=22&amp;publication_year=2021&amp;pmid=34049877&amp;doi=10.1126/sciadv.abg3362&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0076">
<span class="label">76.</span><cite>
Tabata T., Araishi K., Hashimoto K., et al., “Ca2+ activity at GABAB Receptors Constitutively Promotes Metabotropic Glutamate Signaling in the Absence of GABA,” Proceedings National Academy of Science USA
101, no. 48 (2004): 16952–16957.</cite> [<a href="https://doi.org/10.1073/pnas.0405387101" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC529326/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15550547/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proceedings%20National%20Academy%20of%20Science%20USA&amp;title=Ca2+%20activity%20at%20GABAB%20Receptors%20Constitutively%20Promotes%20Metabotropic%20Glutamate%20Signaling%20in%20the%20Absence%20of%20GABA&amp;author=T.%20Tabata&amp;author=K.%20Araishi&amp;author=K.%20Hashimoto&amp;volume=101&amp;issue=48&amp;publication_year=2004&amp;pages=16952-16957&amp;pmid=15550547&amp;doi=10.1073/pnas.0405387101&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0077">
<span class="label">77.</span><cite>
Jiang J., Peng Y., Liang X., et al., “Centrally Administered Cortistation‐14 Induces Antidepressant‐Like Effects in Mice via Mediating Ghrelin and GABA(A) Receptor Signaling Pathway,” Frontiers in Pharmacology
9 (2018): 767.
</cite> [<a href="https://doi.org/10.3389/fphar.2018.00767" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6060333/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30072893/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Pharmacology&amp;title=Centrally%20Administered%20Cortistation%E2%80%9014%20Induces%20Antidepressant%E2%80%90Like%20Effects%20in%20Mice%20via%20Mediating%20Ghrelin%20and%20GABA(A)%20Receptor%20Signaling%20Pathway&amp;author=J.%20Jiang&amp;author=Y.%20Peng&amp;author=X.%20Liang&amp;volume=9&amp;publication_year=2018&amp;pages=767&amp;pmid=30072893&amp;doi=10.3389/fphar.2018.00767&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0078">
<span class="label">78.</span><cite>
Kaupmann K., Schuler V., Mosbacher J., et al., “Human Gamma‐aminobutyric Acid Type B Receptors Are Differentially Expressed and Regulate Inwardly Rectifying K+ Channels,” PNAS
95, no. 25 (1998): 14991–14996.
</cite> [<a href="https://doi.org/10.1073/pnas.95.25.14991" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC24563/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9844003/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PNAS&amp;title=Human%20Gamma%E2%80%90aminobutyric%20Acid%20Type%20B%20Receptors%20Are%20Differentially%20Expressed%20and%20Regulate%20Inwardly%20Rectifying%20K+%20Channels&amp;author=K.%20Kaupmann&amp;author=V.%20Schuler&amp;author=J.%20Mosbacher&amp;volume=95&amp;issue=25&amp;publication_year=1998&amp;pages=14991-14996&amp;pmid=9844003&amp;doi=10.1073/pnas.95.25.14991&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0079">
<span class="label">79.</span><cite>
Marino R. A. M., McDevitt R. A., Gantz S. C., et al., “Control of Food Approach and Eating by a GABAergic Projection From Lateral Hypothalamus to Dorsal Pons,” PNAS
117, no. 15 (2020): 8611–8615.
</cite> [<a href="https://doi.org/10.1073/pnas.1909340117" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7165479/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32229573/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PNAS&amp;title=Control%20of%20Food%20Approach%20and%20Eating%20by%20a%20GABAergic%20Projection%20From%20Lateral%20Hypothalamus%20to%20Dorsal%20Pons&amp;author=R.%20A.%20M.%20Marino&amp;author=R.%20A.%20McDevitt&amp;author=S.%20C.%20Gantz&amp;volume=117&amp;issue=15&amp;publication_year=2020&amp;pages=8611-8615&amp;pmid=32229573&amp;doi=10.1073/pnas.1909340117&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0080">
<span class="label">80.</span><cite>
Miner P., Borkuhova Y., Shimonova L., Khaimov A., and Bodnar R. J., “GABA‐A and GABA‐B Receptors Mediate Feeding Elicited by the GABA‐B Agonist Baclofen in the Ventral Tegmental Area and Nucleus Accumbens Shell in Rats: Reciprocal and Regional Interactions,” Brain Research
1355 (2010): 86–96.
</cite> [<a href="https://doi.org/10.1016/j.brainres.2010.07.109" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20696149/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Brain%20Research&amp;title=GABA%E2%80%90A%20and%20GABA%E2%80%90B%20Receptors%20Mediate%20Feeding%20Elicited%20by%20the%20GABA%E2%80%90B%20Agonist%20Baclofen%20in%20the%20Ventral%20Tegmental%20Area%20and%20Nucleus%20Accumbens%20Shell%20in%20Rats:%20Reciprocal%20and%20Regional%20Interactions&amp;author=P.%20Miner&amp;author=Y.%20Borkuhova&amp;author=L.%20Shimonova&amp;author=A.%20Khaimov&amp;author=R.%20J.%20Bodnar&amp;volume=1355&amp;publication_year=2010&amp;pages=86-96&amp;pmid=20696149&amp;doi=10.1016/j.brainres.2010.07.109&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0081">
<span class="label">81.</span><cite>
Hayes D. J., Hoang J., and Greenshaw A. J., “The Role of Nucleus Accumbens Shell GABA Receptors on Ventral Tegmental Area Intracranial Self‐stimulation and a Potential Role for the 5‐HT(2C) Receptor,” Journal of Psychopharmacology
25, no. 12 (2011): 1661–1675.
</cite> [<a href="https://doi.org/10.1177/0269881110389212" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21169393/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Psychopharmacology&amp;title=The%20Role%20of%20Nucleus%20Accumbens%20Shell%20GABA%20Receptors%20on%20Ventral%20Tegmental%20Area%20Intracranial%20Self%E2%80%90stimulation%20and%20a%20Potential%20Role%20for%20the%205%E2%80%90HT(2C)%20Receptor&amp;author=D.%20J.%20Hayes&amp;author=J.%20Hoang&amp;author=A.%20J.%20Greenshaw&amp;volume=25&amp;issue=12&amp;publication_year=2011&amp;pages=1661-1675&amp;pmid=21169393&amp;doi=10.1177/0269881110389212&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0082">
<span class="label">82.</span><cite>
Marchant N. J., Rabei R., Kaganovsky K., et al., “A Critical Role of Lateral Hypothalamus in Context‐induced Relapse to Alcohol Seeking After Punishment‐imposed Abstinence,” Journal of Neuroscience
34, no. 22 (2014): 7447–7457.
</cite> [<a href="https://doi.org/10.1523/JNEUROSCI.0256-14.2014" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4035512/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24872550/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Neuroscience&amp;title=A%20Critical%20Role%20of%20Lateral%20Hypothalamus%20in%20Context%E2%80%90induced%20Relapse%20to%20Alcohol%20Seeking%20After%20Punishment%E2%80%90imposed%20Abstinence&amp;author=N.%20J.%20Marchant&amp;author=R.%20Rabei&amp;author=K.%20Kaganovsky&amp;volume=34&amp;issue=22&amp;publication_year=2014&amp;pages=7447-7457&amp;pmid=24872550&amp;doi=10.1523/JNEUROSCI.0256-14.2014&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0083">
<span class="label">83.</span><cite>
Stratford T. R. and Kelley A. E., “Evidence of a Functional Relationship Between the Nucleus Accumbens Shell and Lateral Hypothalamus Subserving the Control of Feeding Behavior,” Journal of Neuroscience the Official Journal of the Society for Neuroscience
19, no. 24 (1999): 11040.
</cite> [<a href="https://doi.org/10.1523/JNEUROSCI.19-24-11040.1999" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6784961/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10594084/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Neuroscience%20the%20Official%20Journal%20of%20the%20Society%20for%20Neuroscience&amp;title=Evidence%20of%20a%20Functional%20Relationship%20Between%20the%20Nucleus%20Accumbens%20Shell%20and%20Lateral%20Hypothalamus%20Subserving%20the%20Control%20of%20Feeding%20Behavior&amp;author=T.%20R.%20Stratford&amp;author=A.%20E.%20Kelley&amp;volume=19&amp;issue=24&amp;publication_year=1999&amp;pages=11040&amp;pmid=10594084&amp;doi=10.1523/JNEUROSCI.19-24-11040.1999&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0084">
<span class="label">84.</span><cite>
Carletti R., Tacconi S., Mugnaini M., and Gerrard P., “Receptor Distribution Studies,” Current Opinion in Pharmacology
35 (2017): 94–100.
</cite> [<a href="https://doi.org/10.1016/j.coph.2017.07.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28803835/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Current%20Opinion%20in%20Pharmacology&amp;title=Receptor%20Distribution%20Studies&amp;author=R.%20Carletti&amp;author=S.%20Tacconi&amp;author=M.%20Mugnaini&amp;author=P.%20Gerrard&amp;volume=35&amp;publication_year=2017&amp;pages=94-100&amp;pmid=28803835&amp;doi=10.1016/j.coph.2017.07.008&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0085">
<span class="label">85.</span><cite>
Benke D., “GABAB Receptor Trafficking and Interacting Proteins: Targets for the Development of Highly Specific Therapeutic Strategies to Treat Neurological Disorders?,” Biochemical Pharmacology
86, no. 11 (2013): 1525–1530.
</cite> [<a href="https://doi.org/10.1016/j.bcp.2013.09.016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24084431/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochemical%20Pharmacology&amp;title=GABAB%20Receptor%20Trafficking%20and%20Interacting%20Proteins:%20Targets%20for%20the%20Development%20of%20Highly%20Specific%20Therapeutic%20Strategies%20to%20Treat%20Neurological%20Disorders?&amp;author=D.%20Benke&amp;volume=86&amp;issue=11&amp;publication_year=2013&amp;pages=1525-1530&amp;pmid=24084431&amp;doi=10.1016/j.bcp.2013.09.016&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0086">
<span class="label">86.</span><cite>
Bowery N. G., “GABAB Receptor: A Site of Therapeutic Benefit,” Current Opinion in Pharmacology
6, no. 1 (2006): 37–43.
</cite> [<a href="https://doi.org/10.1016/j.coph.2005.10.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16361115/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Current%20Opinion%20in%20Pharmacology&amp;title=GABAB%20Receptor:%20A%20Site%20of%20Therapeutic%20Benefit&amp;author=N.%20G.%20Bowery&amp;volume=6&amp;issue=1&amp;publication_year=2006&amp;pages=37-43&amp;pmid=16361115&amp;doi=10.1016/j.coph.2005.10.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0087">
<span class="label">87.</span><cite>
Misgeld U., Bijak M., and Jarolimek W., “A Physiological Role for GABAB Receptors and the Effects of Baclofen in the Mammalian central Nervous System—ScienceDirect,” Progress in Neurobiology
46, no. 4 (1995): 423–462.
</cite> [<a href="https://doi.org/10.1016/0301-0082(95)00012-k" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8532848/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Progress%20in%20Neurobiology&amp;title=A%20Physiological%20Role%20for%20GABAB%20Receptors%20and%20the%20Effects%20of%20Baclofen%20in%20the%20Mammalian%20central%20Nervous%20System%E2%80%94ScienceDirect&amp;author=U.%20Misgeld&amp;author=M.%20Bijak&amp;author=W.%20Jarolimek&amp;volume=46&amp;issue=4&amp;publication_year=1995&amp;pages=423-462&amp;pmid=8532848&amp;doi=10.1016/0301-0082(95)00012-k&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0088">
<span class="label">88.</span><cite>
Eric A., “Recent Advances in the Potential of Positive Allosteric Modulators of the GABAB Receptor to Treat Alcohol Use Disorder,” Alcohol and Alcoholism (2021).</cite> [<a href="https://doi.org/10.1093/alcalc/agab003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7906877/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33561865/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Alcohol%20and%20Alcoholism&amp;title=Recent%20Advances%20in%20the%20Potential%20of%20Positive%20Allosteric%20Modulators%20of%20the%20GABAB%20Receptor%20to%20Treat%20Alcohol%20Use%20Disorder&amp;author=A.%20Eric&amp;publication_year=2021&amp;pmid=33561865&amp;doi=10.1093/alcalc/agab003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0089">
<span class="label">89.</span><cite>
Phillips T. J. and Reed C., “Targeting GABAreceptors for Anti‐abuse Drug Discovery,” Expert Opinion on Drug Discovery (2014).</cite> [<a href="https://doi.org/10.1517/17460441.2014.956076" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25195620/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Expert%20Opinion%20on%20Drug%20Discovery&amp;title=Targeting%20GABAreceptors%20for%20Anti%E2%80%90abuse%20Drug%20Discovery&amp;author=T.%20J.%20Phillips&amp;author=C.%20Reed&amp;publication_year=2014&amp;pmid=25195620&amp;doi=10.1517/17460441.2014.956076&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0090">
<span class="label">90.</span><cite>
Imerci A., Rogers K. J., Miller F., and Sees J. P., “Evaluation of Risk Factors for Cerebrospinal Leakage in Pediatric Patients with Cerebral Palsy Treated with Intrathecal Baclofen,” Journal of Pediatric Orthopedics
40, no. 6 (2020): e522–e526.
</cite> [<a href="https://doi.org/10.1097/BPO.0000000000001472" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32501926/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Pediatric%20Orthopedics&amp;title=Evaluation%20of%20Risk%20Factors%20for%20Cerebrospinal%20Leakage%20in%20Pediatric%20Patients%20with%20Cerebral%20Palsy%20Treated%20with%20Intrathecal%20Baclofen&amp;author=A.%20Imerci&amp;author=K.%20J.%20Rogers&amp;author=F.%20Miller&amp;author=J.%20P.%20Sees&amp;volume=40&amp;issue=6&amp;publication_year=2020&amp;pages=e522-e526&amp;pmid=32501926&amp;doi=10.1097/BPO.0000000000001472&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0091">
<span class="label">91.</span><cite>
McIntosh J. M., Absalom N., Chebib M., Elgoyhen A. B., and Vincler M., “Alpha9 nicotinic Acetylcholine Receptors and the Treatment of Pain,” Biochemical Pharmacology
78, no. 7 (2009): 693–702.
</cite> [<a href="https://doi.org/10.1016/j.bcp.2009.05.020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2739401/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19477168/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochemical%20Pharmacology&amp;title=Alpha9%20nicotinic%20Acetylcholine%20Receptors%20and%20the%20Treatment%20of%20Pain&amp;author=J.%20M.%20McIntosh&amp;author=N.%20Absalom&amp;author=M.%20Chebib&amp;author=A.%20B.%20Elgoyhen&amp;author=M.%20Vincler&amp;volume=78&amp;issue=7&amp;publication_year=2009&amp;pages=693-702&amp;pmid=19477168&amp;doi=10.1016/j.bcp.2009.05.020&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0092">
<span class="label">92.</span><cite>
Scherkenbach L. A., Coles L. D., Patterson E. E., Cloyd J. C., Krach L. E., and Kriel R. L., “Pharmacokinetics and Pharmacodynamics of Intravenous Baclofen in Dogs: A Preliminary Study,” Journal of Pharmacy and Pharmacology
66, no. 7 (2014): 935–942.
</cite> [<a href="https://doi.org/10.1111/jphp.12221" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24697865/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Pharmacy%20and%20Pharmacology&amp;title=Pharmacokinetics%20and%20Pharmacodynamics%20of%20Intravenous%20Baclofen%20in%20Dogs:%20A%20Preliminary%20Study&amp;author=L.%20A.%20Scherkenbach&amp;author=L.%20D.%20Coles&amp;author=E.%20E.%20Patterson&amp;author=J.%20C.%20Cloyd&amp;author=L.%20E.%20Krach&amp;volume=66&amp;issue=7&amp;publication_year=2014&amp;pages=935-942&amp;pmid=24697865&amp;doi=10.1111/jphp.12221&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0093">
<span class="label">93.</span><cite>
Belozertseva I. V. and Andreev B. V., “A Pharmaco‐ethological Study of the GABA‐ergic Mechanisms Regulating the Depression‐Like Behavior of Mice,” Zhurnal Vysshei Nervnoi Deiatelnosti Imeni I. P. Pavlova
47, no. 6 (1997): 1024–1031. Farmako‐étologicheskoe izuchenie GAMKergicheskikh mekhanizmov reguliatsii depressivnopodobnogo povedeniia mysheĭ.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/9472168/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Zhurnal%20Vysshei%20Nervnoi%20Deiatelnosti%20Imeni%20I.%20P.%20Pavlova&amp;title=A%20Pharmaco%E2%80%90ethological%20Study%20of%20the%20GABA%E2%80%90ergic%20Mechanisms%20Regulating%20the%20Depression%E2%80%90Like%20Behavior%20of%20Mice&amp;author=I.%20V.%20Belozertseva&amp;author=B.%20V.%20Andreev&amp;volume=47&amp;issue=6&amp;publication_year=1997&amp;pages=1024-1031&amp;pmid=9472168&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0094">
<span class="label">94.</span><cite>
Lecca S., Pelosi A., Tchenio A., et al., “Rescue of GABAB and GIRK Function in the Lateral Habenula by Protein Phosphatase 2A Inhibition Ameliorates Depression‐Like Phenotypes in Mice,” Nature Medicine
22, no. 3 (2016): 254–261.</cite> [<a href="https://doi.org/10.1038/nm.4037" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26808347/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Medicine&amp;title=Rescue%20of%20GABAB%20and%20GIRK%20Function%20in%20the%20Lateral%20Habenula%20by%20Protein%20Phosphatase%202A%20Inhibition%20Ameliorates%20Depression%E2%80%90Like%20Phenotypes%20in%20Mice&amp;author=S.%20Lecca&amp;author=A.%20Pelosi&amp;author=A.%20Tchenio&amp;volume=22&amp;issue=3&amp;publication_year=2016&amp;pages=254-261&amp;pmid=26808347&amp;doi=10.1038/nm.4037&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0095">
<span class="label">95.</span><cite>
Guerzoni S., Pellesi L., Pini L. A., and Caputo F., “Drug‐drug Interactions in the Treatment for Alcohol Use Disorders: A Comprehensive Review,” Pharmacological Research
133 (2018): 65–76.
</cite> [<a href="https://doi.org/10.1016/j.phrs.2018.04.024" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29719204/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacological%20Research&amp;title=Drug%E2%80%90drug%20Interactions%20in%20the%20Treatment%20for%20Alcohol%20Use%20Disorders:%20A%20Comprehensive%20Review&amp;author=S.%20Guerzoni&amp;author=L.%20Pellesi&amp;author=L.%20A.%20Pini&amp;author=F.%20Caputo&amp;volume=133&amp;publication_year=2018&amp;pages=65-76&amp;pmid=29719204&amp;doi=10.1016/j.phrs.2018.04.024&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0096">
<span class="label">96.</span><cite>
Farokhnia M., Sheskier M. B., Lee M. R., et al., “Neuroendocrine Response to GABA‐B Receptor Agonism in Alcohol‐dependent Individuals: Results From a Combined Outpatient and human Laboratory Experiment,” Neuropharmacology
137 (2018): 230–239.
</cite> [<a href="https://doi.org/10.1016/j.neuropharm.2018.04.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6050109/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29665351/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuropharmacology&amp;title=Neuroendocrine%20Response%20to%20GABA%E2%80%90B%20Receptor%20Agonism%20in%20Alcohol%E2%80%90dependent%20Individuals:%20Results%20From%20a%20Combined%20Outpatient%20and%20human%20Laboratory%20Experiment&amp;author=M.%20Farokhnia&amp;author=M.%20B.%20Sheskier&amp;author=M.%20R.%20Lee&amp;volume=137&amp;publication_year=2018&amp;pages=230-239&amp;pmid=29665351&amp;doi=10.1016/j.neuropharm.2018.04.011&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0097">
<span class="label">97.</span><cite>
Miguel E. D., Vekovischeva O., Kuokkanen K., Vesajoki M., and Korpi E. R., “GABA B Receptor Positive Allosteric Modulators With Different Efficacies Affect Neuroadaptation to and Self‐administration of Alcohol and Cocaine,” Addiction Biology
24, no. 11 (2018).</cite> [<a href="https://doi.org/10.1111/adb.12688" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30421860/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Addiction%20Biology&amp;title=GABA%20B%20Receptor%20Positive%20Allosteric%20Modulators%20With%20Different%20Efficacies%20Affect%20Neuroadaptation%20to%20and%20Self%E2%80%90administration%20of%20Alcohol%20and%20Cocaine&amp;author=E.%20D.%20Miguel&amp;author=O.%20Vekovischeva&amp;author=K.%20Kuokkanen&amp;author=M.%20Vesajoki&amp;author=E.%20R.%20Korpi&amp;volume=24&amp;issue=11&amp;publication_year=2018&amp;pmid=30421860&amp;doi=10.1111/adb.12688&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0098">
<span class="label">98.</span><cite>
Jagatsinh Y., “Intrathecal baclofen: Its Effect on Symptoms and Activities of Daily Living in Severe Spasticity due to Spinal Cord Injuries: A Pilot Study,” Indian Journal of Orthopaedics
43, no. 1 (2009): 46–49.
</cite> [<a href="https://doi.org/10.4103/0019-5413.45323" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2739492/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19753179/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Indian%20Journal%20of%20Orthopaedics&amp;title=Intrathecal%20baclofen:%20Its%20Effect%20on%20Symptoms%20and%20Activities%20of%20Daily%20Living%20in%20Severe%20Spasticity%20due%20to%20Spinal%20Cord%20Injuries:%20A%20Pilot%20Study&amp;author=Y.%20Jagatsinh&amp;volume=43&amp;issue=1&amp;publication_year=2009&amp;pages=46-49&amp;pmid=19753179&amp;doi=10.4103/0019-5413.45323&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0099">
<span class="label">99.</span><cite>
Augier E., Dulman R. S., Damadzic R., Pilling A., Hamilton J. P., and Heilig M., “The GABAB Positive Allosteric Modulator ADX71441 Attenuates Alcohol Self‐Administration and Relapse to Alcohol Seeking in Rats,” Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology
42, no. 9 (2017): 1789–1799.
</cite> [<a href="https://doi.org/10.1038/npp.2017.53" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5520784/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28294133/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuropsychopharmacology:%20Official%20Publication%20of%20the%20American%20College%20of%20Neuropsychopharmacology&amp;title=The%20GABAB%20Positive%20Allosteric%20Modulator%20ADX71441%20Attenuates%20Alcohol%20Self%E2%80%90Administration%20and%20Relapse%20to%20Alcohol%20Seeking%20in%20Rats&amp;author=E.%20Augier&amp;author=R.%20S.%20Dulman&amp;author=R.%20Damadzic&amp;author=A.%20Pilling&amp;author=J.%20P.%20Hamilton&amp;volume=42&amp;issue=9&amp;publication_year=2017&amp;pages=1789-1799&amp;pmid=28294133&amp;doi=10.1038/npp.2017.53&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0100">
<span class="label">100.</span><cite>
Madangopal R., Ramsey L. A., Weber S. J., et al., “Inactivation of the Infralimbic Cortex Decreases Discriminative Stimulus‐controlled Relapse to Cocaine Seeking in Rats,” Neuropsychopharmacology (2021).</cite> [<a href="https://doi.org/10.1038/s41386-021-01067-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8429767/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34162997/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuropsychopharmacology&amp;title=Inactivation%20of%20the%20Infralimbic%20Cortex%20Decreases%20Discriminative%20Stimulus%E2%80%90controlled%20Relapse%20to%20Cocaine%20Seeking%20in%20Rats&amp;author=R.%20Madangopal&amp;author=L.%20A.%20Ramsey&amp;author=S.%20J.%20Weber&amp;publication_year=2021&amp;pmid=34162997&amp;doi=10.1038/s41386-021-01067-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0101">
<span class="label">101.</span><cite>
Cruz A. M., Spencer H. F., Kim T. H., Jhou T. C., and Smith R. J., “Prelimbic Cortical Projections to Rostromedial Tegmental Nucleus Play a Suppressive Role in Cue‐induced Reinstatement of Cocaine Seeking,” Neuropsychopharmacology
46, no. 8 (2021): 1399–1406.
</cite> [<a href="https://doi.org/10.1038/s41386-020-00909-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8209220/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33230269/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuropsychopharmacology&amp;title=Prelimbic%20Cortical%20Projections%20to%20Rostromedial%20Tegmental%20Nucleus%20Play%20a%20Suppressive%20Role%20in%20Cue%E2%80%90induced%20Reinstatement%20of%20Cocaine%20Seeking&amp;author=A.%20M.%20Cruz&amp;author=H.%20F.%20Spencer&amp;author=T.%20H.%20Kim&amp;author=T.%20C.%20Jhou&amp;author=R.%20J.%20Smith&amp;volume=46&amp;issue=8&amp;publication_year=2021&amp;pages=1399-1406&amp;pmid=33230269&amp;doi=10.1038/s41386-020-00909-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0102">
<span class="label">102.</span><cite>
Sun K., Mu Q., Chang H., et al., “Postretrieval Microinjection of Baclofen into the Agranular Insular Cortex Inhibits Morphine‐Induced CPP by Disrupting Reconsolidation,” Frontiers in pharmacology
11 (2020): 743.
</cite> [<a href="https://doi.org/10.3389/fphar.2020.00743" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7248341/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32508658/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20pharmacology&amp;title=Postretrieval%20Microinjection%20of%20Baclofen%20into%20the%20Agranular%20Insular%20Cortex%20Inhibits%20Morphine%E2%80%90Induced%20CPP%20by%20Disrupting%20Reconsolidation&amp;author=K.%20Sun&amp;author=Q.%20Mu&amp;author=H.%20Chang&amp;volume=11&amp;publication_year=2020&amp;pages=743&amp;pmid=32508658&amp;doi=10.3389/fphar.2020.00743&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0103">
<span class="label">103.</span><cite>
Ando Y., Hojo M., Kanaide M., et al., “S(+)‐ketamine Suppresses Desensitization of γ‐aminobutyric Acid Type B Receptor‐mediated Signaling by Inhibition of the Interaction of γ‐aminobutyric Acid Type B Receptors With G Protein‐coupled Receptor Kinase 4 or 5,” Anesthesiology
114, no. 2 (2011): 401–411.
</cite> [<a href="https://doi.org/10.1097/ALN.0b013e318204e003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21245733/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Anesthesiology&amp;title=S(+)%E2%80%90ketamine%20Suppresses%20Desensitization%20of%20%CE%B3%E2%80%90aminobutyric%20Acid%20Type%20B%20Receptor%E2%80%90mediated%20Signaling%20by%20Inhibition%20of%20the%20Interaction%20of%20%CE%B3%E2%80%90aminobutyric%20Acid%20Type%20B%20Receptors%20With%20G%20Protein%E2%80%90coupled%20Receptor%20Kinase%204%20or%205&amp;author=Y.%20Ando&amp;author=M.%20Hojo&amp;author=M.%20Kanaide&amp;volume=114&amp;issue=2&amp;publication_year=2011&amp;pages=401-411&amp;pmid=21245733&amp;doi=10.1097/ALN.0b013e318204e003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0104">
<span class="label">104.</span><cite>
Li X., Zeric T., Kambhampati S., Bossert J. M., and Shaham Y., “The central Amygdala Nucleus Is Critical for Incubation of Methamphetamine Craving,” Neuropsychopharmacology
40, no. 5 (2015): 1297–1306.
</cite> [<a href="https://doi.org/10.1038/npp.2014.320" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4367476/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25475163/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuropsychopharmacology&amp;title=The%20central%20Amygdala%20Nucleus%20Is%20Critical%20for%20Incubation%20of%20Methamphetamine%20Craving&amp;author=X.%20Li&amp;author=T.%20Zeric&amp;author=S.%20Kambhampati&amp;author=J.%20M.%20Bossert&amp;author=Y.%20Shaham&amp;volume=40&amp;issue=5&amp;publication_year=2015&amp;pages=1297-1306&amp;pmid=25475163&amp;doi=10.1038/npp.2014.320&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0105">
<span class="label">105.</span><cite>
Di Ciano P. and Everitt B. J., “The GABA(B) Receptor Agonist Baclofen Attenuates Cocaine‐ and Heroin‐seeking Behavior by Rats,” Neuropsychopharmacology
28, no. 3 (2003): 510–518.
</cite> [<a href="https://doi.org/10.1038/sj.npp.1300088" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12629530/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuropsychopharmacology&amp;title=The%20GABA(B)%20Receptor%20Agonist%20Baclofen%20Attenuates%20Cocaine%E2%80%90%20and%20Heroin%E2%80%90seeking%20Behavior%20by%20Rats&amp;author=P.%20Di%20Ciano&amp;author=B.%20J.%20Everitt&amp;volume=28&amp;issue=3&amp;publication_year=2003&amp;pages=510-518&amp;pmid=12629530&amp;doi=10.1038/sj.npp.1300088&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0106">
<span class="label">106.</span><cite>
Czuczwar S. J. and Patsalos P. N., “The New Generation of GABA Enhancers. Potential in the Treatment of Epilepsy,” CNS Drugs
15, no. 5 (2001): 339–350.
</cite> [<a href="https://doi.org/10.2165/00023210-200115050-00001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11475940/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=CNS%20Drugs&amp;title=The%20New%20Generation%20of%20GABA%20Enhancers.%20Potential%20in%20the%20Treatment%20of%20Epilepsy&amp;author=S.%20J.%20Czuczwar&amp;author=P.%20N.%20Patsalos&amp;volume=15&amp;issue=5&amp;publication_year=2001&amp;pages=339-350&amp;pmid=11475940&amp;doi=10.2165/00023210-200115050-00001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0107">
<span class="label">107.</span><cite>
Werner F. M. and Coveñas R., “Neural Networks in Generalized Epilepsy and Novel Antiepileptic Drugs,” Current Pharmaceutical Design
25, no. 4 (2019): 396–400.
</cite> [<a href="https://doi.org/10.2174/1381612825666190319121505" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30892153/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Current%20Pharmaceutical%20Design&amp;title=Neural%20Networks%20in%20Generalized%20Epilepsy%20and%20Novel%20Antiepileptic%20Drugs&amp;author=F.%20M.%20Werner&amp;author=R.%20Cove%C3%B1as&amp;volume=25&amp;issue=4&amp;publication_year=2019&amp;pages=396-400&amp;pmid=30892153&amp;doi=10.2174/1381612825666190319121505&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0108">
<span class="label">108.</span><cite>
Han H. A., Cortez M. A., and Snead O. C. III. GABA(B) Receptor and Absence Epilepsy. In: Noebels JL, Avoli M, Rogawski MA, Olsen RW, Delgado‐Escueta AV, eds. “Jasper's Basic Mechanisms of the Epilepsies” (2012). National Center for Biotechnology Information (US) Copyright © 2012, Michael A Rogawski, Antonio V Delgado‐Escueta, Jeffrey L Noebels, Massimo Avoli and Richard W Olsen.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/22787624/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?title=Jasper's%20Basic%20Mechanisms%20of%20the%20Epilepsies&amp;author=H.%20A.%20Han&amp;author=M.%20A.%20Cortez&amp;author=O.%20C.%20Snead&amp;publication_year=2012&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0109">
<span class="label">109.</span><cite>
Caddick S. J. and Hosford D. A., “The Role of GABAB Mechanisms in Animal Models of Absence Seizures,” Molecular Neurobiology
13, no. 1 (1996): 23–32.
</cite> [<a href="https://doi.org/10.1007/BF02740750" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8892334/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20Neurobiology&amp;title=The%20Role%20of%20GABAB%20Mechanisms%20in%20Animal%20Models%20of%20Absence%20Seizures&amp;author=S.%20J.%20Caddick&amp;author=D.%20A.%20Hosford&amp;volume=13&amp;issue=1&amp;publication_year=1996&amp;pages=23-32&amp;pmid=8892334&amp;doi=10.1007/BF02740750&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0110">
<span class="label">110.</span><cite>
Hosford D. A., Lin F. H., Wang Y., et al., “Studies of the Lethargic (lh/lh) Mouse Model of Absence Seizures: Regulatory Mechanisms and Identification of the Lh Gene,” Advances in Neurology
79 (1999): 239–252.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/10514818/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Advances%20in%20Neurology&amp;title=Studies%20of%20the%20Lethargic%20(lh/lh)%20Mouse%20Model%20of%20Absence%20Seizures:%20Regulatory%20Mechanisms%20and%20Identification%20of%20the%20Lh%20Gene&amp;author=D.%20A.%20Hosford&amp;author=F.%20H.%20Lin&amp;author=Y.%20Wang&amp;volume=79&amp;publication_year=1999&amp;pages=239-252&amp;pmid=10514818&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0111">
<span class="label">111.</span><cite>
Zeng W., Cao L., Zheng J., and Yu L., “Clinical Characteristics and Long‐term Follow‐up of Seven Cases of Anti‐GABABR Encephalitis in Patients of Han Chinese Descent,” Neurological Sciences
41, no. 2 (2020): 373–378.
</cite> [<a href="https://doi.org/10.1007/s10072-019-04095-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7005084/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31659584/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurological%20Sciences&amp;title=Clinical%20Characteristics%20and%20Long%E2%80%90term%20Follow%E2%80%90up%20of%20Seven%20Cases%20of%20Anti%E2%80%90GABABR%20Encephalitis%20in%20Patients%20of%20Han%20Chinese%20Descent&amp;author=W.%20Zeng&amp;author=L.%20Cao&amp;author=J.%20Zheng&amp;author=L.%20Yu&amp;volume=41&amp;issue=2&amp;publication_year=2020&amp;pages=373-378&amp;pmid=31659584&amp;doi=10.1007/s10072-019-04095-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0112">
<span class="label">112.</span><cite>
Yao L., Yue W., Xunyi W., Jianhong W., Guoxing Z., and Zhen H., “Clinical Features and Long‐term Outcomes of Seizures Associated With Autoimmune Encephalitis: A Follow‐up Study in East China,” Journal of Clinical Neuroscience
68 (2019): 73–79.
</cite> [<a href="https://doi.org/10.1016/j.jocn.2019.07.049" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31331752/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Clinical%20Neuroscience&amp;title=Clinical%20Features%20and%20Long%E2%80%90term%20Outcomes%20of%20Seizures%20Associated%20With%20Autoimmune%20Encephalitis:%20A%20Follow%E2%80%90up%20Study%20in%20East%20China&amp;author=L.%20Yao&amp;author=W.%20Yue&amp;author=W.%20Xunyi&amp;author=W.%20Jianhong&amp;author=Z.%20Guoxing&amp;volume=68&amp;publication_year=2019&amp;pages=73-79&amp;pmid=31331752&amp;doi=10.1016/j.jocn.2019.07.049&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0113">
<span class="label">113.</span><cite>
Ong J. and Kerr D. I., “Clinical Potential of GABAB Receptor Modulators,” CNS Drug Reviews
11, no. 3 (2005): 317–334.
</cite> [<a href="https://doi.org/10.1111/j.1527-3458.2005.tb00049.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6741760/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16389296/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=CNS%20Drug%20Reviews&amp;title=Clinical%20Potential%20of%20GABAB%20Receptor%20Modulators&amp;author=J.%20Ong&amp;author=D.%20I.%20Kerr&amp;volume=11&amp;issue=3&amp;publication_year=2005&amp;pages=317-334&amp;pmid=16389296&amp;doi=10.1111/j.1527-3458.2005.tb00049.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0114">
<span class="label">114.</span><cite>
Cui J., Bu H., He J., et al., “The Gamma‐aminobutyric Acid‐B Receptor (GABAB) Encephalitis: Clinical Manifestations and Response to Immunotherapy,” International Journal of Neuroscience
128, no. 7 (2018): 627–633.
</cite> [<a href="https://doi.org/10.1080/00207454.2017.1408618" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29166136/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Journal%20of%20Neuroscience&amp;title=The%20Gamma%E2%80%90aminobutyric%20Acid%E2%80%90B%20Receptor%20(GABAB)%20Encephalitis:%20Clinical%20Manifestations%20and%20Response%20to%20Immunotherapy&amp;author=J.%20Cui&amp;author=H.%20Bu&amp;author=J.%20He&amp;volume=128&amp;issue=7&amp;publication_year=2018&amp;pages=627-633&amp;pmid=29166136&amp;doi=10.1080/00207454.2017.1408618&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0115">
<span class="label">115.</span><cite>
Wang P., Nan S., Zhang Y., and Fan J., “Effects of GABA(B) Receptor Positive Allosteric Modulator BHF177 and IRS‐1 on Apoptosis of Hippocampal Neurons in Rats With Refractory Epilepsy via the PI3K/Akt Pathway,” Cell Biology International
46, no. 11 (2022): 1775–1786.
</cite> [<a href="https://doi.org/10.1002/cbin.11839" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35989486/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Biology%20International&amp;title=Effects%20of%20GABA(B)%20Receptor%20Positive%20Allosteric%20Modulator%20BHF177%20and%20IRS%E2%80%901%20on%20Apoptosis%20of%20Hippocampal%20Neurons%20in%20Rats%20With%20Refractory%20Epilepsy%20via%20the%20PI3K/Akt%20Pathway&amp;author=P.%20Wang&amp;author=S.%20Nan&amp;author=Y.%20Zhang&amp;author=J.%20Fan&amp;volume=46&amp;issue=11&amp;publication_year=2022&amp;pages=1775-1786&amp;pmid=35989486&amp;doi=10.1002/cbin.11839&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0116">
<span class="label">116.</span><cite>
Geis C., Planagumà J., Carreño M., Graus F., and Dalmau J., “Autoimmune Seizures and Epilepsy,” Journal of Clinical Investigation
129, no. 3 (2019): 926–940.
</cite> [<a href="https://doi.org/10.1172/JCI125178" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6391086/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30714986/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Clinical%20Investigation&amp;title=Autoimmune%20Seizures%20and%20Epilepsy&amp;author=C.%20Geis&amp;author=J.%20Planagum%C3%A0&amp;author=M.%20Carre%C3%B1o&amp;author=F.%20Graus&amp;author=J.%20Dalmau&amp;volume=129&amp;issue=3&amp;publication_year=2019&amp;pages=926-940&amp;pmid=30714986&amp;doi=10.1172/JCI125178&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0117">
<span class="label">117.</span><cite>
Oagawa S., Uchida Y., Kobayashi S., Takada K., Terada K., and Matsukawa N., “GABA(B) Receptor Autoimmune Encephalitis Presenting as Transient Epileptic Amnesia,” Rinsho Shinkeigaku. Clinical Neurology
61, no. 1 (2021): 6–11.
</cite> [<a href="https://doi.org/10.5692/clinicalneurol.cn-001425" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33328416/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Rinsho%20Shinkeigaku.%20Clinical%20Neurology&amp;title=GABA(B)%20Receptor%20Autoimmune%20Encephalitis%20Presenting%20as%20Transient%20Epileptic%20Amnesia&amp;author=S.%20Oagawa&amp;author=Y.%20Uchida&amp;author=S.%20Kobayashi&amp;author=K.%20Takada&amp;author=K.%20Terada&amp;volume=61&amp;issue=1&amp;publication_year=2021&amp;pages=6-11&amp;pmid=33328416&amp;doi=10.5692/clinicalneurol.cn-001425&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0118">
<span class="label">118.</span><cite>
Getova D. P. and Bowery N. G., “Effects of High‐affinity GABAB Receptor Antagonists on Active and Passive Avoidance Responding in Rodents With Gamma‐hydroxybutyrolactone‐induced Absence Syndrome,” Psychopharmacology
157, no. 1 (2001): 89–95.
</cite> [<a href="https://doi.org/10.1007/s002130100766" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11512048/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Psychopharmacology&amp;title=Effects%20of%20High%E2%80%90affinity%20GABAB%20Receptor%20Antagonists%20on%20Active%20and%20Passive%20Avoidance%20Responding%20in%20Rodents%20With%20Gamma%E2%80%90hydroxybutyrolactone%E2%80%90induced%20Absence%20Syndrome&amp;author=D.%20P.%20Getova&amp;author=N.%20G.%20Bowery&amp;volume=157&amp;issue=1&amp;publication_year=2001&amp;pages=89-95&amp;pmid=11512048&amp;doi=10.1007/s002130100766&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0119">
<span class="label">119.</span><cite>
Williams S. R., Turner J. P., and Crunelli V., “Gamma‐hydroxybutyrate Promotes Oscillatory Activity of Rat and Cat Thalamocortical Neurons by a Tonic GABAB, Receptor‐mediated Hyperpolarization,” Neuroscience
66, no. 1 (1995): 133–141.
</cite> [<a href="https://doi.org/10.1016/0306-4522(94)00604-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7637863/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuroscience&amp;title=Gamma%E2%80%90hydroxybutyrate%20Promotes%20Oscillatory%20Activity%20of%20Rat%20and%20Cat%20Thalamocortical%20Neurons%20by%20a%20Tonic%20GABAB,%20Receptor%E2%80%90mediated%20Hyperpolarization&amp;author=S.%20R.%20Williams&amp;author=J.%20P.%20Turner&amp;author=V.%20Crunelli&amp;volume=66&amp;issue=1&amp;publication_year=1995&amp;pages=133-141&amp;pmid=7637863&amp;doi=10.1016/0306-4522(94)00604-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0120">
<span class="label">120.</span><cite>
Ostojić Z. S., Ilić T. V., Vesković S. M., and Andjus P. R., “GABAB Receptors as a Common Target for Hypothermia and Spike and Wave Seizures: Intersecting Mechanisms of Thermoregulation and Absence Epilepsy,” Neuroscience
238 (2013): 39–58.
</cite> [<a href="https://doi.org/10.1016/j.neuroscience.2013.01.072" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23415784/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuroscience&amp;title=GABAB%20Receptors%20as%20a%20Common%20Target%20for%20Hypothermia%20and%20Spike%20and%20Wave%20Seizures:%20Intersecting%20Mechanisms%20of%20Thermoregulation%20and%20Absence%20Epilepsy&amp;author=Z.%20S.%20Ostoji%C4%87&amp;author=T.%20V.%20Ili%C4%87&amp;author=S.%20M.%20Veskovi%C4%87&amp;author=P.%20R.%20Andjus&amp;volume=238&amp;publication_year=2013&amp;pages=39-58&amp;pmid=23415784&amp;doi=10.1016/j.neuroscience.2013.01.072&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0121">
<span class="label">121.</span><cite>
Mangan P. S. and Lothman E. W., “Profound Disturbances of Pre‐ and Postsynaptic GABAB‐receptor‐mediated Processes in Region CA1 in a Chronic Model of Temporal Lobe Epilepsy,” Journal of Neurophysiology
76, no. 2 (1996): 1282–1296.
</cite> [<a href="https://doi.org/10.1152/jn.1996.76.2.1282" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8871236/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Neurophysiology&amp;title=Profound%20Disturbances%20of%20Pre%E2%80%90%20and%20Postsynaptic%20GABAB%E2%80%90receptor%E2%80%90mediated%20Processes%20in%20Region%20CA1%20in%20a%20Chronic%20Model%20of%20Temporal%20Lobe%20Epilepsy&amp;author=P.%20S.%20Mangan&amp;author=E.%20W.%20Lothman&amp;volume=76&amp;issue=2&amp;publication_year=1996&amp;pages=1282-1296&amp;pmid=8871236&amp;doi=10.1152/jn.1996.76.2.1282&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0122">
<span class="label">122.</span><cite>
Bortolato M., Frau R., Orrù M., et al., “GABAB Receptor Activation Exacerbates Spontaneous Spike‐and‐wave Discharges in DBA/2J Mice,” Seizure: The Journal of the British Epilepsy Association
19, no. 4 (2010): 226–231.</cite> [<a href="https://doi.org/10.1016/j.seizure.2010.02.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20233662/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Seizure:%20The%20Journal%20of%20the%20British%20Epilepsy%20Association&amp;title=GABAB%20Receptor%20Activation%20Exacerbates%20Spontaneous%20Spike%E2%80%90and%E2%80%90wave%20Discharges%20in%20DBA/2J%20Mice&amp;author=M.%20Bortolato&amp;author=R.%20Frau&amp;author=M.%20Orr%C3%B9&amp;volume=19&amp;issue=4&amp;publication_year=2010&amp;pages=226-231&amp;pmid=20233662&amp;doi=10.1016/j.seizure.2010.02.007&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0123">
<span class="label">123.</span><cite>
Zeman A., Hoefeijzers S., Milton F., Dewar M., Carr M., and Streatfield C., “The GABAB Receptor Agonist, Baclofen, Contributes to Three Distinct Varieties of Amnesia in the human Brain—A Detailed Case Report,” Cortex; A Journal Devoted to the Study of the Nervous System and Behavior
74 (2016): 9–19.
</cite> [<a href="https://doi.org/10.1016/j.cortex.2015.10.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26599496/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cortex;%20A%20Journal%20Devoted%20to%20the%20Study%20of%20the%20Nervous%20System%20and%20Behavior&amp;title=The%20GABAB%20Receptor%20Agonist,%20Baclofen,%20Contributes%20to%20Three%20Distinct%20Varieties%20of%20Amnesia%20in%20the%20human%20Brain%E2%80%94A%20Detailed%20Case%20Report&amp;author=A.%20Zeman&amp;author=S.%20Hoefeijzers&amp;author=F.%20Milton&amp;author=M.%20Dewar&amp;author=M.%20Carr&amp;volume=74&amp;publication_year=2016&amp;pages=9-19&amp;pmid=26599496&amp;doi=10.1016/j.cortex.2015.10.005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0124">
<span class="label">124.</span><cite>
Straessle A., Loup F., Arabadzisz D., Ohning G. V., and Fritschy J. M., “Rapid and Long‐term Alterations of Hippocampal GABAB Receptors in a Mouse Model of Temporal Lobe Epilepsy,” European Journal of Neuroscience
18, no. 8 (2003): 2213–2226.
</cite> [<a href="https://doi.org/10.1046/j.1460-9568.2003.02964.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14622182/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Journal%20of%20Neuroscience&amp;title=Rapid%20and%20Long%E2%80%90term%20Alterations%20of%20Hippocampal%20GABAB%20Receptors%20in%20a%20Mouse%20Model%20of%20Temporal%20Lobe%20Epilepsy&amp;author=A.%20Straessle&amp;author=F.%20Loup&amp;author=D.%20Arabadzisz&amp;author=G.%20V.%20Ohning&amp;author=J.%20M.%20Fritschy&amp;volume=18&amp;issue=8&amp;publication_year=2003&amp;pages=2213-2226&amp;pmid=14622182&amp;doi=10.1046/j.1460-9568.2003.02964.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0125">
<span class="label">125.</span><cite>
Lang M., Moradi‐Chameh H., Zahid T., et al., “Regulating Hippocampal Hyperexcitability Through GABAB Receptors,” Physiological Reports
2, no. 4 (2014): e00278, doi:.
</cite> [<a href="https://doi.org/10.1002/phy2.278" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4001873/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24771688/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Physiological%20Reports&amp;title=Regulating%20Hippocampal%20Hyperexcitability%20Through%20GABAB%20Receptors&amp;author=M.%20Lang&amp;author=H.%20Moradi%E2%80%90Chameh&amp;author=T.%20Zahid&amp;volume=2&amp;issue=4&amp;publication_year=2014&amp;pages=e00278&amp;pmid=24771688&amp;doi=10.1002/phy2.278&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0126">
<span class="label">126.</span><cite>
Premoli I., Rivolta D., Espenhahn S., et al., “Characterization of GABAB‐receptor Mediated Neurotransmission in the human Cortex by Paired‐pulse TMS‐EEG,” Neuroimage
103 (2014): 152–162.
</cite> [<a href="https://doi.org/10.1016/j.neuroimage.2014.09.028" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25245814/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuroimage&amp;title=Characterization%20of%20GABAB%E2%80%90receptor%20Mediated%20Neurotransmission%20in%20the%20human%20Cortex%20by%20Paired%E2%80%90pulse%20TMS%E2%80%90EEG&amp;author=I.%20Premoli&amp;author=D.%20Rivolta&amp;author=S.%20Espenhahn&amp;volume=103&amp;publication_year=2014&amp;pages=152-162&amp;pmid=25245814&amp;doi=10.1016/j.neuroimage.2014.09.028&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0127">
<span class="label">127.</span><cite>
Buritova J., Chapman V., Honoré P., and Besson J. M., “The Contribution of GABAB Receptor‐mediated Events to Inflammatory Pain Processing: Carrageenan Oedema and Associated Spinal c‐Fos Expression in the Rat,” Neuroscience
73, no. 2 (1996): 487–496.
</cite> [<a href="https://doi.org/10.1016/0306-4522(96)00071-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8783264/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuroscience&amp;title=The%20Contribution%20of%20GABAB%20Receptor%E2%80%90mediated%20Events%20to%20Inflammatory%20Pain%20Processing:%20Carrageenan%20Oedema%20and%20Associated%20Spinal%20c%E2%80%90Fos%20Expression%20in%20the%20Rat&amp;author=J.%20Buritova&amp;author=V.%20Chapman&amp;author=P.%20Honor%C3%A9&amp;author=J.%20M.%20Besson&amp;volume=73&amp;issue=2&amp;publication_year=1996&amp;pages=487-496&amp;pmid=8783264&amp;doi=10.1016/0306-4522(96)00071-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0128">
<span class="label">128.</span><cite>
Takeda M., Nasu M., Kanazawa T., and Shimazu Y., “Activation of GABA(B) Receptors Potentiates Inward Rectifying Potassium Currents in Satellite Glial Cells From Rat Trigeminal Ganglia: In Vivo Patch‐clamp Analysis,” Neuroscience
288 (2015): 51–58.
</cite> [<a href="https://doi.org/10.1016/j.neuroscience.2014.12.024" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25542421/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuroscience&amp;title=Activation%20of%20GABA(B)%20Receptors%20Potentiates%20Inward%20Rectifying%20Potassium%20Currents%20in%20Satellite%20Glial%20Cells%20From%20Rat%20Trigeminal%20Ganglia:%20In%20Vivo%20Patch%E2%80%90clamp%20Analysis&amp;author=M.%20Takeda&amp;author=M.%20Nasu&amp;author=T.%20Kanazawa&amp;author=Y.%20Shimazu&amp;volume=288&amp;publication_year=2015&amp;pages=51-58&amp;pmid=25542421&amp;doi=10.1016/j.neuroscience.2014.12.024&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0129">
<span class="label">129.</span><cite>
Gwak Y. S., Tan H. Y., Nam T. S., Paik K. S., Hulsebosch C. E., and Leem J. W., “Activation of Spinal GABA Receptors Attenuates Chronic central Neuropathic Pain After Spinal Cord Injury,” Journal of Neurotrauma
23, no. 7 (2006): 1111–1124.
</cite> [<a href="https://doi.org/10.1089/neu.2006.23.1111" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16866624/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Neurotrauma&amp;title=Activation%20of%20Spinal%20GABA%20Receptors%20Attenuates%20Chronic%20central%20Neuropathic%20Pain%20After%20Spinal%20Cord%20Injury&amp;author=Y.%20S.%20Gwak&amp;author=H.%20Y.%20Tan&amp;author=T.%20S.%20Nam&amp;author=K.%20S.%20Paik&amp;author=C.%20E.%20Hulsebosch&amp;volume=23&amp;issue=7&amp;publication_year=2006&amp;pages=1111-1124&amp;pmid=16866624&amp;doi=10.1089/neu.2006.23.1111&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0130">
<span class="label">130.</span><cite>
Hu C., Zhao Y. T., Zhang G., and Xu M. F., “Antinociceptive Effects of fucoidan in Rat Models of Vincristine‐induced Neuropathic Pain,” Molecular Medicine Reports
15, no. 2 (2017): 975–980.
</cite> [<a href="https://doi.org/10.3892/mmr.2016.6071" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28035379/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20Medicine%20Reports&amp;title=Antinociceptive%20Effects%20of%20fucoidan%20in%20Rat%20Models%20of%20Vincristine%E2%80%90induced%20Neuropathic%20Pain&amp;author=C.%20Hu&amp;author=Y.%20T.%20Zhao&amp;author=G.%20Zhang&amp;author=M.%20F.%20Xu&amp;volume=15&amp;issue=2&amp;publication_year=2017&amp;pages=975-980&amp;pmid=28035379&amp;doi=10.3892/mmr.2016.6071&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0131">
<span class="label">131.</span><cite>
Dias Q. M. and Prado W. A., “The Lesion of Dorsolateral Funiculus Changes the Antiallodynic Effect of the Intrathecal Muscimol and Baclofen in Distinct Phases of Neuropathic Pain Induced by Spinal Nerve Ligation in Rats,” Brain Research Bulletin
124 (2016): 103–115.
</cite> [<a href="https://doi.org/10.1016/j.brainresbull.2016.04.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27063286/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Brain%20Research%20Bulletin&amp;title=The%20Lesion%20of%20Dorsolateral%20Funiculus%20Changes%20the%20Antiallodynic%20Effect%20of%20the%20Intrathecal%20Muscimol%20and%20Baclofen%20in%20Distinct%20Phases%20of%20Neuropathic%20Pain%20Induced%20by%20Spinal%20Nerve%20Ligation%20in%20Rats&amp;author=Q.%20M.%20Dias&amp;author=W.%20A.%20Prado&amp;volume=124&amp;publication_year=2016&amp;pages=103-115&amp;pmid=27063286&amp;doi=10.1016/j.brainresbull.2016.04.001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0132">
<span class="label">132.</span><cite>
Martins I., Carvalho P., de Vries M. G., et al., “GABA Acting on GABAB Receptors Located in a Medullary Pain Facilitatory Area Enhances Nociceptive Behaviors Evoked by Intraplantar Formalin Injection,” Pain
156, no. 8 (2015): 1555–1565.
</cite> [<a href="https://doi.org/10.1097/j.pain.0000000000000203" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25932688/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pain&amp;title=GABA%20Acting%20on%20GABAB%20Receptors%20Located%20in%20a%20Medullary%20Pain%20Facilitatory%20Area%20Enhances%20Nociceptive%20Behaviors%20Evoked%20by%20Intraplantar%20Formalin%20Injection&amp;author=I.%20Martins&amp;author=P.%20Carvalho&amp;author=M.%20G.%20de%20Vries&amp;volume=156&amp;issue=8&amp;publication_year=2015&amp;pages=1555-1565&amp;pmid=25932688&amp;doi=10.1097/j.pain.0000000000000203&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0133">
<span class="label">133.</span><cite>
Li X., Risbrough V. B., Cates‐Gatto C., et al., “Comparison of the Effects of the GABAB Receptor Positive Modulator BHF177 and the GABAB Receptor Agonist Baclofen on Anxiety‐Like Behavior, Learning, and Memory in Mice,” Neuropharmacology
70 (2013): 156–167.
</cite> [<a href="https://doi.org/10.1016/j.neuropharm.2013.01.018" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3644349/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23376712/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuropharmacology&amp;title=Comparison%20of%20the%20Effects%20of%20the%20GABAB%20Receptor%20Positive%20Modulator%20BHF177%20and%20the%20GABAB%20Receptor%20Agonist%20Baclofen%20on%20Anxiety%E2%80%90Like%20Behavior,%20Learning,%20and%20Memory%20in%20Mice&amp;author=X.%20Li&amp;author=V.%20B.%20Risbrough&amp;author=C.%20Cates%E2%80%90Gatto&amp;volume=70&amp;publication_year=2013&amp;pages=156-167&amp;pmid=23376712&amp;doi=10.1016/j.neuropharm.2013.01.018&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0134">
<span class="label">134.</span><cite>
Zemoura K., Ralvenius W. T., Malherbe P., and Benke D., “The Positive Allosteric GABAB Receptor Modulator Rac‐BHFF Enhances Baclofen‐mediated Analgesia in Neuropathic Mice,” Neuropharmacology
108 (2016): 172–178.
</cite> [<a href="https://doi.org/10.1016/j.neuropharm.2016.04.028" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27108932/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuropharmacology&amp;title=The%20Positive%20Allosteric%20GABAB%20Receptor%20Modulator%20Rac%E2%80%90BHFF%20Enhances%20Baclofen%E2%80%90mediated%20Analgesia%20in%20Neuropathic%20Mice&amp;author=K.%20Zemoura&amp;author=W.%20T.%20Ralvenius&amp;author=P.%20Malherbe&amp;author=D.%20Benke&amp;volume=108&amp;publication_year=2016&amp;pages=172-178&amp;pmid=27108932&amp;doi=10.1016/j.neuropharm.2016.04.028&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0135">
<span class="label">135.</span><cite>
Cornelison L. E., Woodman S. E., and Durham P. L., “5‐HT3/7 and GABA(B) Receptors Mediate Inhibition of Trigeminal Nociception by Dietary Supplementation of Grape Seed Extract,” Nutritional Neuroscience
25, no. 8 (2022): 1565–1576.
</cite> [<a href="https://doi.org/10.1080/1028415X.2021.1880211" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8339147/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33544064/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nutritional%20Neuroscience&amp;title=5%E2%80%90HT3/7%20and%20GABA(B)%20Receptors%20Mediate%20Inhibition%20of%20Trigeminal%20Nociception%20by%20Dietary%20Supplementation%20of%20Grape%20Seed%20Extract&amp;author=L.%20E.%20Cornelison&amp;author=S.%20E.%20Woodman&amp;author=P.%20L.%20Durham&amp;volume=25&amp;issue=8&amp;publication_year=2022&amp;pages=1565-1576&amp;pmid=33544064&amp;doi=10.1080/1028415X.2021.1880211&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0136">
<span class="label">136.</span><cite>
Partyka A., Kłodzińska A., Szewczyk B., et al., “Effects of GABAB Receptor Ligands in Rodent Tests of Anxiety‐Like Behavior,” Pharmacological Reports
59, no. 6 (2007): 757–762.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/18195467/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacological%20Reports&amp;title=Effects%20of%20GABAB%20Receptor%20Ligands%20in%20Rodent%20Tests%20of%20Anxiety%E2%80%90Like%20Behavior&amp;author=A.%20Partyka&amp;author=A.%20K%C5%82odzi%C5%84ska&amp;author=B.%20Szewczyk&amp;volume=59&amp;issue=6&amp;publication_year=2007&amp;pages=757-762&amp;pmid=18195467&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0137">
<span class="label">137.</span><cite>
Frankowska M., Filip M., and Przegaliński E., “Effects of GABAB Receptor Ligands in Animal Tests of Depression and Anxiety,” Pharmacological Reports
59, no. 6 (2007): 645–655.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/18195453/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacological%20Reports&amp;title=Effects%20of%20GABAB%20Receptor%20Ligands%20in%20Animal%20Tests%20of%20Depression%20and%20Anxiety&amp;author=M.%20Frankowska&amp;author=M.%20Filip&amp;author=E.%20Przegali%C5%84ski&amp;volume=59&amp;issue=6&amp;publication_year=2007&amp;pages=645-655&amp;pmid=18195453&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0138">
<span class="label">138.</span><cite>
Falco A. M., McDonald C. G., and Smith R. F., “Anxiety Status Affects Nicotine‐ and Baclofen‐induced Locomotor Activity, Anxiety, and Single‐trial Conditioned Place Preference in Male Adolescent Rats,” Developmental Psychobiology
56, no. 6 (2014): 1352–1364.
</cite> [<a href="https://doi.org/10.1002/dev.21217" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24719177/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Developmental%20Psychobiology&amp;title=Anxiety%20Status%20Affects%20Nicotine%E2%80%90%20and%20Baclofen%E2%80%90induced%20Locomotor%20Activity,%20Anxiety,%20and%20Single%E2%80%90trial%20Conditioned%20Place%20Preference%20in%20Male%20Adolescent%20Rats&amp;author=A.%20M.%20Falco&amp;author=C.%20G.%20McDonald&amp;author=R.%20F.%20Smith&amp;volume=56&amp;issue=6&amp;publication_year=2014&amp;pages=1352-1364&amp;pmid=24719177&amp;doi=10.1002/dev.21217&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0139">
<span class="label">139.</span><cite>
Varani A. P., Aso E., Moutinho L. M., Maldonado R., and Balerio G. N., “Attenuation by baclofen of Nicotine Rewarding Properties and Nicotine Withdrawal Manifestations,” Psychopharmacology
231, no. 15 (2014): 3031–3040.
</cite> [<a href="https://doi.org/10.1007/s00213-014-3469-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24553576/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Psychopharmacology&amp;title=Attenuation%20by%20baclofen%20of%20Nicotine%20Rewarding%20Properties%20and%20Nicotine%20Withdrawal%20Manifestations&amp;author=A.%20P.%20Varani&amp;author=E.%20Aso&amp;author=L.%20M.%20Moutinho&amp;author=R.%20Maldonado&amp;author=G.%20N.%20Balerio&amp;volume=231&amp;issue=15&amp;publication_year=2014&amp;pages=3031-3040&amp;pmid=24553576&amp;doi=10.1007/s00213-014-3469-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0140">
<span class="label">140.</span><cite>
Varani A. P., Pedrón V. T., Machado L. M., Antonelli M. C., Bettler B., and Balerio G. N., “Lack of GABAB Receptors Modifies Behavioural and Biochemical Alterations Induced by Precipitated Nicotine Withdrawal,” Neuropharmacology
90 (2015): 90–101.
</cite> [<a href="https://doi.org/10.1016/j.neuropharm.2014.11.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25479464/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuropharmacology&amp;title=Lack%20of%20GABAB%20Receptors%20Modifies%20Behavioural%20and%20Biochemical%20Alterations%20Induced%20by%20Precipitated%20Nicotine%20Withdrawal&amp;author=A.%20P.%20Varani&amp;author=V.%20T.%20Pedr%C3%B3n&amp;author=L.%20M.%20Machado&amp;author=M.%20C.%20Antonelli&amp;author=B.%20Bettler&amp;volume=90&amp;publication_year=2015&amp;pages=90-101&amp;pmid=25479464&amp;doi=10.1016/j.neuropharm.2014.11.013&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0141">
<span class="label">141.</span><cite>
Li X., Kaczanowska K., Finn M. G., Markou A., and Risbrough V. B., “The GABA(B) Receptor Positive Modulator BHF177 Attenuated Anxiety, but Not Conditioned Fear, in Rats,” Neuropharmacology
97 (2015): 357–364.
</cite> [<a href="https://doi.org/10.1016/j.neuropharm.2015.05.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4537349/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26002628/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuropharmacology&amp;title=The%20GABA(B)%20Receptor%20Positive%20Modulator%20BHF177%20Attenuated%20Anxiety,%20but%20Not%20Conditioned%20Fear,%20in%20Rats&amp;author=X.%20Li&amp;author=K.%20Kaczanowska&amp;author=M.%20G.%20Finn&amp;author=A.%20Markou&amp;author=V.%20B.%20Risbrough&amp;volume=97&amp;publication_year=2015&amp;pages=357-364&amp;pmid=26002628&amp;doi=10.1016/j.neuropharm.2015.05.001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0142">
<span class="label">142.</span><cite>
Cryan J. F., Kelly P. H., Chaperon F., et al., “Behavioral Characterization of the Novel GABAB Receptor‐positive Modulator GS39783 (N,N'‐dicyclopentyl‐2‐methylsulfanyl‐5‐nitro‐pyrimidine‐4,6‐diamine): Anxiolytic‐Like Activity Without Side Effects Associated With Baclofen or Benzodiazepines,” Journal of Pharmacology and Experimental Therapeutics
310, no. 3 (2004): 952–963.
</cite> [<a href="https://doi.org/10.1124/jpet.104.066753" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15113848/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Pharmacology%20and%20Experimental%20Therapeutics&amp;title=Behavioral%20Characterization%20of%20the%20Novel%20GABAB%20Receptor%E2%80%90positive%20Modulator%20GS39783%20(N,N'%E2%80%90dicyclopentyl%E2%80%902%E2%80%90methylsulfanyl%E2%80%905%E2%80%90nitro%E2%80%90pyrimidine%E2%80%904,6%E2%80%90diamine):%20Anxiolytic%E2%80%90Like%20Activity%20Without%20Side%20Effects%20Associated%20With%20Baclofen%20or%20Benzodiazepines&amp;author=J.%20F.%20Cryan&amp;author=P.%20H.%20Kelly&amp;author=F.%20Chaperon&amp;volume=310&amp;issue=3&amp;publication_year=2004&amp;pages=952-963&amp;pmid=15113848&amp;doi=10.1124/jpet.104.066753&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0143">
<span class="label">143.</span><cite>
Jacobson L. H. and Cryan J. F., “Evaluation of the Anxiolytic‐Like Profile of the GABAB Receptor Positive Modulator CGP7930 in Rodents,” Neuropharmacology
54, no. 5 (2008): 854–862.
</cite> [<a href="https://doi.org/10.1016/j.neuropharm.2008.01.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18328507/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuropharmacology&amp;title=Evaluation%20of%20the%20Anxiolytic%E2%80%90Like%20Profile%20of%20the%20GABAB%20Receptor%20Positive%20Modulator%20CGP7930%20in%20Rodents&amp;author=L.%20H.%20Jacobson&amp;author=J.%20F.%20Cryan&amp;volume=54&amp;issue=5&amp;publication_year=2008&amp;pages=854-862&amp;pmid=18328507&amp;doi=10.1016/j.neuropharm.2008.01.004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0144">
<span class="label">144.</span><cite>
Chen Y., Menendez‐Roche N., and Sher E., “Differential Modulation by the GABAB Receptor Allosteric Potentiator 2,6‐di‐tert‐butyl‐4‐(3‐hydroxy‐2,2‐dimethylpropyl)‐phenol (CGP7930) of Synaptic Transmission in the Rat Hippocampal CA1 Area,” Journal of Pharmacology and Experimental Therapeutics
317, no. 3 (2006): 1170–1177.
</cite> [<a href="https://doi.org/10.1124/jpet.105.099176" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16507713/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Pharmacology%20and%20Experimental%20Therapeutics&amp;title=Differential%20Modulation%20by%20the%20GABAB%20Receptor%20Allosteric%20Potentiator%202,6%E2%80%90di%E2%80%90tert%E2%80%90butyl%E2%80%904%E2%80%90(3%E2%80%90hydroxy%E2%80%902,2%E2%80%90dimethylpropyl)%E2%80%90phenol%20(CGP7930)%20of%20Synaptic%20Transmission%20in%20the%20Rat%20Hippocampal%20CA1%20Area&amp;author=Y.%20Chen&amp;author=N.%20Menendez%E2%80%90Roche&amp;author=E.%20Sher&amp;volume=317&amp;issue=3&amp;publication_year=2006&amp;pages=1170-1177&amp;pmid=16507713&amp;doi=10.1124/jpet.105.099176&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0145">
<span class="label">145.</span><cite>
Jeng J. S., Li C. T., Lin H. C., et al., “Antidepressant‐resistant Depression Is Characterized by Reduced Short‐ and Long‐interval Cortical Inhibition,” Psychological Medicine
50, no. 8 (2020): 1285–1291.
</cite> [<a href="https://doi.org/10.1017/S0033291719001223" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31155020/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Psychological%20Medicine&amp;title=Antidepressant%E2%80%90resistant%20Depression%20Is%20Characterized%20by%20Reduced%20Short%E2%80%90%20and%20Long%E2%80%90interval%20Cortical%20Inhibition&amp;author=J.%20S.%20Jeng&amp;author=C.%20T.%20Li&amp;author=H.%20C.%20Lin&amp;volume=50&amp;issue=8&amp;publication_year=2020&amp;pages=1285-1291&amp;pmid=31155020&amp;doi=10.1017/S0033291719001223&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0146">
<span class="label">146.</span><cite>
Pilc A. and Nowak G., “GABAergic Hypotheses of Anxiety and Depression: Focus on GABA‐B Receptors,” Drugs of Today (Barcelona, Spain: 1998)
41, no. 11 (2005): 755–766.
</cite> [<a href="https://doi.org/10.1358/dot.2005.41.11.904728" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16395415/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drugs%20of%20Today%20(Barcelona,%20Spain:%201998)&amp;title=GABAergic%20Hypotheses%20of%20Anxiety%20and%20Depression:%20Focus%20on%20GABA%E2%80%90B%20Receptors&amp;author=A.%20Pilc&amp;author=G.%20Nowak&amp;volume=41&amp;issue=11&amp;publication_year=2005&amp;pages=755-766&amp;pmid=16395415&amp;doi=10.1358/dot.2005.41.11.904728&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0147">
<span class="label">147.</span><cite>
Rogasch N. C., Daskalakis Z. J., and Fitzgerald P. B., “Cortical Inhibition, Excitation, and Connectivity in Schizophrenia: A Review of Insights From Transcranial Magnetic Stimulation,” Schizophrenia Bulletin
40, no. 3 (2014): 685–696.
</cite> [<a href="https://doi.org/10.1093/schbul/sbt078" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3984517/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23722199/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Schizophrenia%20Bulletin&amp;title=Cortical%20Inhibition,%20Excitation,%20and%20Connectivity%20in%20Schizophrenia:%20A%20Review%20of%20Insights%20From%20Transcranial%20Magnetic%20Stimulation&amp;author=N.%20C.%20Rogasch&amp;author=Z.%20J.%20Daskalakis&amp;author=P.%20B.%20Fitzgerald&amp;volume=40&amp;issue=3&amp;publication_year=2014&amp;pages=685-696&amp;pmid=23722199&amp;doi=10.1093/schbul/sbt078&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0148">
<span class="label">148.</span><cite>
Maccioni P., Kaczanowska K., Lawrence H., et al., “The Novel Positive Allosteric Modulator of the GABA(B) Receptor, KK‐92A, Suppresses Alcohol Self‐Administration and Cue‐Induced Reinstatement of Alcohol Seeking in Rats,” Frontiers in Cell and Developmental Biology
9 (2021): 727576.
</cite> [<a href="https://doi.org/10.3389/fcell.2021.727576" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8585307/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34778249/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Cell%20and%20Developmental%20Biology&amp;title=The%20Novel%20Positive%20Allosteric%20Modulator%20of%20the%20GABA(B)%20Receptor,%20KK%E2%80%9092A,%20Suppresses%20Alcohol%20Self%E2%80%90Administration%20and%20Cue%E2%80%90Induced%20Reinstatement%20of%20Alcohol%20Seeking%20in%20Rats&amp;author=P.%20Maccioni&amp;author=K.%20Kaczanowska&amp;author=H.%20Lawrence&amp;volume=9&amp;publication_year=2021&amp;pages=727576&amp;pmid=34778249&amp;doi=10.3389/fcell.2021.727576&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0149">
<span class="label">149.</span><cite>
Ranson D. C., Ayoub S. S., Corcoran O., and Casalotti S. O., “Pharmacological Targeting of the GABA(B) Receptor Alters Drosophila's Behavioural Responses to Alcohol,” Addiction Biology
25, no. 2 (2020): e12725.
</cite> [<a href="https://doi.org/10.1111/adb.12725" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7050513/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30761704/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Addiction%20Biology&amp;title=Pharmacological%20Targeting%20of%20the%20GABA(B)%20Receptor%20Alters%20Drosophila's%20Behavioural%20Responses%20to%20Alcohol&amp;author=D.%20C.%20Ranson&amp;author=S.%20S.%20Ayoub&amp;author=O.%20Corcoran&amp;author=S.%20O.%20Casalotti&amp;volume=25&amp;issue=2&amp;publication_year=2020&amp;pages=e12725&amp;pmid=30761704&amp;doi=10.1111/adb.12725&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0150">
<span class="label">150.</span><cite>
Froger‐Colléaux C. and Castagné V., “Effects of Baclofen and Raclopride on Reinstatement of Cocaine Self‐administration in the Rat,” European Journal of Pharmacology
777 (2016): 147–155.
</cite> [<a href="https://doi.org/10.1016/j.ejphar.2016.03.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26948316/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Journal%20of%20Pharmacology&amp;title=Effects%20of%20Baclofen%20and%20Raclopride%20on%20Reinstatement%20of%20Cocaine%20Self%E2%80%90administration%20in%20the%20Rat&amp;author=C.%20Froger%E2%80%90Coll%C3%A9aux&amp;author=V.%20Castagn%C3%A9&amp;volume=777&amp;publication_year=2016&amp;pages=147-155&amp;pmid=26948316&amp;doi=10.1016/j.ejphar.2016.03.008&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0151">
<span class="label">151.</span><cite>
Bianchi P. C., Carneiro de Oliveira P. E., Palombo P., et al., “Functional Inactivation of the Orbitofrontal Cortex Disrupts Context‐induced Reinstatement of Alcohol Seeking in Rats,” Drug and Alcohol Dependence
186 (2018): 102–112.
</cite> [<a href="https://doi.org/10.1016/j.drugalcdep.2017.12.045" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29567624/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drug%20and%20Alcohol%20Dependence&amp;title=Functional%20Inactivation%20of%20the%20Orbitofrontal%20Cortex%20Disrupts%20Context%E2%80%90induced%20Reinstatement%20of%20Alcohol%20Seeking%20in%20Rats&amp;author=P.%20C.%20Bianchi&amp;author=P.%20E.%20Carneiro%20de%20Oliveira&amp;author=P.%20Palombo&amp;volume=186&amp;publication_year=2018&amp;pages=102-112&amp;pmid=29567624&amp;doi=10.1016/j.drugalcdep.2017.12.045&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0152">
<span class="label">152.</span><cite>
de Miguel E., Vekovischeva O., Kuokkanen K., et al., “GABA(B) Receptor Positive Allosteric Modulators With Different Efficacies Affect Neuroadaptation to and Self‐administration of Alcohol and Cocaine,” Addiction Biology
24, no. 6 (2019): 1191–1203.
</cite> [<a href="https://doi.org/10.1111/adb.12688" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30421860/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Addiction%20Biology&amp;title=GABA(B)%20Receptor%20Positive%20Allosteric%20Modulators%20With%20Different%20Efficacies%20Affect%20Neuroadaptation%20to%20and%20Self%E2%80%90administration%20of%20Alcohol%20and%20Cocaine&amp;author=E.%20de%20Miguel&amp;author=O.%20Vekovischeva&amp;author=K.%20Kuokkanen&amp;volume=24&amp;issue=6&amp;publication_year=2019&amp;pages=1191-1203&amp;pmid=30421860&amp;doi=10.1111/adb.12688&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0153">
<span class="label">153.</span><cite>
Ramshini E., Alaei H., Reisi P., Alaei S., and Shahidani S., “The Role of GABAB Receptors in Morphine Self‐Administration,” International Journal of Preventive Medicine
4, no. 2 (2013): 158–164.
</cite> [<a href="/articles/PMC3604847/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23542877/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Journal%20of%20Preventive%20Medicine&amp;title=The%20Role%20of%20GABAB%20Receptors%20in%20Morphine%20Self%E2%80%90Administration&amp;author=E.%20Ramshini&amp;author=H.%20Alaei&amp;author=P.%20Reisi&amp;author=S.%20Alaei&amp;author=S.%20Shahidani&amp;volume=4&amp;issue=2&amp;publication_year=2013&amp;pages=158-164&amp;pmid=23542877&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0154">
<span class="label">154.</span><cite>
Fu Z., Yang H., Xiao Y., Zhao G., and Huang H., “The Gamma‐aminobutyric Acid Type B (GABAB) Receptor Agonist baclofen Inhibits Morphine Sensitization by Decreasing the Dopamine Level in Rat Nucleus Accumbens,” Behavioral and Brain Functions
8, no. 1 (2012): 20.
</cite> [<a href="https://doi.org/10.1186/1744-9081-8-20" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3393629/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22559224/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Behavioral%20and%20Brain%20Functions&amp;title=The%20Gamma%E2%80%90aminobutyric%20Acid%20Type%20B%20(GABAB)%20Receptor%20Agonist%20baclofen%20Inhibits%20Morphine%20Sensitization%20by%20Decreasing%20the%20Dopamine%20Level%20in%20Rat%20Nucleus%20Accumbens&amp;author=Z.%20Fu&amp;author=H.%20Yang&amp;author=Y.%20Xiao&amp;author=G.%20Zhao&amp;author=H.%20Huang&amp;volume=8&amp;issue=1&amp;publication_year=2012&amp;pages=20&amp;pmid=22559224&amp;doi=10.1186/1744-9081-8-20&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0155">
<span class="label">155.</span><cite>
Mombereau C., Lhuillier L., Kaupmann K., and Cryan J. F., “GABAB Receptor‐positive Modulation‐induced Blockade of the Rewarding Properties of Nicotine Is Associated With a Reduction in Nucleus Accumbens DeltaFosB Accumulation,” Journal of Pharmacology and Experimental Therapeutics
321, no. 1 (2007): 172–717.
</cite> [<a href="https://doi.org/10.1124/jpet.106.116228" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17215447/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Pharmacology%20and%20Experimental%20Therapeutics&amp;title=GABAB%20Receptor%E2%80%90positive%20Modulation%E2%80%90induced%20Blockade%20of%20the%20Rewarding%20Properties%20of%20Nicotine%20Is%20Associated%20With%20a%20Reduction%20in%20Nucleus%20Accumbens%20DeltaFosB%20Accumulation&amp;author=C.%20Mombereau&amp;author=L.%20Lhuillier&amp;author=K.%20Kaupmann&amp;author=J.%20F.%20Cryan&amp;volume=321&amp;issue=1&amp;publication_year=2007&amp;pages=172-717&amp;pmid=17215447&amp;doi=10.1124/jpet.106.116228&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0156">
<span class="label">156.</span><cite>
Augier E., “Recent Advances in the Potential of Positive Allosteric Modulators of the GABAB Receptor to Treat Alcohol Use Disorder,” Alcohol and Alcoholism
56, no. 2 (2021): 139–148.
</cite> [<a href="https://doi.org/10.1093/alcalc/agab003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7906877/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33561865/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Alcohol%20and%20Alcoholism&amp;title=Recent%20Advances%20in%20the%20Potential%20of%20Positive%20Allosteric%20Modulators%20of%20the%20GABAB%20Receptor%20to%20Treat%20Alcohol%20Use%20Disorder&amp;author=E.%20Augier&amp;volume=56&amp;issue=2&amp;publication_year=2021&amp;pages=139-148&amp;pmid=33561865&amp;doi=10.1093/alcalc/agab003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0157">
<span class="label">157.</span><cite>
Sturchler E., Li X., de Lourdes Ladino M., et al., “GABA(B) Receptor Allosteric Modulators Exhibit Pathway‐dependent and Species‐selective Activity,” Pharmacology Research &amp; Perspectives
5, no. 2 (2017): e00288.
</cite> [<a href="https://doi.org/10.1002/prp2.288" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5368958/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28357120/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacology%20Research%20&amp;%20Perspectives&amp;title=GABA(B)%20Receptor%20Allosteric%20Modulators%20Exhibit%20Pathway%E2%80%90dependent%20and%20Species%E2%80%90selective%20Activity&amp;author=E.%20Sturchler&amp;author=X.%20Li&amp;author=M.%20de%20Lourdes%20Ladino&amp;volume=5&amp;issue=2&amp;publication_year=2017&amp;pages=e00288&amp;pmid=28357120&amp;doi=10.1002/prp2.288&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0158">
<span class="label">158.</span><cite>
Slattery D. A., Markou A., Froestl W., and Cryan J. F., “The GABAB Receptor‐positive Modulator GS39783 and the GABAB Receptor Agonist Baclofen Attenuate the Reward‐facilitating Effects of Cocaine: Intracranial Self‐stimulation Studies in the Rat,” Neuropsychopharmacology
30, no. 11 (2005): 2065–2072.
</cite> [<a href="https://doi.org/10.1038/sj.npp.1300734" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15841108/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuropsychopharmacology&amp;title=The%20GABAB%20Receptor%E2%80%90positive%20Modulator%20GS39783%20and%20the%20GABAB%20Receptor%20Agonist%20Baclofen%20Attenuate%20the%20Reward%E2%80%90facilitating%20Effects%20of%20Cocaine:%20Intracranial%20Self%E2%80%90stimulation%20Studies%20in%20the%20Rat&amp;author=D.%20A.%20Slattery&amp;author=A.%20Markou&amp;author=W.%20Froestl&amp;author=J.%20F.%20Cryan&amp;volume=30&amp;issue=11&amp;publication_year=2005&amp;pages=2065-2072&amp;pmid=15841108&amp;doi=10.1038/sj.npp.1300734&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0159">
<span class="label">159.</span><cite>
Wierońska J. M., Kłeczek N., Woźniak M., et al., “mGlu₅‐GABAB Interplay in Animal Models of Positive, Negative and Cognitive Symptoms of Schizophrenia,” Neurochemistry International
88 (2015): 97–109.
</cite> [<a href="https://doi.org/10.1016/j.neuint.2015.03.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25863284/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurochemistry%20International&amp;title=mGlu%E2%82%85%E2%80%90GABAB%20Interplay%20in%20Animal%20Models%20of%20Positive,%20Negative%20and%20Cognitive%20Symptoms%20of%20Schizophrenia&amp;author=J.%20M.%20Wiero%C5%84ska&amp;author=N.%20K%C5%82eczek&amp;author=M.%20Wo%C5%BAniak&amp;volume=88&amp;publication_year=2015&amp;pages=97-109&amp;pmid=25863284&amp;doi=10.1016/j.neuint.2015.03.010&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0160">
<span class="label">160.</span><cite>
Arai S., Takuma K., Mizoguchi H., et al., “Involvement of Pallidotegmental Neurons in Methamphetamine‐ and MK‐801‐induced Impairment of Prepulse Inhibition of the Acoustic Startle Reflex in Mice: Reversal by GABAB Receptor Agonist baclofen,” Neuropsychopharmacology
33, no. 13 (2008): 3164–3175.
</cite> [<a href="https://doi.org/10.1038/npp.2008.41" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18354384/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuropsychopharmacology&amp;title=Involvement%20of%20Pallidotegmental%20Neurons%20in%20Methamphetamine%E2%80%90%20and%20MK%E2%80%90801%E2%80%90induced%20Impairment%20of%20Prepulse%20Inhibition%20of%20the%20Acoustic%20Startle%20Reflex%20in%20Mice:%20Reversal%20by%20GABAB%20Receptor%20Agonist%20baclofen&amp;author=S.%20Arai&amp;author=K.%20Takuma&amp;author=H.%20Mizoguchi&amp;volume=33&amp;issue=13&amp;publication_year=2008&amp;pages=3164-3175&amp;pmid=18354384&amp;doi=10.1038/npp.2008.41&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0161">
<span class="label">161.</span><cite>
Arai S., Takuma K., Mizoguchi H., et al., “GABAB Receptor Agonist baclofen Improves Methamphetamine‐induced Cognitive Deficit in Mice,” European Journal of Pharmacology
602, no. 1 (2009): 101–104.
</cite> [<a href="https://doi.org/10.1016/j.ejphar.2008.10.065" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19028488/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Journal%20of%20Pharmacology&amp;title=GABAB%20Receptor%20Agonist%20baclofen%20Improves%20Methamphetamine%E2%80%90induced%20Cognitive%20Deficit%20in%20Mice&amp;author=S.%20Arai&amp;author=K.%20Takuma&amp;author=H.%20Mizoguchi&amp;volume=602&amp;issue=1&amp;publication_year=2009&amp;pages=101-104&amp;pmid=19028488&amp;doi=10.1016/j.ejphar.2008.10.065&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0162">
<span class="label">162.</span><cite>
Featherstone R. E., McMullen M. F., Ward K. R., Bang J., Xiao J., and Siegel S. J., “EEG Biomarkers of Target Engagement, Therapeutic Effect, and Disease Process,” Annals of the New York Academy of Sciences
1344 (2015): 12–26.
</cite> [<a href="https://doi.org/10.1111/nyas.12745" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25823856/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Annals%20of%20the%20New%20York%20Academy%20of%20Sciences&amp;title=EEG%20Biomarkers%20of%20Target%20Engagement,%20Therapeutic%20Effect,%20and%20Disease%20Process&amp;author=R.%20E.%20Featherstone&amp;author=M.%20F.%20McMullen&amp;author=K.%20R.%20Ward&amp;author=J.%20Bang&amp;author=J.%20Xiao&amp;volume=1344&amp;publication_year=2015&amp;pages=12-26&amp;pmid=25823856&amp;doi=10.1111/nyas.12745&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0163">
<span class="label">163.</span><cite>
Draycott B., Loureiro M., Ahmad T., Tan H., Zunder J., and Laviolette S. R., “Cannabinoid Transmission in the Prefrontal Cortex bi‐phasically Controls Emotional Memory Formation via Functional Interactions With the Ventral Tegmental Area,” Journal of Neuroscience
34, no. 39 (2014): 13096–13109.
</cite> [<a href="https://doi.org/10.1523/JNEUROSCI.1297-14.2014" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6608340/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25253856/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Neuroscience&amp;title=Cannabinoid%20Transmission%20in%20the%20Prefrontal%20Cortex%20bi%E2%80%90phasically%20Controls%20Emotional%20Memory%20Formation%20via%20Functional%20Interactions%20With%20the%20Ventral%20Tegmental%20Area&amp;author=B.%20Draycott&amp;author=M.%20Loureiro&amp;author=T.%20Ahmad&amp;author=H.%20Tan&amp;author=J.%20Zunder&amp;volume=34&amp;issue=39&amp;publication_year=2014&amp;pages=13096-13109&amp;pmid=25253856&amp;doi=10.1523/JNEUROSCI.1297-14.2014&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0164">
<span class="label">164.</span><cite>
Sershen H., Balla A., Aspromonte J. M., Xie S., Cooper T. B., and Javitt D. C., “Characterization of Interactions Between Phencyclidine and Amphetamine in Rodent Prefrontal Cortex and Striatum: Implications in NMDA/Glycine‐site‐mediated Dopaminergic Dysregulation and Dopamine Transporter Function,” Neurochemistry International
52, no. 1‐2 (2008): 119–129.
</cite> [<a href="https://doi.org/10.1016/j.neuint.2007.07.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17716783/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurochemistry%20International&amp;title=Characterization%20of%20Interactions%20Between%20Phencyclidine%20and%20Amphetamine%20in%20Rodent%20Prefrontal%20Cortex%20and%20Striatum:%20Implications%20in%20NMDA/Glycine%E2%80%90site%E2%80%90mediated%20Dopaminergic%20Dysregulation%20and%20Dopamine%20Transporter%20Function&amp;author=H.%20Sershen&amp;author=A.%20Balla&amp;author=J.%20M.%20Aspromonte&amp;author=S.%20Xie&amp;author=T.%20B.%20Cooper&amp;volume=52&amp;issue=1%E2%80%902&amp;publication_year=2008&amp;pages=119-129&amp;pmid=17716783&amp;doi=10.1016/j.neuint.2007.07.011&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0165">
<span class="label">165.</span><cite>
Toriumi K., Oki M., Muto E., et al., “Prenatal Phencyclidine Treatment Induces Behavioral Deficits Through Impairment of GABAergic Interneurons in the Prefrontal Cortex,” Psychopharmacology
233, no. 12 (2016): 2373–2381.
</cite> [<a href="https://doi.org/10.1007/s00213-016-4288-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27095448/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Psychopharmacology&amp;title=Prenatal%20Phencyclidine%20Treatment%20Induces%20Behavioral%20Deficits%20Through%20Impairment%20of%20GABAergic%20Interneurons%20in%20the%20Prefrontal%20Cortex&amp;author=K.%20Toriumi&amp;author=M.%20Oki&amp;author=E.%20Muto&amp;volume=233&amp;issue=12&amp;publication_year=2016&amp;pages=2373-2381&amp;pmid=27095448&amp;doi=10.1007/s00213-016-4288-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0166">
<span class="label">166.</span><cite>
Zhang Y. H., Zhao P., Gao H. L., Zhong M. L., and Li J. Y., “Screening Targets and Therapeutic Drugs for Alzheimer's Disease Based on Deep Learning Model and Molecular Docking,” Journal of Alzheimer's Disease
100, no. 3 (2024): 863–878.</cite> [<a href="https://doi.org/10.3233/JAD-231389" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38995776/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Alzheimer's%20Disease&amp;title=Screening%20Targets%20and%20Therapeutic%20Drugs%20for%20Alzheimer's%20Disease%20Based%20on%20Deep%20Learning%20Model%20and%20Molecular%20Docking&amp;author=Y.%20H.%20Zhang&amp;author=P.%20Zhao&amp;author=H.%20L.%20Gao&amp;author=M.%20L.%20Zhong&amp;author=J.%20Y.%20Li&amp;volume=100&amp;issue=3&amp;publication_year=2024&amp;pages=863-878&amp;pmid=38995776&amp;doi=10.3233/JAD-231389&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0167">
<span class="label">167.</span><cite>
Sun Z., Sun L., and Tu L., “GABAB Receptor‐Mediated PI3K/Akt Signaling Pathway Alleviates Oxidative Stress and Neuronal Cell Injury in a Rat Model of Alzheimer's Disease,” Journal of Alzheimer's Disease
76, no. 4 (2020): 1513–1526.</cite> [<a href="https://doi.org/10.3233/JAD-191032" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32651311/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Alzheimer's%20Disease&amp;title=GABAB%20Receptor%E2%80%90Mediated%20PI3K/Akt%20Signaling%20Pathway%20Alleviates%20Oxidative%20Stress%20and%20Neuronal%20Cell%20Injury%20in%20a%20Rat%20Model%20of%20Alzheimer's%20Disease&amp;author=Z.%20Sun&amp;author=L.%20Sun&amp;author=L.%20Tu&amp;volume=76&amp;issue=4&amp;publication_year=2020&amp;pages=1513-1526&amp;pmid=32651311&amp;doi=10.3233/JAD-191032&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0168">
<span class="label">168.</span><cite>
Nava‐Mesa M. O., Jiménez‐Díaz L., Yajeya J., and Navarro‐Lopez J. D., “Amyloid‐β Induces Synaptic Dysfunction Through G Protein‐gated Inwardly Rectifying Potassium Channels in the Fimbria‐CA3 Hippocampal Synapse,” Frontiers in Cellular Neuroscience
7 (2013): 117.
</cite> [<a href="https://doi.org/10.3389/fncel.2013.00117" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3722514/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23898239/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Cellular%20Neuroscience&amp;title=Amyloid%E2%80%90%CE%B2%20Induces%20Synaptic%20Dysfunction%20Through%20G%20Protein%E2%80%90gated%20Inwardly%20Rectifying%20Potassium%20Channels%20in%20the%20Fimbria%E2%80%90CA3%20Hippocampal%20Synapse&amp;author=M.%20O.%20Nava%E2%80%90Mesa&amp;author=L.%20Jim%C3%A9nez%E2%80%90D%C3%ADaz&amp;author=J.%20Yajeya&amp;author=J.%20D.%20Navarro%E2%80%90Lopez&amp;volume=7&amp;publication_year=2013&amp;pages=117&amp;pmid=23898239&amp;doi=10.3389/fncel.2013.00117&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0169">
<span class="label">169.</span><cite>
Li C. J., Lu Y., Zhou M., et al., “Activation of GABAB Receptors Ameliorates Cognitive Impairment via Restoring the Balance of HCN1/HCN2 Surface Expression in the Hippocampal CA1 Area in Rats With Chronic Cerebral Hypoperfusion,” Molecular Neurobiology
50, no. 2 (2014): 704–720.
</cite> [<a href="https://doi.org/10.1007/s12035-014-8736-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24838625/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20Neurobiology&amp;title=Activation%20of%20GABAB%20Receptors%20Ameliorates%20Cognitive%20Impairment%20via%20Restoring%20the%20Balance%20of%20HCN1/HCN2%20Surface%20Expression%20in%20the%20Hippocampal%20CA1%20Area%20in%20Rats%20With%20Chronic%20Cerebral%20Hypoperfusion&amp;author=C.%20J.%20Li&amp;author=Y.%20Lu&amp;author=M.%20Zhou&amp;volume=50&amp;issue=2&amp;publication_year=2014&amp;pages=704-720&amp;pmid=24838625&amp;doi=10.1007/s12035-014-8736-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0170">
<span class="label">170.</span><cite>
Yu Z., Cheng G., and Hu B., “Mechanism of Colchicine Impairment on Learning and Memory, and Protective Effect of CGP36742 in Mice,” Brain Research
750, no. 1‐2 (1997): 53–58.
</cite> [<a href="https://doi.org/10.1016/s0006-8993(96)01158-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9098529/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Brain%20Research&amp;title=Mechanism%20of%20Colchicine%20Impairment%20on%20Learning%20and%20Memory,%20and%20Protective%20Effect%20of%20CGP36742%20in%20Mice&amp;author=Z.%20Yu&amp;author=G.%20Cheng&amp;author=B.%20Hu&amp;volume=750&amp;issue=1%E2%80%902&amp;publication_year=1997&amp;pages=53-58&amp;pmid=9098529&amp;doi=10.1016/s0006-8993(96)01158-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0171">
<span class="label">171.</span><cite>
Helm K. A., Haberman R. P., Dean S. L., et al., “GABAB Receptor Antagonist SGS742 Improves Spatial Memory and Reduces Protein Binding to the cAMP Response Element (CRE) in the Hippocampus,” Neuropharmacology
48, no. 7 (2005): 956–964.
</cite> [<a href="https://doi.org/10.1016/j.neuropharm.2005.01.019" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15857622/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuropharmacology&amp;title=GABAB%20Receptor%20Antagonist%20SGS742%20Improves%20Spatial%20Memory%20and%20Reduces%20Protein%20Binding%20to%20the%20cAMP%20Response%20Element%20(CRE)%20in%20the%20Hippocampus&amp;author=K.%20A.%20Helm&amp;author=R.%20P.%20Haberman&amp;author=S.%20L.%20Dean&amp;volume=48&amp;issue=7&amp;publication_year=2005&amp;pages=956-964&amp;pmid=15857622&amp;doi=10.1016/j.neuropharm.2005.01.019&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0172">
<span class="label">172.</span><cite>
Kleschevnikov A. M., Belichenko P. V., Faizi M., et al., “Deficits in Cognition and Synaptic Plasticity in a Mouse Model of Down syndrome Ameliorated by GABAB Receptor Antagonists,” Journal of Neuroscience
32, no. 27 (2012): 9217–9227.
</cite> [<a href="https://doi.org/10.1523/JNEUROSCI.1673-12.2012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3411326/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22764230/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Neuroscience&amp;title=Deficits%20in%20Cognition%20and%20Synaptic%20Plasticity%20in%20a%20Mouse%20Model%20of%20Down%20syndrome%20Ameliorated%20by%20GABAB%20Receptor%20Antagonists&amp;author=A.%20M.%20Kleschevnikov&amp;author=P.%20V.%20Belichenko&amp;author=M.%20Faizi&amp;volume=32&amp;issue=27&amp;publication_year=2012&amp;pages=9217-9227&amp;pmid=22764230&amp;doi=10.1523/JNEUROSCI.1673-12.2012&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0173">
<span class="label">173.</span><cite>
Kleschevnikov A. M., Belichenko P. V., Gall J., et al., “Increased Efficiency of the GABAA and GABAB Receptor‐mediated Neurotransmission in the Ts65Dn Mouse Model of Down syndrome,” Neurobiology of Disease
45, no. 2 (2012): 683–691.
</cite> [<a href="https://doi.org/10.1016/j.nbd.2011.10.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3259223/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22062771/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurobiology%20of%20Disease&amp;title=Increased%20Efficiency%20of%20the%20GABAA%20and%20GABAB%20Receptor%E2%80%90mediated%20Neurotransmission%20in%20the%20Ts65Dn%20Mouse%20Model%20of%20Down%20syndrome&amp;author=A.%20M.%20Kleschevnikov&amp;author=P.%20V.%20Belichenko&amp;author=J.%20Gall&amp;volume=45&amp;issue=2&amp;publication_year=2012&amp;pages=683-691&amp;pmid=22062771&amp;doi=10.1016/j.nbd.2011.10.009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0174">
<span class="label">174.</span><cite>
Jiang S., Xiao L., Sun Y., et al., “The GABAB Receptor Agonist STX209 Reverses the Autism‑Like Behaviour in an Animal Model of Autism Induced by Prenatal Exposure to Valproic Acid,” Molecular Medicine Reports
25, no. 5 (2022).</cite> [<a href="https://doi.org/10.3892/mmr.2022.12670" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8941376/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35244195/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20Medicine%20Reports&amp;title=The%20GABAB%20Receptor%20Agonist%20STX209%20Reverses%20the%20Autism%E2%80%91Like%20Behaviour%20in%20an%20Animal%20Model%20of%20Autism%20Induced%20by%20Prenatal%20Exposure%20to%20Valproic%20Acid&amp;author=S.%20Jiang&amp;author=L.%20Xiao&amp;author=Y.%20Sun&amp;volume=25&amp;issue=5&amp;publication_year=2022&amp;pmid=35244195&amp;doi=10.3892/mmr.2022.12670&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0175">
<span class="label">175.</span><cite>
Jiang S., He M., Xiao L., et al., “Prenatal GABAB Receptor Agonist Administration Corrects the Inheritance of Autism‐Like Core Behaviors in Offspring of Mice Prenatally Exposed to Valproic Acid,” Front Psychiatry
13 (2022): 835993.
</cite> [<a href="https://doi.org/10.3389/fpsyt.2022.835993" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9051083/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35492716/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Psychiatry&amp;title=Prenatal%20GABAB%20Receptor%20Agonist%20Administration%20Corrects%20the%20Inheritance%20of%20Autism%E2%80%90Like%20Core%20Behaviors%20in%20Offspring%20of%20Mice%20Prenatally%20Exposed%20to%20Valproic%20Acid&amp;author=S.%20Jiang&amp;author=M.%20He&amp;author=L.%20Xiao&amp;volume=13&amp;publication_year=2022&amp;pages=835993&amp;pmid=35492716&amp;doi=10.3389/fpsyt.2022.835993&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0176">
<span class="label">176.</span><cite>
Silverman J. L., Pride M. C., Hayes J. E., et al., “GABAB Receptor Agonist R‐Baclofen Reverses Social Deficits and Reduces Repetitive Behavior in Two Mouse Models of Autism,” Neuropsychopharmacology
40, no. 9 (2015): 2228–2239.
</cite> [<a href="https://doi.org/10.1038/npp.2015.66" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4613612/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25754761/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuropsychopharmacology&amp;title=GABAB%20Receptor%20Agonist%20R%E2%80%90Baclofen%20Reverses%20Social%20Deficits%20and%20Reduces%20Repetitive%20Behavior%20in%20Two%20Mouse%20Models%20of%20Autism&amp;author=J.%20L.%20Silverman&amp;author=M.%20C.%20Pride&amp;author=J.%20E.%20Hayes&amp;volume=40&amp;issue=9&amp;publication_year=2015&amp;pages=2228-2239&amp;pmid=25754761&amp;doi=10.1038/npp.2015.66&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0177">
<span class="label">177.</span><cite>
Born G., Breuer D., Wang S., et al., “Modulation of Synaptic Function Through the α‐neurexin‐specific Ligand Neurexophilin‐1,” PNAS
111, no. 13 (2014): E1274–1283.
</cite> [<a href="https://doi.org/10.1073/pnas.1312112111" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3977266/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24639499/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PNAS&amp;title=Modulation%20of%20Synaptic%20Function%20Through%20the%20%CE%B1%E2%80%90neurexin%E2%80%90specific%20Ligand%20Neurexophilin%E2%80%901&amp;author=G.%20Born&amp;author=D.%20Breuer&amp;author=S.%20Wang&amp;volume=111&amp;issue=13&amp;publication_year=2014&amp;pages=E1274-1283&amp;pmid=24639499&amp;doi=10.1073/pnas.1312112111&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0178">
<span class="label">178.</span><cite>
Merlo D., Mollinari C., Inaba Y., et al., “Reduced GABAB Receptor Subunit Expression and Paired‐pulse Depression in a Genetic Model of Absence Seizures,” Neurobiology of Disease
25, no. 3 (2007): 631–641.
</cite> [<a href="https://doi.org/10.1016/j.nbd.2006.11.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17207629/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurobiology%20of%20Disease&amp;title=Reduced%20GABAB%20Receptor%20Subunit%20Expression%20and%20Paired%E2%80%90pulse%20Depression%20in%20a%20Genetic%20Model%20of%20Absence%20Seizures&amp;author=D.%20Merlo&amp;author=C.%20Mollinari&amp;author=Y.%20Inaba&amp;volume=25&amp;issue=3&amp;publication_year=2007&amp;pages=631-641&amp;pmid=17207629&amp;doi=10.1016/j.nbd.2006.11.005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0179">
<span class="label">179.</span><cite>
Zhou Y. D., Turner T. J., and Dunlap K., “Enhanced G Protein‐dependent Modulation of Excitatory Synaptic Transmission in the Cerebellum of the Ca2+ Channel‐mutant Mouse, Tottering,” The Journal of Physiology
547, no. Pt 2 (2003): 497–507.
</cite> [<a href="https://doi.org/10.1113/jphysiol.2002.033415" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2342657/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12562906/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=The%20Journal%20of%20Physiology&amp;title=Enhanced%20G%20Protein%E2%80%90dependent%20Modulation%20of%20Excitatory%20Synaptic%20Transmission%20in%20the%20Cerebellum%20of%20the%20Ca2+%20Channel%E2%80%90mutant%20Mouse,%20Tottering&amp;author=Y.%20D.%20Zhou&amp;author=T.%20J.%20Turner&amp;author=K.%20Dunlap&amp;volume=547&amp;issue=Pt%202&amp;publication_year=2003&amp;pages=497-507&amp;pmid=12562906&amp;doi=10.1113/jphysiol.2002.033415&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0180">
<span class="label">180.</span><cite>
Minere M., Mortensen M., Dorovykh V., et al., “Presynaptic Hyperexcitability Reversed by Positive Allosteric Modulation of a GABABR Epilepsy Variant,” Brain (2024).</cite> [<a href="https://doi.org/10.1093/brain/awae232" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11788220/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39028675/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Brain&amp;title=Presynaptic%20Hyperexcitability%20Reversed%20by%20Positive%20Allosteric%20Modulation%20of%20a%20GABABR%20Epilepsy%20Variant&amp;author=M.%20Minere&amp;author=M.%20Mortensen&amp;author=V.%20Dorovykh&amp;publication_year=2024&amp;pmid=39028675&amp;doi=10.1093/brain/awae232&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0181">
<span class="label">181.</span><cite>
Salvati K. A., Ritger M. L., Davoudian P. A., et al., “AMPK‐mediated Potentiation of GABAergic Signalling Drives Hypoglycaemia‐provoked Spike‐wave Seizures,” Brain
145, no. 7 (2022): 2332–2346.
</cite> [<a href="https://doi.org/10.1093/brain/awac037" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9337815/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35134125/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Brain&amp;title=AMPK%E2%80%90mediated%20Potentiation%20of%20GABAergic%20Signalling%20Drives%20Hypoglycaemia%E2%80%90provoked%20Spike%E2%80%90wave%20Seizures&amp;author=K.%20A.%20Salvati&amp;author=M.%20L.%20Ritger&amp;author=P.%20A.%20Davoudian&amp;volume=145&amp;issue=7&amp;publication_year=2022&amp;pages=2332-2346&amp;pmid=35134125&amp;doi=10.1093/brain/awac037&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0182">
<span class="label">182.</span><cite>
Huang A., Wang J., Feng D. P., Wang W., and Li X., “Case Analysis and Literature Review of Thirteen Patients With Autoimmune Encephalitis,” Disease Markers
2022 (2022): 4802480.
</cite> [<a href="https://doi.org/10.1155/2022/4802480" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8808122/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35126787/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Disease%20Markers&amp;title=Case%20Analysis%20and%20Literature%20Review%20of%20Thirteen%20Patients%20With%20Autoimmune%20Encephalitis&amp;author=A.%20Huang&amp;author=J.%20Wang&amp;author=D.%20P.%20Feng&amp;author=W.%20Wang&amp;author=X.%20Li&amp;volume=2022&amp;publication_year=2022&amp;pages=4802480&amp;pmid=35126787&amp;doi=10.1155/2022/4802480&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0183">
<span class="label">183.</span><cite>
Maureille A., Fenouil T., Joubert B., et al., “Isolated Seizures Are a Common Early Feature of Paraneoplastic Anti‐GABA(B) Receptor Encephalitis,” Journal of Neurology
266, no. 1 (2019): 195–206.
</cite> [<a href="https://doi.org/10.1007/s00415-018-9132-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30460450/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Neurology&amp;title=Isolated%20Seizures%20Are%20a%20Common%20Early%20Feature%20of%20Paraneoplastic%20Anti%E2%80%90GABA(B)%20Receptor%20Encephalitis&amp;author=A.%20Maureille&amp;author=T.%20Fenouil&amp;author=B.%20Joubert&amp;volume=266&amp;issue=1&amp;publication_year=2019&amp;pages=195-206&amp;pmid=30460450&amp;doi=10.1007/s00415-018-9132-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0184">
<span class="label">184.</span><cite>
Benke D., “GABAB Receptor Trafficking and Interacting Proteins: Targets for the Development of Highly Specific Therapeutic Strategies to Treat Neurological Disorders?,” Biochemical Pharmacology
86, no. 11 (2013): 1525–1530.
</cite> [<a href="https://doi.org/10.1016/j.bcp.2013.09.016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24084431/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochemical%20Pharmacology&amp;title=GABAB%20Receptor%20Trafficking%20and%20Interacting%20Proteins:%20Targets%20for%20the%20Development%20of%20Highly%20Specific%20Therapeutic%20Strategies%20to%20Treat%20Neurological%20Disorders?&amp;author=D.%20Benke&amp;volume=86&amp;issue=11&amp;publication_year=2013&amp;pages=1525-1530&amp;pmid=24084431&amp;doi=10.1016/j.bcp.2013.09.016&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0185">
<span class="label">185.</span><cite>
Enna S. J. and McCarson K. E., “The Role of GABA in the Mediation and Perception of Pain,” Advances in Pharmacology
54 (2006): 1–27.
</cite> [<a href="https://doi.org/10.1016/s1054-3589(06)54001-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17175808/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Advances%20in%20Pharmacology&amp;title=The%20Role%20of%20GABA%20in%20the%20Mediation%20and%20Perception%20of%20Pain&amp;author=S.%20J.%20Enna&amp;author=K.%20E.%20McCarson&amp;volume=54&amp;publication_year=2006&amp;pages=1-27&amp;pmid=17175808&amp;doi=10.1016/s1054-3589(06)54001-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0186">
<span class="label">186.</span><cite>
Bai H. P., Liu P., Wu Y. M., Guo W. Y., Guo Y. X., and Wang X. L., “Activation of Spinal GABAB Receptors Normalizes N‐methyl‐D‐aspartate Receptor in Diabetic Neuropathy,” Journal of the Neurological Sciences
341, no. 1‐2 (2014): 68–72.
</cite> [<a href="https://doi.org/10.1016/j.jns.2014.04.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24787504/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20the%20Neurological%20Sciences&amp;title=Activation%20of%20Spinal%20GABAB%20Receptors%20Normalizes%20N%E2%80%90methyl%E2%80%90D%E2%80%90aspartate%20Receptor%20in%20Diabetic%20Neuropathy&amp;author=H.%20P.%20Bai&amp;author=P.%20Liu&amp;author=Y.%20M.%20Wu&amp;author=W.%20Y.%20Guo&amp;author=Y.%20X.%20Guo&amp;volume=341&amp;issue=1%E2%80%902&amp;publication_year=2014&amp;pages=68-72&amp;pmid=24787504&amp;doi=10.1016/j.jns.2014.04.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0187">
<span class="label">187.</span><cite>
Wang X. L., Zhang H. M., Chen S. R., and Pan H. L., “Altered Synaptic Input and GABAB Receptor Function in Spinal Superficial Dorsal Horn Neurons in Rats With Diabetic Neuropathy,” The Journal of Physiology
579, no. Pt 3 (2007): 849–861.
</cite> [<a href="https://doi.org/10.1113/jphysiol.2006.126102" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2151355/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17218355/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=The%20Journal%20of%20Physiology&amp;title=Altered%20Synaptic%20Input%20and%20GABAB%20Receptor%20Function%20in%20Spinal%20Superficial%20Dorsal%20Horn%20Neurons%20in%20Rats%20With%20Diabetic%20Neuropathy&amp;author=X.%20L.%20Wang&amp;author=H.%20M.%20Zhang&amp;author=S.%20R.%20Chen&amp;author=H.%20L.%20Pan&amp;volume=579&amp;issue=Pt%203&amp;publication_year=2007&amp;pages=849-861&amp;pmid=17218355&amp;doi=10.1113/jphysiol.2006.126102&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0188">
<span class="label">188.</span><cite>
Sands S. A., McCarson K. E., and Enna S. J., “Relationship Between the Antinociceptive Response to Desipramine and Changes in GABAB Receptor Function and Subunit Expression in the Dorsal Horn of the Rat Spinal Cord,” Biochemical Pharmacology
67, no. 4 (2004): 743–749.
</cite> [<a href="https://doi.org/10.1016/j.bcp.2003.10.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14757174/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochemical%20Pharmacology&amp;title=Relationship%20Between%20the%20Antinociceptive%20Response%20to%20Desipramine%20and%20Changes%20in%20GABAB%20Receptor%20Function%20and%20Subunit%20Expression%20in%20the%20Dorsal%20Horn%20of%20the%20Rat%20Spinal%20Cord&amp;author=S.%20A.%20Sands&amp;author=K.%20E.%20McCarson&amp;author=S.%20J.%20Enna&amp;volume=67&amp;issue=4&amp;publication_year=2004&amp;pages=743-749&amp;pmid=14757174&amp;doi=10.1016/j.bcp.2003.10.008&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0189">
<span class="label">189.</span><cite>
Takeda M., Tanimoto T., Ikeda M., Kadoi J., and Matsumoto S., “Activaton of GABAB Receptor Inhibits the Excitability of Rat Small Diameter Trigeminal Root Ganglion Neurons,” Neuroscience
123, no. 2 (2004): 491–505.
</cite> [<a href="https://doi.org/10.1016/j.neuroscience.2003.09.022" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14698756/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuroscience&amp;title=Activaton%20of%20GABAB%20Receptor%20Inhibits%20the%20Excitability%20of%20Rat%20Small%20Diameter%20Trigeminal%20Root%20Ganglion%20Neurons&amp;author=M.%20Takeda&amp;author=T.%20Tanimoto&amp;author=M.%20Ikeda&amp;author=J.%20Kadoi&amp;author=S.%20Matsumoto&amp;volume=123&amp;issue=2&amp;publication_year=2004&amp;pages=491-505&amp;pmid=14698756&amp;doi=10.1016/j.neuroscience.2003.09.022&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0190">
<span class="label">190.</span><cite>
Mueller A., Starobova H., Morgan M., et al., “Antiallodynic Effects of the Selective NaV1.7 Inhibitor Pn3a in a Mouse Model of Acute Postsurgical Pain: Evidence for Analgesic Synergy With Opioids and Baclofen,” Pain
160, no. 8 (2019): 1766–1780.
</cite> [<a href="https://doi.org/10.1097/j.pain.0000000000001567" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31335646/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pain&amp;title=Antiallodynic%20Effects%20of%20the%20Selective%20NaV1.7%20Inhibitor%20Pn3a%20in%20a%20Mouse%20Model%20of%20Acute%20Postsurgical%20Pain:%20Evidence%20for%20Analgesic%20Synergy%20With%20Opioids%20and%20Baclofen&amp;author=A.%20Mueller&amp;author=H.%20Starobova&amp;author=M.%20Morgan&amp;volume=160&amp;issue=8&amp;publication_year=2019&amp;pages=1766-1780&amp;pmid=31335646&amp;doi=10.1097/j.pain.0000000000001567&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0191">
<span class="label">191.</span><cite>
Masocha W., Kombian S. B., and Edafiogho I. O., “Evaluation of the Antinociceptive Activities of Enaminone Compounds on the Formalin and Hot Plate Tests in Mice,” Scientific Reports
6 (2016): 21582.
</cite> [<a href="https://doi.org/10.1038/srep21582" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4768266/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26916642/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Scientific%20Reports&amp;title=Evaluation%20of%20the%20Antinociceptive%20Activities%20of%20Enaminone%20Compounds%20on%20the%20Formalin%20and%20Hot%20Plate%20Tests%20in%20Mice&amp;author=W.%20Masocha&amp;author=S.%20B.%20Kombian&amp;author=I.%20O.%20Edafiogho&amp;volume=6&amp;publication_year=2016&amp;pages=21582&amp;pmid=26916642&amp;doi=10.1038/srep21582&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0192">
<span class="label">192.</span><cite>
Yudin Y. and Rohacs T., “Inhibitory G(i/O)‐coupled Receptors in Somatosensory Neurons: Potential Therapeutic Targets for Novel Analgesics,” Molecular Pain
14 (2018): 1744806918763646.
</cite> [<a href="https://doi.org/10.1177/1744806918763646" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5882016/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29580154/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20Pain&amp;title=Inhibitory%20G(i/O)%E2%80%90coupled%20Receptors%20in%20Somatosensory%20Neurons:%20Potential%20Therapeutic%20Targets%20for%20Novel%20Analgesics&amp;author=Y.%20Yudin&amp;author=T.%20Rohacs&amp;volume=14&amp;publication_year=2018&amp;pages=1744806918763646&amp;pmid=29580154&amp;doi=10.1177/1744806918763646&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0193">
<span class="label">193.</span><cite>
Hartemann A., Attal N., Bouhassira D., et al., “Painful Diabetic Neuropathy: Diagnosis and Management,” Diabetes &amp; Metabolism
37, no. 5 (2011): 377–388.
</cite> [<a href="https://doi.org/10.1016/j.diabet.2011.06.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21820345/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20&amp;%20Metabolism&amp;title=Painful%20Diabetic%20Neuropathy:%20Diagnosis%20and%20Management&amp;author=A.%20Hartemann&amp;author=N.%20Attal&amp;author=D.%20Bouhassira&amp;volume=37&amp;issue=5&amp;publication_year=2011&amp;pages=377-388&amp;pmid=21820345&amp;doi=10.1016/j.diabet.2011.06.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0194">
<span class="label">194.</span><cite>
Lee‐Kubli C. A., Zhou X., Jolivalt C. G., and Calcutt N. A., “Pharmacological Modulation of Rate‐Dependent Depression of the Spinal H‐Reflex Predicts Therapeutic Efficacy Against Painful Diabetic Neuropathy,” Diagnostics (Basel)
11, no. 2 (2021): 283.
</cite> [<a href="https://doi.org/10.3390/diagnostics11020283" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7917809/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33670344/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diagnostics%20(Basel)&amp;title=Pharmacological%20Modulation%20of%20Rate%E2%80%90Dependent%20Depression%20of%20the%20Spinal%20H%E2%80%90Reflex%20Predicts%20Therapeutic%20Efficacy%20Against%20Painful%20Diabetic%20Neuropathy&amp;author=C.%20A.%20Lee%E2%80%90Kubli&amp;author=X.%20Zhou&amp;author=C.%20G.%20Jolivalt&amp;author=N.%20A.%20Calcutt&amp;volume=11&amp;issue=2&amp;publication_year=2021&amp;pages=283&amp;pmid=33670344&amp;doi=10.3390/diagnostics11020283&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0195">
<span class="label">195.</span><cite>
Liu P., Guo W. Y., Zhao X. N., et al., “Intrathecal Baclofen, a GABAB Receptor Agonist, Inhibits the Expression of p‐CREB and NR2B in the Spinal Dorsal Horn in Rats With Diabetic Neuropathic Pain,” Canadian Journal of Physiology and Pharmacology
92, no. 8 (2014): 655–660.
</cite> [<a href="https://doi.org/10.1139/cjpp-2013-0463" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24988216/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Canadian%20Journal%20of%20Physiology%20and%20Pharmacology&amp;title=Intrathecal%20Baclofen,%20a%20GABAB%20Receptor%20Agonist,%20Inhibits%20the%20Expression%20of%20p%E2%80%90CREB%20and%20NR2B%20in%20the%20Spinal%20Dorsal%20Horn%20in%20Rats%20With%20Diabetic%20Neuropathic%20Pain&amp;author=P.%20Liu&amp;author=W.%20Y.%20Guo&amp;author=X.%20N.%20Zhao&amp;volume=92&amp;issue=8&amp;publication_year=2014&amp;pages=655-660&amp;pmid=24988216&amp;doi=10.1139/cjpp-2013-0463&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0196">
<span class="label">196.</span><cite>
McPherson K. B., Leff E. R., Li M. H., et al., “Regulators of G‐Protein Signaling (RGS) Proteins Promote Receptor Coupling to G‐Protein‐Coupled Inwardly Rectifying Potassium (GIRK) Channels,” Journal of Neuroscience
38, no. 41 (2018): 8737–8744.
</cite> [<a href="https://doi.org/10.1523/JNEUROSCI.0516-18.2018" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6181307/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30150362/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Neuroscience&amp;title=Regulators%20of%20G%E2%80%90Protein%20Signaling%20(RGS)%20Proteins%20Promote%20Receptor%20Coupling%20to%20G%E2%80%90Protein%E2%80%90Coupled%20Inwardly%20Rectifying%20Potassium%20(GIRK)%20Channels&amp;author=K.%20B.%20McPherson&amp;author=E.%20R.%20Leff&amp;author=M.%20H.%20Li&amp;volume=38&amp;issue=41&amp;publication_year=2018&amp;pages=8737-8744&amp;pmid=30150362&amp;doi=10.1523/JNEUROSCI.0516-18.2018&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0197">
<span class="label">197.</span><cite>
Yousuf A., Wu X., Bony A. R., et al., “ɑO‐Conotoxin GeXIVA Isomers Modulate N‐type Calcium (Ca(V) 2.2) Channels and Inwardly‐rectifying Potassium (GIRK) Channels via GABA(B) Receptor Activation,” Journal of Neurochemistry
160, no. 2 (2022): 154–171.
</cite> [<a href="https://doi.org/10.1111/jnc.15535" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34738241/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Neurochemistry&amp;title=%C9%91O%E2%80%90Conotoxin%20GeXIVA%20Isomers%20Modulate%20N%E2%80%90type%20Calcium%20(Ca(V)%202.2)%20Channels%20and%20Inwardly%E2%80%90rectifying%20Potassium%20(GIRK)%20Channels%20via%20GABA(B)%20Receptor%20Activation&amp;author=A.%20Yousuf&amp;author=X.%20Wu&amp;author=A.%20R.%20Bony&amp;volume=160&amp;issue=2&amp;publication_year=2022&amp;pages=154-171&amp;pmid=34738241&amp;doi=10.1111/jnc.15535&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0198">
<span class="label">198.</span><cite>
Huang D., Huang S., Peers C., Du X., Zhang H., and Gamper N., “GABAB Receptors Inhibit Low‐voltage Activated and High‐voltage Activated Ca(2+) Channels in Sensory Neurons via Distinct Mechanisms,” Biochemical and Biophysical Research Communications
465, no. 2 (2015): 188–193.
</cite> [<a href="https://doi.org/10.1016/j.bbrc.2015.07.137" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26239659/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochemical%20and%20Biophysical%20Research%20Communications&amp;title=GABAB%20Receptors%20Inhibit%20Low%E2%80%90voltage%20Activated%20and%20High%E2%80%90voltage%20Activated%20Ca(2+)%20Channels%20in%20Sensory%20Neurons%20via%20Distinct%20Mechanisms&amp;author=D.%20Huang&amp;author=S.%20Huang&amp;author=C.%20Peers&amp;author=X.%20Du&amp;author=H.%20Zhang&amp;volume=465&amp;issue=2&amp;publication_year=2015&amp;pages=188-193&amp;pmid=26239659&amp;doi=10.1016/j.bbrc.2015.07.137&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0199">
<span class="label">199.</span><cite>
Huynh T. G., Cuny H., Slesinger P. A., and Adams D. J., “Novel Mechanism of Voltage‐gated N‐type (Cav2.2) Calcium Channel Inhibition Revealed Through α‐conotoxin Vc1.1 Activation of the GABA(B) Receptor,” Molecular Pharmacology
87, no. 2 (2015): 240–250.
</cite> [<a href="https://doi.org/10.1124/mol.114.096156" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25425625/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20Pharmacology&amp;title=Novel%20Mechanism%20of%20Voltage%E2%80%90gated%20N%E2%80%90type%20(Cav2.2)%20Calcium%20Channel%20Inhibition%20Revealed%20Through%20%CE%B1%E2%80%90conotoxin%20Vc1.1%20Activation%20of%20the%20GABA(B)%20Receptor&amp;author=T.%20G.%20Huynh&amp;author=H.%20Cuny&amp;author=P.%20A.%20Slesinger&amp;author=D.%20J.%20Adams&amp;volume=87&amp;issue=2&amp;publication_year=2015&amp;pages=240-250&amp;pmid=25425625&amp;doi=10.1124/mol.114.096156&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0200">
<span class="label">200.</span><cite>
Kapolka N. J. and Roth B. L., “Built‐in Functional Selectivity in Neurons Is Mediated by the Neuronal Protein, GINIP,” Molecular Cell
83, no. 14 (2023): 2392–2394.
</cite> [<a href="https://doi.org/10.1016/j.molcel.2023.06.034" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37478823/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20Cell&amp;title=Built%E2%80%90in%20Functional%20Selectivity%20in%20Neurons%20Is%20Mediated%20by%20the%20Neuronal%20Protein,%20GINIP&amp;author=N.%20J.%20Kapolka&amp;author=B.%20L.%20Roth&amp;volume=83&amp;issue=14&amp;publication_year=2023&amp;pages=2392-2394&amp;pmid=37478823&amp;doi=10.1016/j.molcel.2023.06.034&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0201">
<span class="label">201.</span><cite>
Park J. C., Luebbers A., Dao M., et al., “Fine‐tuning GPCR‐mediated Neuromodulation by Biasing Signaling Through Different G Protein Subunits,” Molecular Cell
83, no. 14 (2023): 2540–2558. e12.
</cite> [<a href="https://doi.org/10.1016/j.molcel.2023.06.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10527995/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37390816/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20Cell&amp;title=Fine%E2%80%90tuning%20GPCR%E2%80%90mediated%20Neuromodulation%20by%20Biasing%20Signaling%20Through%20Different%20G%20Protein%20Subunits&amp;author=J.%20C.%20Park&amp;author=A.%20Luebbers&amp;author=M.%20Dao&amp;volume=83&amp;issue=14&amp;publication_year=2023&amp;pages=2540-2558&amp;pmid=37390816&amp;doi=10.1016/j.molcel.2023.06.006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0202">
<span class="label">202.</span><cite>
Philibert C. E. and Garcia‐Marcos M., “Smooth Operator(s): Dialing up and Down Neurotransmitter Responses by G‐protein Regulators,” Trends in Cell Biology (2024).</cite> [<a href="https://doi.org/10.1016/j.tcb.2024.07.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11757802/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39054106/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Trends%20in%20Cell%20Biology&amp;title=Smooth%20Operator(s):%20Dialing%20up%20and%20Down%20Neurotransmitter%20Responses%20by%20G%E2%80%90protein%20Regulators&amp;author=C.%20E.%20Philibert&amp;author=M.%20Garcia%E2%80%90Marcos&amp;publication_year=2024&amp;pmid=39054106&amp;doi=10.1016/j.tcb.2024.07.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0203">
<span class="label">203.</span><cite>
Gaillard S., Lo Re L., Mantilleri A., et al., “GINIP, a Gαi‐interacting Protein, Functions as a Key Modulator of Peripheral GABAB Receptor‐mediated Analgesia,” Neuron
84, no. 1 (2014): 123–136.
</cite> [<a href="https://doi.org/10.1016/j.neuron.2014.08.056" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7348640/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25242222/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuron&amp;title=GINIP,%20a%20G%CE%B1i%E2%80%90interacting%20Protein,%20Functions%20as%20a%20Key%20Modulator%20of%20Peripheral%20GABAB%20Receptor%E2%80%90mediated%20Analgesia&amp;author=S.%20Gaillard&amp;author=L.%20Lo%20Re&amp;author=A.%20Mantilleri&amp;volume=84&amp;issue=1&amp;publication_year=2014&amp;pages=123-136&amp;pmid=25242222&amp;doi=10.1016/j.neuron.2014.08.056&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0204">
<span class="label">204.</span><cite>
Jorgensen C., Darré L., Oakes V., Torella R., Pryde D., and Domene C., “Lateral Fenestrations in K(+)‐Channels Explored Using Molecular Dynamics Simulations,” Molecular Pharmaceutics
13, no. 7 (2016): 2263–2273.
</cite> [<a href="https://doi.org/10.1021/acs.molpharmaceut.5b00942" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27173896/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20Pharmaceutics&amp;title=Lateral%20Fenestrations%20in%20K(+)%E2%80%90Channels%20Explored%20Using%20Molecular%20Dynamics%20Simulations&amp;author=C.%20Jorgensen&amp;author=L.%20Darr%C3%A9&amp;author=V.%20Oakes&amp;author=R.%20Torella&amp;author=D.%20Pryde&amp;volume=13&amp;issue=7&amp;publication_year=2016&amp;pages=2263-2273&amp;pmid=27173896&amp;doi=10.1021/acs.molpharmaceut.5b00942&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0205">
<span class="label">205.</span><cite>
Chang Y. T., Ling J., and Gu J. G., “Effects of GABA(B) Receptor Activation on Excitability of IB4‐positive Maxillary Trigeminal Ganglion Neurons: Possible Involvement of TREK2 Activation,” Molecular Pain
17 (2021): 17448069211042963.
</cite> [<a href="https://doi.org/10.1177/17448069211042963" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8411610/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34461754/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20Pain&amp;title=Effects%20of%20GABA(B)%20Receptor%20Activation%20on%20Excitability%20of%20IB4%E2%80%90positive%20Maxillary%20Trigeminal%20Ganglion%20Neurons:%20Possible%20Involvement%20of%20TREK2%20Activation&amp;author=Y.%20T.%20Chang&amp;author=J.%20Ling&amp;author=J.%20G.%20Gu&amp;volume=17&amp;publication_year=2021&amp;pages=17448069211042963&amp;pmid=34461754&amp;doi=10.1177/17448069211042963&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0206">
<span class="label">206.</span><cite>
Papon M. A., Le Feuvre Y., Barreda‐Gómez G., et al., “Spinal Inhibition of GABAB Receptors by the Extracellular Matrix Protein Fibulin‐2 in Neuropathic Rats,” Frontiers in Cellular Neuroscience
14 (2020): 214.
</cite> [<a href="https://doi.org/10.3389/fncel.2020.00214" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7378325/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32765223/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Cellular%20Neuroscience&amp;title=Spinal%20Inhibition%20of%20GABAB%20Receptors%20by%20the%20Extracellular%20Matrix%20Protein%20Fibulin%E2%80%902%20in%20Neuropathic%20Rats&amp;author=M.%20A.%20Papon&amp;author=Y.%20Le%20Feuvre&amp;author=G.%20Barreda%E2%80%90G%C3%B3mez&amp;volume=14&amp;publication_year=2020&amp;pages=214&amp;pmid=32765223&amp;doi=10.3389/fncel.2020.00214&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0207">
<span class="label">207.</span><cite>
Laffray S., Bouali‐Benazzouz R., Papon M. A., et al., “Impairment of GABAB Receptor Dimer by Endogenous 14‐3‐3ζ in Chronic Pain Conditions,” Embo Journal
31, no. 15 (2012): 3239–3251.
</cite> [<a href="https://doi.org/10.1038/emboj.2012.161" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3411072/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22692127/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Embo%20Journal&amp;title=Impairment%20of%20GABAB%20Receptor%20Dimer%20by%20Endogenous%2014%E2%80%903%E2%80%903%CE%B6%20in%20Chronic%20Pain%20Conditions&amp;author=S.%20Laffray&amp;author=R.%20Bouali%E2%80%90Benazzouz&amp;author=M.%20A.%20Papon&amp;volume=31&amp;issue=15&amp;publication_year=2012&amp;pages=3239-3251&amp;pmid=22692127&amp;doi=10.1038/emboj.2012.161&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0208">
<span class="label">208.</span><cite>
Malan T. P., Mata H. P., and Porreca F., “Spinal GABA(A) and GABA(B) Receptor Pharmacology in a Rat Model of Neuropathic Pain,” Anesthesiology
96, no. 5 (2002): 1161–1167.
</cite> [<a href="https://doi.org/10.1097/00000542-200205000-00020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11981157/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Anesthesiology&amp;title=Spinal%20GABA(A)%20and%20GABA(B)%20Receptor%20Pharmacology%20in%20a%20Rat%20Model%20of%20Neuropathic%20Pain&amp;author=T.%20P.%20Malan&amp;author=H.%20P.%20Mata&amp;author=F.%20Porreca&amp;volume=96&amp;issue=5&amp;publication_year=2002&amp;pages=1161-1167&amp;pmid=11981157&amp;doi=10.1097/00000542-200205000-00020&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0209">
<span class="label">209.</span><cite>
Akada Y., Mori R., Kato Y., Yamasaki F., and Mochizuki H., “Analgesic Properties of the Novel Compound M43068 in Rat Models of Acute and Neuropathic Pain,” European Journal of Pharmacology
523, no. 1‐3 (2005): 46–53.
</cite> [<a href="https://doi.org/10.1016/j.ejphar.2005.09.016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16226249/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Journal%20of%20Pharmacology&amp;title=Analgesic%20Properties%20of%20the%20Novel%20Compound%20M43068%20in%20Rat%20Models%20of%20Acute%20and%20Neuropathic%20Pain&amp;author=Y.%20Akada&amp;author=R.%20Mori&amp;author=Y.%20Kato&amp;author=F.%20Yamasaki&amp;author=H.%20Mochizuki&amp;volume=523&amp;issue=1%E2%80%903&amp;publication_year=2005&amp;pages=46-53&amp;pmid=16226249&amp;doi=10.1016/j.ejphar.2005.09.016&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0210">
<span class="label">210.</span><cite>
Petty F., “GABA and Mood Disorders: A Brief Review and Hypothesis,” Journal of Affective Disorders
34, no. 4 (1995): 275–281.
</cite> [<a href="https://doi.org/10.1016/0165-0327(95)00025-i" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8550953/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Affective%20Disorders&amp;title=GABA%20and%20Mood%20Disorders:%20A%20Brief%20Review%20and%20Hypothesis&amp;author=F.%20Petty&amp;volume=34&amp;issue=4&amp;publication_year=1995&amp;pages=275-281&amp;pmid=8550953&amp;doi=10.1016/0165-0327(95)00025-i&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0211">
<span class="label">211.</span><cite>
Monteleone P., Maj M., Iovino M., and Steardo L., “GABA, Depression and the Mechanism of Action of Antidepressant Drugs: A Neuroendocrine Approach,” Journal of Affective Disorders
20, no. 1 (1990): 1–5.
</cite> [<a href="https://doi.org/10.1016/0165-0327(90)90043-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/2174069/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Affective%20Disorders&amp;title=GABA,%20Depression%20and%20the%20Mechanism%20of%20Action%20of%20Antidepressant%20Drugs:%20A%20Neuroendocrine%20Approach&amp;author=P.%20Monteleone&amp;author=M.%20Maj&amp;author=M.%20Iovino&amp;author=L.%20Steardo&amp;volume=20&amp;issue=1&amp;publication_year=1990&amp;pages=1-5&amp;pmid=2174069&amp;doi=10.1016/0165-0327(90)90043-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0212">
<span class="label">212.</span><cite>
Kumar K., Sharma S., Kumar P., and Deshmukh R., “Therapeutic Potential of GABA(B) Receptor Ligands in Drug Addiction, Anxiety, Depression and Other CNS Disorders,” Pharmacology Biochemistry and Behavior
110 (2013): 174–184.
</cite> [<a href="https://doi.org/10.1016/j.pbb.2013.07.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23872369/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacology%20Biochemistry%20and%20Behavior&amp;title=Therapeutic%20Potential%20of%20GABA(B)%20Receptor%20Ligands%20in%20Drug%20Addiction,%20Anxiety,%20Depression%20and%20Other%20CNS%20Disorders&amp;author=K.%20Kumar&amp;author=S.%20Sharma&amp;author=P.%20Kumar&amp;author=R.%20Deshmukh&amp;volume=110&amp;publication_year=2013&amp;pages=174-184&amp;pmid=23872369&amp;doi=10.1016/j.pbb.2013.07.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0213">
<span class="label">213.</span><cite>
Felice D., Cryan J. F., and O'Leary O. F., “GABA(B) Receptors: Anxiety and Mood Disorders,” Current Topics in Behavioral Neurosciences
52 (2022): 241–265.
</cite> [<a href="https://doi.org/10.1007/7854_2020_171" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32860591/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Current%20Topics%20in%20Behavioral%20Neurosciences&amp;title=GABA(B)%20Receptors:%20Anxiety%20and%20Mood%20Disorders&amp;author=D.%20Felice&amp;author=J.%20F.%20Cryan&amp;author=O.%20F.%20O'Leary&amp;volume=52&amp;publication_year=2022&amp;pages=241-265&amp;pmid=32860591&amp;doi=10.1007/7854_2020_171&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0214">
<span class="label">214.</span><cite>
Mitten E. H., Souders A., Marron Fernandez de Velasco E., and Wickman K., “Stress‐induced Anxiety‐related Behavior in Mice Is Driven by Enhanced Excitability of Ventral Tegmental Area GABA Neurons,” Frontiers in Behavioral Neuroscience
18 (2024): 1425607.
</cite> [<a href="https://doi.org/10.3389/fnbeh.2024.1425607" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11288924/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39086371/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Behavioral%20Neuroscience&amp;title=Stress%E2%80%90induced%20Anxiety%E2%80%90related%20Behavior%20in%20Mice%20Is%20Driven%20by%20Enhanced%20Excitability%20of%20Ventral%20Tegmental%20Area%20GABA%20Neurons&amp;author=E.%20H.%20Mitten&amp;author=A.%20Souders&amp;author=E.%20Marron%20Fernandez%20de%20Velasco&amp;author=K.%20Wickman&amp;volume=18&amp;publication_year=2024&amp;pages=1425607&amp;pmid=39086371&amp;doi=10.3389/fnbeh.2024.1425607&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0215">
<span class="label">215.</span><cite>
Graeff F. G., Brandão M. L., Audi E. A., and Schütz M. T., “Modulation of the Brain Aversive System by GABAergic and Serotonergic Mechanisms,” Behavioural Brain Research
22, no. 2 (1986): 173–180.
</cite> [<a href="https://doi.org/10.1016/0166-4328(86)90038-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/3024664/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Behavioural%20Brain%20Research&amp;title=Modulation%20of%20the%20Brain%20Aversive%20System%20by%20GABAergic%20and%20Serotonergic%20Mechanisms&amp;author=F.%20G.%20Graeff&amp;author=M.%20L.%20Brand%C3%A3o&amp;author=E.%20A.%20Audi&amp;author=M.%20T.%20Sch%C3%BCtz&amp;volume=22&amp;issue=2&amp;publication_year=1986&amp;pages=173-180&amp;pmid=3024664&amp;doi=10.1016/0166-4328(86)90038-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0216">
<span class="label">216.</span><cite>
Calogero A. E., Gallucci W. T., Chrousos G. P., and Gold P. W., “Interaction Between GABAergic Neurotransmission and Rat Hypothalamic Corticotropin‐releasing Hormone Secretion in Vitro,” Brain Research
463, no. 1 (1988): 28–36.
</cite> [<a href="https://doi.org/10.1016/0006-8993(88)90523-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/3264201/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Brain%20Research&amp;title=Interaction%20Between%20GABAergic%20Neurotransmission%20and%20Rat%20Hypothalamic%20Corticotropin%E2%80%90releasing%20Hormone%20Secretion%20in%20Vitro&amp;author=A.%20E.%20Calogero&amp;author=W.%20T.%20Gallucci&amp;author=G.%20P.%20Chrousos&amp;author=P.%20W.%20Gold&amp;volume=463&amp;issue=1&amp;publication_year=1988&amp;pages=28-36&amp;pmid=3264201&amp;doi=10.1016/0006-8993(88)90523-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0217">
<span class="label">217.</span><cite>
Varani A. P., Pedrón V. T., Bettler B., and Balerio G. N., “Involvement of GABAB Receptors in Biochemical Alterations Induced by Anxiety‐related Responses to Nicotine in Mice: Genetic and Pharmacological Approaches,” Neuropharmacology
81 (2014): 31–41.
</cite> [<a href="https://doi.org/10.1016/j.neuropharm.2014.01.030" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24486711/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuropharmacology&amp;title=Involvement%20of%20GABAB%20Receptors%20in%20Biochemical%20Alterations%20Induced%20by%20Anxiety%E2%80%90related%20Responses%20to%20Nicotine%20in%20Mice:%20Genetic%20and%20Pharmacological%20Approaches&amp;author=A.%20P.%20Varani&amp;author=V.%20T.%20Pedr%C3%B3n&amp;author=B.%20Bettler&amp;author=G.%20N.%20Balerio&amp;volume=81&amp;publication_year=2014&amp;pages=31-41&amp;pmid=24486711&amp;doi=10.1016/j.neuropharm.2014.01.030&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0218">
<span class="label">218.</span><cite>
Koek W., Cheng K., and Rice K. C., “Discriminative Stimulus Effects of the GABAB Receptor‐positive Modulator Rac‐BHFF: Comparison With GABAB Receptor Agonists and Drugs of Abuse,” Journal of Pharmacology and Experimental Therapeutics
344, no. 3 (2013): 553–560.
</cite> [<a href="https://doi.org/10.1124/jpet.112.202226" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3583500/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23275067/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Pharmacology%20and%20Experimental%20Therapeutics&amp;title=Discriminative%20Stimulus%20Effects%20of%20the%20GABAB%20Receptor%E2%80%90positive%20Modulator%20Rac%E2%80%90BHFF:%20Comparison%20With%20GABAB%20Receptor%20Agonists%20and%20Drugs%20of%20Abuse&amp;author=W.%20Koek&amp;author=K.%20Cheng&amp;author=K.%20C.%20Rice&amp;volume=344&amp;issue=3&amp;publication_year=2013&amp;pages=553-560&amp;pmid=23275067&amp;doi=10.1124/jpet.112.202226&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0219">
<span class="label">219.</span><cite>
Sharghi S., Flunkert S., Daurer M., et al., “Evaluating the Effect of R‐Baclofen and LP‐211 on Autistic Behavior of the BTBR and Fmr1‐KO Mouse Models,” Frontiers in neuroscience
17 (2023): 1087788.
</cite> [<a href="https://doi.org/10.3389/fnins.2023.1087788" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10097904/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37065917/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20neuroscience&amp;title=Evaluating%20the%20Effect%20of%20R%E2%80%90Baclofen%20and%20LP%E2%80%90211%20on%20Autistic%20Behavior%20of%20the%20BTBR%20and%20Fmr1%E2%80%90KO%20Mouse%20Models&amp;author=S.%20Sharghi&amp;author=S.%20Flunkert&amp;author=M.%20Daurer&amp;volume=17&amp;publication_year=2023&amp;pages=1087788&amp;pmid=37065917&amp;doi=10.3389/fnins.2023.1087788&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0220">
<span class="label">220.</span><cite>
Lu Y., Li C. J., Chen C., et al., “Activation of GABAB2 Subunits Alleviates Chronic Cerebral Hypoperfusion‐induced Anxiety‐Like Behaviours: A Role for BDNF Signalling and Kir3 Channels,” Neuropharmacology
110, no. Pt A (2016): 308–321.
</cite> [<a href="https://doi.org/10.1016/j.neuropharm.2016.08.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27515806/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuropharmacology&amp;title=Activation%20of%20GABAB2%20Subunits%20Alleviates%20Chronic%20Cerebral%20Hypoperfusion%E2%80%90induced%20Anxiety%E2%80%90Like%20Behaviours:%20A%20Role%20for%20BDNF%20Signalling%20and%20Kir3%20Channels&amp;author=Y.%20Lu&amp;author=C.%20J.%20Li&amp;author=C.%20Chen&amp;volume=110&amp;issue=Pt%20A&amp;publication_year=2016&amp;pages=308-321&amp;pmid=27515806&amp;doi=10.1016/j.neuropharm.2016.08.007&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0221">
<span class="label">221.</span><cite>
Mitten E. H., Souders A., Marron Fernandez de Velasco E., Aguado C., Luján R., and Wickman K., “Chronic Ethanol Exposure in Mice Evokes Pre‐ and Postsynaptic Deficits in GABAergic Transmission in Ventral Tegmental Area GABA Neurons,” British Journal of Pharmacology (2024).</cite> [<a href="https://doi.org/10.1111/bph.17335" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11831720/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39358985/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=British%20Journal%20of%20Pharmacology&amp;title=Chronic%20Ethanol%20Exposure%20in%20Mice%20Evokes%20Pre%E2%80%90%20and%20Postsynaptic%20Deficits%20in%20GABAergic%20Transmission%20in%20Ventral%20Tegmental%20Area%20GABA%20Neurons&amp;author=E.%20H.%20Mitten&amp;author=A.%20Souders&amp;author=E.%20Marron%20Fernandez%20de%20Velasco&amp;author=C.%20Aguado&amp;author=R.%20Luj%C3%A1n&amp;publication_year=2024&amp;pmid=39358985&amp;doi=10.1111/bph.17335&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0222">
<span class="label">222.</span><cite>
Rosa P. B., Neis V. B., Ribeiro C. M., Moretti M., and Rodrigues A. L., “Antidepressant‐Like Effects of Ascorbic Acid and Ketamine Involve Modulation of GABAA and GABAB Receptors,” Pharmacological Reports
68, no. 5 (2016): 996–1001.
</cite> [<a href="https://doi.org/10.1016/j.pharep.2016.05.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27423525/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacological%20Reports&amp;title=Antidepressant%E2%80%90Like%20Effects%20of%20Ascorbic%20Acid%20and%20Ketamine%20Involve%20Modulation%20of%20GABAA%20and%20GABAB%20Receptors&amp;author=P.%20B.%20Rosa&amp;author=V.%20B.%20Neis&amp;author=C.%20M.%20Ribeiro&amp;author=M.%20Moretti&amp;author=A.%20L.%20Rodrigues&amp;volume=68&amp;issue=5&amp;publication_year=2016&amp;pages=996-1001&amp;pmid=27423525&amp;doi=10.1016/j.pharep.2016.05.010&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0223">
<span class="label">223.</span><cite>
Radhu N., Daskalakis Z. J., Guglietti C. L., et al., “Cognitive Behavioral Therapy‐related Increases in Cortical Inhibition in Problematic Perfectionists,” Brain Stimulation
5, no. 1 (2012): 44–54.
</cite> [<a href="https://doi.org/10.1016/j.brs.2011.01.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22037137/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Brain%20Stimulation&amp;title=Cognitive%20Behavioral%20Therapy%E2%80%90related%20Increases%20in%20Cortical%20Inhibition%20in%20Problematic%20Perfectionists&amp;author=N.%20Radhu&amp;author=Z.%20J.%20Daskalakis&amp;author=C.%20L.%20Guglietti&amp;volume=5&amp;issue=1&amp;publication_year=2012&amp;pages=44-54&amp;pmid=22037137&amp;doi=10.1016/j.brs.2011.01.006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0224">
<span class="label">224.</span><cite>
Veronezi B. P., Moffa A. H., Carvalho A. F., et al., “Evidence for Increased Motor Cortical Facilitation and Decreased Inhibition in atypical Depression,” Acta Psychiatrica Scandinavica
134, no. 2 (2016): 172–182.
</cite> [<a href="https://doi.org/10.1111/acps.12565" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27028276/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Psychiatrica%20Scandinavica&amp;title=Evidence%20for%20Increased%20Motor%20Cortical%20Facilitation%20and%20Decreased%20Inhibition%20in%20atypical%20Depression&amp;author=B.%20P.%20Veronezi&amp;author=A.%20H.%20Moffa&amp;author=A.%20F.%20Carvalho&amp;volume=134&amp;issue=2&amp;publication_year=2016&amp;pages=172-182&amp;pmid=27028276&amp;doi=10.1111/acps.12565&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0225">
<span class="label">225.</span><cite>
Steinholtz L., Thörnblom E., Bodén R., et al., “GABAA Receptor Availability in Relation to Cortical Excitability in Depressed and Healthy: A Positron Emission Tomography and Transcranial Magnetic Stimulation Study,” Neuropsychobiology
83, no. 1 (2024): 17–27.
</cite> [<a href="https://doi.org/10.1159/000535512" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10871686/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38151012/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuropsychobiology&amp;title=GABAA%20Receptor%20Availability%20in%20Relation%20to%20Cortical%20Excitability%20in%20Depressed%20and%20Healthy:%20A%20Positron%20Emission%20Tomography%20and%20Transcranial%20Magnetic%20Stimulation%20Study&amp;author=L.%20Steinholtz&amp;author=E.%20Th%C3%B6rnblom&amp;author=R.%20Bod%C3%A9n&amp;volume=83&amp;issue=1&amp;publication_year=2024&amp;pages=17-27&amp;pmid=38151012&amp;doi=10.1159/000535512&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0226">
<span class="label">226.</span><cite>
Kinjo M., Wada M., Nakajima S., et al., “Transcranial Magnetic Stimulation Neurophysiology of Patients With Major Depressive Disorder: A Systematic Review and Meta‐analysis,” Psychological Medicine
51, no. 1 (2021): 1–10.
</cite> [<a href="https://doi.org/10.1017/S0033291720004729" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7856413/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33267920/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Psychological%20Medicine&amp;title=Transcranial%20Magnetic%20Stimulation%20Neurophysiology%20of%20Patients%20With%20Major%20Depressive%20Disorder:%20A%20Systematic%20Review%20and%20Meta%E2%80%90analysis&amp;author=M.%20Kinjo&amp;author=M.%20Wada&amp;author=S.%20Nakajima&amp;volume=51&amp;issue=1&amp;publication_year=2021&amp;pages=1-10&amp;pmid=33267920&amp;doi=10.1017/S0033291720004729&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0227">
<span class="label">227.</span><cite>
Goldstein R. Z. and Volkow N. D., “Drug Addiction and Its Underlying Neurobiological Basis: Neuroimaging Evidence for the Involvement of the Frontal Cortex,” American Journal of Psychiatry
159, no. 10 (2002): 1642–1652.
</cite> [<a href="https://doi.org/10.1176/appi.ajp.159.10.1642" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1201373/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12359667/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Psychiatry&amp;title=Drug%20Addiction%20and%20Its%20Underlying%20Neurobiological%20Basis:%20Neuroimaging%20Evidence%20for%20the%20Involvement%20of%20the%20Frontal%20Cortex&amp;author=R.%20Z.%20Goldstein&amp;author=N.%20D.%20Volkow&amp;volume=159&amp;issue=10&amp;publication_year=2002&amp;pages=1642-1652&amp;pmid=12359667&amp;doi=10.1176/appi.ajp.159.10.1642&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0228">
<span class="label">228.</span><cite>
Liu J. F. and Li J. X., “Drug Addiction: A Curable Mental Disorder?,” Acta Pharmacologica Sinica
39, no. 12 (2018): 1823–1829.
</cite> [<a href="https://doi.org/10.1038/s41401-018-0180-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6289334/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30382181/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Pharmacologica%20Sinica&amp;title=Drug%20Addiction:%20A%20Curable%20Mental%20Disorder?&amp;author=J.%20F.%20Liu&amp;author=J.%20X.%20Li&amp;volume=39&amp;issue=12&amp;publication_year=2018&amp;pages=1823-1829&amp;pmid=30382181&amp;doi=10.1038/s41401-018-0180-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0229">
<span class="label">229.</span><cite>
Filip M., Frankowska M., Sadakierska‐Chudy A., et al., “GABAB Receptors as a Therapeutic Strategy in Substance Use Disorders: Focus on Positive Allosteric Modulators,” Neuropharmacology
88 (2015): 36–47.
</cite> [<a href="https://doi.org/10.1016/j.neuropharm.2014.06.016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24971600/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuropharmacology&amp;title=GABAB%20Receptors%20as%20a%20Therapeutic%20Strategy%20in%20Substance%20Use%20Disorders:%20Focus%20on%20Positive%20Allosteric%20Modulators&amp;author=M.%20Filip&amp;author=M.%20Frankowska&amp;author=A.%20Sadakierska%E2%80%90Chudy&amp;volume=88&amp;publication_year=2015&amp;pages=36-47&amp;pmid=24971600&amp;doi=10.1016/j.neuropharm.2014.06.016&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0230">
<span class="label">230.</span><cite>
Li H., Watkins L. R., and Wang X., “Microglia in Neuroimmunopharmacology and Drug Addiction,” Molecular Psychiatry
29, no. 6 (2024): 1912–1924.
</cite> [<a href="https://doi.org/10.1038/s41380-024-02443-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38302560/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20Psychiatry&amp;title=Microglia%20in%20Neuroimmunopharmacology%20and%20Drug%20Addiction&amp;author=H.%20Li&amp;author=L.%20R.%20Watkins&amp;author=X.%20Wang&amp;volume=29&amp;issue=6&amp;publication_year=2024&amp;pages=1912-1924&amp;pmid=38302560&amp;doi=10.1038/s41380-024-02443-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0231">
<span class="label">231.</span><cite>
Meyer‐Bockenkamp F., Proskynitopoulos P. J., Glahn A., et al., “Cytosine Methylation in GABA B1 Receptor Identifies Alcohol‐related Changes for Men in Blood and Brain Tissues,” Alcohol and Alcoholism
58, no. 3 (2023): 308–314.
</cite> [<a href="https://doi.org/10.1093/alcalc/agad022" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37041103/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Alcohol%20and%20Alcoholism&amp;title=Cytosine%20Methylation%20in%20GABA%20B1%20Receptor%20Identifies%20Alcohol%E2%80%90related%20Changes%20for%20Men%20in%20Blood%20and%20Brain%20Tissues&amp;author=F.%20Meyer%E2%80%90Bockenkamp&amp;author=P.%20J.%20Proskynitopoulos&amp;author=A.%20Glahn&amp;volume=58&amp;issue=3&amp;publication_year=2023&amp;pages=308-314&amp;pmid=37041103&amp;doi=10.1093/alcalc/agad022&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0232">
<span class="label">232.</span><cite>
Knapp C. M., Ciraulo D. A., and Datta S., “Mechanisms Underlying Sleep‐wake Disturbances in Alcoholism: Focus on the Cholinergic Pedunculopontine Tegmentum,” Behavioural Brain Research
274 (2014): 291–301.
</cite> [<a href="https://doi.org/10.1016/j.bbr.2014.08.029" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4179982/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25151622/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Behavioural%20Brain%20Research&amp;title=Mechanisms%20Underlying%20Sleep%E2%80%90wake%20Disturbances%20in%20Alcoholism:%20Focus%20on%20the%20Cholinergic%20Pedunculopontine%20Tegmentum&amp;author=C.%20M.%20Knapp&amp;author=D.%20A.%20Ciraulo&amp;author=S.%20Datta&amp;volume=274&amp;publication_year=2014&amp;pages=291-301&amp;pmid=25151622&amp;doi=10.1016/j.bbr.2014.08.029&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0233">
<span class="label">233.</span><cite>
Dobrovitsky V., Pimentel P., Duarte A., Froestl W., Stellar J. R., and Trzcińska M., “CGP 44532, a GABAB Receptor Agonist, Is Hedonically Neutral and Reduces Cocaine‐induced Enhancement of Reward,” Neuropharmacology
42, no. 5 (2002): 626–632.
</cite> [<a href="https://doi.org/10.1016/s0028-3908(02)00007-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11985820/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuropharmacology&amp;title=CGP%2044532,%20a%20GABAB%20Receptor%20Agonist,%20Is%20Hedonically%20Neutral%20and%20Reduces%20Cocaine%E2%80%90induced%20Enhancement%20of%20Reward&amp;author=V.%20Dobrovitsky&amp;author=P.%20Pimentel&amp;author=A.%20Duarte&amp;author=W.%20Froestl&amp;author=J.%20R.%20Stellar&amp;volume=42&amp;issue=5&amp;publication_year=2002&amp;pages=626-632&amp;pmid=11985820&amp;doi=10.1016/s0028-3908(02)00007-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0234">
<span class="label">234.</span><cite>
Cunningham J. J., Orr E., Lothian B. C., Morgen J., and Brebner K., “Effects of fendiline on Cocaine‐seeking Behavior in the Rat,” Psychopharmacology
232, no. 24 (2015): 4401–4410.
</cite> [<a href="https://doi.org/10.1007/s00213-015-4061-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26345344/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Psychopharmacology&amp;title=Effects%20of%20fendiline%20on%20Cocaine%E2%80%90seeking%20Behavior%20in%20the%20Rat&amp;author=J.%20J.%20Cunningham&amp;author=E.%20Orr&amp;author=B.%20C.%20Lothian&amp;author=J.%20Morgen&amp;author=K.%20Brebner&amp;volume=232&amp;issue=24&amp;publication_year=2015&amp;pages=4401-4410&amp;pmid=26345344&amp;doi=10.1007/s00213-015-4061-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0235">
<span class="label">235.</span><cite>
Spano M. S., Fattore L., Fratta W., and Fadda P., “The GABAB Receptor Agonist baclofen Prevents Heroin‐induced Reinstatement of Heroin‐seeking Behavior in Rats,” Neuropharmacology
52, no. 7 (2007): 1555–1562.
</cite> [<a href="https://doi.org/10.1016/j.neuropharm.2007.02.012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17451755/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuropharmacology&amp;title=The%20GABAB%20Receptor%20Agonist%20baclofen%20Prevents%20Heroin%E2%80%90induced%20Reinstatement%20of%20Heroin%E2%80%90seeking%20Behavior%20in%20Rats&amp;author=M.%20S.%20Spano&amp;author=L.%20Fattore&amp;author=W.%20Fratta&amp;author=P.%20Fadda&amp;volume=52&amp;issue=7&amp;publication_year=2007&amp;pages=1555-1562&amp;pmid=17451755&amp;doi=10.1016/j.neuropharm.2007.02.012&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0236">
<span class="label">236.</span><cite>
Paterson N. E., Froestl W., and Markou A., “The GABAB Receptor Agonists Baclofen and CGP44532 Decreased Nicotine Self‐administration in the Rat,” Psychopharmacology
172, no. 2 (2004): 179–186.
</cite> [<a href="https://doi.org/10.1007/s00213-003-1637-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14610636/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Psychopharmacology&amp;title=The%20GABAB%20Receptor%20Agonists%20Baclofen%20and%20CGP44532%20Decreased%20Nicotine%20Self%E2%80%90administration%20in%20the%20Rat&amp;author=N.%20E.%20Paterson&amp;author=W.%20Froestl&amp;author=A.%20Markou&amp;volume=172&amp;issue=2&amp;publication_year=2004&amp;pages=179-186&amp;pmid=14610636&amp;doi=10.1007/s00213-003-1637-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0237">
<span class="label">237.</span><cite>
Agabio R. and Colombo G., “GABAB Receptor as Therapeutic Target for Drug Addiction: From baclofen to Positive Allosteric Modulators,” Psychiatria Polska
49, no. 2 (2015): 215–223. Receptor GABAB jako cel terapeutyczny w uzależnieniu od substancji psychoaktywnych—od baklofenu do pozytywnych modulatorów allosterycznych. doi:10.12740/pp/33911.
</cite> [<a href="https://doi.org/10.12740/PP/33911" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26093587/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Psychiatria%20Polska&amp;title=GABAB%20Receptor%20as%20Therapeutic%20Target%20for%20Drug%20Addiction:%20From%20baclofen%20to%20Positive%20Allosteric%20Modulators&amp;author=R.%20Agabio&amp;author=G.%20Colombo&amp;volume=49&amp;issue=2&amp;publication_year=2015&amp;pages=215-223&amp;pmid=26093587&amp;doi=10.12740/PP/33911&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0238">
<span class="label">238.</span><cite>
Ong J. and Kerr D. I., “Recent Advances in GABAB Receptors: From Pharmacology to Molecular Biology,” Acta Pharmacologica Sinica
21, no. 2 (2000): 111–123.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/11263257/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Pharmacologica%20Sinica&amp;title=Recent%20Advances%20in%20GABAB%20Receptors:%20From%20Pharmacology%20to%20Molecular%20Biology&amp;author=J.%20Ong&amp;author=D.%20I.%20Kerr&amp;volume=21&amp;issue=2&amp;publication_year=2000&amp;pages=111-123&amp;pmid=11263257&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0239">
<span class="label">239.</span><cite>
Munoz M. B., Padgett C. L., Rifkin R., et al., “A Role for the GIRK3 Subunit in Methamphetamine‐Induced Attenuation of GABAB Receptor‐Activated GIRK Currents in VTA Dopamine Neurons,” Journal of Neuroscience
36, no. 11 (2016): 3106–3114.
</cite> [<a href="https://doi.org/10.1523/JNEUROSCI.1327-15.2016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4792929/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26985023/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Neuroscience&amp;title=A%20Role%20for%20the%20GIRK3%20Subunit%20in%20Methamphetamine%E2%80%90Induced%20Attenuation%20of%20GABAB%20Receptor%E2%80%90Activated%20GIRK%20Currents%20in%20VTA%20Dopamine%20Neurons&amp;author=M.%20B.%20Munoz&amp;author=C.%20L.%20Padgett&amp;author=R.%20Rifkin&amp;volume=36&amp;issue=11&amp;publication_year=2016&amp;pages=3106-3114&amp;pmid=26985023&amp;doi=10.1523/JNEUROSCI.1327-15.2016&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0240">
<span class="label">240.</span><cite>
Ort A., Kometer M., Rohde J., Seifritz E., and Vollenweider F. X., “The Role of GABAB Receptors in human Reinforcement Learning,” European Neuropsychopharmacology
24, no. 10 (2014): 1606–1614.
</cite> [<a href="https://doi.org/10.1016/j.euroneuro.2014.08.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25194227/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Neuropsychopharmacology&amp;title=The%20Role%20of%20GABAB%20Receptors%20in%20human%20Reinforcement%20Learning&amp;author=A.%20Ort&amp;author=M.%20Kometer&amp;author=J.%20Rohde&amp;author=E.%20Seifritz&amp;author=F.%20X.%20Vollenweider&amp;volume=24&amp;issue=10&amp;publication_year=2014&amp;pages=1606-1614&amp;pmid=25194227&amp;doi=10.1016/j.euroneuro.2014.08.013&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0241">
<span class="label">241.</span><cite>
Young K. A., Franklin T. R., Roberts D. C., et al., “Nipping Cue Reactivity in the Bud: Baclofen Prevents Limbic Activation Elicited by Subliminal Drug Cues,” Journal of Neuroscience
34, no. 14 (2014): 5038–5043.
</cite> [<a href="https://doi.org/10.1523/JNEUROSCI.4977-13.2014" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3972727/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24695721/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Neuroscience&amp;title=Nipping%20Cue%20Reactivity%20in%20the%20Bud:%20Baclofen%20Prevents%20Limbic%20Activation%20Elicited%20by%20Subliminal%20Drug%20Cues&amp;author=K.%20A.%20Young&amp;author=T.%20R.%20Franklin&amp;author=D.%20C.%20Roberts&amp;volume=34&amp;issue=14&amp;publication_year=2014&amp;pages=5038-5043&amp;pmid=24695721&amp;doi=10.1523/JNEUROSCI.4977-13.2014&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0242">
<span class="label">242.</span><cite>
DeBaker M. C., Marron Fernandez de Velasco E., McCall N. M., Lee A. M., and Wickman K., “Differential Impact of Inhibitory G‐Protein Signaling Pathways in Ventral Tegmental Area Dopamine Neurons on Behavioral Sensitivity to Cocaine and Morphine,” Eneuro
8, no. 2 (2021).</cite> [<a href="https://doi.org/10.1523/ENEURO.0081-21.2021" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8114902/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33707203/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eneuro&amp;title=Differential%20Impact%20of%20Inhibitory%20G%E2%80%90Protein%20Signaling%20Pathways%20in%20Ventral%20Tegmental%20Area%20Dopamine%20Neurons%20on%20Behavioral%20Sensitivity%20to%20Cocaine%20and%20Morphine&amp;author=M.%20C.%20DeBaker&amp;author=E.%20Marron%20Fernandez%20de%20Velasco&amp;author=N.%20M.%20McCall&amp;author=A.%20M.%20Lee&amp;author=K.%20Wickman&amp;volume=8&amp;issue=2&amp;publication_year=2021&amp;pmid=33707203&amp;doi=10.1523/ENEURO.0081-21.2021&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0243">
<span class="label">243.</span><cite>
Mizoguchi H. and Yamada K., “Pharmacologic Treatment With GABA(B) Receptor Agonist of Methamphetamine‐Induced Cognitive Impairment in Mice,” Current Neuropharmacology
9, no. 1 (2011): 109–112.
</cite> [<a href="https://doi.org/10.2174/157015911795016976" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3137162/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21886573/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Current%20Neuropharmacology&amp;title=Pharmacologic%20Treatment%20With%20GABA(B)%20Receptor%20Agonist%20of%20Methamphetamine%E2%80%90Induced%20Cognitive%20Impairment%20in%20Mice&amp;author=H.%20Mizoguchi&amp;author=K.%20Yamada&amp;volume=9&amp;issue=1&amp;publication_year=2011&amp;pages=109-112&amp;pmid=21886573&amp;doi=10.2174/157015911795016976&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0244">
<span class="label">244.</span><cite>
Li K., Qian L., Zhang C., et al., “The Entorhinal Cortex and Cognitive Impairment in Schizophrenia: A Comprehensive Review,” Progress in Neuro‐Psychopharmacology &amp; Biological Psychiatry
136 (2024): 111218.
</cite> [<a href="https://doi.org/10.1016/j.pnpbp.2024.111218" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39672531/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Progress%20in%20Neuro%E2%80%90Psychopharmacology%20&amp;%20Biological%20Psychiatry&amp;title=The%20Entorhinal%20Cortex%20and%20Cognitive%20Impairment%20in%20Schizophrenia:%20A%20Comprehensive%20Review&amp;author=K.%20Li&amp;author=L.%20Qian&amp;author=C.%20Zhang&amp;volume=136&amp;publication_year=2024&amp;pages=111218&amp;pmid=39672531&amp;doi=10.1016/j.pnpbp.2024.111218&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0245">
<span class="label">245.</span><cite>
Berdeville C., Silva‐Amaral D., Dalgalarrondo P., Banzato C. E. M., and Martins‐de‐Souza D., “A Scoping Review of Protein Biomarkers for Schizophrenia: State of Progress, Underlying Biology, and Methodological Considerations,” Neuroscience and Biobehavioral Reviews
168 (2025): 105949.
</cite> [<a href="https://doi.org/10.1016/j.neubiorev.2024.105949" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39577820/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuroscience%20and%20Biobehavioral%20Reviews&amp;title=A%20Scoping%20Review%20of%20Protein%20Biomarkers%20for%20Schizophrenia:%20State%20of%20Progress,%20Underlying%20Biology,%20and%20Methodological%20Considerations&amp;author=C.%20Berdeville&amp;author=D.%20Silva%E2%80%90Amaral&amp;author=P.%20Dalgalarrondo&amp;author=C.%20E.%20M.%20Banzato&amp;author=D.%20Martins%E2%80%90de%E2%80%90Souza&amp;volume=168&amp;publication_year=2025&amp;pages=105949&amp;pmid=39577820&amp;doi=10.1016/j.neubiorev.2024.105949&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0246">
<span class="label">246.</span><cite>
Cieślik P. and Wierońska J. M., “Regulation of Glutamatergic Activity via Bidirectional Activation of Two Select Receptors as a Novel Approach in Antipsychotic Drug Discovery,” International Journal of Molecular Sciences
21, no. 22 (2020).</cite> [<a href="https://doi.org/10.3390/ijms21228811" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7699963/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33233865/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Journal%20of%20Molecular%20Sciences&amp;title=Regulation%20of%20Glutamatergic%20Activity%20via%20Bidirectional%20Activation%20of%20Two%20Select%20Receptors%20as%20a%20Novel%20Approach%20in%20Antipsychotic%20Drug%20Discovery&amp;author=P.%20Cie%C5%9Blik&amp;author=J.%20M.%20Wiero%C5%84ska&amp;volume=21&amp;issue=22&amp;publication_year=2020&amp;pmid=33233865&amp;doi=10.3390/ijms21228811&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0247">
<span class="label">247.</span><cite>
Woźniak M., Acher F., Marciniak M., et al., “Involvement of GABAB Receptor Signaling in Antipsychotic‐Like Action of the Novel Orthosteric Agonist of the mGlu4 Receptor, LSP4‐2022,” Current Neuropharmacology
14, no. 5 (2016): 413–426.
</cite> [<a href="https://doi.org/10.2174/1570159X13666150516000630" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4983756/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26769224/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Current%20Neuropharmacology&amp;title=Involvement%20of%20GABAB%20Receptor%20Signaling%20in%20Antipsychotic%E2%80%90Like%20Action%20of%20the%20Novel%20Orthosteric%20Agonist%20of%20the%20mGlu4%20Receptor,%20LSP4%E2%80%902022&amp;author=M.%20Wo%C5%BAniak&amp;author=F.%20Acher&amp;author=M.%20Marciniak&amp;volume=14&amp;issue=5&amp;publication_year=2016&amp;pages=413-426&amp;pmid=26769224&amp;doi=10.2174/1570159X13666150516000630&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0248">
<span class="label">248.</span><cite>
Ma J. and Stan Leung L., “Effects of GABA‐B Receptor Positive Modulator on Ketamine‐induced Psychosis‐relevant Behaviors and Hippocampal Electrical Activity in Freely Moving Rats,” Psychopharmacology
234, no. 20 (2017): 3129–3142.
</cite> [<a href="https://doi.org/10.1007/s00213-017-4705-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28756462/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Psychopharmacology&amp;title=Effects%20of%20GABA%E2%80%90B%20Receptor%20Positive%20Modulator%20on%20Ketamine%E2%80%90induced%20Psychosis%E2%80%90relevant%20Behaviors%20and%20Hippocampal%20Electrical%20Activity%20in%20Freely%20Moving%20Rats&amp;author=J.%20Ma&amp;author=L.%20Stan%20Leung&amp;volume=234&amp;issue=20&amp;publication_year=2017&amp;pages=3129-3142&amp;pmid=28756462&amp;doi=10.1007/s00213-017-4705-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0249">
<span class="label">249.</span><cite>
Mizukami K., Ishikawa M., Hidaka S., Iwakiri M., Sasaki M., and Iritani S., “Immunohistochemical Localization of GABAB Receptor in the Entorhinal Cortex and Inferior Temporal Cortex of Schizophrenic Brain,” Progress in Neuro‐Psychopharmacology &amp; Biological Psychiatry
26, no. 2 (2002): 393–396.
</cite> [<a href="https://doi.org/10.1016/s0278-5846(01)00247-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11817519/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Progress%20in%20Neuro%E2%80%90Psychopharmacology%20&amp;%20Biological%20Psychiatry&amp;title=Immunohistochemical%20Localization%20of%20GABAB%20Receptor%20in%20the%20Entorhinal%20Cortex%20and%20Inferior%20Temporal%20Cortex%20of%20Schizophrenic%20Brain&amp;author=K.%20Mizukami&amp;author=M.%20Ishikawa&amp;author=S.%20Hidaka&amp;author=M.%20Iwakiri&amp;author=M.%20Sasaki&amp;volume=26&amp;issue=2&amp;publication_year=2002&amp;pages=393-396&amp;pmid=11817519&amp;doi=10.1016/s0278-5846(01)00247-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0250">
<span class="label">250.</span><cite>
Miyazawa A., Kanahara N., Kogure M., et al., “A Preliminary Genetic Association Study of GAD1 and GABAB Receptor Genes in Patients With Treatment‐resistant Schizophrenia,” Molecular Biology Reports
49, no. 3 (2022): 2015–2024.
</cite> [<a href="https://doi.org/10.1007/s11033-021-07019-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34845648/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20Biology%20Reports&amp;title=A%20Preliminary%20Genetic%20Association%20Study%20of%20GAD1%20and%20GABAB%20Receptor%20Genes%20in%20Patients%20With%20Treatment%E2%80%90resistant%20Schizophrenia&amp;author=A.%20Miyazawa&amp;author=N.%20Kanahara&amp;author=M.%20Kogure&amp;volume=49&amp;issue=3&amp;publication_year=2022&amp;pages=2015-2024&amp;pmid=34845648&amp;doi=10.1007/s11033-021-07019-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0251">
<span class="label">251.</span><cite>
Elhage A., Cohen S., Cummings J., et al., “Defining Benefit: Clinically and Biologically Meaningful Outcomes in the next‐generation Alzheimer's Disease Clinical Care Pathway,” Alzheimer's &amp; Dementia (2024).</cite> [<a href="https://doi.org/10.1002/alz.14425" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11848336/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39697158/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Alzheimer's%20&amp;%20Dementia&amp;title=Defining%20Benefit:%20Clinically%20and%20Biologically%20Meaningful%20Outcomes%20in%20the%20next%E2%80%90generation%20Alzheimer's%20Disease%20Clinical%20Care%20Pathway&amp;author=A.%20Elhage&amp;author=S.%20Cohen&amp;author=J.%20Cummings&amp;publication_year=2024&amp;pmid=39697158&amp;doi=10.1002/alz.14425&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0252">
<span class="label">252.</span><cite>
Khalafi M., Dartora W. J., McIntire L. B. J., et al., “Diagnostic Accuracy of Phosphorylated tau217 in Detecting Alzheimer's Disease Pathology Among Cognitively Impaired and Unimpaired: A Systematic Review and Meta‐analysis,” Alzheimer's &amp; Dementia (2024).</cite> [<a href="https://doi.org/10.1002/alz.14458" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11848338/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39711334/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Alzheimer's%20&amp;%20Dementia&amp;title=Diagnostic%20Accuracy%20of%20Phosphorylated%20tau217%20in%20Detecting%20Alzheimer's%20Disease%20Pathology%20Among%20Cognitively%20Impaired%20and%20Unimpaired:%20A%20Systematic%20Review%20and%20Meta%E2%80%90analysis&amp;author=M.%20Khalafi&amp;author=W.%20J.%20Dartora&amp;author=L.%20B.%20J.%20McIntire&amp;publication_year=2024&amp;pmid=39711334&amp;doi=10.1002/alz.14458&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0253">
<span class="label">253.</span><cite>
Kleschevnikov A., “GIRK2 Channels in Down Syndrome and Alzheimer's Disease,” Current Alzheimer Research
19, no. 12 (2022): 819–829.
</cite> [<a href="https://doi.org/10.2174/1567205020666221223122110" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36567290/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Current%20Alzheimer%20Research&amp;title=GIRK2%20Channels%20in%20Down%20Syndrome%20and%20Alzheimer's%20Disease&amp;author=A.%20Kleschevnikov&amp;volume=19&amp;issue=12&amp;publication_year=2022&amp;pages=819-829&amp;pmid=36567290&amp;doi=10.2174/1567205020666221223122110&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0254">
<span class="label">254.</span><cite>
Bassetti D., Lombardi A., Kirischuk S., and Luhmann H. J., “Haploinsufficiency of Tsc2 Leads to Hyperexcitability of Medial Prefrontal Cortex via Weakening of Tonic GABAB Receptor‐mediated Inhibition,” Cerebral Cortex
30, no. 12 (2020): 6313–6324.
</cite> [<a href="https://doi.org/10.1093/cercor/bhaa187" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32705128/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cerebral%20Cortex&amp;title=Haploinsufficiency%20of%20Tsc2%20Leads%20to%20Hyperexcitability%20of%20Medial%20Prefrontal%20Cortex%20via%20Weakening%20of%20Tonic%20GABAB%20Receptor%E2%80%90mediated%20Inhibition&amp;author=D.%20Bassetti&amp;author=A.%20Lombardi&amp;author=S.%20Kirischuk&amp;author=H.%20J.%20Luhmann&amp;volume=30&amp;issue=12&amp;publication_year=2020&amp;pages=6313-6324&amp;pmid=32705128&amp;doi=10.1093/cercor/bhaa187&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0255">
<span class="label">255.</span><cite>
Abdullah N. S., Jan T. H., Remli R., Mukari S. A. M., and Ibrahim N. M., “Anti‐GABAB Receptor Encephalitis Presenting With Atypical Corticobasal Syndrome in a Patient With Parkinson's Disease,” Journal of Movement Disorders
13, no. 3 (2020): 235–237, doi:.
</cite> [<a href="https://doi.org/10.14802/jmd.20011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7502293/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32894902/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Movement%20Disorders&amp;title=Anti%E2%80%90GABAB%20Receptor%20Encephalitis%20Presenting%20With%20Atypical%20Corticobasal%20Syndrome%20in%20a%20Patient%20With%20Parkinson's%20Disease&amp;author=N.%20S.%20Abdullah&amp;author=T.%20H.%20Jan&amp;author=R.%20Remli&amp;author=S.%20A.%20M.%20Mukari&amp;author=N.%20M.%20Ibrahim&amp;volume=13&amp;issue=3&amp;publication_year=2020&amp;pages=235-237&amp;pmid=32894902&amp;doi=10.14802/jmd.20011&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0256">
<span class="label">256.</span><cite>
Zhu W., Huang L., Cheng H., et al., “GABA and Its Receptors' mechanisms in the Treatment of Insomnia,” Heliyon
10, no. 23 (2024): e40665.
</cite> [<a href="https://doi.org/10.1016/j.heliyon.2024.e40665" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11626785/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39654705/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Heliyon&amp;title=GABA%20and%20Its%20Receptors'%20mechanisms%20in%20the%20Treatment%20of%20Insomnia&amp;author=W.%20Zhu&amp;author=L.%20Huang&amp;author=H.%20Cheng&amp;volume=10&amp;issue=23&amp;publication_year=2024&amp;pages=e40665&amp;pmid=39654705&amp;doi=10.1016/j.heliyon.2024.e40665&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0257">
<span class="label">257.</span><cite>
Karpuz Ağören B., Küpeli Akkol E., Çelik I., and Sobarzo‐Sánchez E., “Sedative and Anxiolytic Effects of Capparis sicula Duhamel: In Vivo and in Silico Approaches With Phytochemical Profiling,” Frontiers in pharmacology
15 (2024): 1443173.
</cite> [<a href="https://doi.org/10.3389/fphar.2024.1443173" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11387179/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39263570/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20pharmacology&amp;title=Sedative%20and%20Anxiolytic%20Effects%20of%20Capparis%20sicula%20Duhamel:%20In%20Vivo%20and%20in%20Silico%20Approaches%20With%20Phytochemical%20Profiling&amp;author=B.%20Karpuz%20A%C4%9F%C3%B6ren&amp;author=E.%20K%C3%BCpeli%20Akkol&amp;author=I.%20%C3%87elik&amp;author=E.%20Sobarzo%E2%80%90S%C3%A1nchez&amp;volume=15&amp;publication_year=2024&amp;pages=1443173&amp;pmid=39263570&amp;doi=10.3389/fphar.2024.1443173&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0258">
<span class="label">258.</span><cite>
Wang P. W., Sailasuta N., Chandler R. A., and Ketter T. A., “Magnetic Resonance Spectroscopic Measurement of Cerebral Gamma‐aminobutyric Acid Concentrations in Patients With Bipolar Disorders,” Acta Neuropsychiatrica
18, no. 2 (2006): 120–126.
</cite> [<a href="https://doi.org/10.1111/j.1601-5215.2006.00132.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26989801/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Neuropsychiatrica&amp;title=Magnetic%20Resonance%20Spectroscopic%20Measurement%20of%20Cerebral%20Gamma%E2%80%90aminobutyric%20Acid%20Concentrations%20in%20Patients%20With%20Bipolar%20Disorders&amp;author=P.%20W.%20Wang&amp;author=N.%20Sailasuta&amp;author=R.%20A.%20Chandler&amp;author=T.%20A.%20Ketter&amp;volume=18&amp;issue=2&amp;publication_year=2006&amp;pages=120-126&amp;pmid=26989801&amp;doi=10.1111/j.1601-5215.2006.00132.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0259">
<span class="label">259.</span><cite>
Fatemi S. H., Folsom T. D., Rooney R. J., and Thuras P. D., “mRNA and Protein Expression for Novel GABAA Receptors θ and ρ2 Are Altered in Schizophrenia and Mood Disorders; Relevance to FMRP‐mGluR5 Signaling Pathway,” Translational Psychiatry
3, no. 6 (2013): e271.
</cite> [<a href="https://doi.org/10.1038/tp.2013.46" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3693405/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23778581/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Translational%20Psychiatry&amp;title=mRNA%20and%20Protein%20Expression%20for%20Novel%20GABAA%20Receptors%20%CE%B8%20and%20%CF%812%20Are%20Altered%20in%20Schizophrenia%20and%20Mood%20Disorders;%20Relevance%20to%20FMRP%E2%80%90mGluR5%20Signaling%20Pathway&amp;author=S.%20H.%20Fatemi&amp;author=T.%20D.%20Folsom&amp;author=R.%20J.%20Rooney&amp;author=P.%20D.%20Thuras&amp;volume=3&amp;issue=6&amp;publication_year=2013&amp;pages=e271&amp;pmid=23778581&amp;doi=10.1038/tp.2013.46&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0260">
<span class="label">260.</span><cite>
Li M., Tan H. E., Lu Z., Tsang K. S., Chung A. J., and Zuker C. S., “Gut‐brain Circuits for Fat Preference,” Nature
610, no. 7933 (2022): 722–730.
</cite> [<a href="https://doi.org/10.1038/s41586-022-05266-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9605869/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36070796/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Gut%E2%80%90brain%20Circuits%20for%20Fat%20Preference&amp;author=M.%20Li&amp;author=H.%20E.%20Tan&amp;author=Z.%20Lu&amp;author=K.%20S.%20Tsang&amp;author=A.%20J.%20Chung&amp;volume=610&amp;issue=7933&amp;publication_year=2022&amp;pages=722-730&amp;pmid=36070796&amp;doi=10.1038/s41586-022-05266-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0261">
<span class="label">261.</span><cite>
Cheng W., Gordian D., Ludwig M. Q., Pers T. H., and Seeley R. J., “Hindbrain Circuits in the Control of Eating Behaviour and Energy Balance,” Nature Metabolism
4, no. 7 (2022): 826–835.</cite> [<a href="https://doi.org/10.1038/s42255-022-00606-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35879458/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Metabolism&amp;title=Hindbrain%20Circuits%20in%20the%20Control%20of%20Eating%20Behaviour%20and%20Energy%20Balance&amp;author=W.%20Cheng&amp;author=D.%20Gordian&amp;author=M.%20Q.%20Ludwig&amp;author=T.%20H.%20Pers&amp;author=R.%20J.%20Seeley&amp;volume=4&amp;issue=7&amp;publication_year=2022&amp;pages=826-835&amp;pmid=35879458&amp;doi=10.1038/s42255-022-00606-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0262">
<span class="label">262.</span><cite>
Al‐Massadi O., Dieguez C., Schneeberger M., et al., “Multifaceted Actions of Melanin‐concentrating Hormone on Mammalian Energy Homeostasis,” Nature reviews Endocrinology
17, no. 12 (2021): 745–755.</cite> [<a href="https://doi.org/10.1038/s41574-021-00559-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34608277/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20reviews%20Endocrinology&amp;title=Multifaceted%20Actions%20of%20Melanin%E2%80%90concentrating%20Hormone%20on%20Mammalian%20Energy%20Homeostasis&amp;author=O.%20Al%E2%80%90Massadi&amp;author=C.%20Dieguez&amp;author=M.%20Schneeberger&amp;volume=17&amp;issue=12&amp;publication_year=2021&amp;pages=745-755&amp;pmid=34608277&amp;doi=10.1038/s41574-021-00559-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0263">
<span class="label">263.</span><cite>
Rao R. E., Wojnicki F. H., Coupland J., Ghosh S., and Corwin R. L., “Baclofen, Raclopride, and Naltrexone Differentially Reduce Solid Fat Emulsion Intake Under Limited Access Conditions,” Pharmacology Biochemistry and Behavior
89, no. 4 (2008): 581–590.
</cite> [<a href="https://doi.org/10.1016/j.pbb.2008.02.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2669792/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18353432/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacology%20Biochemistry%20and%20Behavior&amp;title=Baclofen,%20Raclopride,%20and%20Naltrexone%20Differentially%20Reduce%20Solid%20Fat%20Emulsion%20Intake%20Under%20Limited%20Access%20Conditions&amp;author=R.%20E.%20Rao&amp;author=F.%20H.%20Wojnicki&amp;author=J.%20Coupland&amp;author=S.%20Ghosh&amp;author=R.%20L.%20Corwin&amp;volume=89&amp;issue=4&amp;publication_year=2008&amp;pages=581-590&amp;pmid=18353432&amp;doi=10.1016/j.pbb.2008.02.013&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0264">
<span class="label">264.</span><cite>
Ledonne A., Sebastianelli L., Federici M., Bernardi G., and Mercuri N. B., “The Anorexic Agents, Sibutramine and Fenfluramine, Depress GABA(B)‐induced Inhibitory Postsynaptic Potentials in Rat Mesencephalic Dopaminergic Cells,” British Journal of Pharmacology
156, no. 6 (2009): 962–969.
</cite> [<a href="https://doi.org/10.1111/j.1476-5381.2008.00081.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2697726/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19298257/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=British%20Journal%20of%20Pharmacology&amp;title=The%20Anorexic%20Agents,%20Sibutramine%20and%20Fenfluramine,%20Depress%20GABA(B)%E2%80%90induced%20Inhibitory%20Postsynaptic%20Potentials%20in%20Rat%20Mesencephalic%20Dopaminergic%20Cells&amp;author=A.%20Ledonne&amp;author=L.%20Sebastianelli&amp;author=M.%20Federici&amp;author=G.%20Bernardi&amp;author=N.%20B.%20Mercuri&amp;volume=156&amp;issue=6&amp;publication_year=2009&amp;pages=962-969&amp;pmid=19298257&amp;doi=10.1111/j.1476-5381.2008.00081.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0265">
<span class="label">265.</span><cite>
Rotella F. M., Vig V., Olsson K., et al., “Baclofen Differentially Mediates Fructose‐conditioned Flavor Preference and Quinine‐conditioned Flavor Avoidance in Rats,” European Journal of Pharmacology
775 (2016): 15–21.
</cite> [<a href="https://doi.org/10.1016/j.ejphar.2016.02.015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26852956/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Journal%20of%20Pharmacology&amp;title=Baclofen%20Differentially%20Mediates%20Fructose%E2%80%90conditioned%20Flavor%20Preference%20and%20Quinine%E2%80%90conditioned%20Flavor%20Avoidance%20in%20Rats&amp;author=F.%20M.%20Rotella&amp;author=V.%20Vig&amp;author=K.%20Olsson&amp;volume=775&amp;publication_year=2016&amp;pages=15-21&amp;pmid=26852956&amp;doi=10.1016/j.ejphar.2016.02.015&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0266">
<span class="label">266.</span><cite>
Patel S. M. and Ebenezer I. S., “Effects of Chronic Systemic Administration of the GABA(B) Receptor Agonist Baclofen on Food Intake and Body Weight in Rats,” European Journal of Pharmacology
635, no. 1‐3 (2010): 129–134.
</cite> [<a href="https://doi.org/10.1016/j.ejphar.2010.03.014" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20303943/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Journal%20of%20Pharmacology&amp;title=Effects%20of%20Chronic%20Systemic%20Administration%20of%20the%20GABA(B)%20Receptor%20Agonist%20Baclofen%20on%20Food%20Intake%20and%20Body%20Weight%20in%20Rats&amp;author=S.%20M.%20Patel&amp;author=I.%20S.%20Ebenezer&amp;volume=635&amp;issue=1%E2%80%903&amp;publication_year=2010&amp;pages=129-134&amp;pmid=20303943&amp;doi=10.1016/j.ejphar.2010.03.014&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0267">
<span class="label">267.</span><cite>
Ebenezer I. S. and Pringle A. K., “The Effect of Systemic Administration of baclofen on Food Intake in Rats,” Neuropharmacology
31, no. 1 (1992): 39.
</cite> [<a href="https://doi.org/10.1016/0028-3908(92)90158-l" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1311808/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuropharmacology&amp;title=The%20Effect%20of%20Systemic%20Administration%20of%20baclofen%20on%20Food%20Intake%20in%20Rats&amp;author=I.%20S.%20Ebenezer&amp;author=A.%20K.%20Pringle&amp;volume=31&amp;issue=1&amp;publication_year=1992&amp;pages=39&amp;pmid=1311808&amp;doi=10.1016/0028-3908(92)90158-l&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0268">
<span class="label">268.</span><cite>
Baldwin B. A., Ebenezer I. S., and Riva C., “Effects of Intracerebroventricular Injection of Muscimol or GABA on Operant Feeding in Pigs,” Physiology &amp; Behavior
48, no. 3 (1990): 417–421.
</cite> [<a href="https://doi.org/10.1016/0031-9384(90)90337-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/2176292/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Physiology%20&amp;%20Behavior&amp;title=Effects%20of%20Intracerebroventricular%20Injection%20of%20Muscimol%20or%20GABA%20on%20Operant%20Feeding%20in%20Pigs&amp;author=B.%20A.%20Baldwin&amp;author=I.%20S.%20Ebenezer&amp;author=C.%20Riva&amp;volume=48&amp;issue=3&amp;publication_year=1990&amp;pages=417-421&amp;pmid=2176292&amp;doi=10.1016/0031-9384(90)90337-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0269">
<span class="label">269.</span><cite>
Ebenezer I. S. and Patel S. M., “Effects of Intraperitoneal Administration of the GABA B Receptor Agonist Baclofen on Food Intake in Rats Measured Under Different Feeding Conditions,” European Journal of Pharmacology
653, no. 1‐3 (2011): 58–62.
</cite> [<a href="https://doi.org/10.1016/j.ejphar.2010.11.030" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21167149/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Journal%20of%20Pharmacology&amp;title=Effects%20of%20Intraperitoneal%20Administration%20of%20the%20GABA%20B%20Receptor%20Agonist%20Baclofen%20on%20Food%20Intake%20in%20Rats%20Measured%20Under%20Different%20Feeding%20Conditions&amp;author=I.%20S.%20Ebenezer&amp;author=S.%20M.%20Patel&amp;volume=653&amp;issue=1%E2%80%903&amp;publication_year=2011&amp;pages=58-62&amp;pmid=21167149&amp;doi=10.1016/j.ejphar.2010.11.030&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0270">
<span class="label">270.</span><cite>
Stratford T. R. and Kelley A. E., “GABA in the Nucleus Accumbens Shell Participates in the central Regulation of Feeding Behavior,” Journal of Neuroscience
17, no. 11 (1997): 4434–4440.
</cite> [<a href="https://doi.org/10.1523/JNEUROSCI.17-11-04434.1997" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6573549/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9151760/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Neuroscience&amp;title=GABA%20in%20the%20Nucleus%20Accumbens%20Shell%20Participates%20in%20the%20central%20Regulation%20of%20Feeding%20Behavior&amp;author=T.%20R.%20Stratford&amp;author=A.%20E.%20Kelley&amp;volume=17&amp;issue=11&amp;publication_year=1997&amp;pages=4434-4440&amp;pmid=9151760&amp;doi=10.1523/JNEUROSCI.17-11-04434.1997&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0271">
<span class="label">271.</span><cite>
Ban G. T., Magrum L. J., and Gietzen D. W., “GABA(A) and GABA(B) Receptors in the Anterior Piriform Cortex Modulate Feeding in Rats,” Brain Research
924, no. 1 (2002): 1–9.
</cite> [<a href="https://doi.org/10.1016/s0006-8993(01)03213-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11743989/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Brain%20Research&amp;title=GABA(A)%20and%20GABA(B)%20Receptors%20in%20the%20Anterior%20Piriform%20Cortex%20Modulate%20Feeding%20in%20Rats&amp;author=G.%20T.%20Ban&amp;author=L.%20J.%20Magrum&amp;author=D.%20W.%20Gietzen&amp;volume=924&amp;issue=1&amp;publication_year=2002&amp;pages=1-9&amp;pmid=11743989&amp;doi=10.1016/s0006-8993(01)03213-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0272">
<span class="label">272.</span><cite>
Higgs S. and Barber D. J., “Effects of baclofen on Feeding Behaviour Examined in the Runway,” Progress in Neuro‐Psychopharmacology &amp; Biological Psychiatry
28, no. 2 (2004): 405–408.
</cite> [<a href="https://doi.org/10.1016/j.pnpbp.2003.11.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14751441/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Progress%20in%20Neuro%E2%80%90Psychopharmacology%20&amp;%20Biological%20Psychiatry&amp;title=Effects%20of%20baclofen%20on%20Feeding%20Behaviour%20Examined%20in%20the%20Runway&amp;author=S.%20Higgs&amp;author=D.%20J.%20Barber&amp;volume=28&amp;issue=2&amp;publication_year=2004&amp;pages=405-408&amp;pmid=14751441&amp;doi=10.1016/j.pnpbp.2003.11.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0273">
<span class="label">273.</span><cite>
Miñano F. J., Meneres Sancho M. S., Sancibrián M., Salinas P., and Myers R. D., “GABAA Receptors in the Amygdala: Role in Feeding in Fasted and Satiated Rats,” Brain Research
586, no. 1 (1992): 104–110.
</cite> [<a href="https://doi.org/10.1016/0006-8993(92)91377-q" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1324775/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Brain%20Research&amp;title=GABAA%20Receptors%20in%20the%20Amygdala:%20Role%20in%20Feeding%20in%20Fasted%20and%20Satiated%20Rats&amp;author=F.%20J.%20Mi%C3%B1ano&amp;author=M.%20S.%20Meneres%20Sancho&amp;author=M.%20Sancibri%C3%A1n&amp;author=P.%20Salinas&amp;author=R.%20D.%20Myers&amp;volume=586&amp;issue=1&amp;publication_year=1992&amp;pages=104-110&amp;pmid=1324775&amp;doi=10.1016/0006-8993(92)91377-q&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0274">
<span class="label">274.</span><cite>
Qiu J., Xue C., Bosch M. A., et al., “Serotonin 5‐hydroxytryptamine2C Receptor Signaling in Hypothalamic Proopiomelanocortin Neurons: Role in Energy Homeostasis in Females,” Molecular Pharmacology
72, no. 4 (2007): 885–896.
</cite> [<a href="https://doi.org/10.1124/mol.107.038083" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17622577/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20Pharmacology&amp;title=Serotonin%205%E2%80%90hydroxytryptamine2C%20Receptor%20Signaling%20in%20Hypothalamic%20Proopiomelanocortin%20Neurons:%20Role%20in%20Energy%20Homeostasis%20in%20Females&amp;author=J.%20Qiu&amp;author=C.%20Xue&amp;author=M.%20A.%20Bosch&amp;volume=72&amp;issue=4&amp;publication_year=2007&amp;pages=885-896&amp;pmid=17622577&amp;doi=10.1124/mol.107.038083&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0275">
<span class="label">275.</span><cite>
Ebenezer I. S., “Baclofen Pretreatment Attenuates the Suppressant Effect of Intraperitoneal Administration of Cholecystokinin (CCK) on Food Intake in Rats,” Brain Research Bulletin
41, no. 5 (1996): 269–271.
</cite> [<a href="https://doi.org/10.1016/s0361-9230(96)00188-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8924037/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Brain%20Research%20Bulletin&amp;title=Baclofen%20Pretreatment%20Attenuates%20the%20Suppressant%20Effect%20of%20Intraperitoneal%20Administration%20of%20Cholecystokinin%20(CCK)%20on%20Food%20Intake%20in%20Rats&amp;author=I.%20S.%20Ebenezer&amp;volume=41&amp;issue=5&amp;publication_year=1996&amp;pages=269-271&amp;pmid=8924037&amp;doi=10.1016/s0361-9230(96)00188-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0276">
<span class="label">276.</span><cite>
Miner P., Shimonova L., Khaimov A., et al., “General, Kappa, Delta and Mu Opioid Receptor Antagonists Mediate Feeding Elicited by the GABA‐B Agonist Baclofen in the Ventral Tegmental Area and Nucleus Accumbens Shell in Rats: Reciprocal and Regional Interactions,” Brain Research
1443 (2012): 34–51.
</cite> [<a href="https://doi.org/10.1016/j.brainres.2012.01.015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22305145/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Brain%20Research&amp;title=General,%20Kappa,%20Delta%20and%20Mu%20Opioid%20Receptor%20Antagonists%20Mediate%20Feeding%20Elicited%20by%20the%20GABA%E2%80%90B%20Agonist%20Baclofen%20in%20the%20Ventral%20Tegmental%20Area%20and%20Nucleus%20Accumbens%20Shell%20in%20Rats:%20Reciprocal%20and%20Regional%20Interactions&amp;author=P.%20Miner&amp;author=L.%20Shimonova&amp;author=A.%20Khaimov&amp;volume=1443&amp;publication_year=2012&amp;pages=34-51&amp;pmid=22305145&amp;doi=10.1016/j.brainres.2012.01.015&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0277">
<span class="label">277.</span><cite>
Turenius C. I., Charles J. R., Tsai D. H., et al., “The Tuberal Lateral Hypothalamus Is a Major Target for GABAA–but Not GABAB‐mediated Control of Food Intake,” Brain Research
1283, no. none (2009): 65–72.
</cite> [<a href="https://doi.org/10.1016/j.brainres.2009.05.064" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19501070/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Brain%20Research&amp;title=The%20Tuberal%20Lateral%20Hypothalamus%20Is%20a%20Major%20Target%20for%20GABAA%E2%80%93but%20Not%20GABAB%E2%80%90mediated%20Control%20of%20Food%20Intake&amp;author=C.%20I.%20Turenius&amp;author=J.%20R.%20Charles&amp;author=D.%20H.%20Tsai&amp;volume=1283&amp;issue=none&amp;publication_year=2009&amp;pages=65-72&amp;pmid=19501070&amp;doi=10.1016/j.brainres.2009.05.064&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0278">
<span class="label">278.</span><cite>
Mitra A., Lenglos C., and Timofeeva E., “Inhibition in the Lateral Septum Increases Sucrose Intake and Decreases Anorectic Effects of Stress,” European Journal of Neuroscience
41, no. 4 (2015): 420–433.
</cite> [<a href="https://doi.org/10.1111/ejn.12798" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25417941/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Journal%20of%20Neuroscience&amp;title=Inhibition%20in%20the%20Lateral%20Septum%20Increases%20Sucrose%20Intake%20and%20Decreases%20Anorectic%20Effects%20of%20Stress&amp;author=A.%20Mitra&amp;author=C.%20Lenglos&amp;author=E.%20Timofeeva&amp;volume=41&amp;issue=4&amp;publication_year=2015&amp;pages=420-433&amp;pmid=25417941&amp;doi=10.1111/ejn.12798&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0279">
<span class="label">279.</span><cite>
Echo J. A., Lamonte N., Ackerman T. F., and Bodnar R. J., “Alterations in Food Intake Elicited by GABA and Opioid Agonists and Antagonists Administered Into the Ventral Tegmental Area Region of Rats,” Physiology &amp; Behavior
76, no. 1 (2002): 107–116.
</cite> [<a href="https://doi.org/10.1016/s0031-9384(02)00690-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12175594/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Physiology%20&amp;%20Behavior&amp;title=Alterations%20in%20Food%20Intake%20Elicited%20by%20GABA%20and%20Opioid%20Agonists%20and%20Antagonists%20Administered%20Into%20the%20Ventral%20Tegmental%20Area%20Region%20of%20Rats&amp;author=J.%20A.%20Echo&amp;author=N.%20Lamonte&amp;author=T.%20F.%20Ackerman&amp;author=R.%20J.%20Bodnar&amp;volume=76&amp;issue=1&amp;publication_year=2002&amp;pages=107-116&amp;pmid=12175594&amp;doi=10.1016/s0031-9384(02)00690-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0280">
<span class="label">280.</span><cite>
Królczyk G., Laskiewicz J., Sobocki J., Matyja A., Kolasińska‐Kloch W., and Thor P. J., “The Effects of baclofen on the Feeding Behaviour and Body Weight of Vagally Stimulated Rats,” Journal of Physiology and Pharmacology
56, no. 1 (2005): 121–131.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/15795480/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Physiology%20and%20Pharmacology&amp;title=The%20Effects%20of%20baclofen%20on%20the%20Feeding%20Behaviour%20and%20Body%20Weight%20of%20Vagally%20Stimulated%20Rats&amp;author=G.%20Kr%C3%B3lczyk&amp;author=J.%20Laskiewicz&amp;author=J.%20Sobocki&amp;author=A.%20Matyja&amp;author=W.%20Kolasi%C5%84ska%E2%80%90Kloch&amp;volume=56&amp;issue=1&amp;publication_year=2005&amp;pages=121-131&amp;pmid=15795480&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0281">
<span class="label">281.</span><cite>
Ebenezer I. S. and Pringle A. K., “The Effect of Systemic Administration of baclofen on Food Intake in Rats,” Neuropharmacology
31, no. 1 (1992): 39–42.
</cite> [<a href="https://doi.org/10.1016/0028-3908(92)90158-l" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1311808/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuropharmacology&amp;title=The%20Effect%20of%20Systemic%20Administration%20of%20baclofen%20on%20Food%20Intake%20in%20Rats&amp;author=I.%20S.%20Ebenezer&amp;author=A.%20K.%20Pringle&amp;volume=31&amp;issue=1&amp;publication_year=1992&amp;pages=39-42&amp;pmid=1311808&amp;doi=10.1016/0028-3908(92)90158-l&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0282">
<span class="label">282.</span><cite>
Zhao Z. D., Zhang L., Xiang X., et al., “Neurocircuitry of Predatory Hunting,” Neuroscience Bulletin
39, no. 5 (2023): 817–831.
</cite> [<a href="https://doi.org/10.1007/s12264-022-01018-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10170020/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36705845/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuroscience%20Bulletin&amp;title=Neurocircuitry%20of%20Predatory%20Hunting&amp;author=Z.%20D.%20Zhao&amp;author=L.%20Zhang&amp;author=X.%20Xiang&amp;volume=39&amp;issue=5&amp;publication_year=2023&amp;pages=817-831&amp;pmid=36705845&amp;doi=10.1007/s12264-022-01018-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0283">
<span class="label">283.</span><cite>
Thorpe A. J., Doane D. F., Sweet D. C., Beverly J. L., and Kotz C. M., “Orexin A in the Rostrolateral Hypothalamic Area Induces Feeding by Modulating GABAergic Transmission,” Brain Research
1125, no. 1 (2006): 60–66.
</cite> [<a href="https://doi.org/10.1016/j.brainres.2006.09.075" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1779580/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17092492/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Brain%20Research&amp;title=Orexin%20A%20in%20the%20Rostrolateral%20Hypothalamic%20Area%20Induces%20Feeding%20by%20Modulating%20GABAergic%20Transmission&amp;author=A.%20J.%20Thorpe&amp;author=D.%20F.%20Doane&amp;author=D.%20C.%20Sweet&amp;author=J.%20L.%20Beverly&amp;author=C.%20M.%20Kotz&amp;volume=1125&amp;issue=1&amp;publication_year=2006&amp;pages=60-66&amp;pmid=17092492&amp;doi=10.1016/j.brainres.2006.09.075&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0284">
<span class="label">284.</span><cite>
Sato I., Arima H., Ozaki N., et al., “Peripherally Administered baclofen Reduced Food Intake and Body Weight in db /db as Well as Diet‐induced Obese Mice,” FEBS Letters
581, no. 25 (2007): 4857–4864.
</cite> [<a href="https://doi.org/10.1016/j.febslet.2007.09.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17888909/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=FEBS%20Letters&amp;title=Peripherally%20Administered%20baclofen%20Reduced%20Food%20Intake%20and%20Body%20Weight%20in%20db%20/db%20as%20Well%20as%20Diet%E2%80%90induced%20Obese%20Mice&amp;author=I.%20Sato&amp;author=H.%20Arima&amp;author=N.%20Ozaki&amp;volume=581&amp;issue=25&amp;publication_year=2007&amp;pages=4857-4864&amp;pmid=17888909&amp;doi=10.1016/j.febslet.2007.09.011&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0285">
<span class="label">285.</span><cite>
Cassidy R. M., Lu Y., Jere M., Tian J. B., and Tong Q., “A Lateral Hypothalamus to Basal Forebrain Neurocircuit Promotes Feeding by Suppressing Responses to Anxiogenic Environmental Cues,” Science Advances
5, no. 3 (2019): eaav1640.
</cite> [<a href="https://doi.org/10.1126/sciadv.aav1640" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6402846/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30854429/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Science%20Advances&amp;title=A%20Lateral%20Hypothalamus%20to%20Basal%20Forebrain%20Neurocircuit%20Promotes%20Feeding%20by%20Suppressing%20Responses%20to%20Anxiogenic%20Environmental%20Cues&amp;author=R.%20M.%20Cassidy&amp;author=Y.%20Lu&amp;author=M.%20Jere&amp;author=J.%20B.%20Tian&amp;author=Q.%20Tong&amp;volume=5&amp;issue=3&amp;publication_year=2019&amp;pages=eaav1640&amp;pmid=30854429&amp;doi=10.1126/sciadv.aav1640&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0286">
<span class="label">286.</span><cite>
Han Y., Yuan K., Zheng Y., and Lu L., “Orexin Receptor Antagonists as Emerging Treatments for Psychiatric Disorders,” Neuroscience Bulletin
36, no. 4 (2020): 432–448.
</cite> [<a href="https://doi.org/10.1007/s12264-019-00447-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7142186/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31782044/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuroscience%20Bulletin&amp;title=Orexin%20Receptor%20Antagonists%20as%20Emerging%20Treatments%20for%20Psychiatric%20Disorders&amp;author=Y.%20Han&amp;author=K.%20Yuan&amp;author=Y.%20Zheng&amp;author=L.%20Lu&amp;volume=36&amp;issue=4&amp;publication_year=2020&amp;pages=432-448&amp;pmid=31782044&amp;doi=10.1007/s12264-019-00447-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0287">
<span class="label">287.</span><cite>
Zhang X. Y., Yu L., Zhuang Q. X., Zhu J. N., and Wang J. J., “Central Functions of the Orexinergic System,” Neuroscience Bulletin
29, no. 3 (2013): 355–365.
</cite> [<a href="https://doi.org/10.1007/s12264-012-1297-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5561835/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23299718/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuroscience%20Bulletin&amp;title=Central%20Functions%20of%20the%20Orexinergic%20System&amp;author=X.%20Y.%20Zhang&amp;author=L.%20Yu&amp;author=Q.%20X.%20Zhuang&amp;author=J.%20N.%20Zhu&amp;author=J.%20J.%20Wang&amp;volume=29&amp;issue=3&amp;publication_year=2013&amp;pages=355-365&amp;pmid=23299718&amp;doi=10.1007/s12264-012-1297-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0288">
<span class="label">288.</span><cite>
Herman A. M., Ortiz‐Guzman J., Kochukov M., et al., “A Cholinergic Basal Forebrain Feeding Circuit Modulates Appetite Suppression,” Nature
538, no. 7624 (2016): 253–256.
</cite> [<a href="https://doi.org/10.1038/nature19789" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5507212/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27698417/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=A%20Cholinergic%20Basal%20Forebrain%20Feeding%20Circuit%20Modulates%20Appetite%20Suppression&amp;author=A.%20M.%20Herman&amp;author=J.%20Ortiz%E2%80%90Guzman&amp;author=M.%20Kochukov&amp;volume=538&amp;issue=7624&amp;publication_year=2016&amp;pages=253-256&amp;pmid=27698417&amp;doi=10.1038/nature19789&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0289">
<span class="label">289.</span><cite>
Nieh E. H., Vander Weele C. M., Matthews G. A., et al., “Inhibitory Input From the Lateral Hypothalamus to the Ventral Tegmental Area Disinhibits Dopamine Neurons and Promotes Behavioral Activation,” Neuron
90, no. 6 (2016): 1286–1298.
</cite> [<a href="https://doi.org/10.1016/j.neuron.2016.04.035" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4961212/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27238864/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuron&amp;title=Inhibitory%20Input%20From%20the%20Lateral%20Hypothalamus%20to%20the%20Ventral%20Tegmental%20Area%20Disinhibits%20Dopamine%20Neurons%20and%20Promotes%20Behavioral%20Activation&amp;author=E.%20H.%20Nieh&amp;author=C.%20M.%20Vander%20Weele&amp;author=G.%20A.%20Matthews&amp;volume=90&amp;issue=6&amp;publication_year=2016&amp;pages=1286-1298&amp;pmid=27238864&amp;doi=10.1016/j.neuron.2016.04.035&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0290">
<span class="label">290.</span><cite>
Padgett C. L., Lalive A. L., Tan K. R., et al., “Methamphetamine‐evoked Depression of GABA(B) Receptor Signaling in GABA Neurons of the VTA,” Neuron
73, no. 5 (2012): 978–989.
</cite> [<a href="https://doi.org/10.1016/j.neuron.2011.12.031" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3560416/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22405207/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuron&amp;title=Methamphetamine%E2%80%90evoked%20Depression%20of%20GABA(B)%20Receptor%20Signaling%20in%20GABA%20Neurons%20of%20the%20VTA&amp;author=C.%20L.%20Padgett&amp;author=A.%20L.%20Lalive&amp;author=K.%20R.%20Tan&amp;volume=73&amp;issue=5&amp;publication_year=2012&amp;pages=978-989&amp;pmid=22405207&amp;doi=10.1016/j.neuron.2011.12.031&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0291">
<span class="label">291.</span><cite>
Narayanan N. S., Guarnieri D. J., and DiLeone R. J., “Metabolic Hormones, Dopamine Circuits, and Feeding,” Frontiers in Neuroendocrinology
31, no. 1 (2010): 104–112.
</cite> [<a href="https://doi.org/10.1016/j.yfrne.2009.10.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2813908/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19836414/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Neuroendocrinology&amp;title=Metabolic%20Hormones,%20Dopamine%20Circuits,%20and%20Feeding&amp;author=N.%20S.%20Narayanan&amp;author=D.%20J.%20Guarnieri&amp;author=R.%20J.%20DiLeone&amp;volume=31&amp;issue=1&amp;publication_year=2010&amp;pages=104-112&amp;pmid=19836414&amp;doi=10.1016/j.yfrne.2009.10.004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0292">
<span class="label">292.</span><cite>
Nieh E. H., Matthews G. A., Allsop S. A., et al., “Decoding Neural Circuits That Control Compulsive Sucrose Seeking,” Cell
160, no. 3 (2015): 528–541.
</cite> [<a href="https://doi.org/10.1016/j.cell.2015.01.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4312417/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25635460/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Decoding%20Neural%20Circuits%20That%20Control%20Compulsive%20Sucrose%20Seeking&amp;author=E.%20H.%20Nieh&amp;author=G.%20A.%20Matthews&amp;author=S.%20A.%20Allsop&amp;volume=160&amp;issue=3&amp;publication_year=2015&amp;pages=528-541&amp;pmid=25635460&amp;doi=10.1016/j.cell.2015.01.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0293">
<span class="label">293.</span><cite>
Barbano M. F., Wang H. L., Morales M., and Wise R. A., “Feeding and Reward Are Differentially Induced by Activating GABAergic Lateral Hypothalamic Projections to VTA,” Journal of Neuroscience
36, no. 10 (2016): 2975–2985.
</cite> [<a href="https://doi.org/10.1523/JNEUROSCI.3799-15.2016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4783499/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26961951/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Neuroscience&amp;title=Feeding%20and%20Reward%20Are%20Differentially%20Induced%20by%20Activating%20GABAergic%20Lateral%20Hypothalamic%20Projections%20to%20VTA&amp;author=M.%20F.%20Barbano&amp;author=H.%20L.%20Wang&amp;author=M.%20Morales&amp;author=R.%20A.%20Wise&amp;volume=36&amp;issue=10&amp;publication_year=2016&amp;pages=2975-2985&amp;pmid=26961951&amp;doi=10.1523/JNEUROSCI.3799-15.2016&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0294">
<span class="label">294.</span><cite>
Qualls‐Creekmore E., Yu S., Francois M., et al., “Galanin‐Expressing GABA Neurons in the Lateral Hypothalamus Modulate Food Reward and Noncompulsive Locomotion,” Journal of Neuroscience
37, no. 25 (2017): 6053–6065.
</cite> [<a href="https://doi.org/10.1523/JNEUROSCI.0155-17.2017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5481941/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28539422/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Neuroscience&amp;title=Galanin%E2%80%90Expressing%20GABA%20Neurons%20in%20the%20Lateral%20Hypothalamus%20Modulate%20Food%20Reward%20and%20Noncompulsive%20Locomotion&amp;author=E.%20Qualls%E2%80%90Creekmore&amp;author=S.%20Yu&amp;author=M.%20Francois&amp;volume=37&amp;issue=25&amp;publication_year=2017&amp;pages=6053-6065&amp;pmid=28539422&amp;doi=10.1523/JNEUROSCI.0155-17.2017&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0295">
<span class="label">295.</span><cite>
Brown M. T., Tan K. R., O'Connor E. C., Nikonenko I., Muller D., and Lüscher C., “Ventral Tegmental Area GABA Projections Pause Accumbal Cholinergic Interneurons to Enhance Associative Learning,” Nature
492, no. 7429 (2012): 452–456.
</cite> [<a href="https://doi.org/10.1038/nature11657" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23178810/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Ventral%20Tegmental%20Area%20GABA%20Projections%20Pause%20Accumbal%20Cholinergic%20Interneurons%20to%20Enhance%20Associative%20Learning&amp;author=M.%20T.%20Brown&amp;author=K.%20R.%20Tan&amp;author=E.%20C.%20O'Connor&amp;author=I.%20Nikonenko&amp;author=D.%20Muller&amp;volume=492&amp;issue=7429&amp;publication_year=2012&amp;pages=452-456&amp;pmid=23178810&amp;doi=10.1038/nature11657&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0296">
<span class="label">296.</span><cite>
Lüscher C. and Malenka R. C., “Drug‐evoked Synaptic Plasticity in Addiction: From Molecular Changes to Circuit Remodeling,” Neuron
69, no. 4 (2011): 650–663.
</cite> [<a href="https://doi.org/10.1016/j.neuron.2011.01.017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4046255/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21338877/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuron&amp;title=Drug%E2%80%90evoked%20Synaptic%20Plasticity%20in%20Addiction:%20From%20Molecular%20Changes%20to%20Circuit%20Remodeling&amp;author=C.%20L%C3%BCscher&amp;author=R.%20C.%20Malenka&amp;volume=69&amp;issue=4&amp;publication_year=2011&amp;pages=650-663&amp;pmid=21338877&amp;doi=10.1016/j.neuron.2011.01.017&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0297">
<span class="label">297.</span><cite>
Thompson B. L., Oscar‐Berman M., and Kaplan G. B., “Opioid‐induced Structural and Functional Plasticity of Medium‐spiny Neurons in the Nucleus Accumbens,” Neuroscience and Biobehavioral Reviews
120 (2021): 417–430.
</cite> [<a href="https://doi.org/10.1016/j.neubiorev.2020.10.015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7855607/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33152423/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuroscience%20and%20Biobehavioral%20Reviews&amp;title=Opioid%E2%80%90induced%20Structural%20and%20Functional%20Plasticity%20of%20Medium%E2%80%90spiny%20Neurons%20in%20the%20Nucleus%20Accumbens&amp;author=B.%20L.%20Thompson&amp;author=M.%20Oscar%E2%80%90Berman&amp;author=G.%20B.%20Kaplan&amp;volume=120&amp;publication_year=2021&amp;pages=417-430&amp;pmid=33152423&amp;doi=10.1016/j.neubiorev.2020.10.015&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0298">
<span class="label">298.</span><cite>
Yang H., de Jong J. W., Tak Y., Peck J., Bateup H. S., and Lammel S., “Nucleus Accumbens Subnuclei Regulate Motivated Behavior via Direct Inhibition and Disinhibition of VTA Dopamine Subpopulations,” Neuron
97, no. 2 (2018): 434–449. e4.
</cite> [<a href="https://doi.org/10.1016/j.neuron.2017.12.022" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5773387/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29307710/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuron&amp;title=Nucleus%20Accumbens%20Subnuclei%20Regulate%20Motivated%20Behavior%20via%20Direct%20Inhibition%20and%20Disinhibition%20of%20VTA%20Dopamine%20Subpopulations&amp;author=H.%20Yang&amp;author=J.%20W.%20de%20Jong&amp;author=Y.%20Tak&amp;author=J.%20Peck&amp;author=H.%20S.%20Bateup&amp;volume=97&amp;issue=2&amp;publication_year=2018&amp;pages=434-449&amp;pmid=29307710&amp;doi=10.1016/j.neuron.2017.12.022&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0299">
<span class="label">299.</span><cite>
Gremel C. M. and Costa R. M., “Orbitofrontal and Striatal Circuits Dynamically Encode the Shift Between Goal‐directed and Habitual Actions,” Nature Communications
4 (2013): 2264.</cite> [<a href="https://doi.org/10.1038/ncomms3264" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4026062/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23921250/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Communications&amp;title=Orbitofrontal%20and%20Striatal%20Circuits%20Dynamically%20Encode%20the%20Shift%20Between%20Goal%E2%80%90directed%20and%20Habitual%20Actions&amp;author=C.%20M.%20Gremel&amp;author=R.%20M.%20Costa&amp;volume=4&amp;publication_year=2013&amp;pages=2264&amp;pmid=23921250&amp;doi=10.1038/ncomms3264&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0300">
<span class="label">300.</span><cite>
Duan L. Y., Horst N. K., Cranmore S. A. W., et al., “Controlling One's World: Identification of Sub‐regions of Primate PFC Underlying Goal‐directed Behavior,” Neuron
109, no. 15 (2021): 2485–2498. e5.
</cite> [<a href="https://doi.org/10.1016/j.neuron.2021.06.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8346232/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34171290/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuron&amp;title=Controlling%20One's%20World:%20Identification%20of%20Sub%E2%80%90regions%20of%20Primate%20PFC%20Underlying%20Goal%E2%80%90directed%20Behavior&amp;author=L.%20Y.%20Duan&amp;author=N.%20K.%20Horst&amp;author=S.%20A.%20W.%20Cranmore&amp;volume=109&amp;issue=15&amp;publication_year=2021&amp;pages=2485-2498&amp;pmid=34171290&amp;doi=10.1016/j.neuron.2021.06.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0301">
<span class="label">301.</span><cite>
Forget B., Pushparaj A., and Le Foll B., “Granular Insular Cortex Inactivation as a Novel Therapeutic Strategy for Nicotine Addiction,” Biological Psychiatry
68, no. 3 (2010): 265–271.
</cite> [<a href="https://doi.org/10.1016/j.biopsych.2010.01.029" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20299008/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biological%20Psychiatry&amp;title=Granular%20Insular%20Cortex%20Inactivation%20as%20a%20Novel%20Therapeutic%20Strategy%20for%20Nicotine%20Addiction&amp;author=B.%20Forget&amp;author=A.%20Pushparaj&amp;author=B.%20Le%20Foll&amp;volume=68&amp;issue=3&amp;publication_year=2010&amp;pages=265-271&amp;pmid=20299008&amp;doi=10.1016/j.biopsych.2010.01.029&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0302">
<span class="label">302.</span><cite>
Avena N. M., Bocarsly M. E., Murray S., and Gold M. S., “Effects of Baclofen and Naltrexone, Alone and in Combination, on the Consumption of Palatable Food in Male Rats,” Experimental and Clinical Psychopharmacology
22, no. 5 (2014): 460–467.
</cite> [<a href="https://doi.org/10.1037/a0037223" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25069013/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Experimental%20and%20Clinical%20Psychopharmacology&amp;title=Effects%20of%20Baclofen%20and%20Naltrexone,%20Alone%20and%20in%20Combination,%20on%20the%20Consumption%20of%20Palatable%20Food%20in%20Male%20Rats&amp;author=N.%20M.%20Avena&amp;author=M.%20E.%20Bocarsly&amp;author=S.%20Murray&amp;author=M.%20S.%20Gold&amp;volume=22&amp;issue=5&amp;publication_year=2014&amp;pages=460-467&amp;pmid=25069013&amp;doi=10.1037/a0037223&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0303">
<span class="label">303.</span><cite>
Corwin R. L. and Wojnicki F. H., “Baclofen, Raclopride, and Naltrexone Differentially Affect Intake of Fat and Sucrose Under Limited Access Conditions,” Behavioural Pharmacology
20, no. 5‐6 (2009): 537–548.
</cite> [<a href="https://doi.org/10.1097/FBP.0b013e3283313168" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19724193/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Behavioural%20Pharmacology&amp;title=Baclofen,%20Raclopride,%20and%20Naltrexone%20Differentially%20Affect%20Intake%20of%20Fat%20and%20Sucrose%20Under%20Limited%20Access%20Conditions&amp;author=R.%20L.%20Corwin&amp;author=F.%20H.%20Wojnicki&amp;volume=20&amp;issue=5%E2%80%906&amp;publication_year=2009&amp;pages=537-548&amp;pmid=19724193&amp;doi=10.1097/FBP.0b013e3283313168&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0304">
<span class="label">304.</span><cite>
Wong K. J., Wojnicki F. H., and Corwin R. L., “Baclofen, Raclopride, and Naltrexone Differentially Affect Intake of Fat/Sucrose Mixtures Under Limited Access Conditions,” Pharmacology Biochemistry and Behavior
92, no. 3 (2009): 528–536.
</cite> [<a href="https://doi.org/10.1016/j.pbb.2009.02.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2841009/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19217918/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacology%20Biochemistry%20and%20Behavior&amp;title=Baclofen,%20Raclopride,%20and%20Naltrexone%20Differentially%20Affect%20Intake%20of%20Fat/Sucrose%20Mixtures%20Under%20Limited%20Access%20Conditions&amp;author=K.%20J.%20Wong&amp;author=F.%20H.%20Wojnicki&amp;author=R.%20L.%20Corwin&amp;volume=92&amp;issue=3&amp;publication_year=2009&amp;pages=528-536&amp;pmid=19217918&amp;doi=10.1016/j.pbb.2009.02.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0305">
<span class="label">305.</span><cite>
Vickers S. P., Hackett D., Murray F., Hutson P. H., and Heal D. J., “Effects of Lisdexamfetamine in a Rat Model of Binge‐eating,” Journal of Psychopharmacology
29, no. 12 (2015): 1290–1307.
</cite> [<a href="https://doi.org/10.1177/0269881115615107" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26589243/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Psychopharmacology&amp;title=Effects%20of%20Lisdexamfetamine%20in%20a%20Rat%20Model%20of%20Binge%E2%80%90eating&amp;author=S.%20P.%20Vickers&amp;author=D.%20Hackett&amp;author=F.%20Murray&amp;author=P.%20H.%20Hutson&amp;author=D.%20J.%20Heal&amp;volume=29&amp;issue=12&amp;publication_year=2015&amp;pages=1290-1307&amp;pmid=26589243&amp;doi=10.1177/0269881115615107&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0306">
<span class="label">306.</span><cite>
Bonanno G. and Raiteri M., “gamma‐Aminobutyric Acid (GABA) Autoreceptors in Rat Cerebral Cortex and Spinal Cord Represent Pharmacologically Distinct Subtypes of the GABAB Receptor,” Journal of Pharmacology and Experimental Therapeutics
265, no. 2 (1993): 765–770.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/8388458/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Pharmacology%20and%20Experimental%20Therapeutics&amp;title=gamma%E2%80%90Aminobutyric%20Acid%20(GABA)%20Autoreceptors%20in%20Rat%20Cerebral%20Cortex%20and%20Spinal%20Cord%20Represent%20Pharmacologically%20Distinct%20Subtypes%20of%20the%20GABAB%20Receptor&amp;author=G.%20Bonanno&amp;author=M.%20Raiteri&amp;volume=265&amp;issue=2&amp;publication_year=1993&amp;pages=765-770&amp;pmid=8388458&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0307">
<span class="label">307.</span><cite>
Berner L. A., Bocarsly M. E., Hoebel B. G., and Avena N. M., “Baclofen Suppresses Binge Eating of Pure Fat but Not a Sugar‐rich or Sweet‐fat Diet,” Behavioural Pharmacology
20, no. 7 (2009): 631–634.
</cite> [<a href="https://doi.org/10.1097/FBP.0b013e328331ba47" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3291953/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19752722/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Behavioural%20Pharmacology&amp;title=Baclofen%20Suppresses%20Binge%20Eating%20of%20Pure%20Fat%20but%20Not%20a%20Sugar%E2%80%90rich%20or%20Sweet%E2%80%90fat%20Diet&amp;author=L.%20A.%20Berner&amp;author=M.%20E.%20Bocarsly&amp;author=B.%20G.%20Hoebel&amp;author=N.%20M.%20Avena&amp;volume=20&amp;issue=7&amp;publication_year=2009&amp;pages=631-634&amp;pmid=19752722&amp;doi=10.1097/FBP.0b013e328331ba47&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0308">
<span class="label">308.</span><cite>
Wojnicki F. H. E., Roberts D. C. S., and Corwin R. L. W., “Effects of baclofen on Operant Performance for Food Pellets and Vegetable Shortening After a History of Binge‐type Behavior in Non‐food Deprived Rats,” Pharmacology Biochemistry and Behavior
84, no. 2 (2006): 197–206.
</cite> [<a href="https://doi.org/10.1016/j.pbb.2006.04.015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1769471/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16782181/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacology%20Biochemistry%20and%20Behavior&amp;title=Effects%20of%20baclofen%20on%20Operant%20Performance%20for%20Food%20Pellets%20and%20Vegetable%20Shortening%20After%20a%20History%20of%20Binge%E2%80%90type%20Behavior%20in%20Non%E2%80%90food%20Deprived%20Rats&amp;author=F.%20H.%20E.%20Wojnicki&amp;author=D.%20C.%20S.%20Roberts&amp;author=R.%20L.%20W.%20Corwin&amp;volume=84&amp;issue=2&amp;publication_year=2006&amp;pages=197-206&amp;pmid=16782181&amp;doi=10.1016/j.pbb.2006.04.015&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0309">
<span class="label">309.</span><cite>
Buda‐Levin A., Wojnicki F. H., and Corwin R. L., “Baclofen Reduces Fat Intake Under Binge‐type Conditions,” Physiology &amp; Behavior
86, no. 1‐2 (2005): 176–184.
</cite> [<a href="https://doi.org/10.1016/j.physbeh.2005.07.020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1769468/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16140347/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Physiology%20&amp;%20Behavior&amp;title=Baclofen%20Reduces%20Fat%20Intake%20Under%20Binge%E2%80%90type%20Conditions&amp;author=A.%20Buda%E2%80%90Levin&amp;author=F.%20H.%20Wojnicki&amp;author=R.%20L.%20Corwin&amp;volume=86&amp;issue=1%E2%80%902&amp;publication_year=2005&amp;pages=176-184&amp;pmid=16140347&amp;doi=10.1016/j.physbeh.2005.07.020&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0310">
<span class="label">310.</span><cite>
Arima H. and Oiso Y., “Positive Effect of baclofen on Body Weight Reduction in Obese Subjects: A Pilot Study,” Internal Medicine
49, no. 19 (2010): 2043–2047.
</cite> [<a href="https://doi.org/10.2169/internalmedicine.49.3918" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20930428/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Internal%20Medicine&amp;title=Positive%20Effect%20of%20baclofen%20on%20Body%20Weight%20Reduction%20in%20Obese%20Subjects:%20A%20Pilot%20Study&amp;author=H.%20Arima&amp;author=Y.%20Oiso&amp;volume=49&amp;issue=19&amp;publication_year=2010&amp;pages=2043-2047&amp;pmid=20930428&amp;doi=10.2169/internalmedicine.49.3918&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0311">
<span class="label">311.</span><cite>
Broft A. I., Spanos A., Corwin R. L., et al., “Baclofen for Binge Eating: An Open‐label Trial,” International Journal of Eating Disorders
40, no. 8 (2007): 687–691.
</cite> [<a href="https://doi.org/10.1002/eat.20434" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17647277/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Journal%20of%20Eating%20Disorders&amp;title=Baclofen%20for%20Binge%20Eating:%20An%20Open%E2%80%90label%20Trial&amp;author=A.%20I.%20Broft&amp;author=A.%20Spanos&amp;author=R.%20L.%20Corwin&amp;volume=40&amp;issue=8&amp;publication_year=2007&amp;pages=687-691&amp;pmid=17647277&amp;doi=10.1002/eat.20434&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0312">
<span class="label">312.</span><cite>
Corwin R. L., Boan J., Peters K. F., and Ulbrecht J. S., “Baclofen Reduces Binge Eating in a Double‐blind, Placebo‐controlled, Crossover Study,” Behavioural Pharmacology
23, no. 5‐6 (2012): 616–625.
</cite> [<a href="https://doi.org/10.1097/FBP.0b013e328357bd62" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22854310/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Behavioural%20Pharmacology&amp;title=Baclofen%20Reduces%20Binge%20Eating%20in%20a%20Double%E2%80%90blind,%20Placebo%E2%80%90controlled,%20Crossover%20Study&amp;author=R.%20L.%20Corwin&amp;author=J.%20Boan&amp;author=K.%20F.%20Peters&amp;author=J.%20S.%20Ulbrecht&amp;volume=23&amp;issue=5%E2%80%906&amp;publication_year=2012&amp;pages=616-625&amp;pmid=22854310&amp;doi=10.1097/FBP.0b013e328357bd62&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0313">
<span class="label">313.</span><cite>
Hurley M. M., Maunze B., Block M. E., et al., “Pituitary Adenylate‐Cyclase Activating Polypeptide Regulates Hunger‐ and Palatability‐Induced Binge Eating,” Frontiers in neuroscience
10 (2016): 383.
</cite> [<a href="https://doi.org/10.3389/fnins.2016.00383" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4993128/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27597817/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20neuroscience&amp;title=Pituitary%20Adenylate%E2%80%90Cyclase%20Activating%20Polypeptide%20Regulates%20Hunger%E2%80%90%20and%20Palatability%E2%80%90Induced%20Binge%20Eating&amp;author=M.%20M.%20Hurley&amp;author=B.%20Maunze&amp;author=M.%20E.%20Block&amp;volume=10&amp;publication_year=2016&amp;pages=383&amp;pmid=27597817&amp;doi=10.3389/fnins.2016.00383&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0314">
<span class="label">314.</span><cite>
Brunault P. and Ballon N., “Inter‐Individual Differences in Food Addiction and Other Forms of Addictive‐Like Eating Behavior,” Nutrients
13, no. 2 (2021).</cite> [<a href="https://doi.org/10.3390/nu13020325" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7912266/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33498612/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nutrients&amp;title=Inter%E2%80%90Individual%20Differences%20in%20Food%20Addiction%20and%20Other%20Forms%20of%20Addictive%E2%80%90Like%20Eating%20Behavior&amp;author=P.%20Brunault&amp;author=N.%20Ballon&amp;volume=13&amp;issue=2&amp;publication_year=2021&amp;pmid=33498612&amp;doi=10.3390/nu13020325&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0315">
<span class="label">315.</span><cite>
Gearhardt A. N. and Schulte E. M., “Is Food Addictive? A Review of the Science,” Annual Review of Nutrition (2021).</cite> [<a href="https://doi.org/10.1146/annurev-nutr-110420-111710" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34152831/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Annual%20Review%20of%20Nutrition&amp;title=Is%20Food%20Addictive?%20A%20Review%20of%20the%20Science&amp;author=A.%20N.%20Gearhardt&amp;author=E.%20M.%20Schulte&amp;publication_year=2021&amp;pmid=34152831&amp;doi=10.1146/annurev-nutr-110420-111710&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0316">
<span class="label">316.</span><cite>
Liu C., Rotaru K., Lee R. S. C., et al., “Distress‐driven Impulsivity Interacts With Cognitive Inflexibility to Determine Addiction‐Like Eating,” Journal of Behavioral Addictions (2021).</cite> [<a href="https://doi.org/10.1556/2006.2021.00027" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8997201/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33909594/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Behavioral%20Addictions&amp;title=Distress%E2%80%90driven%20Impulsivity%20Interacts%20With%20Cognitive%20Inflexibility%20to%20Determine%20Addiction%E2%80%90Like%20Eating&amp;author=C.%20Liu&amp;author=K.%20Rotaru&amp;author=R.%20S.%20C.%20Lee&amp;publication_year=2021&amp;pmid=33909594&amp;doi=10.1556/2006.2021.00027&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0317">
<span class="label">317.</span><cite>
Paola M. and Giancarlo C., “Potential of GABAB Receptor Positive Allosteric Modulators in the Treatment of Alcohol Use Disorder,” CNS Drugs (2019).</cite> [<a href="https://doi.org/10.1007/s40263-018-0596-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30604283/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=CNS%20Drugs&amp;title=Potential%20of%20GABAB%20Receptor%20Positive%20Allosteric%20Modulators%20in%20the%20Treatment%20of%20Alcohol%20Use%20Disorder&amp;author=M.%20Paola&amp;author=C.%20Giancarlo&amp;publication_year=2019&amp;pmid=30604283&amp;doi=10.1007/s40263-018-0596-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0318">
<span class="label">318.</span><cite>
Marti‐Prats L., Belin‐Rauscent A., Fouyssac M., et al., “Baclofen Decreases Compulsive Alcohol Drinking in Rats Characterized by Reduced Levels of GAT‐3 in the central Amygdala,” Addiction Biology
26, no. 4 (2021): e13011.
</cite> [<a href="https://doi.org/10.1111/adb.13011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8603926/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33527681/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Addiction%20Biology&amp;title=Baclofen%20Decreases%20Compulsive%20Alcohol%20Drinking%20in%20Rats%20Characterized%20by%20Reduced%20Levels%20of%20GAT%E2%80%903%20in%20the%20central%20Amygdala&amp;author=L.%20Marti%E2%80%90Prats&amp;author=A.%20Belin%E2%80%90Rauscent&amp;author=M.%20Fouyssac&amp;volume=26&amp;issue=4&amp;publication_year=2021&amp;pages=e13011&amp;pmid=33527681&amp;doi=10.1111/adb.13011&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0319">
<span class="label">319.</span><cite>
Farokhnia M., Deschaine S. L., Sadighi A., et al., “A Deeper Insight Into How GABA‐B Receptor Agonism via baclofen May Affect Alcohol Seeking and Consumption: Lessons Learned From a human Laboratory Investigation,” Molecular Psychiatry (2018).</cite> [<a href="https://doi.org/10.1038/s41380-018-0287-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6494745/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30382188/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20Psychiatry&amp;title=A%20Deeper%20Insight%20Into%20How%20GABA%E2%80%90B%20Receptor%20Agonism%20via%20baclofen%20May%20Affect%20Alcohol%20Seeking%20and%20Consumption:%20Lessons%20Learned%20From%20a%20human%20Laboratory%20Investigation&amp;author=M.%20Farokhnia&amp;author=S.%20L.%20Deschaine&amp;author=A.%20Sadighi&amp;publication_year=2018&amp;pmid=30382188&amp;doi=10.1038/s41380-018-0287-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0320">
<span class="label">320.</span><cite>
Coscina D. V., “GABA and Feeding: Reversal of Overeating by central GABA‐transaminase Inhibition,” Progress in Neuro‐Psychopharmacology &amp; Biological Psychiatry
7, no. 4‐6 (1983): 463–467.
</cite> [<a href="https://doi.org/10.1016/0278-5846(83)90012-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/6686689/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Progress%20in%20Neuro%E2%80%90Psychopharmacology%20&amp;%20Biological%20Psychiatry&amp;title=GABA%20and%20Feeding:%20Reversal%20of%20Overeating%20by%20central%20GABA%E2%80%90transaminase%20Inhibition&amp;author=D.%20V.%20Coscina&amp;volume=7&amp;issue=4%E2%80%906&amp;publication_year=1983&amp;pages=463-467&amp;pmid=6686689&amp;doi=10.1016/0278-5846(83)90012-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0321">
<span class="label">321.</span><cite>
Fan S., Xu Y., Lu Y., et al., “A Neural Basis for Brain Leptin Action on Reducing Type 1 Diabetic Hyperglycemia,” Nature Communications
12, no. 1 (2021): 2662.</cite> [<a href="https://doi.org/10.1038/s41467-021-22940-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8113586/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33976218/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Communications&amp;title=A%20Neural%20Basis%20for%20Brain%20Leptin%20Action%20on%20Reducing%20Type%201%20Diabetic%20Hyperglycemia&amp;author=S.%20Fan&amp;author=Y.%20Xu&amp;author=Y.%20Lu&amp;volume=12&amp;issue=1&amp;publication_year=2021&amp;pages=2662&amp;pmid=33976218&amp;doi=10.1038/s41467-021-22940-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0322">
<span class="label">322.</span><cite>
Durant C. F., Paterson L. M., Turton S., et al., “Using Baclofen to Explore GABA‐B Receptor Function in Alcohol Dependence: Insights from Pharmacokinetic and Pharmacodynamic Measures,” Front Psychiatry
9 (2018): 664.
</cite> [<a href="https://doi.org/10.3389/fpsyt.2018.00664" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6302106/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30618857/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Psychiatry&amp;title=Using%20Baclofen%20to%20Explore%20GABA%E2%80%90B%20Receptor%20Function%20in%20Alcohol%20Dependence:%20Insights%20from%20Pharmacokinetic%20and%20Pharmacodynamic%20Measures&amp;author=C.%20F.%20Durant&amp;author=L.%20M.%20Paterson&amp;author=S.%20Turton&amp;volume=9&amp;publication_year=2018&amp;pages=664&amp;pmid=30618857&amp;doi=10.3389/fpsyt.2018.00664&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0323">
<span class="label">323.</span><cite>
Niedzielska‐Andres E., Pomierny‐Chamioło L., Andres M., et al., “Cocaine Use Disorder: A Look at Metabotropic Glutamate Receptors and Glutamate Transporters,” Pharmacology &amp; Therapeutics
221 (2021): 107797.
</cite> [<a href="https://doi.org/10.1016/j.pharmthera.2020.107797" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33359590/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacology%20&amp;%20Therapeutics&amp;title=Cocaine%20Use%20Disorder:%20A%20Look%20at%20Metabotropic%20Glutamate%20Receptors%20and%20Glutamate%20Transporters&amp;author=E.%20Niedzielska%E2%80%90Andres&amp;author=L.%20Pomierny%E2%80%90Chamio%C5%82o&amp;author=M.%20Andres&amp;volume=221&amp;publication_year=2021&amp;pages=107797&amp;pmid=33359590&amp;doi=10.1016/j.pharmthera.2020.107797&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0324">
<span class="label">324.</span><cite>
Addolorato G., Caputo F., Capristo E., Colombo G., Gessa G. L., and Gasbarrini G., “Ability of baclofen in Reducing Alcohol Craving and Intake: II–Preliminary Clinical Evidence,” Alcoholism, Clinical and Experimental Research
24, no. 1 (2000): 67–71.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/10656195/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Alcoholism,%20Clinical%20and%20Experimental%20Research&amp;title=Ability%20of%20baclofen%20in%20Reducing%20Alcohol%20Craving%20and%20Intake:%20II%E2%80%93Preliminary%20Clinical%20Evidence&amp;author=G.%20Addolorato&amp;author=F.%20Caputo&amp;author=E.%20Capristo&amp;author=G.%20Colombo&amp;author=G.%20L.%20Gessa&amp;volume=24&amp;issue=1&amp;publication_year=2000&amp;pages=67-71&amp;pmid=10656195&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0325">
<span class="label">325.</span><cite>
Addolorato G., Leggio L., Cardone S., Ferrulli A., and Gasbarrini G., “Role of the GABA(B) Receptor System in Alcoholism and Stress: Focus on Clinical Studies and Treatment Perspectives,” Alcohol
43, no. 7 (2009): 559–563.
</cite> [<a href="https://doi.org/10.1016/j.alcohol.2009.09.031" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19913201/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Alcohol&amp;title=Role%20of%20the%20GABA(B)%20Receptor%20System%20in%20Alcoholism%20and%20Stress:%20Focus%20on%20Clinical%20Studies%20and%20Treatment%20Perspectives&amp;author=G.%20Addolorato&amp;author=L.%20Leggio&amp;author=S.%20Cardone&amp;author=A.%20Ferrulli&amp;author=G.%20Gasbarrini&amp;volume=43&amp;issue=7&amp;publication_year=2009&amp;pages=559-563&amp;pmid=19913201&amp;doi=10.1016/j.alcohol.2009.09.031&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0326">
<span class="label">326.</span><cite>
Addolorato G., Caputo F., Capristo E., et al., “Baclofen Efficacy in Reducing Alcohol Craving and Intake: A Preliminary Double‐blind Randomized Controlled Study,” Alcohol and Alcoholism
37, no. 5 (2002): 504–508.
</cite> [<a href="https://doi.org/10.1093/alcalc/37.5.504" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12217947/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Alcohol%20and%20Alcoholism&amp;title=Baclofen%20Efficacy%20in%20Reducing%20Alcohol%20Craving%20and%20Intake:%20A%20Preliminary%20Double%E2%80%90blind%20Randomized%20Controlled%20Study&amp;author=G.%20Addolorato&amp;author=F.%20Caputo&amp;author=E.%20Capristo&amp;volume=37&amp;issue=5&amp;publication_year=2002&amp;pages=504-508&amp;pmid=12217947&amp;doi=10.1093/alcalc/37.5.504&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0327">
<span class="label">327.</span><cite>
Piqueras L. and Martinez V., “Peripheral GABAB Agonists Stimulate Gastric Acid Secretion in Mice,” British Journal of Pharmacology
142, no. 6 (2004): 1038–1048.
</cite> [<a href="https://doi.org/10.1038/sj.bjp.0705876" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1575121/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15210585/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=British%20Journal%20of%20Pharmacology&amp;title=Peripheral%20GABAB%20Agonists%20Stimulate%20Gastric%20Acid%20Secretion%20in%20Mice&amp;author=L.%20Piqueras&amp;author=V.%20Martinez&amp;volume=142&amp;issue=6&amp;publication_year=2004&amp;pages=1038-1048&amp;pmid=15210585&amp;doi=10.1038/sj.bjp.0705876&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0328">
<span class="label">328.</span><cite>
Partosoedarso E. R., Young R. L., and Blackshaw L. A., “GABA(B) Receptors on Vagal Afferent Pathways: Peripheral and central Inhibition,” American Journal of Physiology Gastrointestinal &amp; Liver Physiology
280, no. 4 (2001): G658.
</cite> [<a href="https://doi.org/10.1152/ajpgi.2001.280.4.G658" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11254492/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Physiology%20Gastrointestinal%20&amp;%20Liver%20Physiology&amp;title=GABA(B)%20Receptors%20on%20Vagal%20Afferent%20Pathways:%20Peripheral%20and%20central%20Inhibition&amp;author=E.%20R.%20Partosoedarso&amp;author=R.%20L.%20Young&amp;author=L.%20A.%20Blackshaw&amp;volume=280&amp;issue=4&amp;publication_year=2001&amp;pages=G658&amp;pmid=11254492&amp;doi=10.1152/ajpgi.2001.280.4.G658&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0329">
<span class="label">329.</span><cite>
Kaneko K., Iwasaki M., Yoshikawa M., and Ohinata K., “Orally Administered Soymorphins, Soy‐derived Opioid Peptides, Suppress Feeding and Intestinal Transit via Gut Mu(1)‐receptor Coupled to 5‐HT(1A), D(2), and GABA(B) Systems,” American journal of physiology Gastrointestinal and liver physiology
299, no. 3 (2010): G799–805.
</cite> [<a href="https://doi.org/10.1152/ajpgi.00081.2010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20616303/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20journal%20of%20physiology%20Gastrointestinal%20and%20liver%20physiology&amp;title=Orally%20Administered%20Soymorphins,%20Soy%E2%80%90derived%20Opioid%20Peptides,%20Suppress%20Feeding%20and%20Intestinal%20Transit%20via%20Gut%20Mu(1)%E2%80%90receptor%20Coupled%20to%205%E2%80%90HT(1A),%20D(2),%20and%20GABA(B)%20Systems&amp;author=K.%20Kaneko&amp;author=M.%20Iwasaki&amp;author=M.%20Yoshikawa&amp;author=K.%20Ohinata&amp;volume=299&amp;issue=3&amp;publication_year=2010&amp;pages=G799-805&amp;pmid=20616303&amp;doi=10.1152/ajpgi.00081.2010&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0330">
<span class="label">330.</span><cite>
Kim T. H., Bulitta J. B., Kim D. H., Shin S., and Shin B. S., “Novel Extended in Vitro‐in Vivo Correlation Model for the Development of Extended‐release Formulations for baclofen: From Formulation Composition to in Vivo Pharmacokinetics,” International Journal of Pharmaceutics
556 (2019): 276–286.
</cite> [<a href="https://doi.org/10.1016/j.ijpharm.2018.12.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30543888/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Journal%20of%20Pharmaceutics&amp;title=Novel%20Extended%20in%20Vitro%E2%80%90in%20Vivo%20Correlation%20Model%20for%20the%20Development%20of%20Extended%E2%80%90release%20Formulations%20for%20baclofen:%20From%20Formulation%20Composition%20to%20in%20Vivo%20Pharmacokinetics&amp;author=T.%20H.%20Kim&amp;author=J.%20B.%20Bulitta&amp;author=D.%20H.%20Kim&amp;author=S.%20Shin&amp;author=B.%20S.%20Shin&amp;volume=556&amp;publication_year=2019&amp;pages=276-286&amp;pmid=30543888&amp;doi=10.1016/j.ijpharm.2018.12.007&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0331">
<span class="label">331.</span><cite>
Schoeller F., Horowitz A. H., Jain A., et al., “Interoceptive Technologies for Psychiatric Interventions: From Diagnosis to Clinical Applications,” Neuroscience and Biobehavioral Reviews
156 (2024): 105478.
</cite> [<a href="https://doi.org/10.1016/j.neubiorev.2023.105478" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38007168/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuroscience%20and%20Biobehavioral%20Reviews&amp;title=Interoceptive%20Technologies%20for%20Psychiatric%20Interventions:%20From%20Diagnosis%20to%20Clinical%20Applications&amp;author=F.%20Schoeller&amp;author=A.%20H.%20Horowitz&amp;author=A.%20Jain&amp;volume=156&amp;publication_year=2024&amp;pages=105478&amp;pmid=38007168&amp;doi=10.1016/j.neubiorev.2023.105478&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0332">
<span class="label">332.</span><cite>
Vourc'h M., Dailly E., Hourmant Y., et al., “Pharmacokinetics and Toxicity of High‐dose Baclofen in ICU Patients,” Progress in Neuro‐Psychopharmacology &amp; Biological Psychiatry
92 (2019): 450–456.
</cite> [<a href="https://doi.org/10.1016/j.pnpbp.2019.02.016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30826461/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Progress%20in%20Neuro%E2%80%90Psychopharmacology%20&amp;%20Biological%20Psychiatry&amp;title=Pharmacokinetics%20and%20Toxicity%20of%20High%E2%80%90dose%20Baclofen%20in%20ICU%20Patients&amp;author=M.%20Vourc'h&amp;author=E.%20Dailly&amp;author=Y.%20Hourmant&amp;volume=92&amp;publication_year=2019&amp;pages=450-456&amp;pmid=30826461&amp;doi=10.1016/j.pnpbp.2019.02.016&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0333">
<span class="label">333.</span><cite>
Vourc'h M., Dailly E., Hourmant Y., et al., “Pharmacokinetic Data on High Dose Baclofen Administration in Unhealthy Alcohol User in the ICU,” Data Brief
25 (2019): 104231.
</cite> [<a href="https://doi.org/10.1016/j.dib.2019.104231" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6699558/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31440546/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Data%20Brief&amp;title=Pharmacokinetic%20Data%20on%20High%20Dose%20Baclofen%20Administration%20in%20Unhealthy%20Alcohol%20User%20in%20the%20ICU&amp;author=M.%20Vourc'h&amp;author=E.%20Dailly&amp;author=Y.%20Hourmant&amp;volume=25&amp;publication_year=2019&amp;pages=104231&amp;pmid=31440546&amp;doi=10.1016/j.dib.2019.104231&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0334">
<span class="label">334.</span><cite>
Lyu Q., Xue W., Liu R., et al., “A Brain‐to‐gut Signal Controls Intestinal Fat Absorption,” Nature (2024).</cite> [<a href="https://doi.org/10.1038/s41586-024-07929-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39261733/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=A%20Brain%E2%80%90to%E2%80%90gut%20Signal%20Controls%20Intestinal%20Fat%20Absorption&amp;author=Q.%20Lyu&amp;author=W.%20Xue&amp;author=R.%20Liu&amp;publication_year=2024&amp;pmid=39261733&amp;doi=10.1038/s41586-024-07929-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0335">
<span class="label">335.</span><cite>
Golombeck K. S., Bönte K., Mönig C., et al., “Evidence of a Pathogenic Role for CD8(+) T Cells in Anti‐GABAB Receptor Limbic Encephalitis,” Neurol Neuroimmunol Neuroinflamm
3, no. 3 (2016): e232.
</cite> [<a href="https://doi.org/10.1212/NXI.0000000000000232" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4853055/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27213174/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurol%20Neuroimmunol%20Neuroinflamm&amp;title=Evidence%20of%20a%20Pathogenic%20Role%20for%20CD8(+)%20T%20Cells%20in%20Anti%E2%80%90GABAB%20Receptor%20Limbic%20Encephalitis&amp;author=K.%20S.%20Golombeck&amp;author=K.%20B%C3%B6nte&amp;author=C.%20M%C3%B6nig&amp;volume=3&amp;issue=3&amp;publication_year=2016&amp;pages=e232&amp;pmid=27213174&amp;doi=10.1212/NXI.0000000000000232&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0336">
<span class="label">336.</span><cite>
Abdul M., McCray S. D., and Hoosein N. M., “Expression of Gamma‐aminobutyric Acid Receptor (subtype A) in Prostate Cancer,” Acta Oncol
47, no. 8 (2008): 1546–1550.
</cite> [<a href="https://doi.org/10.1080/02841860801961265" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18607852/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Oncol&amp;title=Expression%20of%20Gamma%E2%80%90aminobutyric%20Acid%20Receptor%20(subtype%20A)%20in%20Prostate%20Cancer&amp;author=M.%20Abdul&amp;author=S.%20D.%20McCray&amp;author=N.%20M.%20Hoosein&amp;volume=47&amp;issue=8&amp;publication_year=2008&amp;pages=1546-1550&amp;pmid=18607852&amp;doi=10.1080/02841860801961265&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0337">
<span class="label">337.</span><cite>
Yang Y., Ren L., Li W., et al., “GABAergic Signaling as a Potential Therapeutic Target in Cancers,” Biomedicine &amp; Pharmacotherapy
161 (2023): 114410.
</cite> [<a href="https://doi.org/10.1016/j.biopha.2023.114410" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36812710/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomedicine%20&amp;%20Pharmacotherapy&amp;title=GABAergic%20Signaling%20as%20a%20Potential%20Therapeutic%20Target%20in%20Cancers&amp;author=Y.%20Yang&amp;author=L.%20Ren&amp;author=W.%20Li&amp;volume=161&amp;publication_year=2023&amp;pages=114410&amp;pmid=36812710&amp;doi=10.1016/j.biopha.2023.114410&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0338">
<span class="label">338.</span><cite>
Zhang D., Li X., Yao Z., Wei C., Ning N., and Li J., “GABAergic Signaling Facilitates Breast Cancer Metastasis by Promoting ERK1/2‐dependent Phosphorylation,” Cancer Letters
348, no. 1‐2 (2014): 100–108.
</cite> [<a href="https://doi.org/10.1016/j.canlet.2014.03.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24657659/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Letters&amp;title=GABAergic%20Signaling%20Facilitates%20Breast%20Cancer%20Metastasis%20by%20Promoting%20ERK1/2%E2%80%90dependent%20Phosphorylation&amp;author=D.%20Zhang&amp;author=X.%20Li&amp;author=Z.%20Yao&amp;author=C.%20Wei&amp;author=N.%20Ning&amp;volume=348&amp;issue=1%E2%80%902&amp;publication_year=2014&amp;pages=100-108&amp;pmid=24657659&amp;doi=10.1016/j.canlet.2014.03.006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0339">
<span class="label">339.</span><cite>
Zekeridou A., Majed M., Heliopoulos I., and Lennon V. A., “Paraneoplastic Autoimmunity and Small‐cell Lung Cancer: Neurological and Serological Accompaniments,” Thorac Cancer
10, no. 4 (2019): 1001–1004.
</cite> [<a href="https://doi.org/10.1111/1759-7714.13009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6449272/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30810271/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Thorac%20Cancer&amp;title=Paraneoplastic%20Autoimmunity%20and%20Small%E2%80%90cell%20Lung%20Cancer:%20Neurological%20and%20Serological%20Accompaniments&amp;author=A.%20Zekeridou&amp;author=M.%20Majed&amp;author=I.%20Heliopoulos&amp;author=V.%20A.%20Lennon&amp;volume=10&amp;issue=4&amp;publication_year=2019&amp;pages=1001-1004&amp;pmid=30810271&amp;doi=10.1111/1759-7714.13009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0340">
<span class="label">340.</span><cite>
Schuller H. M., “Regulatory Role of G Protein‐coupled Receptors in Pancreatic Cancer Development and Progression,” Current Medicinal Chemistry
25, no. 22 (2018): 2566–2575.
</cite> [<a href="https://doi.org/10.2174/0929867324666170303121708" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28260499/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Current%20Medicinal%20Chemistry&amp;title=Regulatory%20Role%20of%20G%20Protein%E2%80%90coupled%20Receptors%20in%20Pancreatic%20Cancer%20Development%20and%20Progression&amp;author=H.%20M.%20Schuller&amp;volume=25&amp;issue=22&amp;publication_year=2018&amp;pages=2566-2575&amp;pmid=28260499&amp;doi=10.2174/0929867324666170303121708&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0341">
<span class="label">341.</span><cite>
Kanbara K., Otsuki Y., Watanabe M., et al., “GABA(B) Receptor Regulates Proliferation in the High‐grade Chondrosarcoma Cell Line OUMS‐27 via Apoptotic Pathways,” BMC cancer
18, no. 1 (2018): 263.
</cite> [<a href="https://doi.org/10.1186/s12885-018-4149-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5842535/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29514603/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20cancer&amp;title=GABA(B)%20Receptor%20Regulates%20Proliferation%20in%20the%20High%E2%80%90grade%20Chondrosarcoma%20Cell%20Line%20OUMS%E2%80%9027%20via%20Apoptotic%20Pathways&amp;author=K.%20Kanbara&amp;author=Y.%20Otsuki&amp;author=M.%20Watanabe&amp;volume=18&amp;issue=1&amp;publication_year=2018&amp;pages=263&amp;pmid=29514603&amp;doi=10.1186/s12885-018-4149-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0342">
<span class="label">342.</span><cite>
Gao J., Lin S., Gao Y., et al., “Pinocembrin Inhibits the Proliferation and Migration and Promotes the Apoptosis of Ovarian Cancer Cells Through Down‐regulating the mRNA Levels of N‐cadherin and GABAB Receptor,” Biomedicine &amp; Pharmacotherapy
120 (2019): 109505.
</cite> [<a href="https://doi.org/10.1016/j.biopha.2019.109505" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31634778/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomedicine%20&amp;%20Pharmacotherapy&amp;title=Pinocembrin%20Inhibits%20the%20Proliferation%20and%20Migration%20and%20Promotes%20the%20Apoptosis%20of%20Ovarian%20Cancer%20Cells%20Through%20Down%E2%80%90regulating%20the%20mRNA%20Levels%20of%20N%E2%80%90cadherin%20and%20GABAB%20Receptor&amp;author=J.%20Gao&amp;author=S.%20Lin&amp;author=Y.%20Gao&amp;volume=120&amp;publication_year=2019&amp;pages=109505&amp;pmid=31634778&amp;doi=10.1016/j.biopha.2019.109505&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0343">
<span class="label">343.</span><cite>
Wu J. X., Shan F. X., Zheng J. N., and Pei D. S., “β‐arrestin Promotes c‐Jun N‐terminal Kinase Mediated Apoptosis via a GABA(B)R·β‐arrestin·JNK Signaling Module,” Asian Pacific Journal of Cancer Prevention
15, no. 2 (2014): 1041–1046.
</cite> [<a href="https://doi.org/10.7314/apjcp.2014.15.2.1041" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24568448/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Asian%20Pacific%20Journal%20of%20Cancer%20Prevention&amp;title=%CE%B2%E2%80%90arrestin%20Promotes%20c%E2%80%90Jun%20N%E2%80%90terminal%20Kinase%20Mediated%20Apoptosis%20via%20a%20GABA(B)R%C2%B7%CE%B2%E2%80%90arrestin%C2%B7JNK%20Signaling%20Module&amp;author=J.%20X.%20Wu&amp;author=F.%20X.%20Shan&amp;author=J.%20N.%20Zheng&amp;author=D.%20S.%20Pei&amp;volume=15&amp;issue=2&amp;publication_year=2014&amp;pages=1041-1046&amp;pmid=24568448&amp;doi=10.7314/apjcp.2014.15.2.1041&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0344">
<span class="label">344.</span><cite>
An J., Seok H., and Ha E. M., “GABA‐producing Lactobacillus Plantarum Inhibits Metastatic Properties and Induces Apoptosis of 5‐FU‐resistant Colorectal Cancer Cells via GABA(B) Receptor Signaling,” Journal of Microbiology (Seoul, Korea)
59, no. 2 (2021): 202–216.
</cite> [<a href="https://doi.org/10.1007/s12275-021-0562-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33527319/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Microbiology%20(Seoul,%20Korea)&amp;title=GABA%E2%80%90producing%20Lactobacillus%20Plantarum%20Inhibits%20Metastatic%20Properties%20and%20Induces%20Apoptosis%20of%205%E2%80%90FU%E2%80%90resistant%20Colorectal%20Cancer%20Cells%20via%20GABA(B)%20Receptor%20Signaling&amp;author=J.%20An&amp;author=H.%20Seok&amp;author=E.%20M.%20Ha&amp;volume=59&amp;issue=2&amp;publication_year=2021&amp;pages=202-216&amp;pmid=33527319&amp;doi=10.1007/s12275-021-0562-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0345">
<span class="label">345.</span><cite>
Tian H., Wu J. X., Shan F. X., et al., “Gamma‐aminobutyric Acid Induces Tumor Cells Apoptosis via GABABR1·β‐arrestins·JNKs Signaling Module,” Cell Biochemistry and Biophysics
71, no. 2 (2015): 679–688.
</cite> [<a href="https://doi.org/10.1007/s12013-014-0247-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25234615/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Biochemistry%20and%20Biophysics&amp;title=Gamma%E2%80%90aminobutyric%20Acid%20Induces%20Tumor%20Cells%20Apoptosis%20via%20GABABR1%C2%B7%CE%B2%E2%80%90arrestins%C2%B7JNKs%20Signaling%20Module&amp;author=H.%20Tian&amp;author=J.%20X.%20Wu&amp;author=F.%20X.%20Shan&amp;volume=71&amp;issue=2&amp;publication_year=2015&amp;pages=679-688&amp;pmid=25234615&amp;doi=10.1007/s12013-014-0247-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0346">
<span class="label">346.</span><cite>
Agarwal S. K., Kriel R. L., Cloyd J. C., et al., “A Pilot Study Assessing Pharmacokinetics and Tolerability of Oral and Intravenous Baclofen in Healthy Adult Volunteers,” Journal of Child Neurology
30, no. 1 (2015): 37–41.
</cite> [<a href="https://doi.org/10.1177/0883073814535504" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25028414/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Child%20Neurology&amp;title=A%20Pilot%20Study%20Assessing%20Pharmacokinetics%20and%20Tolerability%20of%20Oral%20and%20Intravenous%20Baclofen%20in%20Healthy%20Adult%20Volunteers&amp;author=S.%20K.%20Agarwal&amp;author=R.%20L.%20Kriel&amp;author=J.%20C.%20Cloyd&amp;volume=30&amp;issue=1&amp;publication_year=2015&amp;pages=37-41&amp;pmid=25028414&amp;doi=10.1177/0883073814535504&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0347">
<span class="label">347.</span><cite>
Aisen M. L., Dietz M. A., Rossi P., Cedarbaum J. M., and Kutt H., “Clinical and Pharmacokinetic Aspects of High Dose Oral baclofen Therapy,” Journal of the American Paraplegia Society
15, no. 4 (1992): 211–216.
</cite> [<a href="https://doi.org/10.1080/01952307.1992.11761520" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1431867/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20the%20American%20Paraplegia%20Society&amp;title=Clinical%20and%20Pharmacokinetic%20Aspects%20of%20High%20Dose%20Oral%20baclofen%20Therapy&amp;author=M.%20L.%20Aisen&amp;author=M.%20A.%20Dietz&amp;author=P.%20Rossi&amp;author=J.%20M.%20Cedarbaum&amp;author=H.%20Kutt&amp;volume=15&amp;issue=4&amp;publication_year=1992&amp;pages=211-216&amp;pmid=1431867&amp;doi=10.1080/01952307.1992.11761520&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0348">
<span class="label">348.</span><cite>
Schep L. J., Knudsen K., Slaughter R. J., Vale J. A., and Mégarbane B., “The Clinical Toxicology of γ‐hydroxybutyrate, γ‐butyrolactone and 1,4‐butanediol,” Clin Toxicol (Phila)
50, no. 6 (2012): 458–470.
</cite> [<a href="https://doi.org/10.3109/15563650.2012.702218" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22746383/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Toxicol%20(Phila)&amp;title=The%20Clinical%20Toxicology%20of%20%CE%B3%E2%80%90hydroxybutyrate,%20%CE%B3%E2%80%90butyrolactone%20and%201,4%E2%80%90butanediol&amp;author=L.%20J.%20Schep&amp;author=K.%20Knudsen&amp;author=R.%20J.%20Slaughter&amp;author=J.%20A.%20Vale&amp;author=B.%20M%C3%A9garbane&amp;volume=50&amp;issue=6&amp;publication_year=2012&amp;pages=458-470&amp;pmid=22746383&amp;doi=10.3109/15563650.2012.702218&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0349">
<span class="label">349.</span><cite>
Leggio L., “Understanding and Treating Alcohol Craving and Dependence: Recent Pharmacological and Neuroendocrinological Findings,” Alcohol and Alcoholism
44, no. 4 (2009): 341–352.
</cite> [<a href="https://doi.org/10.1093/alcalc/agp026" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19451661/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Alcohol%20and%20Alcoholism&amp;title=Understanding%20and%20Treating%20Alcohol%20Craving%20and%20Dependence:%20Recent%20Pharmacological%20and%20Neuroendocrinological%20Findings&amp;author=L.%20Leggio&amp;volume=44&amp;issue=4&amp;publication_year=2009&amp;pages=341-352&amp;pmid=19451661&amp;doi=10.1093/alcalc/agp026&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0350">
<span class="label">350.</span><cite>
Brunet M., Léger M., Billat P. A., et al., “Baclofen Self‐poisoning: Is Renal Replacement Therapy Efficient in Patient With Normal Kidney Function?,” Anaesth Crit Care Pain Med
39, no. 6 (2020): 813–817.
</cite> [<a href="https://doi.org/10.1016/j.accpm.2020.07.021" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33068797/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Anaesth%20Crit%20Care%20Pain%20Med&amp;title=Baclofen%20Self%E2%80%90poisoning:%20Is%20Renal%20Replacement%20Therapy%20Efficient%20in%20Patient%20With%20Normal%20Kidney%20Function?&amp;author=M.%20Brunet&amp;author=M.%20L%C3%A9ger&amp;author=P.%20A.%20Billat&amp;volume=39&amp;issue=6&amp;publication_year=2020&amp;pages=813-817&amp;pmid=33068797&amp;doi=10.1016/j.accpm.2020.07.021&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0351">
<span class="label">351.</span><cite>
Simon N., Franchitto N., and Rolland B., “Pharmacokinetic Studies of Baclofen Are Not Sufficient to Establish an Optimized Dosage for Management of Alcohol Disorder,” Front Psychiatry
9 (2018): 485.
</cite> [<a href="https://doi.org/10.3389/fpsyt.2018.00485" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6186984/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30349489/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Psychiatry&amp;title=Pharmacokinetic%20Studies%20of%20Baclofen%20Are%20Not%20Sufficient%20to%20Establish%20an%20Optimized%20Dosage%20for%20Management%20of%20Alcohol%20Disorder&amp;author=N.%20Simon&amp;author=N.%20Franchitto&amp;author=B.%20Rolland&amp;volume=9&amp;publication_year=2018&amp;pages=485&amp;pmid=30349489&amp;doi=10.3389/fpsyt.2018.00485&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0352">
<span class="label">352.</span><cite>
Wolf E., Kothari N. R., Roberts J. K., and Sparks M. A., “Baclofen Toxicity in Kidney Disease,” American Journal of Kidney Diseases
71, no. 2 (2018): 275–280.
</cite> [<a href="https://doi.org/10.1053/j.ajkd.2017.07.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28899601/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Kidney%20Diseases&amp;title=Baclofen%20Toxicity%20in%20Kidney%20Disease&amp;author=E.%20Wolf&amp;author=N.%20R.%20Kothari&amp;author=J.%20K.%20Roberts&amp;author=M.%20A.%20Sparks&amp;volume=71&amp;issue=2&amp;publication_year=2018&amp;pages=275-280&amp;pmid=28899601&amp;doi=10.1053/j.ajkd.2017.07.005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0353">
<span class="label">353.</span><cite>
Wuis E. W., Dirks M. J., Termond E. F., Vree T. B., and Van der Kleijn E., “Plasma and Urinary Excretion Kinetics of Oral Baclofen in Healthy Subjects,” European Journal of Clinical Pharmacology
37, no. 2 (1989): 181–184.
</cite> [<a href="https://doi.org/10.1007/BF00558228" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/2792173/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Journal%20of%20Clinical%20Pharmacology&amp;title=Plasma%20and%20Urinary%20Excretion%20Kinetics%20of%20Oral%20Baclofen%20in%20Healthy%20Subjects&amp;author=E.%20W.%20Wuis&amp;author=M.%20J.%20Dirks&amp;author=E.%20F.%20Termond&amp;author=T.%20B.%20Vree&amp;author=E.%20Van%20der%20Kleijn&amp;volume=37&amp;issue=2&amp;publication_year=1989&amp;pages=181-184&amp;pmid=2792173&amp;doi=10.1007/BF00558228&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0354">
<span class="label">354.</span><cite>
Chartier M., Tannous S., Benturquia N., et al., “Baclofen‐Induced Neuro‐Respiratory Toxicity in the Rat: Contribution of Tolerance and Characterization of Withdrawal Syndrome,” Toxicological Sciences
164, no. 1 (2018): 153–165.
</cite> [<a href="https://doi.org/10.1093/toxsci/kfy073" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29945230/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Toxicological%20Sciences&amp;title=Baclofen%E2%80%90Induced%20Neuro%E2%80%90Respiratory%20Toxicity%20in%20the%20Rat:%20Contribution%20of%20Tolerance%20and%20Characterization%20of%20Withdrawal%20Syndrome&amp;author=M.%20Chartier&amp;author=S.%20Tannous&amp;author=N.%20Benturquia&amp;volume=164&amp;issue=1&amp;publication_year=2018&amp;pages=153-165&amp;pmid=29945230&amp;doi=10.1093/toxsci/kfy073&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0355">
<span class="label">355.</span><cite>
Dahlin P. A. and George J., “Baclofen Toxicity Associated With Declining Renal Clearance After ibuprofen,” Drug Intelligence &amp; Clinical Pharmacy
18, no. 10 (1984): 805–808.
</cite> [<a href="https://doi.org/10.1177/106002808401801006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/6489161/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drug%20Intelligence%20&amp;%20Clinical%20Pharmacy&amp;title=Baclofen%20Toxicity%20Associated%20With%20Declining%20Renal%20Clearance%20After%20ibuprofen&amp;author=P.%20A.%20Dahlin&amp;author=J.%20George&amp;volume=18&amp;issue=10&amp;publication_year=1984&amp;pages=805-808&amp;pmid=6489161&amp;doi=10.1177/106002808401801006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0356">
<span class="label">356.</span><cite>
Wuis E. W., Dirks M. J., Termond E. F., Vree T. B., and Van der Kleijn E., “Comparison of the Pharmacokinetics of Intravenously Administered Rac‐baclofen and Its (‐)‐(R)‐ and (+)‐(S)‐enantiomers in Dogs,” International Journal of Clinical Pharmacology Research
9, no. 4 (1989): 239–246.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/2777427/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Journal%20of%20Clinical%20Pharmacology%20Research&amp;title=Comparison%20of%20the%20Pharmacokinetics%20of%20Intravenously%20Administered%20Rac%E2%80%90baclofen%20and%20Its%20(%E2%80%90)%E2%80%90(R)%E2%80%90%20and%20(+)%E2%80%90(S)%E2%80%90enantiomers%20in%20Dogs&amp;author=E.%20W.%20Wuis&amp;author=M.%20J.%20Dirks&amp;author=E.%20F.%20Termond&amp;author=T.%20B.%20Vree&amp;author=E.%20Van%20der%20Kleijn&amp;volume=9&amp;issue=4&amp;publication_year=1989&amp;pages=239-246&amp;pmid=2777427&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0357">
<span class="label">357.</span><cite>
Balla A., Nattini M. E., Sershen H., Lajtha A., Dunlop D. S., and Javitt D. C., “GABAB/NMDA Receptor Interaction in the Regulation of Extracellular Dopamine Levels in Rodent Prefrontal Cortex and Striatum,” Neuropharmacology
56, no. 5 (2009): 915–921.
</cite> [<a href="https://doi.org/10.1016/j.neuropharm.2009.01.021" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4681299/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19371582/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuropharmacology&amp;title=GABAB/NMDA%20Receptor%20Interaction%20in%20the%20Regulation%20of%20Extracellular%20Dopamine%20Levels%20in%20Rodent%20Prefrontal%20Cortex%20and%20Striatum&amp;author=A.%20Balla&amp;author=M.%20E.%20Nattini&amp;author=H.%20Sershen&amp;author=A.%20Lajtha&amp;author=D.%20S.%20Dunlop&amp;volume=56&amp;issue=5&amp;publication_year=2009&amp;pages=915-921&amp;pmid=19371582&amp;doi=10.1016/j.neuropharm.2009.01.021&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0358">
<span class="label">358.</span><cite>
Ebenezer I. S., “Effects of Intraperitoneal Administration of the GABAB Receptor Positive Allosteric Modulator 2,6‐di Tert‐butyl‐4‐(2‐hydroxy‐2,2‐dimethyl‐propyl)‐phenol (CGP7930) on Food Intake in Non‐deprived Rats,” European Journal of Pharmacology
690, no. 1‐3 (2012): 115–118.
</cite> [<a href="https://doi.org/10.1016/j.ejphar.2012.05.021" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22652431/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Journal%20of%20Pharmacology&amp;title=Effects%20of%20Intraperitoneal%20Administration%20of%20the%20GABAB%20Receptor%20Positive%20Allosteric%20Modulator%202,6%E2%80%90di%20Tert%E2%80%90butyl%E2%80%904%E2%80%90(2%E2%80%90hydroxy%E2%80%902,2%E2%80%90dimethyl%E2%80%90propyl)%E2%80%90phenol%20(CGP7930)%20on%20Food%20Intake%20in%20Non%E2%80%90deprived%20Rats&amp;author=I.%20S.%20Ebenezer&amp;volume=690&amp;issue=1%E2%80%903&amp;publication_year=2012&amp;pages=115-118&amp;pmid=22652431&amp;doi=10.1016/j.ejphar.2012.05.021&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0359">
<span class="label">359.</span><cite>
Orrù A., Fujani D., Cassina C., Conti M., Di Clemente A., and Cervo L., “Operant, Oral Alcoholic Beer Self‐administration by C57BL/6J Mice: Effect of BHF177, a Positive Allosteric Modulator of GABA(B) Receptors,” Psychopharmacology
222, no. 4 (2012): 685–700.
</cite> [<a href="https://doi.org/10.1007/s00213-012-2672-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22411427/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Psychopharmacology&amp;title=Operant,%20Oral%20Alcoholic%20Beer%20Self%E2%80%90administration%20by%20C57BL/6J%20Mice:%20Effect%20of%20BHF177,%20a%20Positive%20Allosteric%20Modulator%20of%20GABA(B)%20Receptors&amp;author=A.%20Orr%C3%B9&amp;author=D.%20Fujani&amp;author=C.%20Cassina&amp;author=M.%20Conti&amp;author=A.%20Di%20Clemente&amp;volume=222&amp;issue=4&amp;publication_year=2012&amp;pages=685-700&amp;pmid=22411427&amp;doi=10.1007/s00213-012-2672-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0360">
<span class="label">360.</span><cite>
González‐Coloma A., Valencia F., Martín N., et al., “Silphinene Sesquiterpenes as Model Insect Antifeedants,” Journal of Chemical Ecology
28, no. 1 (2002): 117–129.
</cite> [<a href="https://doi.org/10.1023/a:1013566919874" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11868669/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Chemical%20Ecology&amp;title=Silphinene%20Sesquiterpenes%20as%20Model%20Insect%20Antifeedants&amp;author=A.%20Gonz%C3%A1lez%E2%80%90Coloma&amp;author=F.%20Valencia&amp;author=N.%20Mart%C3%ADn&amp;volume=28&amp;issue=1&amp;publication_year=2002&amp;pages=117-129&amp;pmid=11868669&amp;doi=10.1023/a:1013566919874&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0361">
<span class="label">361.</span><cite>
Maccioni P., Zaru A., Loi B., et al., “Comparison of the Effect of the GABAΒ Receptor Agonist, Baclofen, and the Positive Allosteric Modulator of the GABAB Receptor, GS39783, on Alcohol Self‐administration in 3 Different Lines of Alcohol‐preferring Rats,” Alcoholism Clinical &amp; Experimental Research
36, no. 10 (2012): 1748–1766.
</cite> [<a href="https://doi.org/10.1111/j.1530-0277.2012.01782.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3396797/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22486245/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Alcoholism%20Clinical%20&amp;%20Experimental%20Research&amp;title=Comparison%20of%20the%20Effect%20of%20the%20GABA%CE%92%20Receptor%20Agonist,%20Baclofen,%20and%20the%20Positive%20Allosteric%20Modulator%20of%20the%20GABAB%20Receptor,%20GS39783,%20on%20Alcohol%20Self%E2%80%90administration%20in%203%20Different%20Lines%20of%20Alcohol%E2%80%90preferring%20Rats&amp;author=P.%20Maccioni&amp;author=A.%20Zaru&amp;author=B.%20Loi&amp;volume=36&amp;issue=10&amp;publication_year=2012&amp;pages=1748-1766&amp;pmid=22486245&amp;doi=10.1111/j.1530-0277.2012.01782.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0362">
<span class="label">362.</span><cite>
Li X., Terunuma M., Deeb T. G., Wiseman S., and Slesinger P. A., “Direct Interaction of PP2A Phosphatase With GABAB Receptors Alters Functional Signaling,” The Journal of Neuroscience
40, no. 14 (2020): 2808–2816.
</cite> [<a href="https://doi.org/10.1523/JNEUROSCI.2654-19.2020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7117905/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32111696/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=The%20Journal%20of%20Neuroscience&amp;title=Direct%20Interaction%20of%20PP2A%20Phosphatase%20With%20GABAB%20Receptors%20Alters%20Functional%20Signaling&amp;author=X.%20Li&amp;author=M.%20Terunuma&amp;author=T.%20G.%20Deeb&amp;author=S.%20Wiseman&amp;author=P.%20A.%20Slesinger&amp;volume=40&amp;issue=14&amp;publication_year=2020&amp;pages=2808-2816&amp;pmid=32111696&amp;doi=10.1523/JNEUROSCI.2654-19.2020&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0363">
<span class="label">363.</span><cite>
Hearing M., Kotecki L., Marron Fernandez de Velasco E., et al., “Repeated Cocaine Weakens GABA(B)‐Girk Signaling in Layer 5/6 Pyramidal Neurons in the Prelimbic Cortex,” Neuron
80, no. 1 (2013): 159–170.
</cite> [<a href="https://doi.org/10.1016/j.neuron.2013.07.019" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3793643/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24094109/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuron&amp;title=Repeated%20Cocaine%20Weakens%20GABA(B)%E2%80%90Girk%20Signaling%20in%20Layer%205/6%20Pyramidal%20Neurons%20in%20the%20Prelimbic%20Cortex&amp;author=M.%20Hearing&amp;author=L.%20Kotecki&amp;author=E.%20Marron%20Fernandez%20de%20Velasco&amp;volume=80&amp;issue=1&amp;publication_year=2013&amp;pages=159-170&amp;pmid=24094109&amp;doi=10.1016/j.neuron.2013.07.019&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0364">
<span class="label">364.</span><cite>
Dalmau J., Geis C., and Graus F., “Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous System,” Physiological Reviews
97, no. 2 (2017): 839–887.
</cite> [<a href="https://doi.org/10.1152/physrev.00010.2016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5539405/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28298428/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Physiological%20Reviews&amp;title=Autoantibodies%20to%20Synaptic%20Receptors%20and%20Neuronal%20Cell%20Surface%20Proteins%20in%20Autoimmune%20Diseases%20of%20the%20Central%20Nervous%20System&amp;author=J.%20Dalmau&amp;author=C.%20Geis&amp;author=F.%20Graus&amp;volume=97&amp;issue=2&amp;publication_year=2017&amp;pages=839-887&amp;pmid=28298428&amp;doi=10.1152/physrev.00010.2016&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0365">
<span class="label">365.</span><cite>
Kuramoto N., Wilkins M. E., Fairfax B. P., et al., “Phospho‐Dependent Functional Modulation of GABAB Receptors by the Metabolic Sensor AMP‐Dependent Protein Kinase,” Neuron
53, no. 2 (2007): 233–247.
</cite> [<a href="https://doi.org/10.1016/j.neuron.2006.12.015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2570046/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17224405/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuron&amp;title=Phospho%E2%80%90Dependent%20Functional%20Modulation%20of%20GABAB%20Receptors%20by%20the%20Metabolic%20Sensor%20AMP%E2%80%90Dependent%20Protein%20Kinase&amp;author=N.%20Kuramoto&amp;author=M.%20E.%20Wilkins&amp;author=B.%20P.%20Fairfax&amp;volume=53&amp;issue=2&amp;publication_year=2007&amp;pages=233-247&amp;pmid=17224405&amp;doi=10.1016/j.neuron.2006.12.015&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0366">
<span class="label">366.</span><cite>
Guetg N., Abdel Aziz S., Holbro N., et al., “NMDA Receptor‐dependent GABAB Receptor Internalization via CaMKII Phosphorylation of Serine 867 in GABAB1,” PNAS
107, no. 31 (2010): 13924–13929.
</cite> [<a href="https://doi.org/10.1073/pnas.1000909107" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2922270/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20643921/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PNAS&amp;title=NMDA%20Receptor%E2%80%90dependent%20GABAB%20Receptor%20Internalization%20via%20CaMKII%20Phosphorylation%20of%20Serine%20867%20in%20GABAB1&amp;author=N.%20Guetg&amp;author=S.%20Abdel%20Aziz&amp;author=N.%20Holbro&amp;volume=107&amp;issue=31&amp;publication_year=2010&amp;pages=13924-13929&amp;pmid=20643921&amp;doi=10.1073/pnas.1000909107&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0367">
<span class="label">367.</span><cite>
Miller L. G., Kastin A. J., Roy R. B., Gaver A., Fischman A. J., and Horvath A., “Structural Specificity of MIF‐1 and Tyr‐MIF‐1 in Augmenting GABA‐stimulated Benzodiazepine Receptor Binding,” Research Communications in Chemical Pathology and Pharmacology
62, no. 2 (1988): 365–368.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/2908009/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Research%20Communications%20in%20Chemical%20Pathology%20and%20Pharmacology&amp;title=Structural%20Specificity%20of%20MIF%E2%80%901%20and%20Tyr%E2%80%90MIF%E2%80%901%20in%20Augmenting%20GABA%E2%80%90stimulated%20Benzodiazepine%20Receptor%20Binding&amp;author=L.%20G.%20Miller&amp;author=A.%20J.%20Kastin&amp;author=R.%20B.%20Roy&amp;author=A.%20Gaver&amp;author=A.%20J.%20Fischman&amp;volume=62&amp;issue=2&amp;publication_year=1988&amp;pages=365-368&amp;pmid=2908009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0368">
<span class="label">368.</span><cite>
Chen J., Liang L., Ning H., et al., “Cloning, Synthesis and Functional Characterization of a Novel α‐Conotoxin Lt1.3,” Marine Drugs
16, no. 4 (2018).</cite> [<a href="https://doi.org/10.3390/md16040112" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5923399/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29614714/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Marine%20Drugs&amp;title=Cloning,%20Synthesis%20and%20Functional%20Characterization%20of%20a%20Novel%20%CE%B1%E2%80%90Conotoxin%20Lt1.3&amp;author=J.%20Chen&amp;author=L.%20Liang&amp;author=H.%20Ning&amp;volume=16&amp;issue=4&amp;publication_year=2018&amp;pmid=29614714&amp;doi=10.3390/md16040112&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0369">
<span class="label">369.</span><cite>
Zhang W., Xu C., Tu H., et al., “GABAB Receptor Upregulates Fragile X Mental Retardation Protein Expression in Neurons,” Scientific Reports
5 (2015): 10468.
</cite> [<a href="https://doi.org/10.1038/srep10468" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4447080/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26020477/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Scientific%20Reports&amp;title=GABAB%20Receptor%20Upregulates%20Fragile%20X%20Mental%20Retardation%20Protein%20Expression%20in%20Neurons&amp;author=W.%20Zhang&amp;author=C.%20Xu&amp;author=H.%20Tu&amp;volume=5&amp;publication_year=2015&amp;pages=10468&amp;pmid=26020477&amp;doi=10.1038/srep10468&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="mco270163-bib-0370">
<span class="label">370.</span><cite>
Zhao J., Meyerkord C. L., Du Y., Khuri F. R., and Fu H., “14‐3‐3 proteins as Potential Therapeutic Targets,” Seminars in Cell &amp; Developmental Biology
22, no. 7 (2011): 705–712.
</cite> [<a href="https://doi.org/10.1016/j.semcdb.2011.09.012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3207012/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21983031/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Seminars%20in%20Cell%20&amp;%20Developmental%20Biology&amp;title=14%E2%80%903%E2%80%903%20proteins%20as%20Potential%20Therapeutic%20Targets&amp;author=J.%20Zhao&amp;author=C.%20L.%20Meyerkord&amp;author=Y.%20Du&amp;author=F.%20R.%20Khuri&amp;author=H.%20Fu&amp;volume=22&amp;issue=7&amp;publication_year=2011&amp;pages=705-712&amp;pmid=21983031&amp;doi=10.1016/j.semcdb.2011.09.012&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The authors have nothing to report.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from MedComm are provided here courtesy of <strong>Wiley</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1002/mco2.70163"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/MCO2-6-e70163.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (2.1 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12000685/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12000685/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12000685%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12000685/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12000685/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12000685/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40242161/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12000685/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40242161/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12000685/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12000685/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="sN7PtFAm04uyRalc43fV6u3i4D7yFxYpOSD0H3HC0unsJNXthJstW4TAmJD8jl0V">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Web Policies

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    FOIA

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS Vulnerability Disclosure

    
</a>

                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Help

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Accessibility

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Careers

    
</a>

                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NLM

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NIH

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    USA.gov

    
</a>

                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-370d5dd6.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-917ba005.js"></script>
    
    

    </body>
</html>
